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 Synopsis  
Orthopaedic applications commonly involve the use of polymethylmethacrylate (PMMA)-
based cements in an attempt to repair fractures, stabilise metallic prosthesis or fill gaps in bone 
tissue as a result of trauma. These PMMA cements, however, are encased in a fibrous capsule, 
in the organism, which often leads to de-bonding of the cement from the adjacent bone, 
requiring further surgeries and patient discomfort. Alternative materials have been tested 
including calcium phosphate cements and bioceramics in an attempt to provide a more suitable 
material for bone repair compared with PMMA-based cements; however, the cement that may 
successfully repair and lead to regeneration of bone tissue has still to be developed. This work 
used a PMMA-based cement as a starting point to develop a cement based on dimethacrylate 
resins with enhanced physical (degree of conversion) and mechanical characteristics (flexural 
strength and flexural modulus) that integrated with surrounding bone without the formation of 
the fibrous scar at its interface with bone and soft tissues. This new dimethacrylate-based 
cement will contain different types of bioactive glasses, which may provide increased viability 
of bone cells, differentiation of mesenchymal stem cells to bone cells and direct bonding to 
bone (without the formation of a fibrous capsule) .  
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CHAPTER 1 DEVELOPMENT OF LIGHT CURABLE DIMETHACRYLATE RESIN 
SYSTEMS FOR ORTHOPAEDIC APPLICATIONS 
1.1 Development of materials for orthopaedic applications: a historical background 
Orthopaedic applications may involve the use of autografts, allografts and artificial implants 
(polymeric or metallic) to repair bone defects and restore function. The use of autografts and 
allografts despite their limited supply, immune rejection, possibility of transmission of diseases, 
donor-site morbidity, donor-site pain and increased costs are still the treatment of choice in 
orthopaedic applications, requiring the use of transplanted bone to restore function or cover 
defects as a result of trauma (Kanczler and Oreffo 2008; Vakiparta et al 2005; Wang et al. 
2010). Perhaps the most widely used artificial implants in orthopaedic surgeries are metallic 
devices such as titanium alloys employed in hip, knee and dental prosthesis. However, new 
materials are required for the repair of structures that contain complex shapes such as those in 
feet, hand, ear and spinal tissues (Schneider et al. 2010). For an implant to be considered a 
suitable alternative to these treatment options, it should be able to restore function and integrity 
in load bearing applications in the long term (Liu et al. 2011; Schneider et al. 2010), be firm 
enough to limit stress shielding in the adjacent bone (Zou et al. 2009) and exhibit a similar 
elastic modulus to that of bone to provide increased resilience (Lin et al. 2005). Consequently, 
with an ever increasing demand for bone replacement therapies, there is a need for the 
development of artificial materials capable of repairing and restoring function in bone defects 
and also to treat specific orthopaedic problems. Materials which may have a benefit for these 
latter applications include bio-resorbable polymers (polylactides, polyglycolide) and bioactive 
ceramics (hydroxyapatite, tricalcium phosphate, bioactive glasses). The application of bioactive 
materials provides the possibility of integrating the artificial material in the living tissue, leading 
2 
 
not only to attachment, growth, proliferation and differentiation of progenitor cells, but also 
enabling a strong bond of the bioactive material to the bone (Pamula et al. 2011). 
1.2 Development of cement materials for orthopaedic applications and their impact on 
bone tissue 
Bone can be classified according to its structure in cortical (compact) and trabecular bone 
(cancellous, spongy). Cortical bone, with a porosity of 5-10%, is found in the shaft of long 
bones and has a compressive strength of 120-150MPa with an elastic modulus of 10-20GPa 
(An, 2000; Ling et al. 2009; Rahaman et al. 2011; Rho et al. 1995). Trabecular bone, on the 
other hand, has a compressive strength of 2-12MPa and an elastic modulus of 0.1-5GPa; both 
values being considerably lower than those of cortical bone (An, 2000; Ling et al. 2009; 
Rahaman et al. 2011; Rho et al. 1995). The human femoral bone exhibits an ultimate 
compressive strength of 205MPa (Schneider et al. 2010). For a material to be successful in 
repairing and restoring function in orthopaedic applications, it has to closely match the 
mechanical properties (flexural strength and modulus) of bone to provide increased resilience 
and limit stress shielding in the adjacent bone. 
In an era of titanium osseointegration and guided tissue regeneration, materials had to be 
developed to provide mechanical stability to the titanium prosthesis and to ensure screw 
purchase in osteoporotic bone, materials such as PMMA (Poly-methyl methacrylate), calcium 
phosphates and hydroxyapatite-based cements. These materials were also developed as a 
response to the need for a material to be used as a bone void filler for bone reconstruction in 
trauma or in congenital malformations. However, these materials have several shortcomings 
including: formation of a fibrous capsule sourrounding the implant in case of the PMMA 
cement, which negatively interferes with the bone repair and regeneration; brittleness and fast 
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resorbtion rates in the case of the calcium phosphates and hydroxyapatite-based cements which 
fail to provide mechanical support for enough time to allow the sorrounding bone to repair and 
regenerate the site of injury. A cement may be developed, which is able to provide mechanical 
support for bone regeneration and repair to occur (through for example a resin based 
component), while providing a suitable environment (free of inflamation) for migration of 
osteogenic stem cells to the site of injury and their proliferation and differentiation to 
osteoblasts (through for example the use of bioactive glass able to form a hydroxyapatite layer 
on the surface of the material). Such a cement may be used alongside existing cement 
formulations, depending on the type of surgery or reconstruction required: for example it may 
provide a better alternative for surgeries involving non-union fractures due to its strong bonding 
to bone, without the formation of a fibrous capsule.  
1.2.1 Poly-methyl methacrylate (PMMA) cement 
Acrylic bone cements such as PMMA have in their composition a liquid methyl methacrylate 
monomer and a pre-polymerised polymethyl methacrylate powder (Aita et al. 2010; Deb et al. 
2005). PMMA bone cements were first developed by Charnley to help immobilise prosthesis 
(Charnley, 1960). It has become one of the most commonly employed alloplastic materials in 
orthopaedic surgery, and it is used in the repair of skull defects and spinal injuries, amongst 
other applications (Chang et al. 2010; Deb et al. 2005). Commercially available cements based 
on PMMA include: Cobalt (Biomet, Inc.), Simplex (Stryker, Inc.) and Palacos (Heraeus 
Company). In orthopaedic surgery, PMMA’s main role is as an anchoring agent in cemented 
joint replacement of the hip and knee to transfer the service loads and stabilise the prosthesis 
(when pressed between the femoral stem and the bone) (Aita et al. 2010; Deb et al. 2005; Lewis, 
1997; Lewis et al. 1997; Peltola et al. 2012; Saito et al. 1994). Bone cementation is achieved 
through the injection of the fluid material (such as PMMA) into the bone defect leading to its 
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hardening within the target area, thus not only providing mechanical stability but also 
facilitating pain relief and increased mobility post-operatively (Chang et al. 2010). Other roles 
in orthopaedics include screw purchase in osteoporotic bone and stability of bone construct 
implant of metaphyseal fractures in osteoporotic patients (Larsson 2006). 
The advantages of using this type of cement include: a density similar to that of bone, decreased 
thermal conductivity (Peltola et al. 2012), cost efficiency and ease of manufacture (Pryor et al. 
2009). Disadvantages of using PMMA in orthopaedic applications relate to shrinkage (Lewis, 
1997; Lewis et al. 1997), brittleness, poor radiopacity and mechanical strength, an inability to 
be remodelled (Larsson 2006; Pryor et al. 2009), non-degradability (Chang et al. 2010) and 
stiffness (Pryor et al. 2009). PMMA is, moreover, a water-free hydrophobic compound, thus it 
can only be observed indirectly as a lack of signal on magnetic resonance imaging scan (which 
works by visualising free protons) (Wichlas et al. 2010).  The weak radiopacity makes it 
difficult to identify the cement mantle, the interface between the cement and bone and the 
interface between the implant and cement on either an X-ray or a magnetic resonance imaging 
scan (Lewis, 1997; Lewis et al. 1997; Pryor et al. 2009). This cement can be made radiopaque 
through the incorporation of BaSO4 or ZrO2 particles, which may, however, severely limit the 
mechanical properties of the PMMA cement (Pryor et al. 2009). The low mechanical properties 
and increased degradation of such cements containing BaSO4 or ZrO2 particles compared with 
PMMA cements are due to the phase separation of the cement compounds, between the high 
polar ionic radiopaque salt and the low polarity of the resin (Khaled et al. 2011).  
Other shortcomings of employing PMMA in orthopaedic applications include foreign-body 
reactions, significantly high polymerisation exotherm, poor osseo-integration (inability to 
chemically attach to bone and soft tissue), possibility of leaching out, risk of inhibiting the 
healing of fractures of extremities (when located between fracture surfaces), complexity in 
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removal if the patient has to undergo revision surgery and the lifelong possibility of infection 
or extrusion (Aita et al. 2010; Deb et al. 2005; Fukuda et al. 2011; Ha et al. 2011; Larsson 2006; 
Liu et al. 2010; Peltola et al. 2012; Pryor et al. 2009; Saito et al. 1994). Foreign body reactions 
occur due to cement particles interacting with the living tissue, which may lead to an 
inflammatory peri-prosthetic tissue response, resulting in bone destruction  (Lewis, 1997; Lewis 
et al. 1997). The high polymerisation exotherm (with a temperature increase of ≥45°C) may 
lead to denaturation of proteins and necrosis of cells when implanted in the human body 
(Baroud et al. 2004; Belkof and Molloy, 2003; Deramond et al. 1999; Luo et al. 2007; Uchiyama 
et al. 1989), also resulting in bone resorption. Poor osseo-integration may lead to the formation 
of a fibrous tissue at the interface between the cement and the bone, which may play a role in 
the aseptic loosening of the prosthesis together with interfacial, bone and cement failure (Chang 
et al. 2010; Fukuda et al. 2011; He et al. 2012; Lewis, 1997; Lewis et al. 1997; Saito et al. 
1994), which also leads to bone resorption. The leakage of unreacted methyl methacrylate 
monomer into surrounding tissue may lead to chemical necrosis and resorption of bone and to 
the compression and thermal necrosis of the host tissues in percutaneous vertebroplasty 
(employed to treat painful osteoporotic vertebral compression fractures and malignant bone 
tumours) (Anselmetti et al. 2009; Chang et al. 2010; Larsson 2006; Lewis, 1997; Lewis et al. 
1997). Due to its high exothermic reaction during polymerization (which can range between 
67-124°C, depending on the body site where used and amount of cement), PMMA has also 
been shown to cause thermal necrosis of bone and neural tissues, with the formation of a zone 
of adjacent necrosis (Anselmetti et al. 2009; Chang et al. 2010; Saito et al. 1994), restricted 
local blood flow, and formation of a fibrous tissue at the cement-bone interface ( Lewis, 1997; 
Lewis et al. 19977). In bone tissues thermal necrosis occurs when there is an increase in 
temperature (>50°C) lasting for more than one minute, such as that exhibited by PMMA during 
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polymerisation (which can range between 67-124°C, depending on the body site where used 
and amount of cement) (Anselmetti et al. 2009; Berman et al. 1984; Eriksson et al. 1984; Lewis, 
1997). Another disadvantage of PMMA cement is due to the mismatch in stiffness between the 
PMMA cement and the contiguous bone (Lewis, 1997; Lewis et al. 1997). Moreover, a recent 
study has shown a correlation between PMMA cement extract exposure and significantly 
decreased functionality of osteoblasts and a marked cell death (Aita et al. 2010).  
The mechanism through which PMMA bonds to bone is via mechanical interlocking, which 
requires an irregular, rough bone surface. However, as mentioned previously a fibrous tissue 
layer forms at the interface of the PMMA cement with the bone, which can result in loosening 
of the prosthesis. For this reason, methods have been developed to improve the reaction of the 
PMMA cement with the bone including: the addition of bio-ceramics such as glass and calcium 
phosphate compounds (hydroxyapatite and tricalcium phosphate) (He et al. 2012; Mousa et al. 
2000).  
Notably, when ceramics were incorporated into PMMA, the mechanical and handling 
characteristics of the final product were severely reduced. Conversely the incorporation of up 
to 20wt% hydroxyapatite to PMMA cement increased its mechanical properties (Mousa et al. 
2000). When bioactive components (which bond to bone through an apatite layer) were added 
to the PMMA cement, it led to increased bone resorption, which ultimately loosen the implant. 
This loosening of the implant may have been due to free cement particles and to the calcium 
phosphorous layer formation on the cement, which promoted bone resorption (He et al. 2012; 
Mousa et al. 2000). A further study, however, reported that, the incorporation of bioactive 
titania (>20wt%) into PMMA cement led to increased bonding to bone (Fukuda et al. 2011). 
By incorporating bioactive fillers into the PMMA cement, the heat released during 
polymerisation was also reduced, which may have led to better mechanical properties and 
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decreased shrinkage of the final product (Mousa et al. 2000). Table 1.1 presents a summary 
regarding how the cements to be developed based on dimethacrylate resins and bioactive glass  
filler can compete and improve the existing PMMA cements (Table 1.1). 
 
Table 1.1 The advantages and disadvantages of using PMMA in orthopaedic applications and 
how the cements to be developed can either compete (=) or improve (+) the PMMA cements.  
1.2.2 Calcium phosphate cements 
Alternative materials such as calcium phosphate cements (which produce hydroxyapatite or 
brushite (dicalcium phosphate dihydrate) (Figure 1.1 ) as the end product have been developed 
for fracture augmentation involving crushed cancellous bone or osteoporotic bone and offer 
improved biological, chemical and physical properties when compared with standard PMMA 
cements (Larsson 2006; Young et al. 2008). 
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Figure 1.1 The composition of calcium phosphate cements that forms either hydroxyapatite or 
brushite as the end product.  
The most important difference between the hydroxyapatite and brushite forming cements lies 
in the fact that the hydroxyapatite forming calcium phosphate cements are non-degradable 
(which prevents their complete replacement with bone tissue), whereas brushite forming ones 
are resorbable. Moreover, the brushite cements have rapid, water-consuming setting times and 
decreased mechanical strength compared with the hydroxyapatite cements (Hofmann et al. 
2009; Young et al. 2008). 
Commercially available calcium phosphate cements include BoneSource (chemically cured) 
which is used in facial skeleton augmentation (Pryor et al. 2009), Norian SRS which has similar 
characteristics to BoneSource and Alpha-BSM (ETEX Corp) (Larsson 2006). Calcium 
phosphate cements were first synthesised by Brown and Chow in the early eighties and 
compared with PMMA, were mouldable and osteo-conductive (Stadelmann et al. 2010; Wang 
et al. 2010). These calcium phosphate cements consist of two elements: a powder (a mixture of 
monocalcium phosphate, monohydrate, tricalcium phosphate and calcium carbonate) and a 
fluid (sodium phosphate solution). During surgery, these two elements are mixed to form an 
injectable paste which sets in a relatively short time-frame (approximately 15min) resulting in 
the production of a carbonated calcium-phosphate apatite (comparable to the mineral portion 
of bone) (Wang et al. 2010;  Zou et al. 2009) (Figure 1.1). This cement forms a strong bond 
with the adjacent bone; however, it exhibits decreased tensile and shear strength compared with 
cancellous bone. Nonetheless, its compressive strength is between that of cancellous and 
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cortical bone (Larsson 2006). These features made these cements a suitable alternative to 
PMMA cement since 1990s for the use as bone substitutes to repair defects of the facial skeleton 
and also to fill calvarial defects. Thus, their ability to be easily molded to fit the defect has made 
them a popular choice for craniofacial surgeries. Their porous three dimensional arrangement 
also makes these cements a suitable choice for bone tissue repair (Mori et al. 2011; Wang et al. 
2010). Furthermore, animal studies have also demonstrated their osteo-conductivity, 
angiogenic ability, osteoblast adhesion and proliferation and non-toxicity (Chang et al. 2010; 
Larsson 2006; Mori et al. 2011; Wang et al. 2010). 
Nonetheless, these cements also have limitations including low tensile strength (50-70MPa), 
Young’s modulus (35-120GPa), fracture toughness (0.5-1.5MN/m3/2) and brittle fracture, 
which severely hinder their use in orthopaedic surgeries, making them unsuitable for stress 
bearing applications (Harper 1998; Pryor et al. 2009; Wang et al. 2010). Other limitations of 
these cements are due to their relatively long setting time and inability to attain complete 
haemostasis, which may lead to cement washout upon contact with physiological fluids (Wang 
et al. 2010). Table 1.2 presents a summary regarding how the cements to be developed based 
on dimethacrylate resins and bioactive glass fillers can compete and improve the existing 
calcium phosphate cements (Table 1.2).  
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Table 2.2 The advantages and disadvantages of calcium phosphate cements for orthopaedic 
applications and how the cements to be developed can either compete (=) or improve (+) these 
cements. 
1.2.3 Bioactive glass 
A bioactive material (such as bioactive glass) was initially described by Hench et al. (1971) as 
one that “elicits a specific biological response at the interface of the material that results in the 
formation of a bond between the tissues and the material” (Hench et al. 1971; Hattar et al. 2002; 
Valimaki and Aro 2006). Bioactive glasses were formed as possible suitable replacements for 
existing orthopaedic materials to repair and regenerate the cells and tissues that make up the 
skeletal system (Silver et al. 2001).  Bioactive glasses such as 45S5 are part of bio-ceramics, a 
group of materials based on amorphous silicate elements that exhibit a reactive surface, 
bioactivity, osteo-conductivity and osteo-inductivity. Bioglass 45S5 forms part of a family of 
melt-derived, soda-lime-phosphosilicate glasses and was first developed by Hench in 1971 
(Hench et al. 1971). The chemical structure of 45S5 Bioglass consists of: 45% silica, 24.5% 
CaO, 24.5% Na2O and 6% P2O5 in weight percent. These compounds are combined to form a 
homogeneous silica network when subjected to a temperature of 1350°C. These types of glasses 
have been demonstrated to bond to bone through the formation of a carbonate hydroxyapatite 
layer (composed of CaO and P2O5) on their surface that stimulates bone apposition by 
attachment of osteoblasts (Bachar et al. 2013; Cerruti et al. 2005; Huang et al. 2006; Ling et al. 
11 
 
2009; Soundrapandian et al. 2010). The formation of this hydroxyapatite layer in vitro may be 
indicative of these glasses bioactivity in vivo (Bachar et al. 2013; Huang et al. 2006; Rahaman 
et al. 2011; Vakiparta et al. 2005). The mechanism of bioactivity may be due to 45S5 Bioglass’s 
ability to generate a crystalline apatite layer similar to that of bone on its surface upon contact 
with physiological fluids leading to the formation of a bond with the bone (Lusvardi et al. 2009; 
Rahaman et al. 2011). This layer also implies the formation of apatite nuclei, which grow using 
calcium and phosphate ions from the medium (a process called biomimetic mineralisation) 
(Lusvardi et al. 2009; Pryor et al. 2009; Rahaman et al. 2011). Notably its silica and phosphate 
compounds are in the range suitable for the formation of calcium phosphate on its surface upon 
dissolution, while still exhibiting an appropriate rate of degradability (Reilly et al. 2007). 
Another reason for the bioactivity of 45S5 Bioglass may be due to its potential for alkalinisation 
of the physiological environment. Its low SiO2 content, thus reduced network connectivity, 
helps promote dissolution of elements from its structure when placed in a physiological 
environment (Martin et al. 2009; Ouis et al. 2012). Thus, when placed in a biological 
environment, 45S5 Bioglass is capable of leaching Na+ and Ca2+ ions, which in turn make the 
local pH more alkaline. This process may also lead to the production of hydroxyapatite due to 
dissolution of calcium, which in turn may promote bone formation and repair (Lin et al. 2005; 
Martin et al. 2009). The production of hydroxyl calcium apatite possibly occurs through cation 
exchange between the H+ or H3O+ ions from the physiological environment and the Ca2+ ions 
of the 45S5 Bioglass (Martin et al. 2009). The formation of bone in the presence of 45S5 
Bioglass may be due to either its high surface reactivity or elution of ionic dissolution products 
in physiological environments (Misra et al. 2010). To summarise, the bioactivity of 45S5 
Bioglass is resultant of its low SiO2 composition, its high Na2O/CaO and CaO/P2O5 ratios 
(Rahaman et al. 2011).  
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Therefore, bone substitutes based on bioactive glasses such as 45S5 bioglass have previously 
been shown to promote osteoblast proliferation (Xynos et al. 2000). 45S5 Bioglass has 
previously been shown to control the osteogenic precursor cell cycle and the subsequent 
differentiated cell population through dissolution of specific biologically active soluble Si and 
Ca ions (Hattar et al. 2002). The presence of these ions in the physiological medium at 
concentrations of 15-30ppm for Si and 60-90ppm for Ca led to promotion of bone formation 
(Rahaman et al. 2011). The cells unable to fully differentiate to mature osteoblasts underwent 
apoptosis when cultured in the presence of bioactive glasses. The cells that were capable of 
differentiating into mature osteoblasts formed mineralized bone nodules in culture in the 
presence of bioactive glass even in the absence of growth factors such as bone morphogenetic 
proteins (BMPs) (Hench 2009; Rahaman et al. 2011). A  less than 30ppm release of phosphorus 
from bioactive glasses in the physiological solution induced the expression of osteogenic 
messenger RNA transcripts, while release of higher amounts of phosphorous had deleterious 
effects on cells (Goel et al. 2011). Interestingly bioactive glasses have also been shown to be 
able to promote tissue infiltration into implants in vivo in subcutaneous pockets in the dorsum 
of rats (Liu et al. 2011). Furthermore, a mixture of bioactive glass, autogeneous bone particles 
and demineralised bone matrix has been demonstrated to significantly increase bone healing 
when compared with bone grafting (Pryor et al. 2009). 
Conclusively, its bioactivity and positive, non-toxic biological response, has made 45S5 
Bioglass a suitable material as a synthetic bone graft substitute for a  variety of applications 
including middle ear prostheses, endosseous ridge implants and periodontal defect fillers 
(Brauer et al. 2010; Cerruti et al. 2005; Lin et al. 2005; Reilly et al. 2007). There are several 
commercially available products based on Bioglass including NovaBone, NovaBone-C/M and 
PerioGlass, which have been employed in orthopaedic and cranio-maxillo-facial surgery in the 
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last 10 years (Hu and Zhong 2009; Martin et al. 2009). The main drawback of these materials, 
however, is that due to the brittle nature of Bioglass, they cannot be drilled, bent or shaped in 
surgery (Peltola et al. 2012). Moreover, from a mechanical point of view, the stiffness of 
Bioglass has to be similar to that of adjacent bone to permit transfer of stress in load bearing 
situations between the two (Lin et al. 2005). The advantages of using 45S5 Bioglass include its 
controlled degradation, ability to form hydroxyapatite to bond to soft and hard tissues and 
release of ionic dissolution products (Rahaman et al. 2011). A limitation of Bioglass is due to 
its crystallisation during sintering, which means that it cannot be made into amorphous 
bioactive glass scaffolds as can other bio-ceramics. Several new glasses have been developed 
by changing the chemical structure of the 45S5 Bioglass with the aim of improving its 
mechanical, physical and bioactive characteristics. Several studies have reported positive 
effects on bone growth when trace amounts of elements such as copper, zinc and strontium 
were incorporated into bioactive glasses (Rahaman et al. 2011). 
Mechanical properties of 45S5 Bioglass such as strength can also be improved by addition of 
nitrogen into the silicate network. By substituting oxygen with nitrogen, the density, elastic 
modulus and hardness of these glasses increased with increasing nitrogen content, with the 
density increasing up to 1.7%, elastic modulus up to 45% and hardness up to 24% (Bachar et 
al. 2013). This improvement in mechanical properties may be due to the fact that nitrogen acts 
as a network forming anion. Nitrogen addition to these glasses results in an increase (up to 60%) 
in the stiffness of the network structure due to the extra cross-linking offered by the replacement 
of the divalent O2- ion with the trivalent N3- ion (Bachar et al. 2013). This substitution leads to 
the generation of SiO3N and SiO2N2 tetrahedra which exhibit extra bridging anions compared 
with the SiO4 ones found in 45S5 Bioglass. Furthermore, a recent study demonstrated that the 
incorporation of fluoride in these nitrogen containing bioglasses led to additional increase in 
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their mechanical strength (Bachar et al. 2013). Notably however the addition of calcium and 
fluoride to bioactive glasses had no impact on their network connectivity and bioactivity as long 
as the ratio of network formers to network modifiers was kept constant. It was also 
demonstrated that in these glasses the fluorine preferentially complexed calcium. However, the 
substitution of CaO or Na2O with calcium fluoride led to decreased reactivity and bioactivity 
because of increased connectivity and cross-linking of the network (Brauer et al. 2009). 
The Na2O molecule has been replaced with CaF2 in several bioactive glasses in an attempt to 
produce a material with reinforced networks due to generation of Si-O-Ca-Si groups. The 
substitution of CaO by CaF2 resulted in the formation of a glass with decreased mechanical 
strength, possibly because of the production of nano-aggregates of Na+F- and Ca2+F-, which 
weakened the chemical structure of the glass. The glasses generated also exhibited a decreased 
reactivity and solubility due to their lower sodium content (Lusvardi et al. 2009). 
The incorporation of strontium into bioactive glasses has resulted in decreased dissolution and 
bioactivity due to increased network connectivity of the glass. The chemical degradation of 
such glasses has been demonstrated to decrease with increasing strontium content. The lower 
ability of bioactive glasses containing strontium to form an apatite layer may be due to the 
greater metal oxygen bond strength (389kJ/mol for Sr-O compared with 351kJ/mol for Ca-O) 
and decreased electronegativity (0.99 for Sr2+ compared with 1.04 for Ca2+). These factors 
decrease the ability of Sr2+ to be replaced with H+ in the physiological solution. A concentration 
of between 8.7 to 87.1ppm of Sr2+ has been demonstrated to have a stimulatory effect on 
osteoblasts viability; however, a concentration of 8.7 to 2102.8ppm of Sr2+ had an inhibitory 
effect on osteoclasts viability. Nonetheless, strontium-containing bioglasses did produce a 
silica-rich gel layer on their surface, which aided bone regeneration and repair (Goel et al. 
2011). 
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The addition of fluoride to 45S5 Bioglass has been demonstrated to help patients suffering from 
osteoporosis and prevent fractures in these patients through the release of fluoride ions. These 
features make these glasses suitable biomaterials (by formation of fluoroapatite) for the repair 
of bone tissue (Bachar et al. 2013; Brauer et al. 2010). 
 When the SiO2 content in the Bioglass was changed, it was discovered that glasses with content 
of SiO2 higher than 60% do not form a bond with bone (Hench 2006; Martin et al. 2009; 
Valimaki and Aro 2006), while those with a SiO2 content of between 52-60% exhibited 
decreased bonding to bone (Martin et al. 2009). The strongest bond to bone was achieved in 
glasses with a SiO2 content between 45-52% in weight (Valimaki and Aro 2006). 
Borate-based glasses have been recently found to stimulate bone growth and formation, through 
enhanced osteoblast activity, leading to their employment as osseous implants and tissue-
engineering bone scaffolds (Gorustovich et al. 2006; Rahaman et al. 2011). A bioactive glass 
based on 45S5 composition but where the silica content was replaced with boron stimulated the 
growth and differentiation of human mesenchymal stem cells into cells of the skeletal system 
(Huang et al. 2006; Li et al. 2013; Yao et al. 2007). However, borate-based glasses exhibit 
decreased chemical durability, thus increased dissolution rate when compared with 45S5 
Bioglass (Huang et al. 2006). Table 1.3 presents a summary regarding how the cements to be 
developed containing dimethacrylate resins and bioactive glass filler can compete and improve 
existing Bioactive glass cements (Table 1.3). 
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Table 1.3 The advantages and disadvantages of using bioactive glass for orthopaedic 
applications and how the developed cements can either compete (=) or improve (+) the bioactive 
glass. 
1.2.3 The potential of dental resin composite chemistry for orthopaedic applications 
1.3.1 Photo-polymerisable resins used in orthopaedic applications 
Photo-polymerisable resins are not only used as dental restorative materials, but are also, now, 
the subject of research and development of  bone restorative materials, due to their benefits 
from a command set initiation of the polymerisation (or hardening) process. Such materials 
include bisphenol-a-glycidyldimethacrylate/triethylene glycol dimethacrylate 
(bisGMA/TEGDMA) formulations for use as bone substitutes, with the material exhibiting 
decreased toxicity compared with PMMA cement (Harper 1998; Saito et al. 1994; Schneider et 
al. 2010). These bisGMA/TEGDMA based cements exhibit water uptake similar to the PMMA 
cement; moreover, they possess a decreased exothermic reaction and shrinkage after curing. 
These cements also permit the incorporation of increased amounts of filler particles compared 
with PMMA due to the lack of polymer beads in their structure. Nonetheless, the end product 
is difficult to handle due to its increased viscosity given by the increased amount of filler present 
in the bisGMA/TEGDMA cement. However, the use of bisGMA to augment metal screws in 
the treatment of ankle fractures in osteopenic patients, was shown to be a suitable alternative to 
the use of PMMA cement, with reduced rates of failure. Spinal fractures and fractures involving 
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extremities have been successfully treated with bisGMA/TEGDMA composites containing 
combeite (available commercially under the names of Cortoss, Orthovita Inc., Malvern USA) 
(Larsson 2006). However, due to the higher release of residual monomer, brittleness and 
increased modulus (which may lead to higher stress in the cement adjacent to an implanted 
prosthesis), bisGMA-based cements containing fillers are at a clinical disadvantage to PMMA 
cements (Harper 1998; Mousa et al. 2000). 
The incorporation of nano-sized bioactive glass fillers has resulted in increased mechanical 
strength and surface adsorption of proteins to these bisGMA-based composites. The increased 
surface adsorption of proteins and the rough surface of the composites has also led to increased 
cell attachment (Misra et al. 2010). These composites also exhibited increased water uptake and 
weight loss which can be due to increased hydrophilicity (because of the incorporation of nano-
sized bioactive fillers) and dissolution of these filler particles, respectively (Misra et al. 2010). 
Table 1.4 represents a summary regarding how the cements to be developed containing 
dimethacrylate resins and bioactive glass filler can compete and improve the existing bisGMA-
based cements.  
Table 1.4 The advantages and disadvantages of using bisGMA-based cements in orthopaedic 
applications and how the cements to be developed can either compete (=) or improve (+). 
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1.3.2 Constituents of photo-polymerisable resins 
Photo-polymerised resin-based composites most commonly contain an organic resin matrix, 
inorganic filler and a ketone-amine initiator-co-initiator system. Upon light irradiation these 
formulations are transformed into a cross-linked polymer structure. A polymer is a 
macromolecule formed through the linkage of large amounts of monomer molecules. Polymers 
can typically be described according to the polymerisation reaction by which crosslinking is 
achieved as either condensation or addition cured. The condensation polymers are produced 
from poly-functional monomers through the elimination of a small molecule and include 
polyamides and diacides. Addition polymers (such as dimethacrylates), on the other hand, are 
produced by polymerisation of monomers containing carbon double bonds (referred to as vinyl 
(CH2=CH- groups) monomers) without the loss of a small molecule. 
Resin matrix chemistry 
Monomers used in resin composites include: bisGMA, TEGDMA, UDMA (urethane 
dimethacrylate), ethylene- and hexamethylene-glycoldimethacrylate employed to dilute the 
former viscous materials whereas the inorganic filler particles consist of mainly silicate glass 
(Azzopardi et al. 2009; Bouillaguet 2004; Ensaff et al. 2001; Ferracane 1995; Floyd and 
Dickens 2006; Goncalves et al. 2009; Lee et al. 2004; Sideridou et al. 2002). 
The most commonly employed base monomer in composite restorative materials is bisGMA. 
This monomer was developed by Bowen in 1956 through the attachment of methacrylate groups 
to the epoxy monomer, thereby producing bisphenol A-glycidyl methacrylate (bisGMA) 
(Bowen, 1963). The bisGMA molecular structure consists of both hydrophilic and hydrophobic 
components, with its hydrophilicity provided by its two hydroxyl groups and its hydrophobicity 
due to its diphenyl-isopropane core (which contains two aromatic phenol rings exhibiting π-π 
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interactions) (Deb et al. 2005; Sauro et al. 2013). These two aromatic phenol rings and the 
pendant hydroxyl groups are held together by strong intermolecular hydrogen bonds, which 
make bisGMA a highly rigid molecule due to the limited bond rotation (steric hindrance) around 
its aromatic ring structure (Emami and Soderholm 2009). The presence of the two aromatic 
rings and hydroxyl groups make bisGMA a large methacrylate molecule, which also results in 
bisGMA having high viscosity (η=1,200Pa); limiting its degree of conversion to values not 
higher than 42% when used alone or 55-75% when employed as the base monomer in composite 
resins (Elliott et al. 2001; Gajewski et al. 2012; Harper 1998; Pfeifer et al. 2009). Its high 
reactivity is due to the presence of reactive carbon double bonds in the molecular structure. Its 
high molecular weight, rigidity, decreased shrinkage following polymerisation and high 
refractive index (1.55) make it a frequent monomer choice in composite resins (Azzopardi et 
al. 2009; Sideridou et al. 2002). However, bisGMA has several shortcomings including: 
cytotoxicity (due to potential leakage into the surrounding environment) and, as already 
mentioned, increased viscosity (which hinders the mobility of the free radicals during 
polymerisation), lower conversion of carbon double bonds (Elliott et al. 2001) and increased 
stickiness, which affects handling. 
An alternative monomer that can either replace or be used in combination with bisGMA is 
UDMA, which has a lower molecular weight and decreased viscosity (approximately 
11,000mPa) due to the absence of aromatic groups compared with bisGMA (Deb et al. 2005; 
Sauro et al. 2013). The UDMA chemical structure comprises of methacrylates, which are held 
together by aliphatic spacer groups and –NHCOO- or urethane groups (Sideridou et al. 2002). 
The presence of urethane groups also confers increased functionality on UDMA, resulting in 
increased toughness and flexibility of the monomer’s backbone structure; which may also lead 
to increased conversion of the monomer to polymer during the polymerisation reaction. When 
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compared with bisGMA, UDMA has in its structure imino (-NH-) rather than hydroxyl groups 
and exhibits greater flexibility due to lower strength hydrogen bonding interactions; however, 
it has a lower refractive index (1.48), which may limit the depth of cure based on the co-
monomer blend and type of filler incorporated in the UDMA based resins (Azzopardi et al. 
2009; Barszczewska-Rybarek 2009; Gajewski et al. 2012). Consequently, UDMA has the 
following advantages over bisGMA: a lower viscosity and a highly flexible urethane linkage, 
which may improve the toughness and degree of conversion of resin composites based on this 
monomer (Asmussen and Peutzfeldt 1998; Barszczewska-Rybarek 2009). 
As the majority of resin composites use either bisGMA and/or UDMA as the base monomers, 
a diluent monomer such as TEGDMA is usually required to decrease viscosity. This monomer 
has a low molecular weight and decreased viscosity (approximately 10mPa), which gives 
TEGDMA its high reactivity. TEGDMA is also used to increase the conversion of carbon 
double bonds to carbon single bonds (conversion of the monomer to a polymer). This monomer 
not only acts as diluent for bisGMA or UDMA but also makes the addition of filler particles in 
composite resins easier by decreasing viscosity (Khatri et al. 2003) and may improve handling. 
However, because of the absence of aromatic rings and the presence of ether groups (C-O-C), 
this may lead to low mechanical properties of the polymer after the polymerisation reaction. 
Therefore, due to its flexible structure, decreased refractive index (1.46),  low molecular weight, 
decreased viscosity (given by the lack of intermolecular hydrogen interactions) and its ability 
for cyclisation (to form ring structures) (for full description of cyclisation refer to Section 1.4.3 
Polymerisation kinetics and chemistry of light-activated dental composites, below), TEGDMA 
increases radical mobility during the polymerisation reaction, however, it does not lead to 
network formation (Azzopardi et al. 2009; Gajewski et al. 2012). Due to the increased amounts 
of carbon double bonds in their molecular structure, composite resins containing TEGDMA 
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exhibit higher degree of conversion (Gajewski et al.2012). The disadvantages of using 
TEGDMA in composite resins include its increased water sorption and ability to elute in the 
surrounding environment, resulting in a possible negative impact on cells (Atai et al. 2005; 
Ferracane 1995). 
Photo-initiators  
There are three main types of initiators classified according to the nature of the polymerisation 
reaction: free radical, cationic and anionic (Andrzejewska 2001). As this study involves free 
radical polymerisation, the following section covers free radical initiators (referred to as photo-
initiators), which are relevant to the studies presented here.  
Free radical photo-polymerisation can occur through the absorption of an appropriate 
wavelength of light by a photo-initiator molecule, which starts the polymerisation reaction by 
direct light absorption or an indirect mechanism via a co-initiator to produce reactive free 
radical species (Ogunyinka et al. 2007). When the photo-initiator absorbs light at the 
appropriate wavelength, its carbonyl group with the non-bonding electrons is promoted to a π* 
anti-bonding orbital. This leads to an overlap between the lower energy bonding and higher 
energy anti-bonding molecular orbitals, resulting in the initiation of polymerisation (Ikemura 
and Endo 2010; Stansbury 2000). Therefore, a photo-initiator is a species capable of initiating 
the polymerisation reaction through the absorption of external energy (which may include, for 
example, light or heat).  
There are two types of radical photo-initiators depending on how the free radical intermediates 
are produced following light activation of the initiators: Type I and Type II (Andrzejewska 
2001). Type I initiators consist of aromatic carbonyl elements that exhibit haemolytic carbon 
bond scission following ultraviolet or short wavelength visible light irradiation. Such initiators 
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(benzyl ketals, acyclophosphine oxides, benzoin ether derivatives to give some examples) start 
polymerisation through a photo-fragmentation method, where radicals are produced by a 
successful α-cleavage process (Andrzejewska 2001; Fairbanks et al. 2009). Type II initiators 
(those used in this thesis) require two compounds to begin polymerisation: aromatic diketones 
being commonly used together with a weak-covalent bond exhibiting radical precursor.  
Camphorquinone and benzophenones are other examples of such initiators, which start 
polymerisation through a mechanism of “hydrogen abstraction from donor molecules” 
(Fairbanks et al. 2009). There are also initiators that do not belong to this classification such as 
borate salt, which initiates polymerisation through either inter- or intra-molecular electron 
transfer (Andrzejewska 2001). 
Current composite resins usually employ Type II initiators to start the polymerisation reaction, 
with camphorquinone being commonly used as the visible light activated source of free-radicals 
due to its excellent characteristics since its development in 1971 by Dart and Nemcek. This 
photo-initiator requires a co-initiator such as tertiary aliphatic amines photo-reductants (eg 
DMAEMA (dimethylaminoethyl methacrylate)) to act as electron donors to successfully start 
the polymerisation reaction (Leprince et al. 2013; Ogunyinka et al. 2007; Pagoria et al. 2005). 
These tertiary amines are a popular choice of co-initiators for light curable composite resins 
due to their reactivity with the carbon double bonds of the monomers and ability to generate α–
amino alkyl radicals (Andrzejewska 2001). These co-initiators do not play a role in light 
absorption, but interact with the photo-initiator to generate reactive species. Therefore, 
camphorquinone initiates polymerisation through a hydrogen abstraction method, where, 
following light irradiation it absorbs light to create a photo-excitation structure with its 
hydrogen donating tertiary amine co-initiator. This results in the formation of amine-derived 
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free radicals (Fairbanks et al. 2009; Ikemura and Endo, 2010; Nugent et al. 2010, Ogunyinka et 
al. 2007). 
Camphorquinone, due to its α-dicarbonyl group, is capable of absorbing light in the blue visible 
region (400-550nm) at a peak wavelength of 468nm resulting in a transition from n to π* of its 
dicarbonyl group (Arikawa et al. 2009; Ikemura and Endo 2010; Ogunyinka et al. 2007; Pagoria 
et al. 2005). The non-bonding electrons of the carbonyl groups are then promoted to a π* anti-
bonding orbital, creating a short-lived excited energy state, with a half-life of approximately 
0.05ms. When this excited n → π* transition, then, comes into contact with an amine molecule 
through charge transfer, diffusion or prior association, an excited short-lived complex (an 
exciplex) is created as it is shown in Figure 1.2 (Alvim et al. 2007; Asmussen et al. 2009; 
Ikemura and Endo 2010; Stansbury 2000; Watts 2005). 
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Figure 1.2 The molecular structure of CQ and photo-activation mechanism to start the initiation of the polymerisation reaction (adapted from 
Stansbury, 2000). 
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In the excited short-lived complex, an electron is donated by the amine to the camphorquinone 
to generate the radical ion pair and, then, the camphorquinone abstracts a proton from the amine 
to form the free radical species (or the primary radical) (Figure 1.1) (Pagoria et al. 2005; 
Stansbury, 2000). The former CQ radical has the ability to inhibit polymerisation via 
termination reactions by interacting with the growing polymer chains. The latter radical is able 
to attack the carbon double bonds in the monomers leading to a chain reaction process where 
many hundreds of monomer units can be added to the polymer network through the light 
activation of a single photon by the camphorquinone initiator (Alvim et al. 2007; Asmussen et 
al. 2009; Ikemura and Endo 2010; Stansbury 2000; Watts 2005). 
Fillers impact on dimethacrylate resins 
Resin composites consist of a polymerised resin network and fillers, which are mixed in to form 
a chemical or photo-polymerised cured resin (Bouillaguet 2004; Ferracane 1995; Shirai et al. 
2000). Fillers may include micron- or nano-sized particles of SiO2, ZrO2 and Al2O3. However, 
an increased volume of monomer is needed to form a homogenous mixture, when nano-particle 
sized fillers are incorporated into composites, mainly due to the nano-particles large surface-
area to volume ratio (Ensaff et al. 2001; Ferracane 1995). Nano-particles may also form 
aggregates within the resin composite due to agglomeration of the particles within the resin 
matrix. This occurs when inter-particulate forces of attraction exceed the particulate weight and 
this may have a negative impact on the mechanical properties of the final resin composite 
containing nano-particles (Chen et al. 2006).  
The addition of micro-sized fillers to the resin network has the role of reinforcing the resin 
composite by improving its mechanical properties. An increase in the amount of filler present 
also results in a decrease in the polymerisation shrinkage, which is due to decreased amount of 
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monomers and increased amount of filler particles present in the composite. Nonetheless, the 
maximum amount of filler that can be incorporated into a resin mixture is restricted by the 
viscosity of the monomers (Ling et al. 2009). One method to aid the incorporation of fillers in 
resin mixtures is through the addition of TEGDMA, which decreases the viscosity of the base 
monomers bisGMA or UDMA as previously described. 
When these inorganic glassy fillers were initially incorporated into the organic resin mixture, it 
was identified that these two compounds had to form a strong bond in order to produce a 
composite with acceptable physical and mechanical properties. This bond was achieved through 
the coating of the filler particles with a coupling molecule (silane). This molecule has in its 
structure silanol groups (Si-OH), which bond to the silicon-oxygen groups in the glassy fillers 
and methacrylate groups (comprising of C=C), which provide bonding to the methacrylate 
groups of the resin monomers as it is shown in Figure 1.3 (Ferracane 1995).  
 
Figure 1.3 Illustration of the bonding between the silane coupling agent with the filler particles 
and the resin matrix in resin-based materials. The silane coupling agent may lead to better 
chemical bonding between the filler particles and the resin matrix (adapted from Ferracane, 
1995). 
This coupling molecule and an efficient silanisation process also increase fracture toughness by 
modifying crack propagation by transgranular strengthening. Another role played by the silane 
molecule involves the transmission of stress between the soft resin matrix and the harder filler 
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particles (Ferracane 1995; Shirai et al. 2000). Successful coating of fillers with the silane would 
also slow the degradation process of resin composites due to the inevitable failure of the bond 
between the fillers and the resin matrix (Shirai et al. 2000).  
1.3.3 Polymerisation kinetics and chemistry of light-activated dental composites 
Light-curable dimethacrylate resin composites undergo free radical photo-polymerisation in 
response to visible, blue light (wavelength of 400-550nm) curing (500-800mW/cm2 of light) 
for approximately 30-40sec (at 15-24Jcm-2) (Bouillaguet 2004). Thus, as previously mentioned, 
the photo-polymerisation reaction employs photo-initiators capable of absorbing irradiated light 
at specific wavelength to produce primary radicals, which can, then, convert monomers into a 
polymeric network (Figure 1.4) (Ikemura and Endo 2010). These free radicals open the carbon 
double bonds of the methacrylate groups of the monomers, initiating a chain polymerisation 
reaction. This reaction includes three steps: initiation, propagation and termination (Figure 1.5), 
where formation of radicals, initiation and growth of the polymer chain and removal of radicals 
occurs, resulting in the formation of a high molecular weight, cross-linked polymer network 
(Rosentritt et al. 2010). 
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Figure 1.4 The conversion of carbon double bonds to carbon single bonds following photo-
polymerisation of dimethacrylate resin monomers to form a cross-linked polymer matrix 
containing small amounts of unreacted monomers and many pendant methacrylate groups 
(C=C) (adapted from Ferracane, 1995).  
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Figure 1.5 Polymerisation of dimethacrylate resins. The polymerisation reaction ensues through the incorporation of large amounts of monomer 
molecules (CH2=CHY) to the reactive centre R* resulting in the formation of a highly cross-linked polymer network (adapted from LePrince et 
al. 2013). 
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As previously mentioned, during initiation the photo-initiator is decomposed leading to the 
formation of free radicals, which in turn open the carbon double bonds of the monomer 
molecule resulting in the conversion of the monomer to the polymer. This process leads to an 
increase in the viscosity of the resin, thus a decrease in the termination rate, which is known as 
auto-acceleration (gel effect) (Rosentritt et al. 2010; Watts 2005). This effect is produced by 
the rapid conversion of the carbon double bonds to single bonds (monomer to polymer), 
resulting in increased viscosity (Dewaele et al. 2006; LePrince et al. 2013). This increased 
viscosity due to polymer formation and increased cross-link density leads to a decrease in the 
mobility of the radicals, resulting in diffusion controlled propagation (Atai et al. 2005). During 
propagation, the free radical continues attacking the π-bond of a monomer creating an active 
(also referred to as reactive) centre to which monomer molecules are then rapidly added leading 
to the growth of the polymer chain (Watts 2005). Thus, this step implies the interaction of 
monomer molecules (as units consisting of pendant double bonds), resulting in this step being 
the least limited by diffusion in the polymerisation reaction. Propagation continues through the 
incorporation of another monomer molecule to the active centre and through attack of the 
pendant double bond by the radical through cyclisation, inter- or intra- molecular cross-linking. 
Therefore, cyclisation reactions occur during the polymerisation of dimethacrylate resins and 
are of two types: primary or secondary cyclisation. During the primary cyclisation reactions, 
the pendant double bonds of the monomer molecules react with their radical centre leading to 
the growth of the polymer chain, whereas during secondary cyclisation (multiple cross-linking) 
reactions, the pendant double bonds react with a radical located on a different polymer chain 
(Elliott et al. 2001; Lovell et al. 1999, Lovell et al. 2001). Primary cyclisation reactions, thus, 
limit the density of the cross-linked polymer network. Moreover, during the polymerisation 
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reaction, primary cyclisation is reduced with increased conversion of the monomer to a polymer 
network, with an increase in cross-linking reactions (Lovell et al. 2001). 
Thus, the pendant double bonds may interact with propagating radicals to generate primary 
cycles, secondary cycles (multiple cross-links) and cross-links. Cross-linking occurs between 
pendant double bonds and a radical situated on a different growing chain (Lovell et al. 2001). 
On one hand, cyclisation may increase conversion (due to having no negative impact on 
mobility of radicals), nonetheless, on the other hand, this may have a detrimental effect on 
density of the cross-linked polymeric network, because cycles do not play a role in the 
formation of the polymeric system (Elliott et al. 2001; Lovell et al. 2001). Due to the high 
number of monomeric double bonds near the radical site, widespread cyclisation occurs, 
resulting in the formation of micro-gels (which are compact structures). This cyclisation leads 
to a delay in the time required to reach the gel point conversion in the polymerisation reaction. 
It is in these micro-gels that the remaining unreacted pendant double bonds of the monomer 
molecule become entrapped resulting in decreased reactivity through steric hindrance. 
Micro-gel formation is also one of the reasons why conversion of carbon double bonds to single 
bonds never reaches 100%, this being due to the network inhomogeneity created by these 
micro-gel structures. This inhomogeneity of the polymeric network may also have a detrimental 
effect on the mechanical properties of the resin. Micro-gels are generated during primary 
cyclization, with the polymeric network consisting of loosely cross-linked regions interspersed 
between highly cross-linked regions (Lovell et al. 2001). Consequently, polymerisation 
proceeds through the chemical interaction of the micro-gel structures, resulting in the 
generation of macro-gels. During this step, the polymeric chains become trapped in the network. 
A limited amount of radicals are still able to interact by segmental diffusion or propagation, 
with the radicals already trapped in the micro-gels becoming inaccessible for further reaction. 
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There are three main species of radicals in a polymerisation reaction: the free radicals which 
are not bound to the network, the mobile radicals that, although bound to loosely cross-linked 
parts of the network, can still react with others and the trapped radicals, which are terminated. 
However, as the polymeric network becomes increasingly cross-linked the mobility of radical 
sites is governed by propagation, with trapped radicals constituting another method of radical 
deactivation (Elliott et al. 2001; Lovell et al. 2001). 
Therefore, reaction termination may occur through two methods: bimolecular termination of 
polymer radicals (when mobility of the system is high; irreversible) and monomolecular 
termination (here, only one polymer radical is required) (reversible, when network mobility is 
decreased). This step in the polymerisation reaction ensues due to radical-radical interaction 
and entrapment of radicals in an increasingly cross-linked network, which hinders any further 
reaction with the vinyl double bonds. The termination step of the polymerisation reaction is 
dependent on the amount of carbon double bond conversion to single bonds and the conditions 
in which the reaction occurs such as: temperature, the chemical structure of monomers and the 
density of the cross-linked network. Diffusion controlled termination constitutes the main 
method of termination in the polymerisation of light-curable dimethacrylate resins (Elliott et al. 
2001; Lovell et al. 2001). This diffusion controlled reaction has a negative impact on the 
physical (degree of conversion) and mechanical (flexural strength and flexural modulus) 
properties of dimethacrylate resins because the reaction is terminated before all the monomer 
is converted into polymer (Lovell et al. 1999). Therefore, the early termination of free radicals 
leads to decreased degree of conversion, which may also have a detrimental impact on the 
mechanical characteristics of the final resin and filled composite. However, when bimolecular 
termination (interaction between two radicals attached to long, polymer chains) is severely 
hindered, termination can also occur through chain transfer, which reduces both the rate of 
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polymerisation and the lifetime of radicals, leading to a decrease in the monomolecular rate of 
termination (Andrzejewska 2001). As the polymerisation reaction proceeds the movement of 
the free radicals and their interaction with the monomer molecules becomes more and more 
restricted, with a sudden decrease in the rate of polymerisation, a phenomenon known as auto-
deceleration. During this stage, the monomer movement to the reactive sites is severely limited 
leading to a drop in the polymerisation rate (Goodner and Bowman 1999). This eventually leads 
to vitrification (transition from a rubber to a glass state) where the mobility of the radicals is 
restricted leading to the formation of a polymer network where residual monomer and unreacted 
pendant groups bound to the polymer chain remain pres,ent (Atai et al. 2005; Lee et al. 2004; 
LePrince et al. 2010; Rosentritt et al. 2010; Sideridou et al. 2002). 
Polymerisation does not, however, stop with the cessation of light irradiation, but it continues 
in the absence of further irradiation. The primary radicals formed during light irradiation keep 
interacting with growing polymer chains or terminate micro-radicals. Therefore, chain 
propagation will continue, but at a significantly reduced rate compared with that during light 
irradiation (Goodner and Bowman 1999).  
To summarise, during polymerisation, an increase in the degree of conversion and the density 
of the polymeric network occurs. As the cross-linked network is generated, the viscosity 
increases resulting in gelation (transition from a liquid to a rubber state) of the medium. During 
gelation, which occurs at the beginning of the polymerisation reaction, the mobility of radicals 
interacting with the growing polymer chain becomes restricted due to an increase in density, 
however, the small monomer molecules are still able to diffuse easily (Atai et al. 2005; 
Rosentritt et al. 2010). This results in a significant decrease of the termination step, with 
initiation producing new growth centres. This subsequently leads to auto-acceleration, where 
the rate of polymerisation and the amount of free radicals are increased reaching a maximum 
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rate of polymerisation. Auto-deceleration then occurs, when the viscosity of the systems hinders 
even the movement of the small monomer molecules, leading to a significant drop in the rate 
of polymerisation (Atai et al. 2005). At this stage, vitrification occurs with the transition from 
rubber to glass of the polymeric system. Vitrification is also the main reason why the degree of 
conversion of monomer to polymer can never reach 100%, with up to 50% of the monomer 
carbon double bonds remaining unreacted (Asmussen and Peutzfeldt 2001; Bouillaguet 2004; 
Floyd and Dickens 2006; Lee et al. 2004; LePrince et al. 2013; Sideridou et al. 2002).  
The main problem encountered with free radical polymerisation is shrinkage. This phenomenon 
occurs when monomers are converted into polymers, due to a density change from the liquid 
monomer (lower density) to the highly cross-linked polymer (higher density) (Gilbert et al. 
2000). Another limitation of photo-polymerisation is given by the presence of atmospheric 
oxygen. Not only does oxygen quench the excited states of the photo-initiator (thus decreasing 
the amount of initiating radicals), but it, also, has the ability to form peroxy radicals with the 
carbon-based polymerising radicals (preventing them from reacting with the carbon double 
bonds of the monomers) resulting in a decrease in the effectiveness of initiation. This may either 
lead to the complete inhibition or a significant reduction of the polymerisation reaction 
(Andrzejewska 2001). 
Therefore, a thorough understanding of appropriate resin chemistry is required for the 
development of bioactive glass containing materials based on such resins, for orthopaedic 
applications. By changing the concentration, composition and amount of either the resin 
component or the bioactive glass component in these materials, cements can be developed that 
have enhanced mechanical, physical and biological properties compared with current materials, 
which could further lead to the generation of versatile bone substitutes for orthopaedic repair. 
35 
 
1.4 Study aims 
This work aimed to develop a material based on dimethacrylate resins and bioactive glasses 
that provides enhanced physical and mechanical characteristics (degree of conversion, flexural 
strength, flexural modulus, water sorption and water solubility) as well as improved viability 
of bone marrow stromal cells compared with existing cement materials based on PMMA 
cement.  Studies aimed to investigate various resin types and monomer blends (in terms of 
degree of conversion, rate of polymerisation, hardness, flexural strength and flexural modulus) 
(Chapter 3) to provide a versatile system in regard to physical, mechanical and biological 
characteristics to be used for different orthopaedic applications. Subsequently, the impact of 
the addition of different sizes and concentrations of bioactive glass to resin systems on the 
mechanical and physical properties of the final resin composites (in terms of degree of 
conversion, flexural strength and flexural modulus) was analysed (Chapter 4). Further, the 
impact of water immersion on the mechanical properties (bi-axial flexural strength, flexural 
strength and flexural modulus) as well as the water sorption and solubility of the optimum 
formulations of resin composites (Chapter 5 and 6) were determined. Finally, the impact of 
these resin composites on bone marrow stromal cells viability as well as changes in the acidity 
of the culture media were analysed (Chapter 7).   
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CHAPTER 2 MATERIALS AND METHODS COMMON TO CHAPTERS 
CONTAINING EXPERIMENTAL DATA 
2.1 Synthesis of unfilled resin systems containing 60/40wt% UDMA/TEGDMA 
Unfilled resins systems were made containing 60/40wt% UDMA/TEGDMA, 0.2wt% CQ 
(photo-initiator) and 0.8wt% DMAEMA (co-initiator). Each substance was, accurately 
measured using a balance accurate to 0.0001mg (TS400D, Ohaus, USA). TEGDMA was 
carefully placed into a beaker, then the photo-initiator and co-initiator carefully added and 
gently mixed with a spatula for 15sec to reach a homogenous texture. UDMA was added to this 
mixture. The resulting resin formulation was mixed in a beaker covered with aluminium foil 
(to avoid photo-curing as a result of ambient light) on a magnetic stirrer at 60°C for 30min to 
obtain a homogenous solution. The resulting resin formulation was stored in a lightproof 
container at 4°C to avoid premature photo-curing prior to further testing.  
The synthesis of 60/40wt% UDMA/TEGDMA was required in Chapters 4, 5, 6 and 7. 
2.2 Synthesis of 45S5 bioactive glass 
SiO2 was employed to make melt-quenched glass samples (Alfa Aesar, 99.5%), P2O5 (Sigma-
Aldrich, 98.5%), CaCO3 (Alfa Aesar, 99.95–100.5%) and Na2CO3 (Sigma-Aldrich, 99.5%). A 
BRF16/5 chamber furnace (Elite furnaces) was used to heat a platinum-rhodium crucible, which 
contained the precursors to 1400°C following mixing for 5min with a spatula at 10°Cmin1 and 
held at temperature for 1.5h. The molten glass was poured into a pre-heated split graphite mould 
(length: 6cm; diameter: 10mm) (350°C) and annealed at this temperature for 12h. The glass 
was then allowed to slowly cool inside the insulated furnace at room temperature by switching 
off the chamber furnace. This glass had the following composition 
(CaO)26.9(Na2O)24.4(SiO2)46.1(P2O5)2.6. The Bioglass was then gently and carefully manually 
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ground using a ceramic pestle and mortar (to avoid the possible contamination and over-heating 
of the bioactive glass as it may occur in the speedmixer/zirconia balls method) and subsequently 
sieved (using 100µm and 50µm sieves) (Fisherbrand, Fisher Scientific, UK) to ≤50µm particle 
diameter size (Martin et al. 2009). 
The synthesis of 45S5 bioactive glass was required in Chapters 4, 5, 6 and 7. 
2.3 Synthesis of filled resin composites containing bioactive glass and barium silicate 
filler 
Filled resin composites (FRC) were synthesised containing the unfilled resin system (refer to 
Section 2.1 Synthesis of unfilled resin systems), barium silicate glass and bioactive glass fillers. 
Barium silicate glass filler (G018-186) was purchased from Schott Glass (Landshut, Germany) 
and had the composition: (Al2O3)10(B2O3)10(BaO)35(SiO2)45(F)<2 with a Silane content of 6.0%. 
The size of the particles was approximately 0.7µm. There were three types of bioactive glass 
fillers tested. There were two types of bioactive glass fillers (G018-144) purchased from Schott 
Glass (Landshut, Germany): silanated (silane content of 0.5%) (Type I) and non-silanated (Type 
II). The third bioactive glass filler (45S5) was synthesised in the laboratory and it was non-
silanated (Type III) (Table 2.1 and 2.2) (refer to Section 2.2 Synthesis of bioactive glass, above).  
 
Table 2.1 Filled resin composite (FRC) compositions in wt% for both low filler (46vol% 
filler) and high filler (60vol% filler) content. 
The Type I and Type II fillers had an average particle size diameter of 10µm, whereas Type III 
fillers had a particle size diameter <50µm (Table 2.2). 
51 
 
 
Table 2.2 The type and size of bioactive glass filler particles present in each filled resin composite.
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Low and high viscosity FRCs (with low and high filler content) were made containing 
60/40wt% UDMA/TEGDMA; 20, or 40wt% bioactive glass and barium silicate glass to a ratio 
of resin to filler in the final FRC at 30:70wt% (low filler content) or 60/40wt% 
UDMA/TEGDMA; 23, or 45wt% bioactive glass and barium silicate glass to a ratio of resin to 
filler in the final FRC at 20:80wt% (high filler content) (Table 2.3).  FRCs containing barium 
silicate glass filler only (70 or 80wt%, low and high filler content, respectively) were used as 
positive control.  The FRCs were synthesised to form either a low viscosity or a high viscosity 
filler content in the final filled resin composite keeping the ratio of resin to filler at 30:70wt% 
(low filler content) or 20:80wt% (high filler content) (Table 2.2). All the substances were 
measured using a balance accurate to 0.0001mg (TS400D, Ohaus, USA). The bioactive glass 
and barium silicate filler particles were placed in a container and gently mixed with a spatula. 
The resin mixture was then added to this bioactive glass, barium silicate mixture. This 
formulation was, then, mixed in a Speed Mixer (DAC 150 FV2-K, Hauschild Engineering, 
Germany) for 90s at low speed (1000rpm) and 180s at high speed (3000rpm). The mixed 
formulations were subsequently stored in a lightproof container at 4°C to avoid premature 
photo-curing prior to further testing.   
The synthesis of filled resin composites was required in Chapters 5, 6 and 7. 
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Table 2.3 Filled resin composites compositions in wt% for both low filler (46vol% filler) and high filler (60vol% filler) content. 60/40 UT represents 
the unfilled resin formulation containing 60/40wt% UDMA/TEGDMA. Bioglass represents the three different types of bioactive glass used: Type 
I, Type II and Type III. Barium Silicate refers to barium silicate glass filler.  
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2.4 Synthesis of polymethylmethacrylate 
Polymethylmethacrylate (PMMA) cement (Palamed, Hereus Medical GMBH, Germany), a 
commercially available material for hip and knee arthroplasties, was used as a control for the 
experimentally developed FRCs. The PMMA constituents were measured with a balance 
accurate to 0.0001mg (TS400D, Ohaus, USA) to obtain a ratio of 2:40 powder to liquid 
monomer, which was, then, manually mixed with a plastic spatula for 30sec, at room 
temperature. The mixed cement was then carefully placed at the bottom of the mould, avoiding 
the inclusion of air bubbles, flattened with a glass slide and allowed to set for 10min. Disc 
shaped molds (diameter: 10mm and height 2mm) were used for testing the degree of 
conversion, whereas disc shaped molds (diameter: 15mm and height: 1mm) were used for water 
sorption, solubility and bi-axial flexural testing. Split aluminium rectangular shaped molds 
(25mmx2mmx2mm) were used for three point bend testing. The cement was, then, carefully 
removed from the mold and stored in Petri dishes prior to use.  
The synthesis of PMMA cement was required in Chapters 4, 5, 6 and 7. 
2.5 Preparation and light curing of unfilled resin systems and filled resin composite 
samples 
For mechanical (three point bend) testing, rectangular bars (n=10 for each sample condition) of 
unfilled resin systems and FRCs were made using a rectangular aluminium split mold. Each 
resin bar was carefully polished manually with 1000 grit silicon carbide paper (Struers, UK) to 
the dimensions of 25(length)x2(height)x2(width)mm; to obtain a flat surface, with no poorly-
polymerised layer due to oxygen inhibition (Sauro et al. 2013; Tian et al. 2008). For water 
sorption, solubility and bi-axial flexure strength testing, disks of FRCs (n=10 for each sample 
condition) were made using a black Teflon disc shaped mold (15mm diameter and 1mm 
thickness). For bone marrow stromal cell viability studies (n=9 for each sample condition; 3 
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biological replicates), disks of unfilled resin systems and FRCs were made using a black Teflon 
disk shaped mold (10mm diameter, 2mm thickness). A thin layer of Vaseline (Unilever, UK) 
(release agent) was used to cover the surfaces of the mold that came into contact with the 
unfilled resin systems/FRCs formulation. The unfilled resin systems/FRCs formulations were 
carefully pipetted at the bottom of each mold, which was placed on a glass microscope slide. 
Each mold was, then, covered with acetate film (to prevent oxygen inhibition) and another glass 
slide in order to achieve a flat specimen.   
Each mixture was, then, irradiated from the top for 40sec with a blue light (spectral range of 
400-500nm) using a Quarts-Tungsten-Halogen light curing unit (tip diameter 10mm) (Optilux 
501, Sybron Dental Specialists Kerr, USA). The spectral irradiance of the Optilux 501 light 
curing unit was 695±43mW/cm2, which was measured using a fibre-coupled UV-Vis 
spectrometer and 3.9mm cosine corrector sensor (Ocean Optics) calibrated with a NIST-
traceable halogen-deuterium lamp (DH-2000; Ocean Optics). The curing light tip was aligned 
centrally, 0mm above the sensor using a universal joint and clamp securely fixed to an optical 
breadboard. The irradiance of the curing unit was determined prior to each experiment to ensure 
the output did not vary significantly (695±43mW/cm-2). For the preparation of specimens for 
mechanical testing, an overlapping curing protocol was used, which was necessary as a 
consequence of the diameter of the curing tip (10mm) being less than the length of the 
specimens. For the preparation of specimens for water sorption, solubility and bi-axial flexure 
testing, FRCs formulations were photo-activated with 5 overlapping exposures for 40sec each, 
with a total of 200sec curing time (according to the ISO standard protocol for polymer based 
restorations (ISO 4049)). The cured unfilled resin systems or filled resin composite specimens 
were then placed in Petri dishes covered with aluminium foil (to allow dark polymerisation to 
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occur) and stored overnight at room temperature to ensure completion of the polymerisation 
reaction prior to further testing. 
2.6 Physical testing of unfilled resin systems and filled resin composites 
The degree of conversion of a substance provides an evaluation of the amount of monomer 
converted to a three dimensional polymer network, during the polymerisation reaction. DC may 
also indirectly provide details about the mechanical, fatigue and elution properties of the 
substance tested (Dewaele et al. 2006). The degree of conversion of unfilled resin systems and 
filled resin composites is commonly tested using spectroscopic methods such as Fourier 
transform and Raman spectroscopy. These spectroscopic methods can be employed to acquire 
infrared (IR) spectra of light polymerisable materials such as dimethacrylate resins. These 
methods are commonly based on absorption spectroscopy of the electromagnetic spectrum in 
the infrared region. This infrared region is composed of three main sub-regions: the far 
(wavenumber: 25-400cm-1), mid (wavenumber: 400-4000cm-1) and near IR (wavenumber; 
4000-14000cm-1) according to their connection to the visible spectrum of light (Guerra et al. 
1996). The degree of conversion and polymerisation rate (for unfilled resin systems) of each 
sample were recorded at an acquisition rate of 10s-1 and spectra taken at an 8cm-1 wavenumber 
resolution,  3scans to average for 180sec. 
2.6.1 Real-time near infrared spectroscopy  
The real-time near infrared spectroscopy was used to analyse the degree of conversion and rate 
of polymerisation of unfilled resin systems using a Fourier transform infrared spectrometer (FT-
IR) (Nicolet 6700, Thermo Scientific). There were two types of unfilled resin systems analysed 
based on the chemical structure of the monomers used: a system based on bisGMA as the main 
monomer and another system based on UDMA as the main monomer. The uncured unfilled 
resin system formulation was gently pipetted at the base of a disc shaped mould (diameter: 
57 
 
10mm, height: 2mm) (which was placed on a glass slide) and carefully covered with another 
glass slide to avoid air inclusion and attain a flat surface for the specimen. This resin mixture 
was then exposed to a curing light for 40sec (Optilux 501, Sybron Dental Specialists Kerr, 
USA), to polymerise the resin monomer. Real time near infrared spectroscopy was used to 
measure the continuous change in absorbance of the =C-H group of monomers (wavenumber: 
6165cm-1) for bisGMA/TEGDMA unfilled resin systems and the C=O group (wavenumber: 
1730cm-1) for UDMA/TEGDMA unfilled resin systems (Guerra et al. 1996; Podgorski, 2010; 
Stansbury and Dickens, 2001) at room temperature, for 3min, with 3scans/spectrum and 8cm-1 
wavenumber resolution, utilising series run. During the measurement of the polymerisation of 
each unfilled resin system formulation, the infrared spectra were collected every 3sec (in this 
study). The light curing unit was manually switched on at 10sec (Figure 2.1). Then the 
conversion of the monomer to polymer was calculated for each unfilled resin system containing 
bisGMA/TEGDMA, UDMA/TEGDMA (Equation 2.1): 
Equation 2.1 DC%=1-
𝐹𝑖𝑛𝑎𝑙 𝑎𝑏𝑠𝑜𝑟𝑏𝑎𝑛𝑐𝑒
𝐼𝑛𝑖𝑡𝑖𝑎𝑙 𝑎𝑏𝑠𝑜𝑟𝑏𝑎𝑛𝑐𝑒
𝑥100 
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Figure 2.1 Schematic representation of a typical curve of the degree of conversion (%) of light 
curable dimethacrhylate resins over time (s). 
The rate of polymerisation was also calculated by dividing the change in the degree of 
conversion of the unfilled resin systems with the change in time (Figure 2.2). 
Equation 2.2 Rp=
𝐷𝐶𝑛−𝐷𝐶𝑛−1
𝑇𝑛−𝑇𝑛−1
, where 𝐷𝐶𝑛 representes the degree of conversion at time n, and 
𝑇𝑛 represents time at each point of analysis.  
 
Figure 2.2 Schematic representation of a typical curve of the rate of polymerisation of light 
curable dimethacrylate resins over time (s). 
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2.6.2 Mid infra-red spectroscopy 
Fourier transform infrared spectra in the mid-IR region was used to analyse the conversion of 
carbon double bonds to carbon single bonds of FRCs. This spectra was obtained using 
attenuated total reflection from un-polymerised 2mm thick FRC formulations. This ATR 
method can be employed with infrared spectroscopy to analyse samples in liquid or solid state. 
The Fourier transform mid-IR method employs the reflection of the infrared radiation at the 
lower specimen surface to calculate the DC of a material, in this case, the filled resin composites 
(Stansbury and Dickens, 2001). This method also requires reference bands, which are stable 
during polymerisation to normalise the spectra of the monomer and polymer. In this study, the 
reference band at 1716cm-1 (corresponding to the C=O group of urethane dimethacrylates) was 
used (Nomoto and Hirasawa 1999; Stansbury and Dickens). The same reference bands were 
used to determine the degree of conversion of PMMA. The uncured FRC formulation for each 
condition was carefully pipetted at the base of a disc shaped mould (diameter: 10mm; thickness 
2mm) (which was placed on the diamond tip of the FT-IR machine) and covered with acetate 
film (to prevent oxygen inhibition and attain a flat specimen). The uncured filled resin 
composite formulation was then exposed to a curing light for 40sec (Optilux 501, Sybron Dental 
Specialists Kerr, USA), to allow polymerisation of the resin monomer. Then, the conversion of 
the monomer to polymer of each FRC condition was calculated from the intensity at each band 
(Dewaele et al. 2006) (Equation 2.3): 
Equation 2.3 DC%=
1730𝑐𝑚−1/1716𝑐𝑚−1 cured 
1730𝑐𝑚−1/1716𝑐𝑚−1 uncured
𝑥100 
This method was used in Chapters 3 and 4. 
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2.7 Mechanical testing of unfilled resin systems and filled resin composites 
The mechanical properties of the unfilled resin systems, filled resin composites and PMMA 
were determined using the three point bend test, as described in the ISO standard protocol for 
polymer based restorations (ISO 4049). Each specimen bar was placed centrally on a support 
span of 20mm and loaded centrally using a blunt point tip. Each specimen bar was, then, 
subjected to load using a universal testing instrument (Instron 5544, UK) at a cross head speed 
of 1mm/min with a 2kN load cell to determine the strain and stress levels within each sample. 
Failure was initiated by tensile stresses acting on the lower convex surface of the specimen, 
when the specimen bars were subjected to loading (Hosseinalipour et al. 2010; Palin et al. 
2005). By producing a stress-strain graph, the fracture stress, the yield stress and the flexural 
modulus were determined for each sample. The elastic value provided information regarding 
the rigidity of a particular sample (the steeper the slope of the stress-strain graph, the more rigid 
the sample was). The width and the thickness of each sample bar were also measured using a 
micrometre scale accurate to 10µm. Equation 2.4 was employed for the calculation of the 
flexural stress of each sample condition: 
Equation 2.4 σ = 3PL 2bd⁄ ; 
The strain of each sample was calculated using Equation 2.5: 
Equation 2.5 ԑ = 6Dd L2⁄ ∗ 100; 
where P=load at fracture, L=support span, b=specimen width, d=specimen thickness, 
D=midspan deflection. 
The calculation of the flexural modulus of each sample condition was calculated using Equation 
2.6: 
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Equation 2.6 E = σ ԑ;⁄  
where σ=stress and ԑ=strain (Palin et al. 2005).  
This method was employed in Chapters 3, 4 and 6.  
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CHAPTER 3 DEVELOPMENT OF UNFILLED RESIN SYSTEMS FOR 
ORTHOPAEDIC RESIN-BASED COMPOSITE CEMENTS 
3.1 Introduction 
The majority of orthopaedic cements are chemically cured by the mixture of two or more 
components using a set curing time relevant for different specific applications. For example a 
cement that hardens in less than 5 minutes after the mixture of components may be suitable for 
spinal repair, however, it may be unsuitable for the repair of cranial injuries where more time 
may be required by the surgeon to mould the cement in the desired shape. By introducing a 
material that command sets following exposure to intense blue light, this time constraint may 
be removed. The surgeon is then able to harden the material only when the desired shape and 
appropriate placement have been achieved. Such materials that harden upon light exposure are 
frequently used in dental applications as components in tooth filling materials, adhesives and 
sealants. These materials are monomers (including bisGMA (bisphenol-a-
glycidyldimethacrylate), UDMA (urethane dimethacrylates), TEGDMA (triethylene glycol 
dimethacrylate)), which by the addition of suitable photo-initiator systems (such as 
diketone/amine) form a cross-linked polymer network following light activation (chemical 
structures of those used in the current study are presented in Figure 3.1) (Sideridou et al. 2002).  
Resins systems can be further developed by varying the amount and type of monomers used to 
enable modification of viscosity that may enable suitability for different orthopaedic 
applications such as bone void fillings or cranio-facial repair surgeries. The viscosity of the 
resin systems is influenced by the chemical structure and molecular weight of the monomers 
and has an impact on the polymerisation kinetics and the cross-linkage of the polymer network 
(Cornelio et al. 2013; Ferracane et al. 1985; Floyd and Dickens 2006; Kalachandra et al. 1997). 
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Moreover, adjusting the viscosity of the resin system by varying the monomer ratios may have 
an impact on the mechanical and physical properties of the set composite materials (Gajewski 
et al. 2012; Goncalves et al. 2009).
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Figure 3.1 Chemical structures of the 3 different monomers and the photo-initiator system employed in this study (adapted from Asmussen et al. 
2009; Ikemura and Endo, 2010).
67 
 
By increasing the concentration of TEGDMA in unfilled resin systems containing 
bisGMA/TEGDMA monomers, the viscosity of the system is reduced and the concentration of 
double bonds available for conversion increased, resulting in increased degree of conversion 
(DC) (percentage of carbon double bonds converted to carbon single bonds during 
polymerisation) of the monomer to a three dimensional polymer network (Cornelio et al. 2013; 
Ferracane et al. 1985). However, an increase in TEGDMA concentration in bisGMA/TEGDMA 
unfilled resin systems may lead to a decrease in mechanical strength due to a decrease in 
aromatic rings (present in the bisGMA molecule) and an increase in ether groups (present in 
the TEGDMA molecule) (Asmussen and Peutzfeldt 1998; Barszczewska-Rybarek 2009; 
Emami and Soderholm 2009; Floyd and Dickens 2006; Gajewski et al. 2012; Goncalves et al. 
2009; Lovell et al. 1999). For unfilled resin systems containing UDMA and TEGDMA 
monomers, an increase in UDMA concentration results in increased mechanical strength and 
possibly degree of conversion due to the presence of urethane groups, which lead to increased 
flexibility of such unfilled resin systems (Asmussen and Peutzfeldt 1998; Barszczewska-
Rybarek 2009; Emami and Soderholm 2009; Floyd and Dickens 2006; Gajewski et al. 2012; 
Goncalves et al. 2009; Lovell et al. 1999).   
The aims of this chapter were to analyse the effect of different concentrations of three 
commonly used monomers in dental applications (namely bisGMA, UDMA, TEGDMA) on 
their physical and mechanical properties to determine whether comparable results with the ones 
conducted in previous studies are obtained and to develop the basis for possible formulations 
that may be employed as the base for cements in orthopaedic applications. The degree of 
conversion, rate of polymerisation (RP), hardness (physical characteristics) and the flexural 
strength (FS) and modulus (FM) (mechanical properties) were analysed to determine suitable 
formulations for filled resin composites that may have usage in orthopaedic applications.   
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3.2 Materials and Methods 
3.2.1 Synthesis of unfilled resin systems 
All monomers were sourced from Sigma Aldrich, UK and used without modification unless 
otherwise stated (Table 3.1).  
 
Table 3.1 Properties of monomers used in this study. The viscosity, concentration of double 
bonds, molecular mass and density, all have an impact on the mechanical and physical 
properties of the final unfilled resin system. 
Three types of unfilled resin systems were synthesised for analysis: two co-monomers 
containing UDMA/TEGDMA or bisGMA/TEGDMA and a ter-monomer containing 
bisGMA/UDMA/TEGDMA to determine a suitable unfilled resin system by mixing different 
concentrations of the most common monomers (Ekworapoj et al. 2002) in different 
concentrations to which bioactive glass can be added to form a filled resin composite for use in 
orthopaedic applications. The ter-monomer system was tested to determine whether the 
addition of UDMA (which exhibits increased flexibility and decreased viscosity) to resins 
containing bisGMA/TEGDMA can enhance the degree of conversion, flexural strength and 
flexural modulus of such resins. The photo-initiator system was composed of CQ 
(camphorquinone) and a co-initiator (DMAEMA (2 dimethylaminoethylmethacrylate)). The 
concentrations used to synthesise the organic matrix of the unfilled resin systems were: 20/80; 
30/70; 40/60; 50/50; 60/40; 70/30; 80/20wt% UDMA/TEGDMA or bisGMA/TEGDMA or 
30/60/10; 20/60/20; 10/60/30; 40/50/10; 30/50/20; 20/50/30; 10/50/40; 50/40/10; 50/30/20; 
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50/20/30; 50/10/40wt% bisGMA/UDMA/TEGDMA. 100wt% UDMA, 100wt% bisGMA and 
100wt% TEGDMA were used as controls. The photo-initiator system was added to either 
UDMA/TEGDMA, bisGMA/TEGDMA, or bisGMA/UDMA/TEGDMA formulations in 
proportion of 0.2wt% CQ (this value was selected to ensure the initiator was completely 
consumed during the polymerisation reaction (Lovell et al. 2003) and 0.8wt% DMAEMA. Each 
unfilled resin system formulation was mixed in a beaker on a magnetic stirrer at 60°C for 30min 
covered with aluminium foil (to avoid photo-curing as a result of ambient light). The unfilled 
resin system formulations were stored in a lightproof container at 4°C to avoid premature photo-
curing prior to further testing.  
For the analysis of the degree of conversion and rate of polymerisation of unfilled resin systems 
refer to Chapter 2, Section 2.6 
3.2.2 Mechanical properties: Hardness testing of unfilled resin systems  
Hardness testing refers to the property of a given material to resist surface plastic deformation. 
The unfilled resin systems mixture was placed into disc shaped molds (diameter: 10mm, height: 
2mm) between acetate sheets (to minimise the effects of oxygen inhibition) and cured using 
blue light (Optilux 501, Sybron Dental Specialists Kerr, USA ) for 40sec (Figure 3.2).   
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Figure 3.2 Experimental set-up for synthesis of disc shaped specimens. Each disc shaped 
specimen was cured for 40s using visible blue light curing and stored in a light proof container 
to avoid premature photo-curing prior to testing. 
Three discs containing unfilled resin systems were tested for each sample condition on both the 
upper (curing light applied to this surface of the disc) (n=3) and lower surface (n=3) and an 
average taken by using a hardness tester (Struers-Duramin, Glasgow, UK) to perform 6 Vickers 
indentations on each disc. This test assessed the hardness of specimens by determining the size 
of these indentations left on the surface of the specimen using a pyramid-shaped diamond 
indenter, which has a square base and a 136⁰ apex angle. Each unfilled resin system specimen 
disk was subjected to a load of 1.96N for 10sec applied to the pyramid indenter causing 
indentations that appeared as dark squares on a lighter background, when visualised using a 
microscope (integral to the equipment) (Hosseinalipour et al. 2010). The two diagonals of each 
square were measured and an average calculated as shown in Figure 3.3.  
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Figure 3.3 Diagram of Vickers hardness indentation appearance on the surface of a material 
(used to calculate the hardness value of each resin specimen). 
Equation 3.1 was applied to calculate the Vickers hardness values of the unfilled resin systems: 
Equation 3.1 𝐻𝑉 = 1.854𝑥𝐹 𝑑2⁄ ; 
where HV is the hardness Vickers number in kg/mm2, F is the force applied to the specimen 
and d2 represents the surface area determined by taking the average of the 2 diagonals of the 
square left by the indenter in µm (Hosseinalipour et al. 2010). The hardness value of each disc 
containing unfilled resin systems was calculated on both the upper surface and the lower surface 
to determine the extent of cure of each unfilled resin system formulation condition.  
For the preparation and light curing of specimens for mechanical testing and the analysis of 
flexural strength and modulus using the three point bend test refer to Chapter 2, Section 2.5 and 
Section 2.7. 
3.2.3 Statistical analysis 
Minitab statistical software (Minitab, UK) was used to analyse the data using one-way analysis 
of variance (ANOVA) test. An Anderson-Darling test was used to determine whether the data 
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followed a normal distribution. Tukey’s post hoc tests were used for pair-wise comparison using 
a significance value of P=0.05.  
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3.3 Results  
3.3.1 Physical properties: degree of conversion and rate of polymerisation of unfilled 
resin systems  
For analysis of significant differences between the degree of conversion of unfilled resin 
systems refer to Appendix 1, Tables 1.1-1.3. The DC of bisGMA/TEGDMA unfilled resin 
systems was significantly lower compared with the DC of UDMA/TEGDMA unfilled resin 
systems (p<0.005) (Figure 3.4). The bisGMA/TEGDMA unfilled resin system formulation 
concentrations that exhibited the highest DC were 30/70 (statistically higher compared with 
20/80 bisGMA/TEGDMA and 80/20 bisGMA/TEGDMA (p<0.001, p<0.001, respectively) and 
50/50wt% (statistically higher compared with 20/80 bisGMA/TEGDMA (P<0.001), 70/30 
bisGMA/TEGDMA (p=0.002) and 80/20 bisGMA/TEGDMA (p<0.001)); whereas the 
UDMA/TEGDMA unfilled resin systems exhibited a similar DC irrespective of the 
concentration of base monomers (Figure 3.4). The UDMA/TEGDMA unfilled resin systems 
exhibited a significantly higher DC compared with TEGDMA control resins (p<0.001). The 
bisGMA/TEGDMA unfilled resin systems, also, exhibited significantly higher DC compared 
with bisGMA control and TEGDMA control resins (p<0.001) (Figure 3.4).  
The DC of bisGMA/UDMA/TEGDMA unfilled resin systems increased with increasing 
concentration of TEGDMA and decreasing concentration of bisGMA. The unfilled resin system 
formulation containing 40/10/50wt% bisGMA/UDMA/TEGDMA exhibited significantly 
higher DC compared with all the ternary monomer unfilled resin systems studied (p<0.005) 
(Figure 3.5).  The DC of each unfilled resin system containing the highest amount of TEGDMA 
(30 or 40wt%) was significantly higher compared with the other unfilled resin system mixtures 
in each group tested (unfilled resin systems containing either 60wt%, 50wt% UDMA or 50wt% 
bisGMA) (p<0.035). Similarly, the DC of each unfilled resin systems containing the highest 
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amount of bisGMA (30 or 40wt%) was significantly lower compared with the other unfilled 
resin system mixtures in each group tested (unfilled resin systems containing either 60wt% or 
50wt% UDMA) (p<0.010). The highest DC in the present study was found to be 89%, which 
was exhibited by an unfilled resin system containing 40/60wt% UDMA/TEGDMA (Figure 
3.4). This value was also much higher than that of the DC of bisGMA/TEGDMA unfilled resin 
systems (75.1 for 30/70 bisGMA/TEGDMA unfilled resin system formulation) and 
bisGMA/UDMA/TEGDMA unfilled resin systems (82.02 for 10/50/40 
bisGMA/UDMA/TEGDMA unfilled resin system formulation) (Figures 3.4, 3.5).   
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Figure 3.4 Degree of conversion of TEGDMA based unfilled resin systems containing increasing concentration of either bisGMA or UDMA (BT 
or UT). Unfilled resin system percentage inclusions are shown within bar labels. * denotes statistical differences with unfilled resin systems 
containing 100wt% bisGMA; X denotes statistical differences with unfilled resin systems containing 100wt% UDMA. UDMA/TEGDMA unfilled 
resin systems exhibited increased degree of conversion compared with bisGMA/TEGDMA unfilled resin systems. Error bars indicate standard 
deviation over mean average of 3 samples. 
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Figure 3.5 Degree of conversion of unfilled resin systems containing bisGMA/UDMA/TEGDMA resins (BUT). Unfilled resin system percentage 
inclusions are shown within bar labels. * denotes statistical differences with unfilled resin systems containing 10/60/30wt% 
bisGMA/UDMA/TEGDMA; X denotes statistical differences with unfilled resin systems containing 10/50/40wt% bisGMA/UDMATEGDMA and 
l denotes statistical differences with unfilled resin systems containing 50/10/40wt% bisGMA/UDMA/TEGDMA. The degree of conversion 
increased with increasing concentration of TEGDMA. Error bars indicate standard deviation over mean average of 3 samples.
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For analysis of significant differences between the rate of polymerisation (RP) of unfilled resin 
systems refer to Appendix 1, Tables 1.4-1.6. The RP was significantly higher for 
UDMA/TEGDMA unfilled resin systems compared with bisGMA/TEGDMA unfilled resin 
systems (p<0.005). The addition of TEGDMA significantly increased the RP of unfilled resin 
systems containing bisGMA (p<0.001); compared with unfilled resin systems containing 
UDMA, which was only statistically smaller compared with 30/70 UDMA/TEGDMA 
(p=0.007) and 60/40 UDMA/TEGDMA (p<0.001). UDMA/TEGDMA unfilled resin systems 
exhibited an increasing RP with decreasing concentrations of TEGDMA used, whereas 
bisGMA/TEGDMA unfilled resin systems exhibited a similar RP regardless of the amount of 
TEGDMA present. The bisGMA/TEGDMA unfilled resin systems exhibited significantly 
higher RP compared with bisGMA and TEGDMA control resins (p<0.001); whereas 
UDMA/TEGDMA unfilled resin systems exhibited significantly higher RP compared with 
TEGDMA control resins (p<0.001). The maximum RP was achieved faster for 
bisGMA/TEGDMA unfilled resin systems compared with UDMA/TEGDMA unfilled resin 
systems in the co-monomer based resins (Table 3.2).  
BisGMA/UDMA/TEGDMA unfilled resin systems containing the highest concentration of 
UDMA exhibited the highest RP. The RP increased with increasing concentration of TEGDMA 
up to 30wt% TEGDMA for bisGMA/UDMA/TEGDMA unfilled resin systems containing 
50wt% UDMA, whereas, the RP decreased with increasing concentration of TEGDMA for 
bisGMA/UDMA/TEGDMA unfilled resin systems containing either 60wt% UDMA, or 50wt% 
bisGMA (Table 3.3). The unfilled resin system group containing the highest amount of bisGMA 
(50wt%) exhibited a significantly lower RP compared with all the bisGMA/UDMA/TEGDMA 
unfilled resin systems studied (p<0.033). The unfilled resin system containing 50/10/40wt% 
bisGMA/UDMA/TEGDMA exhibited significantly lower RP compared with all the 
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bisGMA/UDMA/TEGDMA unfilled resin systems studied (p<0.030), with the exception of the 
unfilled resin system containing 50/20/30wt% bisGMA/UDMA/TEGDMA (p=0.063). The RP 
was achieved faster for the bisGMA/UDMA/TEGDMA unfilled resin systems containing the 
highest amount of bisGMA (Table 3.3). 
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Table 3.2 The average time to the maximum RP and maximum DC of bisGMA/TEGDMA (B/T) or UDMA/TEGDMA (U/T) unfilled resin 
systems. The bisGMA/TEGDMA unfilled resin systems exhibited lower DC and RP compared with the UDMA/TEGDMA unfilled resin 
systems.
80 
 
 
Table 3.3 The average time to the maximum RP and maximum DC of bisGMA/UDMA/TEGDMA (BUT) unfilled resin systems. The unfilled 
resin systems containing the highest amount of bisGMA exhibited lower RP compared with all the TEGDMA/bisGMA/UDMA unfilled resins 
systems studied.
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3.3.2 Mechanical properties: Vickers hardness of unfilled resin systems 
For analysis of significant differences between the hardness values of unfilled resin systems 
refer to Appendix 1, Tables 1.7-1.15. Hardness values were analysed for both the upper and 
lower surface of the unfilled resin system specimen (Figure 3.6). The UDMA/TEGDMA 
unfilled resin system exhibited higher hardness values on their upper and lower surface 
compared with bisGMA/TEGDMA unfilled resin systems. The bisGMA/TEGDMA unfilled 
resin system exhibited significantly different values for hardness compared with each other, 
with the 60/40 bisGMA/TEGDMA unfilled resin system exhibiting the highest value of 
hardness of all unfilled resin systems containing bisGMA tested (p<0.001). Unfilled resin 
systems containing 70/30wt% UDMA/TEGDMA exhibited the highest hardness value of all 
unfilled resin systems specimens tested on both the upper and lower surface (p<0.033), with 
the exception of 70/30 UDMA/TEGDMA (lower surface), which was statistically similar 
(p=0.532). 100wt% bisGMA control resin exhibited the lowest value for hardness, when both 
surfaces were tested (p<0.001) (Figure 3.6). BisGMA/TEGDMA unfilled resin systems 
exhibited significantly lower hardness values compared with TEGDMA control resins 
(p<0.001); whereas UDMA/TEGDMA unfilled resin systems exhibited significantly higher 
hardness values compared with the TEGDMA control resins (p<0.001) (Figure 3.6). The 60/40 
bisGMA/TEGDMA unfilled resin system exhibited the highest value of hardness of all unfilled 
resin systems containing bisGMA (p<0.001). BisGMA/TEGDMA unfilled resin systems 
exhibited significantly lower hardness values compared with TEGDMA control resins 
(p<0.001); whereas UDMA/TEGDMA unfilled resin systems exhibited significantly higher 
hardness values compared with the TEGDMA control resins (p<0.001) (Figure 3.6). 
The lowest hardness value of bisGMA/UDMA/TEGDMA unfilled resin systems containing 
60wt% UDMA was exhibited by the unfilled resin system containing the smallest amount of 
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TEGDMA (10wt%) on both the upper and lower surface (p<0.001). The hardness value 
increased with increasing concentration of TEGDMA up to 30wt%, which was significantly 
higher compared with all the ter-monomer unfilled resin systems containing 50wt% UDMA 
(p<0.001) (Figure 3.7). The hardness value of the ter-monomer unfilled resin systems 
containing 50wt% bisGMA followed a similar trend to the unfilled resin systems containing 
50wt% UDMA. Thus, the hardness value increased with increasing concentration of TEGDMA 
up to 30wt%, which was significantly higher compared with all the ter-monomer unfilled resin 
systems containing 50wt% bisGMA (p<0.001) (Figure 3.7).  
The hardness values were significantly higher on the upper side compared with the lower side 
of bisGMA/TEGDMA, UDMA/TEGDMA and bisGMA/UDMA/TEGDMA unfilled resin 
systems (p<0.001) (Figures 3.6, 3.7). 
For analysis of correlation between the degree of conversion and hardness values of unfilled 
resin systems refer to Appendix 6, Tables 6.1-6.28. There was a strong positive correlation 
between the degree of conversion and hardness values (upper surface) of unfilled resin systems 
containing 20/80wt% UDMA/TEGDMA (r=0.630), 40/60wt% UDMA/TEGDMA (r=0.907), 
50/50wt% UDMA/TEGDMA (r=0.956), 60/40wt% UDMA/TEGDMA (r=0.870), 40/60/0wt% 
bisGMA/TEGDMA (r=0.905), 50/50wt% bisGMA/TEGDMA (r=0.998), 80/20wt% 
bisGMA/TEGDMA (r=0.816), 100wt% bisGMA (r=0.807), 40/50/10wt% 
bisGMA/UDMA/TEGDMA (r=0.811), 30/50/20wt% bisGMA/UDMA/TEGDMA (r=0.860), 
20/50/30wt% bisGMA/UDMA/TEGDMA (r=0.958) (Figure 3.8). 
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Figure 3.6 Hardness values of the upper (US) and lower (LS) surfaces of TEGDMA based unfilled resin systems containing increasing 
concentration of bisGMA (BT) or UDMA (UT). Unfilled resin system percentage inclusions are shown within bar labels. * denotes statistical 
differences with unfilled resin systems containing 100wt% bisGMA; X denotes statistical differences with unfilled resin systems containing 
100wt% UDMA (for both upper and lower surfaces). bisGMA/TEGDMA unfilled resin systems exhibited similar hardness values on both surfaces, 
whereas UDMA/TEGDMA unfilled resin systems exhibited increased hardness on the upper surface compared with the lower surface. Error bars 
indicate standard deviation of a mean average of 3 samples.
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Figure 3.7 Hardness values of the upper (US) and lower (LS) surfaces of bisGMA/UDMA/TEGDMA unfilled resin systems (BUT). Unfilled resin 
system percentage inclusions are shown within bar labels. * denotes statistical differences with unfilled resin systems containing 10/60/30wt% 
bisGMA/UDMA/TEGDMA; X denotes statistical differences with unfilled resin systems containing 10/50/40wt% bisGMA/UDMATEGDMA and 
l denotes statistical differences with unfilled resin systems containing 50/10/40wt% bisGMA/UDMA/TEGDMA (for both upper and lower 
surfaces). Increased concentration of TEGDMA resulted in increased hardness on the upper surface of these unfilled resin systems up to 30wt% 
TEGDMA. Error bars indicate standard deviation of a mean average of 3 samples. 
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Figure 3.8 Pearson correlation between the degree of conversion and hardness values of unfilled resin systems containing bisGMA/TEGDMA 
(BT), UDMA/TEGDMA (UT), or bisGMA/UDMA/TEGDMA (BUT). Unfilled resin system percentage inclusions are shown within labels. There 
was a strong positive correlation between the degree of conversion and hardness values of unfilled resin systems containing 60/40 
UDMA/TEGDMA (r=0.870). 
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3.3.3 Mechanical properties: flexural strength and modulus analysis of unfilled resin 
systems 
For analysis of significant differences between the flexural strength (FS) of unfilled resin 
systems refer to Appendix 1, Tables 1.16-1.18. The highest FS value of bisGMA/TEGDMA 
unfilled resin systems was exhibited by those containing 70/30 bisGMA/TEGDMA (only 
significantly higher compared with 20/80 bisGMA/TEGDMA (p<0.001) and 80/20 
bisGMA/TEGDMA (p=0.001)); whereas 50/50 UDMA/TEGDMA unfilled resin system 
exhibited the highest FS values of UDMA/TEGDMA unfilled resin systems (significantly 
higher compared with 80/20 UDMA/TEGDMA (p=0.012), 40/60 UDMA/TEGDMA 
(p=0.023), 60/40 UDMA/TEGDMA (p=0.007), 70/30 UDMA/TEGDMA (p<0.001) and 80/20 
UDMA/TEGDMA (p<0.001). The FS of bisGMA/TEGDMA unfilled resin systems was 
significantly higher compared with the bisGMA control resin (p<0.001). The 40/60, 50/50, 
60/40 and 70/30 bisGMA/TEGDMA unfilled resin systems exhibited significantly higher FS 
values compared with TEGDMA control resin (p<0.005). All the UDMA/TEGDMA unfilled 
resin systems exhibited higher FS values compared with TEGDMA control resin (p<0.005), 
with the exception of 20/80 (which was significantly lower: p<0.001) and 80/20 (statistically 
similar: p=615) UDMA/TEGDMA unfilled resin systems. The FS of all UDMA/TEGDMA 
unfilled resin systems was significantly higher compared with UDMA control resin (p<0.001), 
with the exception of 20/80 (significantly lower: p<0.001) and 80/20 (statistically similar: 
p=0.561) UDMA/TEGDMA resins (Figure 3.9).  
Except of 20/80wt% UDMA/TEGDMA, the bisGMA/UDMA/TEGDMA unfilled resin 
systems exhibited decreased FS compared with UDMA/TEGDMA unfilled resin systems 
(Figures 3.9, 3.10).  For the ter-monomer unfilled resin systems containing 60wt% UDMA, the 
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highest FS was exhibited by the unfilled resin system containing equal amount of bisGMA and 
TEGDMA monomers (p<0.048) (Figure 3.10).  
For analysis of correlation between the degree of conversion and flexural strength values of 
unfilled resin systems refer to Appendix 6, Tables 6.1-6.28. There was a strong positive 
correlation between the degree of conversion and flexural strength values of unfilled resin 
systems containing 20/80wt% bisGMA/TEGDMA (r=0.980), 30/70wt% bisGMA/TEGDMA 
(r=1.000), 50/50wt% bisGMA/TEGDMA (r=1.000), 80/20wt% bisGMA/TEGDMA (r=0.651), 
100wt% bisGMA (r=0.983), 20/60/20wt/% bisGMA/UDMA/TEGDMA (r=0.955), 
20/50/30wt% bisGMA/UDMA/TEGDMA (r=0.867), 50/20/30wt% 
bisGMA/UDMA/TEGDMA (r=0.931) (Figure 3.11).  
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Figure 3.9 Flexural strength of TEGDMA based resins containing increasing concentration of bisGMA or UDMA.  Unfilled resin system percentage 
inclusions are shown within bar labels. Error bars indicate standard deviation of a mean average of 10 samples. * denotes statistical differences 
with unfilled resin systems containing 100wt% bisGMA; X denotes statistical differences with unfilled resin systems containing 100wt% UDMA. 
UDMA/TEGDMA unfilled resin systems exhibited higher flexural strength compared with bisGMA/TEGDMA unfilled resin systems.
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Figure 3.10 Flexural strength of bisGMA/UDMA/TEGDMA unfilled resin systems (BUT). Unfilled resin system percentage inclusions are shown 
within bar labels.  Error bars indicate standard deviation of a mean average of 10 samples. For the unfilled resin systems containing 60 or 50wt% 
UDMA, the flexural strength increased with increasing concentration of TEGDMA up to 20wt%.* denotes statistical differences with unfilled resin 
systems containing 10/60/30wt% bisGMA/UDMA/TEGDMA; X denotes statistical differences with unfilled resin systems containing 
10/50/40wt% bisGMA/UDMATEGDMA and l denotes statistical differences with unfilled resin systems containing 50/10/40wt% 
bisGMA/UDMA/TEGDMA 0wt% TEGDMA. 
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Figure 3.11 Pearson correlation between the degree of conversion and flexural strength values of unfilled resin systems containing 
bisGMA/TEGDMA (BT), UDMA/TEGDMA (UT), or bisGMA/UDMA/TEGDMA (BUT). Unfilled resin system percentage inclusions are shown 
within labels. There was a strong negative correlation between the degree of conversion and flexural strength values of unfilled resin systems 
containing 60/40 UDMA/TEGDMA (r=-0.999).
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For analysis of significant differences between the flexural modulus (FM) of unfilled resin 
systems refer to Appendix 1, Tables 1.19-1.21. The highest FM value of bisGMA/TEGDMA 
unfilled resin systems was exhibited by those containing 70/30 bisGMA/TEGDMA 
(significantly higher compared with 20/80 bisGMA/TEGDMA (p=0.001)); whereas 50/50 
UDMA/TEGDMA exhibited the highest FM values of UDMA/TEGDMA unfilled resin 
systems (statistically higher compared with 20/80 UDMA/TEGDMA (p=0.006), 60/40 
UDMA/TEGDMA (p=0.012), 70/30 UDMA/TEGDMA (p<0.001) and 80/20 
UDMA/TEGDMA (p<0.001)). The FM of bisGMA/TEGDMA unfilled resin systems was 
significantly higher compared with the bisGMA control resin (p<0.001). All the 
bisGMA/TEGDMA unfilled resin systems exhibited higher FM values compared with 
TEGDMA control resins (p<0.005) with the exception of 20/80 (statistically similar: p=0.222) 
and 80/20 (statistically similar: p=0.145,) bisGMA/TEGDMA unfilled resin system. All the 
UDMA/TEGDMA unfilled resin systems exhibited higher FM values compared with 
TEGDMA control resin (p<0.050), with the exception of 80/20 (statistically similar: p=0.387) 
UDMA/TEGDMA unfilled resin systems. The FM of all UDMA/TEGDMA unfilled resin 
systems was significantly higher compared with UDMA control resin (p<0.005), with the 
exception of 80/20 (statistically similar: p=0.511) UDMA/TEGDMA unfilled resin system 
(Figure 3.12). 
However, the bisGMA/UDMA/TEGDMA unfilled resin systems exhibited decreased FM 
compared with UDMA/TEGDMA unfilled resin systems (Figure 3.11). For the ter-monomer 
unfilled resin systems containing 60wt% UDMA, the highest FM was exhibited by the unfilled 
resin system containing equal amount of bisGMA and TEGDMA monomers (p<0.005) (Figure 
3.13).   
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For analysis of correlation between the degree of conversion and flexural modulus values of 
unfilled resin systems refer to Appendix 6, Tables 6.1-6.28. There was a strong positive 
correlation between the degree of conversion and flexural modulus values of unfilled resin 
systems containing 60/40wt% UDMA/TEGDMA (r=0.788), 20/80wt% bisGMA/TEGDMA 
(r=0.999), 30/70wt% bisGMA/TEGDMA (r=0.995), 80/20wt% bisGMA/TEGDMA (r=0.619), 
100wt% bisGMA (r=0.998), 20/6020wt% bisGMA/UDMA/TEGDMA (r=0.996),   
30/50/20wt% bisGMA/UDMA/TEGDMA (r=0.632), 50/30/20wt% 
bisGMA/UDMA/TEGDMA (r=0.816) (Figure 3.14).
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Figure 3.12 Flexural modulus of TEGDMA based unfilled resin systems containing increasing concentration of either bisGMA (BT) or UDMA 
(UT). Unfilled resin system percentage inclusions are shown within labels. Error bars indicate standard deviation of a mean average of 10 samples. 
* denotes statistical differences with unfilled resin systems containing 100wt% bisGMA; X denotes statistical differences with unfilled resin 
systems containing 100wt% UDMA. The bisGMA/TEGDMA unfilled resin systems exhibited similar values for flexural modulus compared with 
UDMA/TEGDMA unfilled resin systems. 
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Figure 3.13 Flexural modulus of bisGMA/UDMA/TEGDMA unfilled resin systems (BUT). Unfilled resin system percentage inclusions are shown 
within bar labels.  Error bars indicate standard deviation of a mean average of 10 samples. * denotes statistical differences with unfilled resin 
systems containing 10/60/30wt% bisGMA/UDMA/TEGDMA; X denotes statistical differences with unfilled resin systems containing 
10/50/40wt% bisGMA/UDMATEGDMA and l denotes statistical differences with unfilled resin systems containing 50/10/40wt% 
bisGMA/UDMA/TEGDMA. The flexural modulus increased with increasing concentration of TEGDMA for the unfilled resin systems containing 
50wt% bisGMA. 
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Figure 3.14 Pearson correlation between the degree of conversion and flexural modulus values of unfilled resin systems containing 
bisGMA/TEGDMA (BT), UDMA/TEGDMA (UT), or bisGMA/UDMA/TEGDMA (BUT). Unfilled resin system percentage inclusions are shown 
within labels. There was a strong positive correlation between the degree of conversion and flexural modulus values of unfilled resin systems 
containing 60/40 UDMA/TEGDMA (r=0.788).
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3.4 Discussion 
3.4.1 Physical properties of the unfilled resin systems 
DC is dependent upon the structure and concentration of the monomers present, with monomers 
exhibiting increased flexibility in their molecular structure having higher degree of conversion 
values (Asmussen and Peutzfeldt 1998). Due to the formation of a highly cross-linked polymer 
network that limits the mobility of reacting radicals following polymerisation, the DC of 
unfilled photo-polymerisable dimethacrylate resin systems can never reach 100% without 
increased temperature and pressure and is normally in the range of 55-75% (Cornelio et al. 
2013; Emami and Soderholm 2009; Ferracane et al. 1985). The conversion of such unfilled 
resin systems as those analysed in the current study (Tables 3.2, 3.3) might have been due to 
the chemical structure of the monomers (Figure 3.1) and the kinetics of the polymerisation 
reaction. Incomplete conversion of carbon double to single bonds shows that there is a 
significant amount of residual monomer (in the range of 20 to 50%) in the polymeric network 
following photo-curing (Cornelio et al. 2013; Lovell et al. 2003). The chemical structure and 
viscosity of the unfilled resin system mixtures significantly affected not only the DC, but also 
the RP of these unfilled resin systems.  
The molecular structure of monomers also had an impact on the DC, with monomers that had 
decreased size such as UDMA and TEGDMA (Figure 3.1) exhibiting lower molecular weight 
and increased concentration of double bonds compared with bisGMA monomers (Moszner et 
al. 2008). bisGMA consists of a relatively stiff isopropylidene-diphenoxy central core and 
hydroxyl groups that caused steric hindrance and lack of chain mobility causing diffusion 
controlled kinetics directly following light irradiation (Floyd and Dickens 2006; Lovell et al. 
1999). For this reason and due to the rigidity of bisGMA molecules, DC was limited prior to 
the maximum RP for unfilled resin systems containing 100wt% bisGMA, which occurred less 
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for unfilled resin systems containing 100wt% UDMA, the latter also exhibited the highest DC 
compared with resins  containing 100wt% bisGMA or 100wt% TEGDMA (Figure 3.4, Table 
3.2).  
The higher DC of unfilled resin systems containing 100wt% UDMA compared with that of 
100wt% TEGDMA (DC = 76 and 30%, respectively) (Figure 3.4) might be explained by the 
chain transfer reactions of the NH groups of the UDMA molecule (Equation 3.2):  
Equation 3.2  𝑀𝑛 +  −𝑁𝐻− →  𝑀𝑛𝐻 +  −𝑁 −; where 𝑀𝑛 is a microradical, −𝑁𝐻 − can be 
part of either a monomer or polymer molecule and −𝑁 − is the newly formed radical (Pfeifer 
et al. 2009; Sideridou et al. 2002).  
The presence of NH groups in the UDMA molecule also led to increased viscosity of the 
UDMA/TEGDMA unfilled resin systems during polymerisation (Pfeifer et al. 2009; Sideridou 
et al. 2002). 
The increased polymerisation reactivity of unfilled resin systems containing UDMA (Tables 
3.2, 3.3) might have also been due to these chain transfer reactions (Sideridou et al. 2002). 
Moreover, increased concentration of UDMA (up to 70wt%) (Figure 3.4) resulted in higher DC 
due to the presence of aliphatic spacer groups, which led to stronger hydrogen bonding 
interactions between the imino group of UDMA and the carbonyl group of the co-monomer 
(Pfeifer et al. 2009). Nonetheless, due to the increased viscosity of samples containing more 
than 70wt% UDMA, the movement of free radicals to functional monomer groups might have 
been restricted leading to decreased DC (Figure 3.4), which concurs with previous research 
using UDMA/TEGDMA unfilled resin systems (Sideridou et al. 2002). This restriction in 
radical movement also resulted in lower polymerisation rate of methacrylate double bonds and 
finished prior to conversion of all carbon double bonds to single bonds because of vitrification 
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of the resin network (Table 3.2), which concurs with previous research (Palin et al. 2003). 
Recently, unfilled resin systems containing UDMA/TEGDMA were found to exhibit an 
increased degree of polymer conversion compared with bisGMA/TEGDMA unfilled resin 
systems (Moszner et al. 2008). Indeed, only a relatively small increase in UDMA resulted in a 
significant rise in RP and DC owing to its higher reactivity compared with bisGMA using 
similar diluent ratios including for unfilled resin systems containing 
bisGMA/UDMA/TEGDMA monomers (Figures 3.4, 3.5; Tables 3.2, 3.3). Moreover, stronger 
hydrogen bonding conferred by the UDMA molecule and increased concentration of double 
bonds given by the TEGDMA molecule of unfilled resin systems containing 
bisGMA/UDMA/TEGDMA in the organic matrix likely led to higher values for the DC of these 
unfilled resin systems compared with bisGMA/TEGDMA unfilled resin systems (Figure 3.5), 
which concurs with previous research (Sideridou et al. 2002). However, the addition of UDMA 
to unfilled resin systems containing TEGDMA/bisGMA did not increase the DC compared with 
UDMA/TEGDMA unfilled resin systems, which might be explained by the increased viscosity 
and lower flexibility conferred by the bisGMA molecule to this unfilled resin system (Figures 
3.4, 3.5). 
When TEGDMA was incorporated into unfilled resin systems containing bisGMA the viscosity 
of the system decreased, which led to increased movement of free radicals and an off-set of the 
diffusion controlled propagation during polymerisation (Lovell et al. 1999). This also led to 
increased DC with increasing concentration of TEGDMA for bisGMA/TEGDMA unfilled resin 
systems (Figure 3.4), which concurs with previous research (Asmussen and Peutzfeldt 2002). 
Moreover, bisGMA/TEGDMA unfilled resin systems that contained decreased amounts of 
TEGDMA exhibited decreased DC (Figure 3.4) due to a more rapid on-set of auto-acceleration, 
which severely hindered the mobility of free radicals (Tanimoto et al. 2005). These data further 
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demonstrated the negative impact of bisGMA on the DC of the final polymer even when used 
in combination with UDMA and TEGDMA (Figure 3.5). This low conversion might have been 
due to the high viscosity of the bisGMA molecule (Table 3.1) conferred by the π-π interactions 
of the aromatic rings in its chemical structure, resulting in decreased flexibility therefore low 
mobility of radicals during polymerisation reaction. The low DC of unfilled resin systems 
containing bisGMA (Figure 3.4) might also have been due to the low mobility of radicals, which 
might have led the resin mixture to reach the gelation stage at lower conversion of carbon 
double bonds during polymerisation (Gajewski et al. 2012).    
3.4.2 Mechanical properties: Vickers hardness of the unfilled resin systems 
DC refers to the amount of polymer formed during the polymerisation reaction, whereas 
hardness refers to the ability of a material to resist wear.  Indirectly, the hardness test also assess 
the brittleness of a material, because the harder a material, the brittle it is. The hardness of 
unfilled resin systems provides information about longevity (shelf life) of such systems and is 
influenced by the chemical structure and weight ratio of the monomers present (Ekworapoj et 
al. 2002).  
Both the bisGMA/TEGDMA and the UDMA/TEGDMA unfilled resin systems exhibited 
relatively constant DC, whereas hardness values increased up to 60/40wt% bisGMA/TEGDMA 
or UDMA/TEGDMA followed by a decrease. The decrease in hardness values of unfilled resin 
systems containing >60wt% bisGMA/TEGDMA or UDMA/TEGDMA might have been due to 
increased viscosity of the system, decreased mobility of the free radicals and lower cross-
linking density of the polymer network (Lovell et al. 2001). For unfilled resin systems 
containing bisGMA/UDMA/TEGDMA, the DC increased with increasing concentration of 
TEGDMA, whereas the hardness values increased up to a maximum amount of TEGDMA of 
30wt% for unfilled resin systems containing either 50wt% bisGMA or 50wt% UDMA and up 
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to 20wt% TEGDMA for unfilled resin systems containing 60wt% UDMA. The lowest 
concentration of carbon double bonds was exhibited by the Bis-GMA molecule possibly due to 
its relatively stiff bisphenol A core and two pendant hydroxyl groups, which formed strong 
hydrogen bonds. Thus, the bisGMA/TEGDMA unfilled resin systems exhibited the lowest 
hardness values (Figure 3.6).   
The analysis of the hardness values of both the upper and lower surface of unfilled resin systems 
provided information about the extent of cure of such systems. There was a >1% decrease in 
the hardness values for the lower surface compared with the upper surface of unfilled resin 
systems (Figures 3.6, 3.7). The higher hardness values observed for the upper surface compared 
with the lower surface of bisGMA/TEGDMA, UDMA/TEGDMA or 
bisGMA/UDMA/TEGDMA unfilled resin systems (Figures 3.6, 3.7) might be explained by the 
optical characteristics (refractive index and light transmission through depth) of the final 
polymer network. The larger difference between upper and lower surfaces of 
bisGMA/UDMA/TEGDMA unfilled resin systems compared with bisGMA/TEGDMA, 
UDMA/TEGDMA unfilled resin systems may be due to a more pronounced decrease in light 
transmission and an increase in light scattering and opacity with increasing depth of the resin, 
possibly because of a significant increase in refractive index during the polymerisation reaction 
of such unfilled resin systems.  
3.4.3 Mechanical properties: flexural strength and modulus of the unfilled resin systems 
Mechanical properties of dimethacrylate unfilled resin systems were influenced by the DC and 
the formation of a three-dimensional network of the final polymer (Gajewski et al. 2012). While 
hardness tests provided information about “localised, non-uniform deformation”, flexure tests 
provided information about the fracture of the entire specimen when subjected to loading 
(Hosseinalipour et al. 2010).   
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The increased viscosity and rigidity of the bisGMA molecule might have been responsible for 
the decreased strength and modulus of unfilled resins systems containing 100wt% bisGMA 
compared with 100wt% UDMA, or 100wt% TEGDMA (Figures 3.9, 3.10, 3.12, 3.13), because 
of the restriction in radical movement during the polymerisation reaction and relatively stiff 
polymer network formation upon light irradiation (Barszczewska-Rybarek 2009; Gajewski et 
al. 2012). However, the addition of TEGDMA to unfilled resin systems containing bisGMA 
resulted in increased FS, which might have been due to increased flexibility conferred by the 
TEGDMA monomer to the free radicals during the polymerisation reaction (because of 
decreased viscosity and increased reactivity), while still retaining the formation of a stiff 
polymer network (Figure 3.9). The increased FS of unfilled resin systems containing 
bisGMA/TEGDMA compared with resins containing only bisGMA may also be a result of the 
increased degree of conversion of such resins; possibly because of increased concentration of 
carbon double bonds available for conversion with the introduction of the TEGDMA monomer 
to the unfilled resin system containing bisGMA. The increase in FS for unfilled resin systems 
containing bisGMA/TEGDMA occurred up to 70wt% TEGDMA, with unfilled resin systems 
containing 20/80wt% bisGMA/TEGDMA exhibiting lower FS, which might have been due to 
the ability of the TEGDMA molecule to cyclise (as a result of the presence of ether linkages in 
its molecular structure), leading to decreased cross-linkage and network formation (Figure 3.9). 
BisGMA/TEGDMA unfilled resin systems exhibited lower FS and FM values compared with 
unfilled resin systems containing UDMA/TEGDMA (Figures 3.9, 3.12), which might have 
been due to increased flexibility of the UDMA molecule and higher degree of crosslinking in 
the polymer network of these latter unfilled resin system formulations. The significant increase 
in FS and FM of unfilled resin systems containing up to 70:30wt% UDMA/TEGDMA was a 
result of increased cross-linked networks (Figures 3.9, 3.12), which is in agreement with 
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previous research (Berger et al. 2009). Moreover, when UDMA was added to unfilled resin 
systems containing bisGMA/TEGDMA, there was a marginal increase in FS, but not FM. This 
observation might be attributed to the decreased DC of carbon double bonds to single bonds 
due to bisGMA stiff backbone and high intermolecular interactions (Figures 3.10, 3.13), which 
is in agreement with previous research (Gajewski et al. 2012). However, compared with 
100wt% bis-GMA and 100wt% UDMA, 100wt% TEGDMA exhibited the highest FS and FM 
(Figures 3.9, 3.12), probably due to increased reactivity because of the presence of ether groups 
and cross-linkage of the polymer network (Pfeifer et al. 2009). 
The degree of conversion, rate of polymerisation, hardness, flexural strength and modulus of 
UDMA/TEGDMA unfilled resin systems were significantly higher compared with 
bisGMA/TEGDMA unfilled resin systems and bisGMA/UDMA/TEGDMA unfilled resin 
systems. Concentrations of 50/50, 60/40 and 70/30wt% UDMA/TEGDMA exhibited the most 
suitable values in terms of the properties studied (degree of conversion, rate of polymerisation, 
hardness, flexural strength and modulus). Further studies were performed on these 
UDMA/TEGDMA unfilled resin systems, with the 60/40wt% UDMA/TEGDMA concentration 
chosen for the incorporation of bioactive glass. 
3.5 Conclusions 
Physical and mechanical properties of unfilled resin systems containing bisGMA, UDMA, 
TEGDMA are influenced by the viscosity of the system as well as the chemical structure of the 
individual monomers, which has an impact on the mobility of the radicals during the 
polymerisation reaction. Unfilled resin systems containing UDMA/TEGDMA exhibited higher 
physical (DC and RP) and mechanical (hardness, FS and FM) compared with 
bisGMA/TEGDMA or bisGMA/UDMA/TEGDMA resins. These unfilled resin systems 
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containing UDMA/TEGDMA can further be optimised (Chapter 4) to develop new materials 
that exhibit similar or higher DC, RP, FS, FM compared with conventional resin systems. 
3.6 Limitations of present work and recommendations for future studies 
Only resins containing the amine-diketone photo-initiator system were tested. Future studies 
may involve the analysis of resin systems containing novel photo-initiator systems to increase 
the degree of conversion and mechanical properties (flexural strength) of such resins. 
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CHAPTER 4 DEVELOPMENT OF LOW AND HIGH VISCOSITY RESIN BASED 
COMPOSITES AND THEIR MECHANICAL AND PHYSICAL CHARACTERISTICS 
4.1 Introduction 
Orthopaedic applications involve the use of metallic implants to repair fractures and bone 
cements (such as calcium phosphates, acrylics and composites) to stabilise the metallic implants 
and fill gaps in the skeleton following trauma or as a result of congenital malformations 
(Stadelmann et al. 2010; Chang et al. 2010; Clarkin et al. 2009). These cements, however, need 
to be much improved to resemble the structure and functionality of bone tissue. By combining 
bioactive glass with unfilled resin systems, a bone cement may be developed, which exhibits 
direct bond to bone, reduced exothermicity during polymerisation and mechanical properties 
that closer match the adjacent bone compared with existing cements. A suitable unfilled resin 
system may consist of 60/40wt% UDMA/TEGDMA monomers and 1wt% photo-initiator 
system as it was determined in Chapter 3. The addition of filler particles to this system may 
lead to the development of a filled resin composite (FRC) material for orthopaedic applications. 
The size, type, morphology, chemical structure and amount of filler particles have a direct 
impact on the viscosity, physical and mechanical properties of the FRC material (Begum et al. 
2006; Masouras et al. 2008; Shen et al. 2004; Tanimoto et al. 2005). For chemical bonding, 
through the formation of covalent bonds between the organic resin matrix and the inorganic 
filler particles, a silane coupling agent may be added (Figure 4.1), which was, also, shown to 
increase the mechanical properties of the FRCs (Lin et al. 2000; Shen et al, 2004). Mechanical 
strength and hardness increase with an increase in the amount of filler present in the FRCs 
(Hosseinalipour et al. 2010; Masouras et al. 2008). 
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Figure 4.1 Illustration of the bonding between the silane coupling agent with the filler particles 
and the resin matrix in filled resin composite materials.  The silane coupling agent may lead to 
better chemical bonding between the filler particles and the resin matrix (adapted from 
Ferracane, 1995). 
Therefore, the aims of this chapter were to analyse different concentrations and sizes of 
bioactive glass and barium silicate filler added to 60/40wt% UDMA/TEGDMA and to 
determine the optimum FRC formulations in terms of degree of conversion (DC), flexural 
strength (FS) and modulus (FM) for orthopaedic applications. A low (46vol%) (suitable for 
injectable cements) and a high (60vol%) (suitable to be moulded in shape in situ) filler content 
in the final FRC was analysed in order to adapt the viscosity of the system to different 
orthopaedic applications.  
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4.2 Materials and methods 
All substances were sourced from Sigma Aldrich, UK and used without modification unless 
otherwise stated.  
For the synthesis of unfilled resin systems containing 60/40wt% UDMA/TEGDMA refer to 
Chapter 2, Section 2.1.  
For the synthesis of bioactive glass refer to Chapter 2, Section 2.2. 
For the synthesis of polymethylmethacrylate refer to Chapter 2, Section 2.4. 
FRCs were synthesised containing the 60/40wt% UDMA/TEGDMA unfilled resin system, 
barium silicate glass and bioactive glass fillers. Barium silicate glass filler (G018-186) (Figure 
4.1A) was purchased from Schott Glass (Landshut, Germany) and had the composition: 
(Al2O3)10(B2O3)10(BaO)35(SiO2)45(F)<2 with a Silane content of 6.0%. The average size of the 
particles was approximately 0.7µm. There were three types of bioactive glass fillers tested. 
There were two types of bioactive glass fillers (G018-144) purchased from Schott Glass 
(Landshut, Germany): silanated (silane content of 0.5%) (Type I) (Figure 4.1B) and non-
silanated (Type II) (Figure 4.1C). The third bioactive glass filler (45S5) was synthesised in the 
laboratory and it was non-silanated (Type III) (Table 4.1).  
The morphology of the commercially available bioactive glass filler particles and barium 
silicate filler was observed using scanning electron microscopy (SEM). Particles of each 
bioactive glass filler type (Type I or Type II) as well as particles of barium silicate filler were 
carefully placed on an aluminium specimen stub to avoid particle agglomeration (Berger et al. 
2009; Lin et al, 2000; Tian et al. 2008). Each specimen was then examined using a scanning 
electron microscope (EVO MA10, ZEISS, Germany) operating in backscatter electron mode 
under high vacuum. For the commercially available bioactive glass fillers, the average particle 
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size was 10µm; whereas for the laboratory synthesised bioactive glass, the average particle size 
was of <50µm. The filament gun conditions were kept constant throughout the experiment 
through the control of the spot size and the operating current and maintaining the accelerating 
voltage at 5kV (Palin et al. 2005; Sideridou et al 2007). Representative micrographs of the 
particles for each condition were photographed at x1500 magnification (Figure 4.2). 
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Figure 4.2 The morphology and silanisation of commercially available fillers and the filler synthesised in the laboratory. Barium silicate glass 
filler (A) had a silane content of 6% and had a particle size of 0.7µm.The were two types of bioactive glass fillers with an average particle size of 
10µm: silanated (silane content of 0.5%) (B) and non-silanted (C). The filler synthesised in the laboratory (D) had an average particle size of <50 
µm and was non-silanated.
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Table 4.1 Filled resin composite compositions in wt% for both low filler (46vol% filler) and high filler (60vol% filler) content. Type I, Type II 
and Type III refer to the types of bioactive glass used in this study. 
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FRCs were synthesised to have either a low viscosity or a high viscosity filler content and 
consisted of 60/40wt% UDMA/TEGDMA; 10, 20, 30 or 40wt% (low filler), 11, 23, 34, 45 
(high filler) bioactive glass (Type I, Type II or Type III) and barium silicate glass to a ratio of 
resin to filler in the final FRC of 30:70wt% (low filler) or 20:80wt% (high filler) (Table 4.2).  
FRCs containing 70wt% (low filler) or 80wt% (high filler) barium silicate glass filler only were 
used as positive control, whereas FRCs containing 70w%  (low filler) or 80wt% (high filler) 
Type I, II or III bioactive glass fillers were used as negative controls. All the substances were 
measured using a balance accurate to 0.0001mg (TS400D, Ohaus, USA). The bioactive glass 
and barium silicate filler particles were placed in a container and gently mixed with a spatula. 
The unfilled resin system formulation containing 60/40wt% UDMA/TEGDMA was then added 
to this bioactive glass, barium silicate mixture. This formulation was then mixed in a Speed 
Mixer (DAC 150 FV2-K, Hauschild Engineering, Germany) for 90s at low speed (1000rpm) 
and 180s at high speed (3000rpm). The mixed formulations were, subsequently, stored in a 
lightproof container at 4°C to avoid premature photo-curing prior to further testing.   
As the weight percentage calculations do not take into consideration the density of a particular 
substance, the wt% were transformed to volume percentage for increased accuracy, with the 
results shown in Table 4.2. Thus, the total filler volume used was approximately 47vol% for 
low content filler and 60vol% for high filler content formulations.  
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Table 4.2 Filled resin composite formulations based on low and high filler content. Different concentrations of Bioglass (Type I, Type II or Type 
III bioactive glass) and Barium Silicate (barium silicate filler) were added to 60/40UT (60/40wt% UDMA/TEGDMA unfilled resin system mixture) 
in 30:70wt% (low filler) or 20:80wt% (high filler) unfilled resin system to filler ratio. 
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For testing of the degree of conversion of filled resin composites refer to Chapter 2, Section 
2.6.1. 
For the preparation and light curing of FRCs for mechanical (three point bend) testing refer to 
Chapter 2, section 2.5. 
4.2.1 Statistical analysis 
Minitab statistical software (Minitab, UK) was used to analyse the data using one-way analysis 
of variance (ANOVA) test. A difference of P<0.05 was considered statistically significant. 
Anderson-Darling test was used to determine whether the data followed a normal distribution. 
Tukey’s post hoc tests were used for pair-wise comparison using a significance value of P=0.05.  
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4.3 Results 
4.3.1 Physical properties: degree of conversion of filled resin systems 
Type I and Type II FRCs containing 20, or 30wt% bioactive glass and Type III FRCs containing 
20wt% bioactive glass exhibited the highest DC (Figure 4.3). Type I, Type II and Type III FRCs 
containing low filler content exhibited similar DC up to 30wt% bioactive glass filler content 
(Figure 4.3). Type I FRCs containing high filler content exhibited a decrease in DC with 
increased filler content (p<0.001). Type II and Type III FRCs containing high filler content 
exhibited an increase in DC with increased filler content up to 34wt% bioactive glass filler 
content (Figure 4.3); which was statistically significant for Type III FRCs (high filler content) 
(p=0.001), but not Type III FRCs (p>0.398, low filler content) and Type II FRCs both low and 
high filler content (p>0.100). The DC of FRCs containing bioactive glass and barium silicate 
filler was lower compared with the DC of PMMA cement, which exhibited a DC of 89.7 +/- 
1.5 %. For analysis of significant differences between the degree of conversion values of filled 
resin composites refer to Appendix 2, Tables 2.1-2.9. 
Due to the low DC of FRCs containing 45wt% Type III bioactive glass and 34wt% barium 
silicate filler (high filler) (not measurable), there was no analysis performed on filled resin 
composites containing 80wt% Type III bioactive glass (high filler). Due to the low DC (<30%) 
of FRCs containing 80wt% Type I or Type II bioactive glass filler (low and high filler content), 
there was no further analysis performed on these FRCs (Figure 4.3).
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Figure 4.3 Degree of conversion of filled resin composites containing Type I, Type II or Type III bioactive glass (low and high filler content). 
Filled resin composite percentage inclusions are shown within bar labels. * denotes statistical differences with filled resin composites containing 
70wt% barium silicate filler; X denotes statistical differences with filled resin composites containing 80wt% barium silicate filler. Type II and 
Type III filled resin composites containing high filler content exhibited an increase in DC with increased filler content up to 34wt% bioactive glass 
filler content. Error bars indicate standard deviation over mean average of 5 samples. 
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4.3.2 Mechanical properties: three point flexural strength and modulus analysis 
Flexural strength of FRCs and PMMA 
For filled resin composites containing 20, 30, or 40wt% bioactive glass (low filler) and 11wt% 
bioactive glass (high filler), the FS increased in the order: Type II < Type I < Type III.  For 
filled resin composites containing 10wt% bioactive glass (low filler) and 23, 34, or 45wt% 
bioactive glass (high filler), the flexural strength increased in the order: Type I < Type II < Type 
III. The filled resin composites containing 20, 30, or 40wt% bioactive glass exhibited 
significantly higher flexural strength for low filler content compared with filled resin 
composites containing 23, 34, or 45wt% bioactive glass high filler content (Figure 4.4). For 
both low and high filler content, FRCs containing 20 or 23wt%  bioactive glass filler exhibited 
higher flexural strength compared with FRCs containing 40 or 45wt%, respectively, bioactive 
glass filler, regardless of the type of filler (Type I, Type II or Type III) (p<0.001). For analysis 
of significant differences between the flexural strength values of filled resin composites refer 
to Appendix 2, Tables 2.10-2.18.  
PMMA cement exhibited an FS value of 52.46±10.26MPa. The FS of filled resin composites 
containing 70wt% barium silicate filler was 84.3±14.3MPa (low filler) and 72.4±24.3MPa 
(high filler). 
For analysis of correlation between the degree of conversion and flexural strength values of 
filled resin composites refer to Appendix 6, Tables 6.29-6.54. There was a strong positive 
correlation between the degree of conversion and flexural strength values of Type III filled resin 
composites containing 20wt% bioactive glass filler (r=0.951), Type III filled resin composites 
containing 11wt% bioactive glass filler (r=0.610) (Figure 4.5). 
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Flexural modulus of FRCs and PMMA 
The lowest FM was exhibited by filled resin composites containing 40 or 45wt% bioactive glass 
(low and high filler content), which was significantly lower compared with the filled resin 
composites containing 10, 20, 30wt% (low filler content) or 11, 23, 34 (high filler content) 
bioactive glass (p<0.001) (Figure 4.6). PMMA cement exhibited a flexural modulus of 
1.80±0.3MPa. Filled resin composites containing 70 or 80wt% barium silicate filler exhibited 
a FM value of 7.0±1.0GPa (low filler) and 7.0±1.7GPa (high filler). 
The filled resin composites containing 60/40wt% UDMA/TEGDMA, 20 or 23wt% bioactive 
glass and 50 or 57wt% barium silicate glass exhibited the optimum DC and FS of all the filled 
resin composites tested (Figures 4.3, 4.4). Moreover, 40 or 45wt% bioactive glass was the 
highest amount that could be added to 60/40wt% UDMA/TEGDMA resins containing 30 or 
34wt% barium silicate filler (low and high filler content), that resulted in a degree of conversion 
of >45% of the final filled resin composite (Figures 4.3, 4.4). These filled resin composites 
containing 40 or 45wt% bioactive glass (low and high filler) were tested for use in applications 
where the focus is on providing a scaffold containing bioactive glass, which promotes tissue 
regeneration and repair, as it may be the case for cranio-facial reconstruction surgeries. Filled 
resin composites containing 40 or 45wt% (low and high filler content) bioactive glass were also 
tested to determine whether such composites provide increased viability and proliferation of 
bone marrow stromal stem cells compared with filled resin composites containing 20 or 23wt% 
bioactive glass (low and high filler content).  FRCs containing 20 or 23wt% bioactive glass 
filler exhibited higher flexural modulus compared with FRCs containing 40 or 45wt% bioactive 
glass filler, regardless of the type (Type I, Type II or Type III) or amount (low or high) of filler 
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(p<0.001). For analysis of significant differences between the flexural strength values of filled 
resin composites refer to Appendix 2, Tables 2.19-2.27. 
For analysis of correlation between the degree of conversion and flexural modulus values of 
filled resin composites refer to Appendix 6, Tables 6.29-6.54. There was a strong negative 
correlation between the degree of conversion and flexural modulus of Type II filled resin 
composites containing 34wt% bioactive glass filler (r=-0.666) and Type II filled resin 
composites containing 45wt% bioactive glass filler (r=-0.663) (Figure 4.7). 
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Figure 4.4 Flexural strength of filled resin composites containing low (LF) and high (HF) filler content. * denotes statistical differences with filled 
resin composites containing 70wt% barium silicate filler; X denotes statistical differences with filled resin composites containing 80wt% barium 
silicate filler. Filled resin composites containing 20wt% Type I or Type II bioactive glass exhibited higher flexural strength for low filler compared 
with high filler content (23wt%). Filled resin composites containing Type III bioactive glass filler exhibited the highest flexural strength of all 
FRCs studied. Error bars indicate standard deviation over mean average of 10 samples. 
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Figure 4.5 Correlation between the degree of conversion and flexural strength of filled resin composites containing Type I filler (SIL), Type II 
filler (NS) and Type III filler (AB). Filled resin composite percentage inclusions are shown within labels.  There was a strong positive correlation 
between the degree of conversion and flexural strength of filled resin composites containing 20wt% Type III bioactive glass filler (r=0.951).
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Figure 4.6 Flexural modulus of filled resin composites containing low (LF) and high (HF) filler content. * denotes statistical differences with 
filled resin composites containing 70wt% barium silicate filler; X denotes statistical differences with filled resin composites containing 80wt% 
barium silicate filler. Filled resin composites containing 23wt% Type I, Type II or Type III bioactive glass exhibited higher FM for high filler 
compared with low filler content (20wt%). Error bars indicate standard deviation over mean average of 10 samples. 
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Figure 4.7 Correlation between the degree of conversion and flexural modulus of filled resin composites containing Type I filler (SIL), Type II 
filler (NS) and Type III filler (AB). Filled resin composite percentage inclusions are shown within labels.  There was a strong negative correlation 
between the degree of conversion and flexural modulus of filled resin composites containing 45wt% Type II bioactive glass filler (r=-0.663).
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4.4 Discussion 
The physical and mechanical characteristics of a cement based on filled resin composites 
containing bioactive glass are influenced by the chemical structure of the monomers and the 
filler particles (Figure 4.2) present in the final polymer (Pfeifer et al. 2009).  Dimethacrylate 
resins and silica fillers are usually employed in dental applications as tooth filling materials. 
For a dental material based on dimethacrylate resins and silica fillers to be considered as a 
viable option in orthopaedic applications it must not only exhibit mechanical properties similar 
to adjacent bone but also a high degree of conversion of the monomer to polymer; which for 
dental materials was deemed to be between 55-75% (higher conversion also leads to decreased 
amount of leachable monomer) (Ekworapoj et al. 2002). 
Bioactive glass filler and barium silicate filler were added to the suitable formulation of base 
monomers determined to be 60/40wt% UDMA/TEGDMA (Chapter 3). Barium silicate is an 
inert filler usually added to reinforce the organic resin matrix, increase viscosity and make the 
material more manageable for the dentist. For the development of the orthopaedic cement, this 
inert filler was combined with two commercially available types of bioactive glass fillers or 
with 45S5 bioactive glass filler, which was synthesised in the laboratory (Figure 4.2). These 
bioactive glass fillers are known to increase viability of mesenchymal stem cells as well as their 
differentiation to bone cells (Rahaman et al. 2011).  
There were two types of filled resin composite cements formulated depending on viscosity, 
referred to as low and high viscosity cements (with low or high filler content), each developed 
for particular orthopaedic applications. The low viscosity filled resin composite (with a low 
filler content) was formulated for ex situ preparation and for injectable cements, where the 
cement can be placed in premade moulds (for example for auditory and cranio-facial repair 
surgeries) to harden and then placed at the required site in the body. This will lead to a reduction 
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in the time and cost of the surgery due to the use of cost effective materials that can be made 
into the required shape before surgery. The high viscosity cement (with high filler content), on 
the other hand, was developed to be used and moulded in shape in situ. This cement can be 
employed for hand and wrist reconstruction where the command set of curing allows the 
surgeon the time to place the material in the desired shape and location. 
4.4.1 Physical properties of the filled resin systems 
The degree of conversion of filled resin composites containing dimethacrylate unfilled resin 
systems and fillers was reported to be between 55 and 75% (Chung and Greener, 1990; 
Ferracane et al. 1998; Ruyter and Oysaed, 1987; Stansbury and Dickens, 2001). In this study, 
for FRCs containing bioactive glass (up to 30wt%) and barium silicate filler, the lowest DC 
was 60.1% exhibited by the FRC containing 20wt% bioactive glass (low filler, Type II), 
whereas the highest DC was exhibited by the FRC containing 11wt% bioactive glass (high 
filler, Type I composites) (76.4%) (Figure 4.3), both values in the range of those reported for 
DC in literature. The higher DC in the current investigation compared with previous studies 
(Chung and Greener, 1990; Ferracane et al. 1998; Ruyter and Oysaed, 1987; Stansbury and 
Dickens, 2001) might have also been due to the use of UDMA instead of bisGMA as the base 
monomer. The UDMA molecule is less viscous and more flexible than the bisGMA molecule, 
due to the absence of aromatic rings and presence of urethane groups in the UDMA molecule, 
which might have led to stronger hydrogen bonding interactions between the imino group of 
the UDMA molecule and the carbonyl group of the  co-monomer, thus higher concentration of 
carbon double bonds and  increased mobility of free radicals in the polymerising network 
(Pfeifer et al. 2009). 
The degree of conversion of filled resin composites containing bioactive glass and barium 
silicate filler was influenced by the size and amount of the filler particles, with the composition 
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of the resin matrix and light curing kept constant. The incorporation of filler particles in the 
unfilled resin system matrix results in increased viscosity of the final filled resin composite, 
which was influenced by the morphology, size and amount of the filler, possibly leading to 
decreased degree of conversion, with increasing amount of filler particles present in the polymer 
network.  
Thus, the maximum amount of filler that could be added to the FRCs without a detrimental 
effect on the degree of conversion was 30wt% for low filler, Type I, 23wt% for high filler, Type 
I, 30 or 34wt% for low and high filler, Type II and 30 or 34wt% for low and high filler, Type 
III composites (Figure 4.3).  The increase in filler content might, nonetheless, have led to 
increased insulating properties of the final FRCs, which might have resulted in a slight increase 
in degree of conversion (Figure 4.3), with the slight increase in temperature during the 
polymerisation reaction. Therefore, increased amount of bioactive glass filler could be added 
to the unfilled resin system matrix (up to 30 or 34wt%, low and high filler content), with the 
final FRC still exhibiting an increase in the degree of conversion (Figure 4.3). This might have 
been due to the higher flexibility and decreased viscosity of such FRCs compared with FRCs 
containing >30 or 34wt% (low and high filler content) bioactive glass at the beginning of the 
polymerisation reaction, resulting in increased conversion to a gel phase before the propagation 
step of the reaction, therefore increased degree of conversion (Nicolae et al. 2014).    
The degree of conversion of the FRCs was also affected by the difference in refractive index 
between the unfilled resin system matrix and the filler particles. The filled resin composites 
containing Type III bioactive glass filler exhibited increased degree of conversion compared 
with all the FRCs studied (Figure 4.3), which might have been due to a similar refractive index 
between the unfilled resin system matrix and the filler particles of these FRCs, possibly because 
of decreased bioactive glass filler –resin matrix interfacial light scattering (Stansbury, 2000). 
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During the polymerisation reaction, the filler particles in the FRCs interacted with the light, 
leading to decreased degree of conversion with high filler content (>30 or 34wt%, low and high 
filler content), because of high scattering, light absorption and increased opacity (LePrince et 
al. 2011; Stansbury, 2000). The size of filler particles also had an impact on the DC of FRCs, 
possibly due to the direct impact such fillers had on the scattering of light during the 
polymerisation reaction of such filled resin composites (Turssi et al. 2005). Thus Type III FRCs 
exhibited overall higher degree of conversion compared with Type I and Type II composites 
(Figure 4.3), which was in agreement with previous research (Turssi et al. 2005). The low DC 
of FRCs containing high amount of filler particles (>30 or 34wt%. low and high filler content) 
might have also been due to increased viscosity during the polymerisation reaction, which 
negatively affected the mobility of the radicals, regardless of whether the filler particles were 
silanised (Du and Zheng, 2008, Nicolae et al. 2014).  
The increased degree of conversion of PMMA compared with filled resin composites might be 
explained by its increased temperature and reactivity during the polymerisation reaction, with 
increased carbon double bonds converted to carbon single bonds (Ha et al. 2011). The increased 
degree of conversion of PMMA compared with both filled resin composites and unfilled 
60/40wt% UDMA/TEGDMA unfilled resin systems might also be due to the curing time of the 
PMMA (600sec) compared with the unfilled resin systems and filled resin composites (40sec). 
4.4.2 Mechanical properties: flexural strength and modulus of the filled resin systems 
The composition and chemical structure of the unfilled resin system matrix had a direct impact 
on the amount of released monomer, mechanical characteristics and ability to absorb liquids of 
the final filled resin composite (Deb et al. 2005). Moreover, by adding fillers to the resin matrix 
of unfilled resin systems, the mechanical properties might be improved, depending on the type, 
shape, concentration and size of the filler particles (Curtis et al. 2009; Masouras et al. 2008; 
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Hosseinalipour et al. 20110). Silica was also added to the FRCs containing bioactive glass as a 
reinforcement filler to preserve proper mechanical strength for orthopaedic applications 
(Vakiparta et al. 2005). By applying a load to the filled resin composite specimen, an area of 
stress formed at the interface betweeen the unfiled resin system matrix and the filler, which 
ultimately resulted in the failure of the specimen, when a certain load was exceded (Du and 
Zheng, 2007). The failure of these specimens was also affected by the viscosity of the FRC 
formulation. The point where the filled resin composite specimen failed under such a constant 
load determined the flexural strength of the FRC material (Kim and Han, 2004). The flexural 
modulus of a filled resin composite depended on the amount of filler particles to resin matrix 
(Du and Zheng, 2007; Kim and Han 2004). Moreover, the flexural strength and modulus of 
FRCs were also directly influenced by the formation of a chemical bond between the organic 
matrix and the filler particles. Effective coupling should have enabled successful transfer of 
stress between the unfilled resin system matrix and the filler particles, when the filled resin 
composites were subjected to loading (Masouras et al. 2008). Thus, filled resin composites 
which had silanised filler particles in their compositions (Type I in the current study), should 
have exhibited a strong chemical bond between the organic and inorganic components and thus 
increased mechanical strength (Shirai et al. 2000).  This was, however, not observed with high 
filler content FRCs formulations containing silanised (Type I), which exhibited lower flexural 
strength compared with high filler content FRCs containing non-silanised (Type II) bioactive 
glass fillers (Figure 4.4), which might have been due to the small amount of silane content in 
the Type I fillers (0.5%). The lower flexural strength of such FRCs (Figure 4.4) might also be 
explained by the significantly increased viscosity of the Type I FRCs formulations compared 
with Type II FRC formulations, which hindered the mobility of free radicals during 
polymerisation. However, FRCs containing silanised filler particles (Type I in this study) 
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exhibited a small increase in flexural strength compared with FRCs containing non-silanised 
filler particles (Type II and Type III) (Figure 4.4), which might have been due to the stronger 
chemical connection between the unfilled resin system matrix and the filler achieved through 
the coupling agent. Moreover, the silanised filler particles present in Type I FRCs, through the 
presence of a silanating agent might have led to the formation of a flexible, mechanically strong 
polymer network, because of the optimum stress transfer from the unfilled resin system matrix 
to the bioactive glass filler; whereas the absence of such a coupling agent as was the case of 
Type II FRCs might have led to the formation of a rigid, brittle polymer network, leading to the 
development of a high stress area between the resin matrix and filler particles, thus lower 
flexural strength (Figure 4.4), which concurs with previous research (Du and Zheng, 2007).  
When the effect of filler size on the flexural strength of FRCs was analysed, it was observed 
that FRCs containing larger sized particles (Type III) exhibited increased flexural strength 
compared with FRCs containing smaller sized particles (Type I and Type II) (Figure 4.4). The 
incorporation of smaller sized filler particles considerably increased the viscosity of Type I and 
Type II FRCs compared with Type III FRCs, possibly due to the effect of increased surface 
area of the smaller size filler particles at equivalent volume%, which was in agreement with 
previous research (Masouras et al. 2008). Moreover, the smaller filler size of Type I and Type 
II FRCs might have resulted in increased packing of filler particles inside the resin matrix, 
possibly resulting in regions with increased stress area between the unfilled resin system matrix 
and the filler particles, leading to a decrease in the flexural strength of such FRCs compared 
with Type III FRCs (Figure 4.4).  
Not only the size but also the amount of filler particles influenced the flexural strength of FRCs, 
with Type III FRCs (up to 20 or 23wt% bioactive glass, low and high filler content) exhibiting 
higher strength compared with Type I and Type II FRCs (Figure 4.4). For FRCs containing <20 
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or 23wt% bioactive glass (low and high filler content), there was no significant deterioration in 
flexural strength and flexural modulus observed (Figures 4.4, 4.6). Increasing the bioactive 
glass content for Type I, II and III FRCs (>20 or 23wt%, low and high filler content) 
significantly affected optical characteristics (light scattering and absorption), which led to a 
reduction in degree of conversion (Figure 4.3) and consequently flexural strength and flexural 
modulus (Figures 4.4, 4.6). Therefore, a decrease in the amount of filler present in the FRCs 
resulted in a lower viscosity of the polymer, thus an increase in degree of conversion as well as 
flexural strength for FRCs containing less than 30 or 34wt% bioactive glass for both low and 
high filler content. This increase in DC (Figures 4.3) might have been due to increased mobility 
of radical species thus increased conversion of carbon double to single bonds, which was in 
agreement with previous research (Tanimoto et al. 2005).   
Moreover, FRCs of varying mechanical characteristics may be required for particular 
orthopaedic applications depending on the flexural strength and modulus of the surrounding 
bone (Asmussen and Peutzfeldt 1998).  For example, cortical bone exhibits a flexural modulus 
of between 5-15GPa and a compressive strength of 100-150MPa in perpendicular direction to 
orientation axis of bone; whereas when tested in perpendicular direction to the long axis of bone 
the strength and modulus are approximately 2 times lower (Rahaman et al. 2011). Trabecular 
bone exhibits a compressive strength of 2-12MPa and an elastic modulus of 0.1-5GPa 
(Rahaman et al. 2011). Thus, bone exhibits different mechanical properties depending on the 
direction of load applied to it due to its oriented microstructure (known as anisotropy). 
Therefore, to successfully replace cortical or trabecular bone, FRCs should exhibit similar 
mechanical strength to the bone being replaced and similar flexural modulus (Table 4.3) to 
avoid high stress formation between the material and the surrounding bone which may lead to 
the failure of the implant when a certain load is exceeded (Giannoudis et al. 2005; Larsson 
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2006; Lin et al. 2005). Moreover, the optimum flexural strength for a synthetic material to be 
considered in orthopaedic applications should be between 50 and 125MPa (Table 4.3) (Lewis 
1997). For some filler types the ideal value may be obtained at a specific filler concentration, 
followed by a significant decrease in the properties of the end product (Masouras et al. 2008). 
For the FRCs developed in this study, the maximum amount of bioactive glass filler that could 
be added to the resin matrix without a detrimental effect on flexural strength and modulus was 
30 or 34wt%, low and high filler content. The flexural strength and flexural modulus decreased 
significantly in FRCs containing 40 or 45wt% bioactive glass (low and high filler content), 
which might have been due to the presence of bioactive glass fillers which might have resulted 
in decreased light absorption in during curing, increased light scattering, both having a negative 
impact on the degree of conversion and mechanical properties (Figures 4.4, 4.6; Tables 4.3). 
Flexural modulus was also higher in the developed FRCs compared with PMMA cement 
(1.80GPa). Due to the low modulus, the use of PMMA cement to stabilise implants in cortical 
bones (flexural modulus of 5 to 15GPa) might lead to the formation of a stress area between the 
cement and the bone, which ultimately may result in the aseptic loosening of the cement and 
failure of the implant. The high filler FRCs (23wt% bioactive glass) developed in this study 
exhibited a flexural modulus higher than 6.5GPa, which makes such cements more suitable for 
stabilisation of implants in cortical bone compared with PMMA, due to the absence of a stress 
area between the cement and the bone. Nonetheless, PMMA cement could be used to stabilise 
implants in trabecular bone, which has a flexural modulus of between 0.1 and 5GPa. The FRCs 
containing low filler content (20wt%) exhibited a flexural modulus of 5.8GPa, which is slightly 
higher than the flexural modulus of trabecular bone, however the slight increase in flexural 
modulus may provide an area with increased stress transfer from the bone to the cement, thus 
providing the bone with time to heal following the implant procedure.   
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Table 4.3  The flexural strength and modulus of bone and filled resin composites. PMMA refers 
to the commercially available bone cement; Silica70 and Silica80 refer to the filled resin 
composite containing 70, respectively 80wt% barium silicate filler (low and high filler content). 
FS refers to the flexural strength of filled resin composites tested dry. FM refers to the flexural 
modulus of filled resin composites tested dry. The Type I, Type II and Type III filled resin 
composites containing 20, respectively 23wt% bioactive glass (low and high filler content) 
exhibited flexural strength and flexural modulus values in the range of those of cortical bone. 
The Type I, Type II and Type III filled resin composites containing 40, or 45wt% bioactive 
glass (low and high filler content) exhibited flexural modulus values in the range of those of 
trabecular bone, however, higher values of flexural strengtth compared with trabecular bone. 
Therefore the optimum physical and mechanical properties in terms of degree of conversion, 
flexural strength and flexural modulus were exhibited by FRCs containing 20 or 23wt% 
bioactive glass filler and 50 or 57wt% barium silicate filler (low and high filler content). The 
maximum amount of bioactive glass filler that could be added to the FRCs without a significant 
decrease in the degree of conversion, flexural strength and flexural modulus was 40 or 45wt% 
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(low and high filler content). To further analyse the possible application of FRCs to orthopaedic 
applications, the impact of water immersion was determined on these FRC formulations in 
Chapter 5.  
4.5 Conclusion 
By analyzing the effect of bioactive glass filler addition to 60/40wt% UDMA/TEGDMA resin 
formulations, the most suitable filled resin composites in terms of degree of conversion, flexural 
strength and flexural modulus were determined to be those containing 20 or 23wt% bioactive 
glass (low and high filler content). These characteristics of the filled resin composites (degree 
of conversion, flexural strength and flexural modulus) were influenced by the size (10µm and 
50µm), type (silanised and non-silanised) and filler volume% added (low and high), which in 
turn affected the viscosity, handling and optical properties of the final composite. By changing 
the viscosity, while still maintaining suitable physical and mechanical properties, filled resin 
composites can be developed for injectable, in situ and ex situ orthopedic applications.  
Therefore, a filled resin composite system was developed containing 20 or 23wt% (low and 
high filler content) bioactive glass (known for its advantageous effect on the viability of cells) 
and 50 or 57wt% (low and high filler content) barium silicate filler that still retained high degree 
of conversion and flexural strength. Moreover, this filled resin composite system was based on 
a set curing command (the composite hardened following exposure to light), thus eliminating 
the waiting time required for PMMA cement formulations (approximately 15min), before the 
operation can be closed. This is of key importance for surgeons.   
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4.6 Limitations of present work and recommendations for future studies  
1. Only two types of bioactive glasses were analysed (limitation). By varying the size, 
chemical structure and amount of bioactive glasses present in the filled resin 
composites, these materials can be optimised for a wide range of orthopaedic 
applications (future studies). 
2. The Type I FRCs contained bioactive glass filler particles with a silane content of 0.5%. 
By increasing the silane content of the bioactive glass fillers, filled resin composites 
may be developed with increased flexural strength for orthopaedic applications.  
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CHAPTER 5 WATER SORPTION AND SOLUBILITY OF FILLED RESIN 
COMPOSITES AND PMMA CEMENT 
5.1 Introduction 
Filled resin composites are formed of a hydrophobic resin matrix and a hydrophilic glass filler, 
with absorption of water occurring in the resin matrix and at the resin and filler interface (Ito et 
al. 2005). The resin matrix may undergo plasticization following water immersion, leading to 
the swelling of the resin matrix, which may have a detrimental impact on the mechanical 
characteristics of the filled resin composite. Water sorption (WS) by the filled resin composites 
may also lead to hygrothermal degradation following water storage, development of 
microcracks, weakening of the interfacial bond between the resin matrix and filler particles and 
scission of the polymer chain as a result of hydrolytic cleavage (Ito et al. 2005; Berger et al. 
2009; Sideridou and Achilias 2005). The interface between the resin matrix and the filler has a 
significant impact on the ability of the filled resin composite to resist deformation under 
loading. Stronger bonding between the resin matrix and the filler can be achieved through 
silanization of the filler particles (formation of covalent bonds between the filler and the resin). 
However, this silane coupling agent may dissolve following water immersion leading to 
increased absorption of water inside the filled resin composites, leading to decreased 
mechanical strength (Lin et al. 2000; Podgorski, 2010). Thus, following water immersion, filled 
resin composites exhibit degradation and a decrease in mechanical strength, which is mainly 
due to sorption of water mostly in the resin matrix. The general decrease in mechanical strength 
of FRCs following water immersion is influenced by the amount of time in water as well as the 
amount and size of the filler present in the filled resin composite (Gohring et al. 2002; Musanje 
et al. 2001; Sideridou et al. 2003; Soderholm and Roberts, 1990)”. 
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The aims of this particular study were to determine the solubility (SO) and water sorption of 
filled resin composite specimens exposed to water for up to three months to further analyse 
their suitability for orthopaedic applications and the impact of water immersion on the bi-axial 
flexural strength (BIFS) of such filled resin composites. 
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5.2 Materials and Methods 
For synthesis of filled resin composites containing different sizes and types of bioactive glass 
and barium silicate filler refer to Chapter 2, Section 2.3. 
For synthesis of polymethylmethacrylate refer to Chapter 2, Section 2.4. 
For preparation and light curing of FRCs for water sorption, solubility and bi-axial flexure 
testing refer to Chapter 2, Section 2.5. 
5.2.1 Water sorption and solubility of filled resin composites and PMMA cement 
Water sorption and solubility of FRC and PMMA specimens were measured at 1 day, 7 days, 
1 month and 3 months. The initial mass (m0) of FRCs and PMMA for each sample condition 
was measured using a balance accurate to 0.0001g (TS400D, Ohaus, USA). The thickness and 
diameter of every specimen were also recorded for the calculation of volume (V) of each disc. 
The specimens were, then, placed in Petri dishes covered with aluminium foil, stored in a 
desiccator (Nalgene, Sigma Aldrich, UK) at room temperature (21°C) and weighed daily until 
a stable mass was recorded (m1) (change of mass of ≤0.001g over 3 days). When a stable mass 
was reached, FRC and PMMA samples were immersed in double distilled water (10 resin 
specimens for each condition in 30ml water). Water was replaced every 7 days to avoid changes 
in pH. At each time point (1 day, 7 days, 1 month, or 3 months), samples were removed from 
water, dried in air for 15sec and reweighed (m2). Specimens were then placed again in a 
desiccator at room temperature and weighed daily until a stable mass reading was recorded (m3) 
(change of mass of ≤0.001g over 3 days). Water sorption (WS:µg/mm3) and solubility (SL: 
µg/mm3) were than calculated using the following Equations (Berger et al. 2009; Gajewski et 
al. 2012; Ito et al. 2005; Pearson 1979; Podgorski, 2010; Ortengren et al. 2001):  
Equation 5.1 WS=
𝑚2−𝑚3
𝑉
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Equation 5.2 SL=
𝑚1−𝑚2
𝑉
 
5.2.2 Bi-axial flexural strength of filled resin composites and PMMA cement 
The disc shaped FRCs and PMMA used to determine the water sorption and solubility were 
also employed to determine the bi-axial flexural strength of each sample condition. The disc 
shaped specimens were placed centrally (the FRC specimens were placed with the cured surface 
in tension) on a thin sheet of rubber on a 10mm knife edge support (to avoid variations in 
peripheral thickness of the filled resin composites and promote uniform loading) and were 
loaded centrally using a 3mm ball indenter at a crosshead speed of 1mm/min on a universal 
tensile testing instrument (Instron Ltd, Buckinghamshire, England). The load of each filled 
resin composite and PMMA disc was, then, recorded at failure and the bi-axial flexural strength 
was calculated using Timoshenko and Woinowsky-Kreiger Equation (Timoshenko and 
Woinowsky-Krieger 1959): 
Equation 5.3 BiFS=
𝑃
ℎ2
{(1 + 𝜈) [0.485𝑥 ln [
𝛼
ℎ
] + ℎ] + 0.48}, where 
BiFS was the bi-axial flexural strength, P: the measured load at fracture, α: the radius of the 
knife edge support, h: the sample thickness and ν: the Poisson ratio for each specimen condition. 
The Poisson’s ratio (“change in cross-linked density” (Begum et al. 2006)) of a material can be 
determined from the lateral contraction per unit breadth divided by the longitudinal extension 
per unit length and a value of 0.300 was used for FRCs and PMMA in the current study (Boyd 
et al. 2008; Higgs et al. 2001). The thickness of each filled resin composite and PMMA disc 
was measured at the point of fracture with a micrometre screw gauge (Moore and Wright, 
Sheffield, England) accurate to 10µm (Palin et al. 2003).  
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5.2.3 Statistical analysis 
Minitab statistical software (Minitab, UK) was used to analyse the data using one-way analysis 
of variance (ANOVA) test. A difference of P<0.05 was considered statistically significant. 
Anderson-Darling test was used to determine whether the data followed a normal distribution. 
Tukey’s post hoc tests were used for pair-wise comparison using a significance value of P=0.05.  
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5.3 Results 
5.3.1 Water sorption and solubility of filled resin composites and PMMA cement 
By plotting water sorption and water solubility values for each filled resin composite or PMMA 
sample condition against time, it was determined that the lowest water sorption occurred in 
Type III composites containing 20wt% bioactive glass (Figure 5.1). Filled resin composite 
specimens containing the highest amount of bioactive glass filler (40wt%) exhibited the highest 
water sorption, regardless of the type of bioactive glass particles (Type I, Type II or Type III) 
(Figure 5.1). For analysis of significant differences between the water sorption of filled resin 
composites and PMMA refer to Appendix 3, Tables 3.1-3.14. 
The water sorption of filled resin composites containing low filler content increased with 
decreasing filler size in the order: AB40<SIL40<NS40<SIL20<NS20<AB20, with filled resin 
composites containing 70wt% barium silicate filler exhibiting higher water sorption compared 
with AB40 filled resin composites, however, these were lower compared with SIL40 filled resin 
composites (Figures 5.1, 5.2). For filled resin composites containing 40wt% bioactive glass, 
water sorption was higher with higher particle size. For filled resin composites containing 
20wt% bioactive glass, water sorption was lower with increased particle size (Figure 5.1). Filled 
resin composites containing 20wt% bioactive glass filler exhibited an increase in water sorption 
at 3 months compared with 1 day, regardless of the filler type (Type I, Type II, or Type III) 
(p<0.001). However, Type I and Type II filled resin composites containing 40wt% bioactive 
glass filler exhibited similar values for water sorption at 3 months compared with 1 day 
(p>0.060), with the exception of Type III FRCs, which exhibited an increase in water sorption 
(p<0.001). FRCs containing 80wt% barium silicate filler exhibited a decrease (p<0.001) for 
high filler and a similar value (p=0.146) for low filler (70wt%) of water sorption at 3 months 
water immersion compared with 1 day. There was a %increase in the water sorption of filled 
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resin composites containing low filler content in the order: 
NS40<SIL40<AB40<SIL20<AB20<NS20, with water sorption increasing with decreased 
bioactive glass filler particle size (Figure 5.2). 
For analysis of significant differences between the water solubility of filled resin composites 
and PMMA refer to Appendix 3, Tables 3.15-3.28. The solubility of filled resin composites 
containing low filler content increased with decreasing bioactive glass filler size in the order: 
AB40<AB20<SIL20<NS20<NS40<SIL40, with filled resin composites containing 70wt% 
barium silicate filler exhibiting the lowest SO (Figures 5.3, 5.4). For Type III resin composites, 
solubility decreased with decreasing amount of filler present in the filled resin composite. For 
Type I and Type II filled resin composites, solubility increased with increasing amount of filler 
present in the filled resin composite (Figure 5.2). There was an increase in the water solubility 
of filled resin composites at month 3 water immersion compared with day 1 water immersion 
for all types of bioactive glass filler particles (Type I, Type II, or Type III) (p<0.002). FRCs 
containing barium silicate filler only exhibited a similar value of water solubility for both low 
(70wt%) (p=0.548) and high (80wt%) (p=0.674) filler at 3 months water immersion compared 
with 1 day. There was a %increase in the water solubility of resin composites containing low 
filler content in the order: NS40<SIL40<AB40<AB20<SIL20<NS20, with water solubility 
increasing with decreased bioactive glass filler size particle (Figure 5.4). 
The water sorption of filled resin composites containing high filler content increased with 
increasing filler size in the order: NS45<SIL45<SIL23<NS23<AB23, with filled resin 
composites containing 80wt% barium silicate filler exhibiting the lowest water sorption (Figure 
5.5). There was a %increase in the water sorption of resin composites containing high filler 
content in the order: NS45<SIL45<SIL23<NS23<AB23, with water sorption increasing with 
decreased bioactive glass filler particle size (Figure 5.6). 
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The solubility of filled resin composites containing the high filler content increased with 
increasing amount of filler in the order: NS23<AB23<SIL23<NS45<SIL45, with filled resin 
composites containing 80wt% barium silicate filler exhibiting the lowest solubility. The Type 
I filled resin composites exhibited the highest solubility for both 23 and 45wt% bioactive glass 
content (Figure 5.7). There was a %increase in the water solubility of resin composites 
containing high filler content in the order: NS23<SIL23<SIL45<NS45<AB23.
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Figure 5.1 The water sorption of filled resins composites containing low filler content following wet storage for 1 day, 7 days, 1 month and 3 
months. Filled resin composite percentage inclusions are shown within bar labels. Silica70 refers to filled resin composites containing 70wt% 
barium silicate filler. SIL20 and SIL40 refer to Type I filled resin composites. NS20 and NS40 refer to Type II filled resin composites. AB20 and 
AB40 refer to Type III filled resin composites. The water sorption of filled resin composites containing low filler content decreased in the order: 
AB40<SIL40<NS40<SIL20<NS20<AB20. Error bars indicate one standard deviation from the mean for 10 samples. 
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Figure 5.2 The %increase in water sorption of filled resins composites containing low filler content following wet storage for 1 day, 7 days, 1 
month and 3 months. Filled resin composite percentage inclusions are shown within bar labels. Silica70 refers to filled resin composites containing 
70wt% barium silicate filler. SIL20 and SIL40 refer to Type I filled resin composites. NS20 and NS40 refer to Type II filled resin composites. 
AB20 and AB40 refer to Type III filled resin composites. The water sorption of filled resin composites containing low filler content increased in 
the order: NS40<SIL40<AB40<SIL20<AB20<NS20. 
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Figure 5.3 The water solubility of resins composites containing low filler content following wet storage for 1 day, 7 days, 1 month and 3 months. 
Filled resin composite percentage inclusions are shown within bar labels. Silica70 refers to filled resin composites containing 70wt% barium silicate 
filler. SIL20 and SIL40 refer to Type I filled resin composites. NS20 and NS40 refer to Type II filled resin composites. AB20 and AB40 refer to 
Type III filled resin composites. The water solubility of resin composites containing low filler content increased in the order: 
AB40<AB20<SIL20<NS20<NS40<SIL40. Error bars indicate standard deviation over a mean average of 10 samples. 
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Figure 5.4 The %increase in water solubility of resins composites containing low filler content following wet storage for 1 day, 7 days, 1 month 
and 3 months. Filled resin composite percentage inclusions are shown within bar labels. Silica70 refers to filled resin composites containing 70wt% 
barium silicate filler. SIL20 and SIL40 refer to Type I filled resin composites. NS20 and NS40 refer to Type II filled resin composites. AB20 and 
AB40 refer to Type III filled resin composites. The water solubility of resin composites containing low filler content increased in the order: 
NS40<SIL40<AB40<AB20<SIL20<NS20. 
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Figure 5.5 The water sorption of resins composites containing high filler content following wet storage for 1 day, 7 days, 1 month and 3 months. 
Filled resin composite percentage inclusions are shown within bar labels. Silica80 refers to filled resin composites containing 80wt% barium silicate 
filler. SIL23 and SIL45 refer to Type I filled resin composites. NS23 and NS45 refer to Type II filled resin composites. AB23 refers to Type III 
filled resin composites. The water sorption of resin composites containing high filler content increased in the order: 
NS45<SIL45<SIL23<NS23<AB23. Error bars indicate standard deviation over a mean average of 10 samples.   
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Figure 5.6 The %increase in water sorption of resins composites containing high filler content following wet storage for 1 day, 7 days, 1 month 
and 3 months. Filled resin composite percentage inclusions are shown within bar labels. Silica80 refers to filled resin composites containing 80wt% 
barium silicate filler. SIL23 and SIL45 refer to Type I filled resin composites. NS23 and NS45 refer to Type II filled resin composites. AB23 refers 
to Type III filled resin composites. The water sorption of resin composites containing high filler content increased in the order: 
NS45<SIL45<SIL23<NS23<AB23.  
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Figure 5.7 The water solubility of resins composites containing high filler content following wet storage for 1 day, 7 days, 1 month and 3 months. 
Filled resin composite percentage inclusions are shown within bar labels. Silica80 refers to filled resin composites containing 80wt% barium silicate 
filler. SIL23 and SIL45 refer to Type I filled resin composites. NS23 and NS45 refer to Type II filled resin composites. AB23 refers to Type III 
filled resin composites. The water solubility of resin composites containing high filler content increased in the order: 
NS23<AB23<SIL23<NS45<SIL45. Error bars indicate standard deviation over a mean average of 10 samples.  
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Figure 5.8 The %increase in water solubility of resins composites containing high filler content following wet storage for 1 day, 7 days, 1 month 
and 3 months. Filled resin composite percentage inclusions are shown within bar labels. Silica80 refers to filled resin composites containing 80wt% 
barium silicate filler. SIL23 and SIL45 refer to Type I filled resin composites. NS23 and NS45 refer to Type II filled resin composites. AB23 refers 
to Type III filled resin composites.  
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5.3.2 Bi-axial flexural strength of filled resin composites and PMMA cement 
The BIFS of filled resin composites containing low filler content increased with decreasing 
filler content in the order: SIL40<NS40<AB40<SIL20<AB20<NS20 (Figure 5.9). The filled 
resin composites containing 70 or 80wt% barium silicate filler (low and high filler content) 
exhibited the highest BIFS. For filled resin composites containing 40wt% bioactive glass, the 
BIFS increased with increasing filler size (Figure 5.13). For filled resin composites containing 
either 40wt% bioactive glass, or 20wt% bioactive glass the lowest BIFS was exhibited by Type 
I filled resin composites (Figure 5.9). The %decrease in bi-axial flexural strength of resin 
composites containing low filler content increased with decreasing filler content in the order: 
SIL40<NS40<AB40<AB20<NS20<SIL20 (Figure 5.10). 
The BIFS of filled resin composites containing high filler content increased in the order: 
SL45<SIL23<NS45<NS23<AB23 (or Type I < Type II < Type III filled resin composites) 
(Figure 5.11). The filled resin composites containing 80wt% barium silicate filler exhibited the 
highest BIFS. The resin composites containing bioactive glass exhibited higher BIFS with 
increasing filler size, thus, Type III composites exhibiting the highest BIFS. The Type I 
composites exhibited the lowest BIFS (Figure 5.11). The %decrease in bi-axial flexural strength 
of resin composites containing high filler content increased in the order: 
SIL45<AB23<NS23<SIL23<NS45 (Figure 5.12). 
For analysis of significant differences between the bi-axial flexural strength values of filled 
resin composites and PMMA refer to Appendix 3, Tables 3.28-3.42. FRCs containing bioactive 
glass filler particles exhibited a decrease in bi-axial flexural strength values at 3 months water 
immersion compared with 1 day, regardless of amount (low, or high filler content), type (Type 
I, Type II, or Type III) and size of particles (p<0.040). The only exception was the low filler 
FRCS containing 40wt% Type I bioactive glass filler, which exhibited a similar bi-axial flexural 
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strength value at 3 months water immersion compared with 1 month water immersion 
(p=0.190). FRCs containing barium silicate filler only exhibited a decrease (p=0.014) for low 
filler (70wt%) and a similar value (p=0.161) for high filler (80wt%) of bi-axial flexural strength 
at 3 months water immersion compared with 1 day.
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Figure 5.9 The bi-axial flexural strength of filled resins composites containing low filler content tested following water immersion for 1 day, 7 
days, 1 month and 3 months. Filled resin composite percentage inclusions are shown within bar labels. Silica70 refers to filled resin composites 
containing 70wt% barium silicate filler. SIL20 and SIL40 refer to Type I filled resin composites. NS20 and NS40 refer to Type II filled resin 
composites. AB20 and AB40 refer to Type III filled resin composites. The bi-axial flexural strength of resin composites containing low filler 
content increased with decreasing filler content in the order: SIL40<NS40<AB40<SIL20<AB20<NS20. Error bars indicate standard deviation over 
a mean average of 10 samples.  
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Figure 5.10 The %decrease in bi-axial flexural strength of filled resins composites containing low filler content tested following water immersion 
for 1 day, 7 days, 1 month and 3 months compared with specimens tested dry. Filled resin composite percentage inclusions are shown within bar 
labels. Negative values denote a % increase in the bi-axial flexural strength of filled resin composites containing low filler content. Silica70 refers 
to filled resin composites containing 70wt% barium silicate filler. SIL20 and SIL40 refer to Type I filled resin composites. NS20 and NS40 refer 
to Type II filled resin composites. AB20 and AB40 refer to Type III filled resin composites. The % decrease in bi-axial flexural strength of resin 
composites containing low filler content increased with decreasing filler content in the order: SIL40<NS40<AB40<AB20<NS20<SIL20. 
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Figure 5.11 The bi-axial flexural strength of resins composites containing high filler content tested following water immersion for 1 day, 7 days, 1 
month and 3 months. Filled resin composite percentage inclusions are shown within bar labels. Silica80 refers to filled resin composites containing 
80wt% barium silicate filler. SIL23 and SIL45 refer to Type I filled resin composites. NS23 and NS45 refer to Type II filled resin composites. 
AB23 refers to Type III filled resin composites. The bi-axial flexural strength of resin composites containing high filler content increased in the 
order: SIL45<SIL23<NS45<NS23<AB23. Error bars indicate standard deviation over a mean average of 10 samples.  
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Figure 5.12 The %decrease in bi-axial flexural strength of resins composites containing high filler content tested following water immersion for 1 
day, 7 days, 1 month and 3 months compared with specimens tested dry. Negative values denote a % increase in the bi-axial flexural strength of 
filled resin composites containing low filler content. Filled resin composite percentage inclusions are shown within bar labels. Silica80 refers to 
filled resin composites containing 80wt% barium silicate filler. SIL23 and SIL45 refer to Type I filled resin composites. NS23 and NS45 refer to 
Type II filled resin composites. AB23 refers to Type III filled resin composites. The % decrease in bi-axial flexural strength of resin composites 
containing high filler content increased in the order: SIL45<AB23<NS23<SIL23<NS45.  
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Figure 5.13 The bi-axial flexural strength increased with an increase in the filler particle size.  The filled resin composites containing 10µm bioactive glass 
filler exhibited an increase in the bi-axial flexural strength when the filler particles were non-silanised compared with silanised particles. 
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5.4 Discussion 
5.4.1 Water sorption and solubility of filled resin composites and PMMA cement 
FRCs were composed of the organic resin matrix and the inorganic filler particles. Bioactive 
glass filler particles had hydrogen groups through which sorption of water might have occurred 
into the polymer network (Lin et al. 2000). The resin matrix in the present study consisted of 
hydrophobic monomers UDMA and TEGDMA, which during the polymerisation reaction 
formed a three dimensional polymer network, which was composed of both highly cross-linked 
and weakly cross-linked regions (Sauro et al. 2013). Therefore, the amount of polymer formed 
during the polymerising reaction, the hydrophilicity, the dimensional structure, volume of this 
polymer and chemical structure of the filler particles had a direct impact on the water sorption 
of the final filled resin composite (Berger et al. 2009; Skrtic and Antonucci 2003). The water 
sorption of filled resin composite materials was previously shown to be less than 1% (Skrtic 
and Antonucci 2003). The filled resin composites in the current investigation exhibited water 
sorption values of less than 10µl/mm-3 (Figures 5.2, 5.6), which were lower than those required 
by the ISO4049 standard (maximum water sorption value of 40µg/mm3) (Berger et al. 2009; 
Sauro et al. 2013).  
Water sorption increased with a decrease in the degree of conversion (for more information 
refer to Chapter 4, Section 4.3.1) of the FRCs and an increase in water storage time only for 
filled resin composites containing low filler content, whereas the filled resin composites 
containing high filler content became saturated after two weeks immersion time (Figures 5.1, 
5.5), which was, however, in contrast with previous research (Sideridou et al. 2002). The 
increased water sorption with decreased degree of conversion might be explained by the 
increased volume of resin matrix in the FRCs, where hydrogen bonds were developed when 
water molecules were attracted to the polar groups found in the filled resin composites, leading 
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to swelling of the resin matrix and plasticisation of the polymer, with degradation of the 
filler/resin interface (Ito et al. 2005; Masouras et al. 2008). 
Each FRC condition exhibited fast water sorption in the first 2 weeks, with the FRCs being 
saturated after 2 weeks water immersion (Figures 5.1, 5.2, 5.5, 5.6), as expected from a 
diffusion process. Thus, in the first two weeks, water was absorbed in the polymer network, 
filling the voids left by release of unreacted monomer between polymer chains, which were 
influenced by the concentration and chemical structure of the unreacted monomer (including 
polarity and hydrogen bonding ability), the amount of absorbed water as well as the plasticising 
effect of monomer and water. The barium silicate filler in the filled resin composites forms a 
low-solubility molecular network of silicate chains for the ions contained in the bioactive glass 
(Na+, P+, Ca2+). These ions stimulate the biochemical environment surrounding the filled resin 
composite following immersion in a physiological environment. There is an exchange of ions 
between the bioactive glass from the filled resin composite and the biochemical environment 
of the organism, with sodium ions leaching out of the filled resin composite and hydrogen ions 
entering the composite (due to charge electro-neutrality) (Figure 5.14). The dissolution of these 
ions from the bioactive glass fillers contained in the filled resin composites has a significant 
role in the bonding of the composite to the surrounding bone. Immediately, after implantation, 
there is a rapid release of ions from the cement with the development of a polycrystalline 
hydroxy carbonate apatite and hydrated silica by-layer on the surface of the cement containing 
bioactive glass. Bonding of the filled resin composites containing bioactive glass to surrounding 
bone, thus, involves a series of chemical reactions taking place at the surface of the composite, 
resulting in the formation of a dynamic interface between the two, consisting of calcium 
phosphates. This interface is a result of the assimilation of calcium monoacid phosphate 
(formed from the transformation of calcium phosphates), which can then turn into 
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hydroxyapatite, thus promoting the migration of osteoblasts to the interface formed between 
the bone and the filled resin composite, through the recruitment of collagen, 
mucopolysaccharides and glycoproteins from the surrounding bone. The migration and 
attachment of such cells is further stimulated by the alkalinisation of the local pH as a result of 
ions dissolution from the bioactive glass contained in the filled resin composites. Moreover, 
there will be attachment of osteogenic stem cells to the surface of the cement due to the 
dissolution of silica ions from the cement containing bioactive glass. The formation of such a 
by-layer also has a crucial role in the recruitment of growth factors (such as VEGF (vascular 
endothelial growth factor), IGF2 (insulin like growth factor 2)); macrophages, which play a role 
in tissue repair and regeneration. Matrix mineralisation and osteocytes formation in a matrix 
formed from collagen (from the osteoblasts) and the HCA layer, then, occurs at the surface of 
the cement; with the resin component providing a scaffold for new bone ingrowth (Hench, 
2006; Pryor et al. 2009). Therefore, filled resin composites containing bioactive glass should 
stimulate the migration, attachment and proliferation of mesenchymal stem cells and 
osteoblasts at the interface between the bone and the composite (Figure 5.14).
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Figure 5.14 The mechanism of the potential adhesion of the developed filled resin composites containing bioactive glass to surrounding bone. 
There is dissolution of ions from the surface of the bioactive glass fillers contained in the filled resin composites, which with time in a 
physiological environment has a bactericidal effect (thus preventing infection), stimulates angiogenesis, which in turn promotes osteogenesis 
through the recruitment of osteogenic stem cells and osteoblasts to the interface zone formed between the filled resin composites and the 
surrounding bone.  
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The FRCs containing barium silicate filler without bioactive glass exhibited decreased water 
sorption compared with FRCs containing bioactive glass (Figure 5.1, 5.5), which might be 
explained by the presence of siloxane groups in their structure through which a strong chemical 
bond was formed between the methyl acrylate groups of the resin polymer and the hydroxyl 
groups of the filler particles (Shawkat et al. 2009, Skrtic and Antonucci 2003). However, when 
silanised bioactive glass filler particles were added to the FRCs containing barium silicate filler 
an increase in water sorption was observed (Figures 5.1, 5.5), possibly because of the 
dissolution of ions from the particles and chemical interaction between the water molecules and 
the filler particles; which might have resulted in degradation of the interface between the filler 
particles and the resin matrix, through breakage of the siloxane bonds (Berger et al. 2009). The 
degradation of the interface between the organic resin matrix and inorganic filler particles and 
infiltration of water inside the polymer matrix might have resulted in de-bonding of the filler 
particles from the resin matrix, thus increased water sorption and reduced mechanical strength 
as was the case with FRCs containing 40 or 45wt% (low and high filler content) bioactive glass 
particles (Figures 5.1, 5.2, 5.5, 5.6), which concurs with previous research (Soderholm, 1981).  
The FRCs containing low filler content exhibited higher water sorption compared with FRCs 
containing higher filler content (Figures 5.1, 5.5), possibly because of increased amount of 
polymer, thus increased capacity of the FRC to absorb water, which was in accordance with 
previous literature (Braden and Clarke 1984; Masouras et al. 2008; Ortengren et al. 2001; 
Oysaed and Ruyter 1986; Schneider et al. 2010). The increased water sorption of FRCs 
containing low filler content compared with high filler content (Figures 5.1, 5.5) might be 
explained by the fact that the polymer network consisted of regions of unreacted monomers 
trapped inside microgel clusters, between polymer chains. When immersed in water, the 
polymer network swelled, thus opening up the regions between the polymer chains, with 
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unreacted monomers leaching out as a consequence of this diffusion process (swelling of the 
polymer and leaching of unreacted monomer); where the amount of water in the resin matrix 
was inversely proportional to the diffusion coefficient, which also resulted in less water sorption 
with immersion period of FRCs (Figures 5.1, 5.5), which was in agreement with previous 
research (Ortengren et al. 2001; Sauro et al. 2013; Schneider et al. 2010; Sideridou et al. 2007).  
The amount of water sorption increased with a decrease in the size of filler particles and increase 
in the amount of filler as seen in FRCs containing both low and high filler content (Figures 5.1, 
5.2, 5.5, 5.6), possibly because of increased surface area and volume of filler particles to the 
polymer, leading to increased packing of filler particles inside the resin matrix, which was in 
accordance with previous research (Turssi et al. 2005). Moreover, the increase in the amount 
of water sorption of low filler content FRCs containing small size silanised bioactive glass filler 
particles (Type I FRCs) (Figure 5.1) might be explained by the increased surface area of such 
fillers to the resin matrix, which due to their hydrophilic characteristics might have interacted 
with water molecules leading to the degradation of the chemical bond between the filler and the 
resin matrix. The increase in the amount of water sorption of low filler content Type I filled 
resin composites might also be due to the degradation of the silane coupling agent due to water 
dissolution, also resulting in increased loss of filler ass suggested by Soderholm (Soderholm, 
1981). PMMA exhibited slow water sorption with time occurring through the unsaturated bonds 
present in the monomer molecules (Miettinen and Vallittu 1997).  
The hydrophilicity and quantity of monomers present, amount, type and size of filler particles, 
as well as water sorption of the resin matrix influenced the solubility of the filled resin 
composites, resulting in a reduction in the mass weight of the filled resin composite with storage 
time (Ortengren et al. 2001). The filled resin composites (low and high filler content) containing 
20 or23wt% bioactive glass exhibited water solubility values less than 5µg (Figures 5.3, 5.7), 
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which were lower compared with the maximum values stipulated by the ISO4049 standard 
(<7.5µg/mm3) (Berger et al. 2009; Sauro et al. 2013). However, the filled resin composites (low 
and high filler content) containing 40 or 45wt’% bioactive glass exhibited water solubility 
values >7.5µg (Figures 5.4, 5.8), which were higher compared with the maximum values 
stipulated by the ISO4049 standard (<7.5µg/mm3) (Berger et al. 2009). For filled resin 
composites containing low filler content, the highest solubility was exhibited by those 
containing Type I or Type II bioactive glass filler particles which contained the lowest size of 
filler particles (Figures 5.3, 5.7).  The Type I filled resin composites containing silanised filler 
particles consisted of silane bonds due to a condensation reaction occurring between the silane 
coupling agent and the silanol groups of the silica particles resulting in the development of 
siloxane bridge bonds and covalent bonds with the resin matrix. Following water immersion, 
the siloxane bonds degraded to silanol groups probably through a hydrolysis reaction, possibly 
resulting in the high water solubility of these filled resin composites (Figures 5.3, 5.7), however, 
further analysis testing hydrolysis of these filled resin composites is required.  
5.4.2 Bi-axial flexural strength of resin composites and PMMA cement 
The bi-axial flexural testing may be more reliable than three point bend test as it eliminates the 
impact of intersecting planes of shear as well as edge defects from analysis, resulting in easy 
detection of structural differences in the integrity of the composite material (Boyd et al. 2008). 
Therefore, the bi-axial flexural strength was also analysed to further determine the suitability 
of these filled resin composites for orthopaedic applications. Following immersion in water, 
filled resin composites swelled, which might be advantageous by reducing the interfacial stress 
between the filler particles and the resin matrix formed during polymerisation. However, there 
is a maximum limit of filler addition into the resin matrix, which when exceeded might 
negatively impact on the mixing of the filler particles within the liquid resin matrix, resulting 
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in absorption of high amounts of water which might have a detrimental effect on the mechanical 
strength of the filled resin composite by decreasing the strength of the chemical bond between 
the resin matrix and bioactive glass particles. The bonding of the resin matrix and filler particles 
might have led to the formation of a matrix-filler interface, with decreased capacity for water 
sorption, resulting in higher bi-axial flexural strength for Type III filled resin composites instead 
of Type I filled resin composites, which contain silanised filler particles (Figures 5.1, 5.5, 5.9, 
5.11), which was in contrast with previous research (Sauro et al. 20113). Moreover, the 
absorption of water into the FRCs might have led to breakdown of the intermolecular 
connection between the monomer molecules and the filler particles, with increasing bioactive 
glass content resulting in reduced BIFS values for FRCs containing 40wt% bioactive glass filler 
(Figure 5.10). The possible breakdown of the filler/resin interface due to water sorption might 
also explain the decreased BIFS of FRCs with increased immersion period (Figures 5.10, 5.12). 
The reduced BIFS for such FRCs might be explained by the hydrophilic characteristics of and 
dissolution of sodium and calcium ions from the bioactive glass filler particles present in the 
FRC. Immediately after immersion in water of the filled resin composites containing bioactive 
glass fillers, there is a fast exchange of sodium and potassium ions from the bioactive glass 
filler particles with hydrogen and hydronium ions from the surrounding water. This ion 
exchange resulted in a dissolution of the structure of the bioactive glass filler particles, with the 
leaching out of sodium, calcium, phosphorus and silicon ions (Jones, 2013; Valimaki and Aro, 
2006). A silica rich surface layer was formed on the bioactive glass filler particles (which were 
in contact with water) “through polycondensation of the hydrated silica groups” (Valimaki and 
Aro, 2006). Therefore, higher dissolution of ions from bioactive glass filler particles of the 
filled resin composites might have resulted in increased water sorption and decreased BIFS. 
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5.5 Conclusions 
The amount, size and type of bioactive glass filler had a significant impact on the water sorption, 
solubility and BIFS of filled resin composites. The water sorption and solubility increased with 
an increase in the amount of bioactive glass filler present. The bi-axial flexural strength 
increased with decreased amount and increased size of bioactive glass filler present. Therefore 
by varying the type, size or amount of bioactive glass filler particles, filled resin composites 
with a wide range of sorption and solubility values (which are less than 40µl/mm3 (water 
sorption) and 7.5µl/mm3 (water solubility)) can be developed for specific orthopaedic 
applications, for use either as pre-made, injectable or in situ materials for bone regeneration and 
repair.  
5.6 Limitations of present work and recommendations for future studies  
1. Only the water sorption and solubility of two concentrations of bioactive glass filler in 
the filled resin composites (20, 40wt% (low filler content) and 23, 45wt% (high filler 
content)) were analysed (limitation). Future studies may involve the analysis of water 
sorption and solubility of filled resin composites containing bioactive glass fillers with 
different chemical structures. By changing the chemical structure of the bioactive glass 
fillers, dissolution of ions, sorption and solubility values can be varied, which may lead 
to increased bone regeneration and repair compared with current materials.   
2. The water sorption and solubility of only resin composites containing micron-sized 
bioactive glass filler particles were tested (limitation). Future studies may analyse the 
water sorption and solubility of filled resin composites containing either nanoscale sized 
bioactive particles or a mixture of microscopic and nano-sized particles. The use of such 
particles may increase the filler volume to resin matrix of such composites, possibly 
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leading to an increase the viability of bone cells in contact with these filled resin 
composites.  
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CHAPTER 6 AGEING OF FILLED RESIN COMPOSITES AND PMMA CEMENT 
6.1 Introduction 
Filled resin composites (FRCs) consisting of a polymerisable resin matrix and filler particles of 
different sizes, structure and bioactive behaviour may be developed as suitable materials 
(biocompatible) for specific orthopaedic applications. Such orthopaedic applications may 
include cranio-facial bone repair surgeries as a result of trauma or disease, bone void fillings 
and fixation of metallic prosthesis due to their set command cure and low exothermicity during 
polymerisation (Shirai et al. 2000). Suitable FRCs may contain 60/40wt% UDMA/TEGDMA, 
20wt% bioactive glass and 50wt% barium silicate filler (low filler content) or 60/40wt% 
UDMA/TEGDMA, 23wt% bioactive glass and 57wt% barium silicate filler (high filler content) 
as was shown in Chapter 4 and Chapter 5. These FRCs exhibited the highest flexural strength 
and a suitable flexural modulus compared with bone. Therefore FRCs containing 23wt% 
bioactive glass (high filler content) exhibited slightly lower values of flexural modulus (6.7-
8.9GPa) (Chapter 4, Section 4.3.2, Table 4.4)  compared with cortical bone (10-20GPa) (An, 
2000; Ling et al. 2009; Rahaman et al. 2011; Rho et al. 1995); whereas FRCs containing 40 or 
45wt% bioactive glass (both low and high filler content) exhibited suitable flexural modulus 
(1.7-3.6GPa) (Chapter 4, Section 4.3.2, Table 4.4) for trabecular bone (0.1-5GPa) (An, 2000; 
Ling et al. 2009; Rahaman et al. 2011; Rho et al. 1995). FRCs containing 20wt% bioactive glass 
(low filler content) exhibited slightly higher values of flexural modulus (5.8-6.9GPa) (Chapter 
4, Section 4.3.2, Table 4.4) compared with trabecular bone (0.1-5GPa) (An, 2000; Ling et al. 
2009; Rahaman et al. 2011; Rho et al. 1995). These FRCs can, thus, possibly be used in 
repairing bone tissue and restoring function as such FRCs exhibit flexural modulus values that 
are similar to the flexural modulus of bone. Therefore, such FRCs may provide increased 
resilience and limit stress shielding in the adjacent bone. 
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Moreover, bioactive glass filler was shown to increase the attachment, viability, proliferation 
and differentiation of osteogenic cells to osteoblasts (Pryor et al. 2009; Rahaman et al. 2011, 
Soundrapandian et al. 2010).  Thus, FRCs containing 60/40wt% UDMA/TEGDMA, 40wt% 
bioactive glass and 30wt% barium silicate filler (low filler content) or 60/40wt% 
UDMA/TEGDMA, 45wt% bioactive glass and 34wt% barium silicate filler (high filler content) 
may provide enhanced biocompatibility to surrounding hard and soft tissue, due to increased 
bioactive glass content. However, increasing the content of bioactive glass in the FRCs may 
have a detrimental impact on the mechanical properties of the FRCs, when exposed to an 
aqueous solution as encountered in the body. Therefore, following assessment of the water 
sorption and solubility of these FRCs (Chapter 5), the impact of aqueous solution compared 
with dry environment on the mechanical behaviour of the FRCs was analysed to determine any 
significant differences in strength and modulus of these filled resin composites. The size, 
amount and type of filler particles as well as the mass of resin present in the FRCs have an 
impact on the amount of liquid absorbed from an aqueous environment as it was shown in 
Chapter 5. Following immersion or exposure to a liquid environment the strength of FRCs 
commonly decreases in association with the absorption of water into the material (Gohring et 
al. 2002; Musanje et al. 2001; Podgorski, 2010; Sideridou et al. 2003; Soderholm and Roberts, 
1990).   
The aims of this chapter were to determine the impact of short, medium and long water 
immersion periods on the flexural strength and flexural modulus of the most suitable developed 
FRCs formulations as well as those containing the highest amount of bioactive glass: 60/40wt% 
UDMA/TEGDMA, 20wt% bioactive glass and 50wt% barium silicate glass or 60/40wt% 
UDMA/TEGDMA, 40wt% bioactive glass and 30wt% barium silicate glass (low filler content) 
or 60/40wt% UDMA/TEGDMA, 23wt% bioactive glass and 57wt% barium silicate glass or 
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60/40wt% UDMA/TEGDMA, 45wt% bioactive glass and 34wt% barium silicate glass (high 
filler content). 
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6.2 Materials and methods 
For the synthesis of FRCs containing bioactive glass and barium silicate filler refer to Chapter 
2, Section 2.3. 
For synthesis of PMMA cement, refer to Chapter 2, section 2.4. 
For the preparation and light curing of specimens for mechanical (three point bend) testing refer 
to Chapter 2, Section 2.5. 
6.2.1 Water immersion of filled resin composites and PMMA cement 
FRCs and PMMA rectangular bar specimens were wet aged for 12 months (time periods: 1 day, 
7 days, 1 month, 3 months, 6 months, 9 months and 12 months)  at 37°C.  For each sample 
condition, there were 10 rectangular bars made, which were placed in Petri dishes covered with 
aluminium foil. Each Petri dish contained 30ml of double distilled water (changed every 7days) 
and the analysis was performed on wet specimens. 
For the mechanical (three point bend) testing of FRCs and PMMA refer to Chapter 2, Section 
2.7. 
6.2.2 Fracture surface of filled resin composite specimens  
Scanning electron microscopy (SEM) may be used to determine the mechanism of failure of 
RBCs subjected to load following three point bend testing (Du and Zheng, 2008). Thus, SEM 
was used to analyse the fracture surface of FRCs following each water immersion period: 1 
day, 7 days, 1, 3, 6, 9, or 12 months.  Each FRC specimen was mounted on an aluminium 
specimen stub and sputter coated with a gold layer for 2min to minimise charge accumulation 
during testing using a sputter coater (Emitech K55OX, Quorum Technologies Ltd, UK) (Berger 
et al. 2009; Lin et al. 2000; Tian et al. 2008). Each FRC specimen was examined using a 
scanning electron microscope (EVO MA10, ZEISS, Germany) operating in backscatter electron 
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mode under high vacuum. The filament gun conditions were kept constant throughout the 
experiment through the control of the spot size and the operating current and maintaining the 
accelerating voltage at 5kV (Palin et al. 2005; Sideridou et al 2007). Representative sections of 
fracture surfaces of each FRC sample condition were photographed at x1500 magnification. 
6.2.3 Statistical analysis 
Minitab statistical software (Minitab, UK) was used to analyse the data using one-way analysis 
of variance (ANOVA) test. A difference of P<0.05 was considered statistically significant. The 
Anderson-Darling test was used to determine whether the data followed a normal distribution. 
Tukey’s post hoc tests were used for pair-wise comparison using a significance value of P=0.05. 
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6.3 Results 
6.3.1 The impact of wet ageing on the flexural strength and modulus of PMMA and 
filled resin composites  
FRCs and PMMA were subjected to three point bend test to assess the FS and FM values of 
each condition following water immersion for 1 day, 7 days, 1 month, 3 months, 6 months, 9 
months and 12 months.  
For analysis of significant differences between the flexural strength values of filled resin 
composites and PMMA refer to Appendix 4, Tables 4.1-4.14. There was a general decrease in 
the FS of FRCs following water immersion for 12 months (maximum immersion period) 
compared with 1 day (Figure 6.2, 6.6). The low filler content FRCs containing 20wt% Type II, 
or 40wt% Type III bioactive glass filler exhibited similar FRCs at 1 day compared with 12 
months wet ageing (p>0.052) (Figure 6.1, 6.2). The high filler content FRCs containing 23wt% 
Type I bioactive glass filler also exhibited a similar FS value at 1 day compared with 12 months 
wet ageing  (p=0.078) (Figure 6.5, 6.6). All the other FRCs containing bioactive glass filler 
exhibited a decrease in FS value at 12 months compared with 1 day wet ageing (p<0.030). Low 
filler FRCs containing 70wt% barium silicate filler exhibited an increase in FS value at 1 day 
compared with 12 months wet ageing  (p=0.025). High filler FRCs containing 80wt% barium 
silicate filler exhibited similar FS value at 1 day compared with 12 months wet ageing  
(p=0.827) (Figure 6.5, 6.6). The %decrease in flexural strength of filled resin composites 
containing low filler content increased with a decrease in the filler size in the order: 
NS40<SIL40<AB40<NS20<SIL20<AB20 (Figure 6.2). 
The FS of filled resin composites (low filler content) containing bioactive glass and barium 
silicate filler increased in the order: Type II composite (40wt%)< Type I composite (40wt%)< 
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Type III composite (40wt%)< Type I composite (20wt%)< Type II composite (20wt%)< Type 
III composite (20wt%)< Control, following water immersion at 37°C for 12 months (Figure 
6.1). The filled resin composites (low filler) containing bioactive glass and barium silicate filler 
exhibited an increase in FM in the order: Type II composites (40wt%)< Type III composites 
(40wt%)< Type I composites (40wt%)< Type III composites (20wt%)< Type I composites 
(20wt%)< Type II composites (20wt%)< Control, following water immersion at 37°C for 12 
months (Figure 6.3).  
The FS of resin composites (high filler content) increased in the order: Type II composites 
(45wt%)< Type I composites (45wt%)< Type I composites (23wt%)< Type III composites 
(23wt%)< Type II composites (23wt%)< Control following water immersion at 37°C for 12 
months (Figure 6.5). The %decrease in flexural strength of filled resin composites containing 
high filler content increased with increasing filler size in the order: 
SIL45<SIL23<NS23<NS45<AB23 (Figure 6.6). 
For analysis of significant differences between the flexural modulus values of filled resin 
composites and PMMA refer to Appendix 4, Tables 4.14-4.28. There was a general increase in 
the FM value of FRCs containing bioactive glass filler at 12 months compared with 1 day wet 
ageing.  However, FRCs containing low filler Type III 20wt% bioactive glass and FRCs 
containing high filler 23wt% (Type I and Type III) and 40wt% Type II exhibited a decrease in 
FM values at 12 months compared with 1 day wet ageing (p<0.004). The FRCs containing low 
filler Type II (20 and 40wt%) bioactive glass filler exhibited similar FM value at 12 months 
compared with 1 day wet ageing (p=0.595, p=0.8804, respectively). The %decrease in the 
flexural modulus of filled resin composites containing low filler content increased with 
increasing filler size in the order: NS40<SIL40<NS20<SIL0<AB40<AB20 (Figure 6.4). 
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The filled resin composites (high filler) containing bioactive glass and barium silicate filler 
exhibited an increase in FM in the order: Type II composites (45wt%)< Type I composites 
(45wt%)< Type I composites (23wt%)< Type II composites (23wt%)< Type III composites 
(23wt%)< Control following water immersion at 37°C for 12 months (Figure 6.7). The 
%decrease in the flexural modulus of filled resin composites containing high filler content 
increased with decreasing filler content in the order: NS45<SIL45<NS23<AB23<SIL23 
(Figure 6.8). 
The specimens containing the highest amount of bioactive glass filler (40 or 45wt% (low and 
high filler content)) exhibited lower FS compared with filled resin composites containing 20 or 
23wt% bioactive glass (low and high filler content).  
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Figure 6.1 Flexural strength of filled resin composites (low filler content) tested following wet ageing for 1 day, 7 days, 1 month, 3 months, 6 
months, 9 months and 12 months. Filled resin composite percentage inclusions are shown within bar labels. Silica70 refers to filled resin composites 
containing 70wt% barium silicate filler. SIL20 and SIL40 refer to Type I filled resin composites. NS20 and NS40 refer to Type II filled resin 
composites. AB20 and AB40 refer to Type III filled resin composites. The filled resin composites containing 20wt% bioactive glass exhibited 
higher flexural strength compared with the filled resin composites containing 40wt% bioactive glass. 
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Figure 6.2 The %decrease in flexural strength of filled resin composites (low filler content) tested following wet ageing for 1 day, 7 days, 1 month, 
3 months, 6 months, 9 months and 12 months compared with specimens tested dry. Negative values denote a % increase in the flexural strength of 
such filled resin composites. Filled resin composite percentage inclusions are shown within bar labels. Silica70 refers to filled resin composites 
containing 70wt% barium silicate filler. SIL20 and SIL40 refer to Type I filled resin composites. NS20 and NS40 refer to Type II filled resin 
composites. AB20 and AB40 refer to Type III filled resin composites. The %decrease in flexural strength of filled resin composites containing low 
filler content increased with a decrease in the filler size in the order: NS40<SIL40<AB40<NS20<SIL20<AB20. 
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Figure 6.3 Flexural modulus of filled resin composites (low filler content) tested following wet ageing for 1 day, 7 days, 1 month, 3 months, 6 
months, 9 months and 12 months. Filled resin composite percentage inclusions are shown within bar labels. Silica70 refers to filled resin composites 
containing 70wt% barium silicate filler. SIL20 and SIL40 refer to Type I filled resin composites. NS20 and NS40 refer to Type II filled resin 
composites. AB20 and AB40 refer to Type III filled resin composites. The filled resin composites containing 20wt% bioactive glass exhibited 
higher flexural modulus compared with filled resin composites containing 40wt% bioactive glass. 
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Figure 6.4 The %decrease in the flexural modulus of filled resin composites (low filler content) tested following wet ageing for 1 day, 7 days, 1 
month, 3 months, 6 months, 9 months and 12 months compared with specimens tested dry. Negative values denote a % increase in the flexural 
modulus of such filled resin composites. Filled resin composite percentage inclusions are shown within bar labels. Silica70 refers to filled resin 
composites containing 70wt% barium silicate filler. SIL20 and SIL40 refer to Type I filled resin composites. NS20 and NS40 refer to Type II filled 
resin composites. AB20 and AB40 refer to Type III filled resin composites. The %decrease in the flexural modulus of filled resin composites 
containing low filler content increased with increasing filler size in the order: NS40<SIL40<NS20<SIL0<AB40<AB20.
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Figure 6.5 Flexural strength of filled resin composites (high filler content) tested following wet ageing for 1 day, 7 days, 1 month, 3 months, 6 
months, 9 months and 12 months. Filled resin composite percentage inclusions are shown within bar labels. Silica80 refers to filled resin composites 
containing 80wt% barium silicate filler. SIL23 and SIL45 refer to Type I filled resin composites. NS23 and NS45 refer to Type II filled resin 
composites. AB23 refers to Type III filled resin composites. The filled resin composites containing 23wt% bioactive glass exhibited higher flexural 
strength and flexural modulus compared with filled resin composites containing 45wt% bioactive glass. 
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Figure 6.6 The %decrease in the flexural strength of filled resin composites (high filler content) tested following wet ageing for 1 day, 7 days, 1 
month, 3 months, 6 months, 9 months and 12 months compared with specimens tested dry. Negative values denote a % increase in the flexural 
strength of such filled resin composites. Filled resin composite percentage inclusions are shown within bar labels. Silica80 refers to filled resin 
composites containing 80wt% barium silicate filler. SIL23 and SIL45 refer to Type I filled resin composites. NS23 and NS45 refer to Type II filled 
resin composites. AB23 refers to Type III filled resin composites. The %decrease in flexural strength of filled resin composites containing high 
filler content increased with increasing filler size in the order: SIL45<SIL23<NS23<NS45<AB23. 
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Figure 6.7 Flexural modulus of filled resin composites (high filler content) tested following wet ageing for 1 day, 7 days, 1 month, 3 months, 6 
months, 9 months and 12 months. Filled resin composite percentage inclusions are shown within bar labels. Silica80 refers to filled resin composites 
containing 80wt% barium silicate filler. SIL23 and SIL45 refer to Type I filled resin composites. NS23 and NS45 refer to Type II filled resin 
composites. AB23 refers to Type III filled resin composites. The Type II resin composites containing 23wt% bioactive glass exhibited higher 
flexural modulus compared with Type I and Type III filled resin composites. 
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Figure 6.8 The %decrease in the flexural modulus of filled resin composites (high filler content) tested following wet ageing for 1 day, 7 days, 1 
month, 3 months, 6 months, 9 months and 12 months compared with specimens tested dry. Negative values denote a % increase in the flexural 
strength of such filled resin composites. Filled resin composite percentage inclusions are shown within bar labels. Silica80 refers to filled resin 
composites containing 80wt% barium silicate filler. SIL23 and SIL45 refer to Type I filled resin composites. NS23 and NS45 refer to Type II filled 
resin composites. AB23 refers to Type III filled resin composites. The %decrease in the flexural modulus of filled resin composites containing high 
filler content increased with decreasing filler content in the order: NS45<SIL45<NS23<AB23<SIL23.
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6.3.3 Fracture surface of filled resin composites 
The fracture surface of filled resin composites containing 70 or 80wt% barium silicate filler 
(low and high filler content) exhibited a smooth surface, with evidence of fracture lines (Figure 
6.9). However, the filled resin composites containing bioactive glass exhibited an irregular 
surface, with evidence of filler “plucking” (de-bonding of filler from the resin matrix, with a 
void, or gap left behind), filler “shearing” (fracture of filler particle) and de-bonding of the filler 
particles from the resin (fracture of the interfacial surface between the resin matrix and the filler 
particles) (Figure 6.9). 
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Figure 6.9 Representative SEM micrographs of the fracture morphology of filled resin composites subjected to three point bend test following 
water immersion for 12 months. The fractured surface was visualised using an SEM. The morphology of the fractured surface of (low (A) and high 
(B) filler content)  FRCs containing Type I (2, 6), Type II (3, 7), or Type III (4, 8) bioactive glass filler as well as of FRCs containing 70wt% 
barium silicate filler (1, 5) is shown. The FRCs containing bioactive glass filler exhibited an irregular surface, with evidence of filler “plucking” 
(P) and filler “shearing” (S). The FRCs containing 70wt% barium silicate filler exhibited a smooth surface, with strong chemical affinity between 
the filler particles and the resin matrix.
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6.4 Discussion 
6.4.1 The impact of wet ageing on the mechanical properties of FRCs and PMMA 
A key property of a material to be successfully used in orthopaedic applications with low rates 
of failure is a similar mechanical strength to the surrounding cortical or cancellous bone tissue 
as well as flexural modulus that closely matches the flexural modulus of bone in order to allow 
transfer of stress from the cement to the bone, when load is applied (Giannoudis et al. 2005; 
Lin et al. 2005; Liu et al. 2011). The maximum stress that a filled resin composite can resist 
before failure when subjected to load is referred to as flexural strength (FS). The FS, thus, 
involves the analysis of tensile strength on the lower surface of the specimen with compressive 
strength on the upper surface of the specimen and shear strength in parallel direction to load 
(Sideridou et al. 2007; Kim and Han 2004; Khaled et al. 2011). Flexural testing is probably the 
most precise analysis of strength of a material due to the fact that a material can only fail through 
separation of the planes of atoms (tensile failure), or through slipping of the planes of atoms 
(shear failure) (Sideridou et al. 2007). The analysis of the flexural strength and modulus of the 
commercial PMMA cement showed that this cement exhibited higher modulus compared with 
trabecular vertebral bone, thus when used in vertebroplasty, it might lead to an increase in the 
stiffness of the bone. The increase in the stiffness of the bone results in a transfer of stress from 
the treated vertebrae to neighbouring ones, ultimately leading to failure of the PMMA cement 
implant in the body (Boyd et al. 2008). FRCs containing bioactive glass and barium silicate 
fillers might provide a suitable alternative with a flexural modulus and flexural strength closer 
to that of the surrounding bone compared with PMMA for orthopaedic applications. The 
polymerisation of such filled resin composites results in the formation of a three dimensional, 
heterogeneous network, where barium silicate filler was added as a reinforcement filler to 
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maintain appropriate mechanical characteristics for orthopaedic applications as specified by 
Vakiparta and colleagues (Vakiparta et al. 2005). The filled resin composites contained UDMA 
molecules in the resin matrix, which could have influenced the viscosity and degree of 
conversion of the final filled resin composite material (Cornelio et al. 2014; Pfeifer et al. 2009). 
However, during the polymerisation process, the carbon double bonds were converted to carbon 
single bonds resulting in the growth of the polymer chain and formation of a highly cross-linked 
three dimensional polymer matrix. However, due to the decrease in the mobility of free radicals 
during the polymerisation process, unreacted monomer molecules and functional groups were 
still present in the polymer network (Cornelio et al. 2014; Floyd and Dickens 2006; Pfeifer et 
al. 2009). Moreover, the organic matrix had a direct impact on the mechanical characteristics 
and the amount of water absorption of the final composite (Deb et al. 2005). The heterogeneity 
of the filled resin composite containing bioactive glass filler particles and barium silicate filler 
might mean that there is an increased microscopic space between the polymer clusters and the 
filler particles resulting in the possibility of increased water infiltration in the polymer network 
as it was shown in Chapter 5, Section 5.3.1, which concurs with studies performed on a similar 
system (Sideridou et al. 2003).  
 
199 
 
 
Table 6.1 Flexural strength and modulus of bone and filled resin composites. PMMA refers to 
the commercially available cement; Silica70 and Silica80 refer to filled resin composites 
containing 70, or 80wt% barium silicate filler (low and high filler content). FS1 refers to the 
flexural strength of dry specimens, whereas FS2 refers to the flexural strength of specimens 
tested wet following 12 months water immersion. FM1 refers to the flexural modulus of dry 
specimens, whereas FM2 refers to the flexural modulus of specimens tested wet following 12 
months water immersion. Type I, Type II and Type III filled resin composites containing 20, or 
23wt% bioactive glass (low and high filler content) exhibited flexural strength values lower 
compared with the values for the flexural strength of cortical bone. Type I, Type II and Type 
III filled resin composites containing 20, 40wt% (low filler content) or 23, 45wt% (filler 
content) bioactive glass exhibited flexural modulus in the range of the values for the flexural 
modulus of both trabecular and cortical bone.  
 
The flexural strength and flexural modulus of filled resin composites tested following water 
immersion was influenced by the type (silanised or non-silanised) and concentration (20 or 
40wt% (low filler content) and 23 or 45wt% (high filler content)) of bioactive glass filler in the 
polymer network (Figures 6.1-6.8), which concurs with previous research in a similar system 
(Skrtic and Antonucci 2003; Kim and Han, 2004). The FRCs containing 20 or 23wt% bioactive 
glass filler particles (low and high filler content) exhibited higher FS compared with FRCs 
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containing 40 or 45wt% bioactive glass (low and high filler content) following water immersion 
(Figures 6.1, 6.2, 6.5, 6.6), which might have been due to stronger chemical affinity between 
the resin matrix and the filler particles and lower viscosity during polymerisation allowing 
increased conversion, which might have also resulted in decreased absorption of water, which 
was also indicated by Sauro, Turssi and colleagues in a similar system (Sauro et al. 2013; Turssi 
et al. 2005). By increasing the amount of bioactive glass filler particles from 20 to 40wt% (low 
filler content) or from 23 to 45wt% (high filler content) present in the FRCs, a decrease was 
observed in the flexural strength of such filled resin composites (Figure 6.2, 6.6), which might 
have been due to increased viscosity of the FRC formulation, which hindered the mobility of 
free radicals during polymerisation leading to the formation of a three dimensional polymer 
network with lower cross-linked density, which concurs with previous research in a similar 
system (Kim and Han, 2004; Sideridou et al. 2007). Following water immersion, the high 
modulus of FRCs containing 20 or 23wt% bioactive glass (low and high filler content) (Figures 
6.2, 6.4) compared with dry specimens (Chapter 4, Figure 4.6)  might be explained by the ability 
of UDMA to form hydrogen bonds and the flexibility of TEGDMA as indicated in a similar 
system (Emami and Soderholm 2009). Thus, FS and FM were influenced by the compatibility 
between the chemical structure of the resin matrix and filler particles, which had a direct impact 
on the transfer of stress between the resin matrix and the filler particles (Du and Zheng 2007; 
Khaled et al. 2011). 
6.4.2 Morphology of the fractured surface of filled resin composites and PMMA 
When subjected to load, the FRCs fracture through the propagation of cracks under tensile 
stresses (Hosseinalipour et al. 2009).  Griffith’s law stipulates that any flaw or defect (such as 
poor interfacial bonding between the filler particles and the resin matrix) occurring in the 
microscopic structure of the material might act as a crack (Palin et al. 2005). Following flexural 
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loading, a stress area forms at the interface between the filler particles and resin matrix, with 
failure of the filled resin composite specimen occurring when the applied load exceeds a 
specific point, which was greater than the ability of the filled resin composite specimen to 
transfer the stress between the resin matrix and the filler particles (Du and Zheng 2007). 
Therefore, failure of a filled resin composite specimen under a constant load might be due to 
the viscoelasticity of the resin matrix, the length or mechanism of the propagating crack tip 
(Ekworapoj et al. 2002). The fractured surface of FRCs (tested following water immersion for 
specified periods of time) was observed by scanning electron microscopy (SEM), which could 
provide information about the mechanism and location of fracture (Figure 6.9). The fracture 
surface of the filled resin composites showed different mechanisms of failure: adhesive, 
cohesive and brittle fracture (Figure 6.9), which concurs with previous research on a similar 
system (Sideridou et al. 2007).   
Adhesive fracture involved the “plucking” of filler particles from the resin matrix, with fracture 
occurring at the interface between the resin matrix and filler particles. Therefore, the Type II 
and Type III filled resin composites exhibited adhesive fracture, which might have been due to 
the absence of the silanating agent, which might have decreased the bonding strength between 
the filler particles and the resin matrix (Figure 6.9), which concurs with previous research in a 
similar system (Oh et al. 1967). 
Cohesive fracture involved “shearing” of filler particles because of scission of the polymer 
chain through hydrolytic cleavage, where the fracture occurred through the filler particle 
(Dewaele et al. 2005; Ito et al. 2005; Shen et al. 2004; Shirai et al. 2000). The resin matrix 
stretches under a constant load, whereas the filler particles are solid, which might have resulted 
in the start of the propagation of the crack tip at the resin filler interface, followed by 
propagation through the soft resin matrix, instead of through the filler particles (Curtis et al. 
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2009b; Ekworapoj et al. 2002; Pfeifer et al. 2009;). Thus, the filled resin composites containing 
only barium silicate filler exhibited a smooth, brittle surface, with oriented fracture lines with 
the propagating crack tip, requiring little energy for failure of specimen to occur (Figure 6.9), 
which concurs with previous research in a similar system (Ekworapoj et al. 2002; Kenny and 
Buggy 2003; Tian et al. 2008). Moreover, the FRCs containing barium silicate filler and no 
bioactive glass filler exhibited a fractured surface with no distinguishable interface between the 
resin matrix and the filler particles (Figure 6.9), which might have been related to the strong 
chemical affinity between the barium silicate filler and the resin matrix (Lin et al. 2000). Type 
I, Type II and Type III filled resin composites exhibited cohesive fracture which might have 
been due to the absorption of stress under flexural loading by the softer resin matrix, which was 
then transferred from the resin matrix to the stronger filler particles, resulting in breaking of the 
filler particles, which was in agreement with previous research on a similar system (Khaled et 
al. 2011; Shen et al. 2004; Sideridou et al. 2007).  
Moreover, the filled resin composites containing both barium silicate filler and bioactive glass 
had a rough, heterogeneous fracture surface due to the presence of irregular filler particles with 
no clear crack propagation initiation site or distinguishable fracture lines (Figure 6.9), which 
was in agreement with previous research in a similar system (Tian et al. 2008). Thus, the 
propagating crack tip might have experienced the irregular filler particles as obstacles, with 
more energy required to break the specimen.  
FRCs containing non-silanised bioactive glass fillers exhibited a fractured surface with 
protrusion and “plucking” (de-bonding) of particles from the resin matrix (Figure 6.9), which 
might have been due to the weaker chemical affinity between the organic resin matrix and 
inorganic filler particles because of the absence of the silanasing agent (Liu et al. 2011). 
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On the other hand, the irregular filler particles might have failed to dissipate or deflect the 
energy required for the propagation of the crack tip resulting in lower mechanical strength 
following water immersion in filled resin composites containing 40 or 45wt% bioactive glass 
(low and high filler content), which might have been due to a weaker chemical bond between 
the resin matrix and the filler particles (Figure 6.9). However, the propagation of the crack tip, 
following flexural load application, could be significantly reduced, by water infiltrating in the 
polymer network, due to plasticisation of the resin matrix, which decreased the amount of stress 
present as well as dissipated the crack (Curtis et al. 2009a).  Moreover, different sizes of filler 
particles might have had a direct influence on the geometry of the packing of filler particles in 
the resin matrix (Turssi et al. 2005). Therefore, a decrease in the amount of bioactive filler 
particles from 40 to 20wt% (low filler content) or from 45 to 23wt% (high filler content) present 
in Type I, Type II and Type III filled resin composites might have led to different propagation 
of cracks following load application on specimens, which might have also resulted in the 
blunting of the progressing crack tip and higher flexural strength (Figures 6.1, 6.5, 6.9), which 
was in agreement with previous research on a similar system (Curtis et al. 2009a). 
Moreover, the irregular filler particles also had a direct impact on the amount of filler present 
in the polymer network, as well as the orientation and distribution of the particles in the resin 
matrix (Figure 6.9), which was in agreement with previous research in a similar system (Curtis 
et al. 2009a). Thus, the larger size of filler particles present in the Type III compared with Type 
I and Type II filled resin composites might have had a detrimental effect on the surface area to 
volume ratio of the particles present in the resin matrix and might have also extended further 
through the polymer network, which might  have resulted in early “filler plucking” (pull out of 
the filler glass particles from the resin matrix, with gaps left behind), when a load was applied 
to the filled resin composites specimen (Figure 6.9), which was in agreement with previous 
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research (Tian et al. 2008, Turssi et al. 2005). Moreover, the larger, irregular size of the particles 
present in Type III filled resin composites might have led to the formation of a defect area at 
the interface between the filler particle and the resin matrix, thereby increased the stress transfer 
between the filler and the resin matrix leading to stress induced damage (Figure 6.9), which 
was in agreement with previous research in a similar system (Curtis et al. 2009b). When the 
filled resin composites were tested wet at specific periods of times, it was previously noticed 
(Curtis et al. 2009a; Turssi et al. 2005) that for filled resin composites containing 20wt% 
bioactive glass filler, the water in the polymer network might have resulted in decreased area 
of stress between the filler particles and resin matrix due to plasticisation of the resin matrix, 
which might have reduced the propagation of the crack tip leading to higher mechanical strength 
in such filled resin composites (Figure 6.1, 6.5).  
The failure of the PMMA cement under flexural loading, might have started with the crack tip 
propagating through the resin surface, ultimately resulting in the formation of a single, 
continuous crack tip (Lewis 1997; Nguyen et al. 1997). The propagation of the crack tip in the 
PMMA cement might have first developed in micro-defect zones (which could have been 
produced during mixing), which might have extended and resulted in unstable growth of the 
crack tip resulting in failure of the cement and thus the implant, with the fracture surface 
exhibiting an irregular surface on several planes (Hosseinalipour et al. 2009; Lewis 1997a; 
Nguyen et al. 1997). Nonetheless, the propagation of the crack tip might be stopped by the 
presence of pores in the polymer network, which might have led to higher mechanical strength 
and longevity of the final PMMA as indicated by Lewis and colleagues (Lewis 1997a, Lewis 
et al. 1997b).  
The type, amount and size of bioactive glass filler particles influenced water sorption and 
solubility of filled resin composites as it was showed in Chapter 5, which in turn had an impact 
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on the flexural strength and modulus of these filled resin composites tested following water 
immersion. As these FRCs also contain bioactive glass filler particles in their composition, the 
effect on bone marrow stromal cells of such FRCs will be analysed (Chapter 7). 
6.5 Conclusions 
The filled resin composites containing 20 or 23wt% bioactive glass (low and high filler content) 
exhibited increased flexural strength following water immersion compared with filled resin 
composites containing 40 or 45wt% bioactive glass (low and high filler content), regardless of 
the type, size or amount of particles. The flexural modulus of these filled resins composites 
better matched the flexural modulus of bone compared with PMMA cement, which might make 
these filled resin composites containing bioactive glass a suitable alternative to PMMA cement.  
6.6 Limitations of present work and recommendations for future studies 
1. Only the flexural strength and modulus were analysed for these filled resin composites 
following water immersion. A more suitable test may involve assessing the fracture 
toughness of these filled resin composites following water immersion as this test 
assesses the ability of the FRC containing a pre-made crack to resist fracture, whereas 
the three point test performed in this study assess the stress and strain behaviour of the 
FRCs.  
2. The surface composition of the filled resin composites tested following water immersion 
for 12 months was not analysed (limitation). Testing of the surface composition may 
determine the FRCs’ ability to bond to bone and the mechanism through which such 
bonding occurs. 
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CHAPTER 7 THE IMPACT OF RESIN-BASED SYSTEMS ON THE VIABILITY OF 
BONE MARROW STROMAL CELLS VIABILITY 
7.1 Introduction 
The use of PMMA cement in orthopaedic applications often leads to the formation of a fibrous 
capsule at the interface of the cement with the surrounding bone as well as tissue necrosis as a 
result of the heat released during the polymerisation reaction. These events can contribute to 
implant failure (Aita et al. 2010, Anselmetti et al. 2009). Moreover, the culture of primary 
osteoblasts in the presence of PMMA cement results in cell death, decreased expression of 
osteoblast phenotypic markers and increased expression of inflammatory cytokines (Aita et al. 
2010). By developing alternative materials based on bioactive glass, the viability of cells and 
differentiation of mesenchymal stem cells down the osteoblast lineage may be enhanced, which 
may lead to local bone regeneration and repair. Bioactive glass is part of a specific group of 
bioceramics, which are able to promote the attachment, growth, proliferation and differentiation 
of progenitor cells into osteoblasts enabling the formation of new bone at the interface between 
the implant and living tissue. One postulated mechanism for this effect is the dissolution of 
calcium ions, which may stimulate osteogenic cells to form new bone matrix (Jones 2013; 
Pamula et al. 2011; Pryor et al. 2009; Rahaman et al. 2011; Soundrapandian et al. 2010). The 
ability of bioactive glass to bond with bone is further enhanced reportedly through the specific 
concentration of silica (45wt%) in its composition (Cacciotti et al. 2012; Hench 2006; Martin 
et al. 2009). The dissolution of calcium ions from the bioactive glass when exposed to an 
aqueous environment is understood to initiate the formation of a layer of hydroxyl calcium 
apatite on its surface, due to the exchange of calcium cations with hydrogen ions with the tissue 
fluid (Martin et al. 2009). Thus, bioactive glass may form an interfacial bond with the 
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surrounding soft and hard tissue through the formation of a surface layer comprised of 
carbonate-containing hydroxyapatite. This may be due to its decreased SiO2 concentration, the 
increased amount of Na2O and increased CaO/P2O5 ratio, which subsequently may enable 
collagen secretion directly onto the surface of the bioactive glass when exposed to culture media 
(Brauer et al. 2010; Jones 2013; Lusvardi et al. 2009; Pamula et al. 2011; Pryor et al. 2009; 
Rahaman et al. 2011; Soundrapandian et al. 2010). Due to their potential to increase the pH, 
bioactive glasses may also exhibit antimicrobial characteristics, reducing the risk of post-
operative infection (Sauro et al. 2013).  However, a significant increase in pH may also have a 
detrimental effect on the viability and proliferation of cells surrounding the implant such as 
blood cells.  
By culturing osteoblasts in the presence of FRCs containing bioactive glass, their increased 
attachment and proliferation was noted, furthermore differentiation of mesenchymal stem cells 
into osteoblast-like cells has also been reported in a similar system (Cacciotti et al. 2012; Wang 
et al. 2011). These cellular events were attributed to increased expression of alkaline 
phosphatase, osteocalcin and Type I collagen, which ultimately lead to bone regeneration and 
repair and were postulated to be mediated by the release of calcium and silicon ions from the 
material (Cacciotti et al. 2012; Wang et al. 2011). Indeed, following immersion in culture 
media, FRCs containing bioactive glass exhibit dissolution of calcium and sodium ions and 
formation of a polycrystalline hydroxy carbonate apatite and hydrated silica on their surface. 
The formation of this bilayer reportedly leads to recruitment of the growth factor IGFII (insulin 
growth factor II) and initiation of repair of tissue surrounding the implant, through the 
promotion of attachment, proliferation and differentiation of osteoblasts; a process that takes 6 
to 12 days to complete (Hench 2006).  
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The aims of this study were to analyse the viability of bone marrow stromal cells containing 
mesenchymal stem cells cultured in direct contact with resin-based composites and PMMA 
cement and the impact such composites and PMMA have on the acidity of the culture media.   
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7.2 Materials and methods  
7.2.1 Culture and transport media 
All culture media and its components were purchased from Sigma Aldrich (UK), unless 
otherwise stated. All culture media were generated under aseptic conditions within a laminar 
flow hood and stored under sterile conditions at 4⁰C.  
α-MEM (minimum essential medium eagle, Alpha modification) was synthesised using 9.6g/L 
α-MEM, 2.2g/L sodium bicarbonate to which double distilled water was added to make up 1L 
of solution to a final pH of 7.3 prior to filter sterilisation by filtration using a nitrocellulose 
0.2µm filter. 
Transport medium comprised of 20ml α-MEM, 2ml Penicillin/Streptomycin 
(penicillin/100units/ml, streptomycin/100units/ml), 500µl HEPES (2-[4-(2-
hydroxyethyl)piperazin-1-yl]ethansulfonic acid) (1M) and 200µl Amphotericin (250µl/ml) 
(Invitrogen, USA).  
Culture medium for bone marrow stromal cells (BMSCs) was made using 60ml α-MEM, 600µl 
Penicillin/Streptomycin, 600µl L-Glutamine, 1500µl HEPES (1M) and 9ml Foetal Calf Serum. 
All media changes (every two days) were performed in the laminar flow hood. The culture 
medium was removed using a pipette, and replaced with fresh 12ml culture medium. Cultures 
were also checked visually for bacterial or fungal contamination using a phase contrast 
microscope (Fluovert FS, Leitz Leica, Germany). 
7.2.2 Isolation of bone marrow stromal cells 
Bone marrow stromal cells (BMSCs) were extracted from the femora of 250g male, Albino-
Wistar rats ( ). An incision running from the angle of the knee 
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and a lateral, relieving incision were made, to expose the soft tissue. The femur was cleaned of 
external soft tissues, using a scalpel (Swann Morton, Sheffield, England) and subsequently 
placed in the transport medium. Femora were then placed in a petri dish, and the distal and 
proximal ends removed using bone cutters. A syringe containing 10ml of culture medium was 
used to irrigate the femur at both ends and the resulting liquid containing cells was collected 
into a fresh universal container. This mixture was centrifuged (Durafuge 100, Thermo electron 
corporation) for 3min at 1200rpm to pellet the collected cells. The supernatant was removed, 
and the cells were re-suspended in 5ml culture medium immediately prior to seeding in a T75 
flask (Thermo Scientific, USA) containing a further 10ml culture medium. The BMSCs were 
allowed to adhere to the bottom of the flask, by incubating the culture at 37°C and 5% CO2 
(Panasonic Healthcare Co. Ltd; CO2 Incubator MCO-18 AC, Japan) for 48h prior to changing 
the medium every 2 days. When BMSCs reached confluence, were detached from the substrate 
using 5ml of 0.25% Trypsin/EDTA and seeded on the top surface of disc specimens at a ratio 
of 5x103 cells/disk. 
For the preparation and light curing of unfilled resin systems and FRCs for bone marrow 
stromal cell viability analysis refer to Chapter 2, Section 2.5.  
7.2.3 Experimental design of viability analysis of BMSCs seeded in contact with unfilled 
resin systems, FRCs and PMMA discs specimens 
The discs corresponding to each sample condition were disinfected by immersion in 70% 
ethanol for 2 minutes and allowed to air dry in the laminar flow hood prior to transferring to 24 
well culture plates (Figure 3.1). 300µl of 1wt% Agarose gel (used to maintain the composite 
disc in a fixed position) was placed into each well and a sample disc added. Cells grown in 24 
well plates containing 300µl of 1wt% Agarose gel, in the absence of composite discs were used 
as negative controls, cells grown in the presence of composite discs containing 70 or 80wt% 
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barium silicate filler (low and high filler content) and cells grown in the presence of the unfilled 
resin system containing 60/40wt% UDMA/TEGDMA were used as positive controls. 
5,000cells/well were seeded onto the cured surface (the curing light was applied to this side of 
the discs) of each composite disc for viability analysis and 2ml of culture medium was added 
to each well. Culture plates were then incubated at 37°C and 5% CO2 (Panasonic Healthcare 
Co. Ltd; CO2 Incubator MCO-18 AC, Japan) prior to cell viability analysis at 1, 3, 5, 7 and 12 
days (n=3). 
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Figure 7.1 Experimental set-up for viability analysis of BMSCs seeded in direct contact on unfilled resin systems, FRCs or PMMA specimen discs. 
The viability of BMSCs was determined in the presence of low and high filler content FRCs containing either Type I (SIL20, SIL40, SIL23, SIL45), 
Type II (NS20, NS40, NS23, NS45), or Type III (AB20, AB40, AB23, AB45) bioactive glass and barium silicate filler. The viability of BMSCs 
in the presence of FRCs containing 70wt% barium silicate filler (Silica70) or 80wt% barium silicate filler (Silica80), PMMA, or in the absence of 
disc specimens (BMSCs were seeded in the space of a removed specimen disc) were used as controls. Each specimen disc was fixed to the bottom 
of the well with 300µl Agarose (1wt%). BMSCs (5x103) were seeded on the top surface of each disc specimen and 2ml culture medium added.
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7.2.4 Viability analysis: Trypan blue staining 
Cell viability was determined using Trypan blue which was used to stain non-viable cells blue, 
whilst viable cells remained unstained. To determine the number of viable cells found on the 
disk specimens at each time point (1 day, 3 days, 5 days, 7 days and 12 days), each disc was 
transferred to a sterile 24 well plate. Cultured cells were detached from the substrate using 1ml 
of 0.25% Trypsin/EDTA for each well and after cell detachment the trypsin was neutralised 
with 1ml of culture medium. The number of viable cells was determined by staining with 0.4% 
Trypan blue added to an equal volume of cell suspension. Viable cells were counted using a 
Neubauer-haemocytometer (Sigma Aldrich, UK) and a phase contrast microscope (Fluovert 
FS, Leitz Leica, Germany). The haemocytometer and the cover slips were cleaned using 70% 
ethanol and the cleaned cover slip was moistened with exhaled breath in order to affix it on the 
haemocytometer. Approximately 10µl of cell suspension/trypan blue stain was pipetted at one 
edge of the cover slip, to enable its uptake into the assembly by capillary action. The 
haemocytometer grid was then visualised using phase contrast microscopy ((Fluovert FS, Leitz 
Leica, Germany), where the viable cells appeared bright and colourless, whereas the dead cells 
appeared blue. Both viable and dead cells were counted in the 4 large, corner squares of the 
grid and an average value determined. The total number of viable cells in 1ml was, then, 
calculated: 
Equation 7.1 𝑇𝐶 = 𝑥 4 ∗ 2 ∗ 104⁄ ; 
Where TC was the number of total viable cells in 1ml; 𝑥  was the average of the cell counts 
from the squares of the haemocytometer grid, 2 was the dilution factor (1:1 dilution of cell 
suspension and trypan blue stain) and 104 represented the volume overlying the large corner 
square relative to 1ml. 
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7.2.5 Acidity measurements   
The impact of the FRCs and PMMA specimen disks on the acidity (pH) of the culture media 
was determined using a pH meter (Mettler-Toledo, Leicester, UK), which was calibrated prior 
to each experiment using pH buffer solutions (4.00±0.002 and 7.00±00,002) (Fisher Scientific, 
UK).  The pH of the culture medium was measured at 37°C, at 1, 3, 5, 7, 12 days following 
BMSCs culture.   
7.2.5 Statistical analysis 
Minitab statistical software (Minitab, UK) was used to analyse the data using one-way analysis 
of variance (ANOVA) test. A difference of P<0.05 was considered statistically significant. 
Anderson-Darling test was used to determine whether the data followed a normal distribution. 
Tukey’s post hoc tests were used for pair-wise comparison using a significance value of P=0.05. 
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7.3 Results 
7.3.1 The effect of PMMA and filled resin composite discs on the acidity (pH) of culture 
media  
The pH value at day 0 for all culture media was 7.3. For analysis of significant differences 
between the pH of culture media following immersion of filled resin composites and PMMA 
refer to Appendix 5, Tables 5.1-5.16. The pH values of the culture media following immersion 
of filled resin composites containing bioactive glass exhibited a marked increase in the first day 
(p<0.003) and reached a relatively constant value after day 3 up to the end of the pH 
measurements (which lasted 12 days). The pH of culture media following immersion of filled 
resin composite discs containing Type III bioactive glass filler (20 or 23wt%, low and high 
filler content) was ~7.6. The pH of culture media in the absence of filled resin composite discs 
or composite discs containing 70 or 80wt% barium silicate filler (low and high filler content) 
was ~7.3 and this value remained constant up to day 12. The culture media following immersion 
of discs containing Type II filled resin composites exhibited a pH value in excess of 7.9 (Figures 
7.2, 7.3). 
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Figure 7.2 The pH of culture media following immersion of composite discs containing PMMA; Type I (SIL20, SIL40), Type II (NS20, NS40) or 
Type III (AB20, AB40) (low filler content) bioactive glass or 70wt% barium silicate filler (Silica70) compared with pH in the absence of composite 
discs (Control) in the presence of bone marrow stromal cells. The culture media following immersion of composite discs containing bioactive glass 
exhibited an increase in pH in the first two days, then remained at constant value for the experimental period.  
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Figure 7.3 The pH of culture media following immersion of composite discs containing PMMA; Type I (SIL23, SIL45), Type II (NS23, NS45) or 
Type III (AB23, AB45) (high filler content) bioactive glass or 80wt% barium silicate filler (Silica80) compared with pH in the absence of composite 
discs (Control) in the presence of bone marrow stromal cells. The culture media following immersion of composite discs containing bioactive glass 
exhibited a significant increase in pH in the first two days, then reaching a relatively constant value for the remainder of the experimental period.  
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7.3.2 Viability of bone marrow stromal cells in the presence of unfilled resin systems, 
filled resin composites and PMMA cement 
For analysis of significant differences between the viability values of bone marrow stromal cells 
seeded in the presence of unfilled resin systems, filled resin systems and PMMA refer to 
Appendix 5, Tables 5.17-5.34. Bone marrow stromal cells cultured in the presence of discs 
containing 60/40wt% UDMA/TEGDMA exhibited the lowest viability values of all sample 
conditions studied. There was a marked decrease in the number of viable bone marrow stromal 
cells seeded in direct contact on discs containing 60/40wt% UDMA/TEGDMA at day 12 
compared with day 1 (p=0.002). There was a marked increase in the number of viable bone 
marrow stromal cells seeded in direct contact on discs containing filled resin composites and 
PMMA at day 12 compared with day 1 (p<0.001), with the exception of cells seeded in direct 
contact on filled resin composites containing 70wt% barium silicate filler (p=0.237).  
Low filler content filled resin composites 
The viability ranking of bone marrow stromal cells cultured in direct contact on composite discs 
containing bioactive glass was in the order: Type II, 40wt% (NS40)<Type III, 40wt% 
(AB40)<Type II, 20wt% (NS20)<Type III, 20wt% (AB20)<Type I, 20wt% (SIL20)<Type I, 
40wt% (SIL40). Bone marrow stromal cells cultured in the absence of composite discs 
exhibited the highest viability, whereas when cells were cultured in the presence of composite 
discs containing 70wt% barium silicate filler exhibited the lowest viability. Bone marrow 
stromal cells cultured in the presence of composite discs containing PMMA cement exhibited 
similar viability compared with cells cultured in the presence of discs containing 40wt% Type 
II filled resin composites (Figure 7.4).  
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The number of non-viable bone marrow stromal cells was calculated in order to determine the 
total number of cells on the unfilled resin systems, filled resin composites and PMMA. For 
analysis of significant differences between the values for non-viable bone marrow stromal cells 
seeded in the presence of unfilled resin systems, filled resin systems and PMMA refer to 
Appendix 5, Tables 5.35-5.51. The number of non-viable bone marrow stromal cells when 
cultured in the presence of composite discs containing bioactive glass was in the order: (lowest 
to highest) Type III, 20wt% (AB20)<Type II, 20wt% (NS20)<Type I, 20wt% (SIL20)<Type 
II, 40wt% (NS40)<Type III, 40wt% (AB40)<Type I, 40wt% (SIL40). The number of non-
viable bone marrow stromal cells cultured in the presence of resin composite discs containing 
20wt% Type III bioactive glass was similar with cells cultured in the absence of composite 
discs. Bone marrow stromal cells cultured in the presence of composite discs containing 70wt% 
barium silicate filler exhibited higher non-viability compared with cells cultured in the presence 
of composite discs containing bioactive glass filler. The highest non-viability was exhibited by 
bone marrow stromal cells cultured in the presence of composite discs containing PMMA 
cement (Figure 7.5). 
High filler content filled resin composites 
When cells were cultured in the presence of filled resin composite discs with high filler content, 
the lowest viability occurred in the presence of composite discs containing barium silicate filler. 
The viability of bone marrow stromal cells in the presence of composite discs containing 
PMMA cement was lower compared with those cultured in the presence of composite discs 
containing bioactive glass filler. The viability of bone marrow stromal cells cultured in the 
presence of composite discs containing bioactive glass filler increased in the order: Type I, 
23wt% (SIL23)<Type I, 45wt% (SIL45)<Type III, 23wt% (AB23)<Type II, 23wt% 
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(NS23)<Type II, 45wt% (NS45). Bone marrow stromal cells cultured in the absence of 
composite discs exhibited the highest viability (Figure 7.6).  
For analysis of significant differences between the values for non-viable bone marrow stromal 
cells seeded in the presence of unfilled resin systems, filled resin systems and PMMA refer to 
Appendix 5, Tables 5.35-5.51. There was a marked increase in the number of non-viable bone 
marrow stromal cells seeded in direct contact on discs containing PMMA or high filler content 
filled resin composites containing 80wt% barium silicate filler at day 12 compared with day 1 
(p<0.001, p=0.006, respectively) of all conditions studied (Figure 7.7). The number of non-
viable bone marrow stromal cells, when cultured in the presence of filled resin composite discs 
containing bioactive glass increased in the order: Type III, 23wt% (AB23)<Type I, 23wt% 
(SIL23)<Type II, 45wt% (NS45)<Type I, 45wt% (SIL45)<Type II, 23wt% (NS23). Bone 
marrow stromal cells cultured in the presence of Type III filled resin composite discs containing 
23wt% bioactive glass filler exhibited slightly lower non-viability rates than cells cultured in 
the absence of filled resin composite discs. Whereas the non-viability rates were higher for cells 
cultured in the presence of discs containing 45wt% compared with 23wt% silanated bioactive 
glass filler, the converse was true for non-silanated glass filler (cells exhibited higher non-
viability rates in the presence of 23wt% compared with 45wt% non-silanated bioactive glass 
filler).  The bone marrow stromal cells cultured in the presence of discs containing PMMA 
cement exhibited the highest non-viability (Figure 7.7).  
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Figure 7.4 The number of viable bone marrow stromal cells cultured in direct contact on discs with low filler content. Cells seeded in the absence 
of disk, cells seeded in direct contact on unfilled resin systems containing 60/40wt% UDMA/TEGDMA (UT) and cells seeded in direct contact on 
PMMA discs were used as controls. Cells were seeded on discs containing SIL20 or SIL40 (Type I filled resin composites); NS20 or NS40 (Type 
II filled resin composites); AB20 or AB40 (Type III filled resin composites). Cells cultured in direct contact on discs containing 70wt% barium 
silicate filler (Silica70) exhibited the lowest viability. Bone marrow stromal cells cultured in the presence of discs containing 40wt% non-silanised 
bioactive glass filler (NS40) exhibited values for viability similar to those cultured in the absence of discs (control). The culture media was changed 
every 2-days. Error bars indicate standard deviation over a mean average for 3 biological samples. 
228 
 
0 3 6 9 12 15
0
1
2
3
4
5
6
7
Control
Silica70
AB20
AB40
SIL20
SIL40
NS20
NS40
PMMA
UT
Time (days)
N
o
n
-v
ia
b
le
 c
e
ll
s
 (
*1
0
0
0
)
 
Figure 7.5 The number of non-viable cells in cultures which were in direct contact on discs with low filler content. Cells seeded in the absence of 
disk, cells seeded in direct contact on unfilled resin systems containing 60/40wt% UDMA/TEGDMA (UT) and cells seeded in direct contact on 
PMMA discs were used as controls. Cells were seeded on discs containing SIL20 or SIL40 (Type I filled resin composites); NS20 or NS40 (Type 
II filled resin composites); AB20 or AB40 (Type III filled resin composites). Cells cultured in the presence of discs containing 70wt% barium 
silicate filler (Silica70) exhibited the highest non-viability. However, cells cultured in the presence of discs containing 20wt% 45S5 bioactive glass 
filler (AB20) exhibited values for non-viability similar to that for cells cultured in the absence of discs (control). The culture media was replaced 
every 2-days. Error bars indicate standard deviation over a mean average of 3 biological samples.
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Figure 7.6 The number of viable cells in the presence of discs containing high filler content. Cells seeded in the absence of disk, cells seeded in 
direct contact on unfilled resin systems containing 60/40wt% UDMA/TEGDMA (UT) and cells seeded in direct contact on PMMA discs were 
used as controls. Cells were seeded on discs containing SIL23 or SIL45 (Type I filled resin composites); NS23 or NS45 (Type II filled resin 
composites); AB23 (Type III filled resin composites). Cells cultured in the presence of discs containing 80wt% barium silicate filler (Silica80) 
exhibited the lowest viability. However, cells cultured in the presence of discs containing 23wt% 45S5 bioactive glass filler (AB23), 23wt% non-
silanated bioactive glass filler (NS23) and 455wt% non-silanated bioactive glass filler (NS45) exhibited the highest viability of cells cultured in 
the presence of composite discs. The cell culture medium was exchanged every 2-days. Error bars indicate standard deviation over a mean average 
of 3 biological samples, with some exhibiting insignificant differences. 
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Figure 7.7 The number of non-viable cells in the presence of discs containing 60vol% filler (high filler content). Cells seeded in the absence of 
disk, cells seeded in direct contact on unfilled resin systems containing 60/40wt% UDMA/TEGDMA (UT) and cells seeded in direct contact on 
PMMA discs were used as controls. Cells were seeded on discs containing SIL23 or SIL45 (Type I filled resin composites); NS23 or NS45 (Type 
II filled resin composites); AB23 (Type III filled resin composites). Cells cultured in the presence of discs containing 80wt% barium silicate filler 
(Silica80) exhibited the lowest viability. However, the lowest number of non-viable cells occurred in the presence of discs containing 23wt% 45S5 
bioactive glass filler (AB23) compared with cells cultured in the presence of composite discs; which was lower than the cells cultured in the absence 
of composite discs (Control). The culture media was replaced every 2-days. Error bars indicate standard deviation over a mean average of 3 
biological samples. 
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All the cells cultured in the presence of filled resin composite discs containing bioactive glass 
filler exhibited higher viability compared with cells cultured in the presence of filled resin 
composite discs containing only barium silicate filler. The cells cultured in the presence of filled 
resin composite discs containing 20wt% bioactive glass filler exhibited higher viability than 
cells cultured in the presence of filled resin composite discs containing 40wt% bioactive glass 
filler with the exception of 20wt% silanated bioactive glass filler, which was lower than the 
40wt%. The cells cultured in the presence of filled resin composite discs containing 40wt% 
non-silanated bioactive glass filler exhibited the lowest viability of all cells cultured in the 
presence of filled resin composite discs containing bioactive glass filler.    
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7.4 Discussion 
Marked cell death was observed when cells were cultured in the presence of unfilled resin 
systems most likely due to toxic monomer leaching into the culture media, which also increased 
the acidity of the culture media compared with viability of cells cultured in the presence of 
filled resin composites. However, when cells were exposed to filled resin composites containing 
bioactive glass filler particles their viability was significantly increased (Figures 7.4, 7.6) 
compared with cells cultured in the presence of the unfilled resin system; which might have 
been due to the alkalinisation of the culture media. The increased cell viability when seeded in 
the presence of filled resin composite discs containing bioactive glass (Figures 7.4, 7.6) might 
have been due to the release of calcium, sodium and silica ions from the bioactive glass present 
in the filled resin composite discs as suggested previously on a similar system, where 
dissolution of these ions decreased with increasing time in culture media (Cacciotti et al. 2012; 
Rahaman et al. 2011; Wang et al. 2014). The low viability of bone marrow stromal cells cultured 
in the presence of Type I and Type II filled resin composite discs containing 40wt% bioactive 
glass (Figure 7.4) might have been due to a high release of phosphorous ions (>30ppm ) as was 
suggested previously on a similar system (Goel et al. 2011). Low viability of bone marrow 
stromal cells, however, did not occur in the presence of Type filled resin composite discs 
containing 40wt% bioactive glass (Figure 7.4), which might be explained by the presence of a 
coupling agent between the bioactive glass and the resin matrix. The high viability of bone 
marrow stromal cells in the presence of filled resin composite discs containing 20 or 23wt% 
bioactive glass (low and high filler content) (Figure 7.4) might have been due the release of 
phosphorous ions from such composites in the culture media in a concentration less than 30ppm 
as suggested previously on a similar system (Goel et al. 2011).  
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Moreover, previous research had proposed that when exposed to an aqueous environment such 
as culture media, filled resin composite discs containing bioactive glass might have released 
silicon, calcium and sodium ions and might have absorbed ions of hydrogen from the water 
present in the culture media leading to an increase in pH, thus alkalinisation of the culture media 
(Brauer et al. 2010; Cacciotti et al. 2012; Cerutti et al. 2005; Sauro et al. 2013; Silver et al. 
2001), which was in agreement with the current study (Figures 7.2, 7.3). The calcium ions from 
the filled resin composites containing bioactive glass particles reacted with the phosphate from 
the culture media, leading to the formation of hydroxyapatite, resulting in an increase in pH of 
the culture media (Huang et al. 2006). The alkalinisation of the culture media might have had 
a positive impact on bone cell metabolism and proliferation of osteoblasts as was suggested in 
previous research (Silver et al. 2001; Xynos et al. 2000). As previously suggested, the formation 
of collagen and hydroxyapatite required for bonding of the filled resin composite with the 
surrounding bone and thus for promotion of bone regeneration and repair also necessitated an 
alkaline pH (Silver et al. 2001; Soundrapandian et al. 2010).  The compatibility of the filled 
resin composites containing bioactive glass filler particles might have also depended on the 
maintenance of a constant pH of 7.8 in the environment (in this case the culture media) (Figures 
7.2, 7.3). This constant pH was suggested previously to be optimum for osteoblast viability and 
growth, with minimum variations in pH (Bellucci et al. 2011). The higher viability of bone 
marrow stromal cells cultured in the presence of filled resin composite discs containing smaller 
filler particle size (Type I and Type II fillers) compared with filled resin composite discs 
containing the larger filler particle size (Type III) might have been due to the larger surface area 
exhibited by the smaller particles, which might have resulted in increased cell viability (Figures 
7.4-7.7), because more bioactive glass particles were exposed on the surface of the filled resin 
composite upon immersion in culture media, which was also shown previously on a similar 
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system Mousa et al. 2000). The increased viability of bone marrow stromal cells in the presence 
of filled resin composites containing small size filler particles (Figure 7.4) might have also been 
due to a rapid ion dissolution and precipitation of phosphate and calcium ions as suggested in 
a previous study (Wang et al. 2014).  
The initial decrease observed at day 1 in bone marrow stromal cell viability in the presence of 
filled resin composites and PMMA (Figures 7.4, 7.6) might have been due to the fact that not 
all cells seeded attached on the specimen discs. Bone marrow stromal cells cultured in the 
presence of PMMA disks exhibited decreased viability compared with cells cultured in the 
presence of filled resin composite disks containing bioactive glass (Figures 7.4, 7.6). Moreover, 
the highest number of non-viable cells occurred in the presence of PMMA disks (Figures 7.5, 
7.7), which might be explained by the significant decrease in pH (Figure 7.2), which might have 
had a detrimental effect on cellular metabolism.  
Interestingly, the increased concentration of alkali ions in the surrounding environment from 
filled resin composites containing bioactive glass might also have had an antibacterial effect 
reducing the risk of infection as previously suggested (Sauro et al. 2013). 
7.5 Conclusions 
Bone marrow stromal cells cultured in the presence of filled resin composite discs containing 
bioactive glass exhibited significantly higher viability compared with cells cultured in the 
presence of unfilled resin systems containing 60/40wt% UDMA/TEGDMA, or PMMA cement. 
The addition of bioactive glass to filled resin composites also leads to the alkalinisation of the 
culture media to a pH, which was determined to be optimum for the differentiation of bone 
marrow stromal cells into osteoblasts and for the regeneration and repair of hard tissues. 
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These finding have potential applications for tissue engineering where 3D bioactive glass 
ceramic substrates could be used as scaffolds for in vitro production of bioengineered bone.  
7.6 Limitations of present work and recommendations for future studies 
1. Viability of bone marrow stromal cells was tested in direct contact on disks containing 
unfilled resin system, filled resin composites or PMMA in a two dimensional 
environment (limitation). Testing the viability of bone marrow stromal cells in a three 
dimensional environment (for example when seeded in hydrogel scaffolds) while in 
contact with the disk specimens will resemble more closely the in vivo conditions 
(future studies). 
2. Only the pH of the culture media was determined (limitation). By testing the pH changes 
in the culture media and the specific ion dissolution products the molecular mechanism 
of bone marrow stromal cell viability in the presence of filled resin composites 
containing bioactive glass may be determined (future studies). 
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8. FINAL CONCLUSIONS 
The majority of biomaterials used to cement artificial joints or for bone augmentation consist 
of PMMA based materials. PMMA based biomaterials have been used in orthopeadic 
applications for more then 60 years and provided a reasonable service history. However, the 
use of PMMA has many limitations including: a volatile liquid monomer component, which 
requires mixing in surgery, long working time, high setting temperature and inability to bond 
to bone, leading to the formation of a fibrous capsule surrounding the implant leading to adverse 
inflammatory responses. There have been numerous attempts to use alternative material types 
either by adapting existing PMMA formulations or by using new material types such as 
bisGMA based cements, which also suffer from adverse inflammatory responses. Therefore, in 
numerous orthopeadic applications including bone void filling and fixation of metallic implants 
there is a need for cements that are bio-compatible with surrounding hard and soft tissues and 
also capable of forming a bond to bone. Filled resin composites consisting of a polymerisable 
resin matrix and bioactive filler particles may be developed as such bio-compatible cements 
with surrounding soft and hard tissues for these specific orthopeadic applications.  
Unfilled resin systems containing monomers with different chemical structures, thus viscosities 
and reactivities may be used as the base for such filled resin systems for orthopeadic 
applications. By testing resin formulations containing different concentrations of bisGMA, 
UDMA and TEGDMA, the optimum one in terms of physical and mechanical characteristics 
was determined to be 60/40wt% UDMA/TEGDMA. This formulation was used as the base 
unfilled resin system for the development of filled resin composites for orthopeadic 
applications. There were two types of filled resin composite cements formulated depending on 
viscosity referred to as low and high viscosity cement formulations (with low or high filler 
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content), each developed for particluar orthopeadic applications. The low viscosity cement (low 
filler content) was formulated for ex situ preparation, where the cement can be placed in 
premade molds (for example for auditory and cranio-facial repair surgeries) to harden and then 
placed at the required site in the body. The low viscosity cement (low filler content) may also 
be used as an injectable cement. This will also lead to a reduction in time and cost of the surgery 
due to the use of cost effective materials that are made into the required shape before surgery. 
The high viscosity cement (high filler content) was developed to be used and molded in shape 
in situ (for example for vertebroplasty surgeries, or for hand and wrist reconstruction). 
Changing the concentration of filler particles to the resin matrix had a crucial impact on the 
physical and mechanical properties of the final filled resin composite. The optimum formulation 
for the possible development of a material for use in orthopeadic applications was determined 
to be 60/40wt% UDMA/TEGDMA containing 20wt% bioactive glass filler and 50wt% barium 
silicate filler (low filler content) or 60/40wt% UDMA/TEGDMA containing 23wt% bioactive 
glass filler and 57wt% barium silicate filler (high filler content). By increasing the concentration 
of bioactive glass to 40 or 45wt% (low and high filler content) in filled resin composites did 
not result in an increase in viability of bone marrow stromal cells compared with filled resin 
composites containing 20 or 23w% (low and high filler content) bioactive glass. Moreover, 
filled resin composites containing 40 or 45wt% (low and high filler content) exhibited a 
decrease in flexural strength and modulus, with an increase in water sorption following wet 
ageing compared with filled resin composites containing 20 or 23wt% (low and high filler 
content) bioactive glass, regardless of the viscosity of the filled resin composites. Both low and 
high filler content cements, due to the presence of bioactive glass particles, were also shown to 
enhance proliferation of bone marrow stromal cells compared with existing PMMA cement. 
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Conclusively, it was shown for the first time that by incorporating bioactive glass to filled resin 
composites containing UDMA and TEGDMA as the base monomers, new materials can be 
developed for orthopeadic applications that exhibit increased bio-compatibility with 
surrounding soft and hard tissues while maintaining comparable physical and mechanical 
properties with current cement formulations. 
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Appendix 1 Statistical analysis of unfilled resin systems 
Degree of conversion of unfilled resin systems 
 20/80 BT 30/70 BT 40/60 BT 50/50 BT 60/40 BT 70/30 BT 80/20 BT bisGMA 
TEGDMA <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 
20/80 BT  <0.001 <0.001 <0.001 0.005 0.012 0.071 <0.001 
30/70 BT   0.552 0.639 0.034 0.013 <0.001 <0.001 
40/60 BT    0.264 0.115 0.048 <0.001 <0.001 
50/50 BT     0.006 0.002 <0.001 <0.001 
60/40 BT      0.692 <0.001 <0.001 
70/30 BT       <0.001 <0.001 
80/20 BT        <0.001 
Table 1.3 Significant differences between the degree of conversion of bisGMA/TEGDMA (BT) unfilled resin 
systems (One-way ANOVA, n=3). The numbers represent the p value, with the numbers in bold showing 
significant difference between sample conditions. Unfilled resin system percentage inclusions are shown within 
bar labels. 
 
 20/80 UT 30/70 
UT 
40/60 
UT 
50/50 
UT 
60/40 
UT 
70/30 
UT 
80/20 
UT 
TEGDMA 
UDMA 0.651 0.394 0.015 0.034 0.063 <0.001 0.005 <0.001 
20/80 
UT 
 0.268 0.015 0.030 0.053 0.001 0.007 <0.001 
30/70 
UT 
  0.174 0.296 0.456 0.031 0.138 <0.001 
40/60 
UT 
   0.720 0.459 0.480 0.974 <0.001 
50/50 
UT 
    0.708 0.263 0.712 <0.001 
60/40 
UT 
     0.113 0.419 <0.001 
70/30 
UT 
      0.401 <0.001 
80/20 
UT 
       <0.001 
Table 1.4 Significant differences between the degree of conversion of UDMA/TEGDMA (UT) unfilled resins 
systems (One-way ANOVA, n=3). The numbers represent the p value, with the numbers in bold showing 
significant difference between sample conditions. Unfilled resin system percentage inclusions are shown within 
bar labels. 
 
 
 
 
 
 
 
 
II 
 
BUT 20/60/
20 
10/60/
30 
40/50/ 
10 
30/50/ 
20 
20/50/ 
30 
10/50/ 
40 
50/40/ 
10 
50/30/ 
20 
50/20/ 
30 
50/10/ 
40 
30/60/10 <0.001 <0.001 0.009 0.002 <0.001 <0.001 0.001 0.084 0.117 0.011 
20/60/20  <0.001 <0.001 <0.001 0.006 <0.001 <0.001 <0.001 <0.001 0.001 
10/60/30   <0.001 <0.001 0.005 0.004 <0.001 <0.001 <0.001 <0.001 
40/50/10    <0.001 <0.001 <0.001 0.001 0.006 0.001 <0.001 
30/50/20     <0.001 <0.001 <0.001 <0.001 0.001 0.034 
20/50/30      <0.001 <0.001 <0.001 <0.001 <0.001 
10/50/40       <0.001 <0.001 <0.001 <0.001 
50/40/10        <0.001 <0.001 <0.001 
50/30/20         0.002 <0.001 
50/20/30          0.024 
Table 1.5 Significant differences between the degree of conversion of bisGMA/UDMA/TEGDMA (TBU) unfilled 
resin systems (One-way ANOVA, n=3). The numbers represent the p value, with the numbers in bold showing 
significant difference between sample conditions. Unfilled resin system percentage inclusions are shown within 
bar labels. 
Rate of polymerisation of unfilled resin systems 
 20/80 BT 30/70 BT 40/60 BT 50/50 BT 60/40 BT 70/30 BT 80/20 BT bisGMA 
TEGDMA <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 
20/80 BT  <0.001 <0.001 <0.001 <0.001 <0.001 0.146 <0.001 
30/70 BT   0.648 0.166 0.884 0.903 0.003 <0.001 
40/60 BT    0.371 0.563 0.580 0.001 <0.001 
50/50 BT     0.142 0.150 <0.001 <0.001 
60/40 BT      0.982 0.008 <0.001 
70/30 BT       0.007 <0.001 
80/20 BT        <0.001 
Table 1.6 Significant differences between the rate of polymerisation of bisGMA/TEGDMA (BT) unfilled resin 
systems (One-way ANOVA, n=3). The numbers represent the p value, with the numbers in bold showing 
significant difference between sample conditions. Unfilled resin system percentage inclusions are shown within 
bar labels. 
 
 20/80 UT 30/70 
UT 
40/60 
UT 
50/50 
UT 
60/40 
UT 
70/30 
UT 
80/20 
UT 
TEGDMA 
UDMA <0.001 0.007 0.233 0.334 <0.001 0.400 0.319 <0.001 
20/80 
UT 
 0.094 0.001 <0.001 0.375 <0.001 <0.001 <0.001 
3070 UT   0.078 0.046 0.415 <0.001 <0.001 <0.001 
40/60 
UT 
   0.800 0.009 0.029 0.022 <0.001 
50/50 
UT 
    0.005 0.052 0.039 <0.001 
60/40 
UT 
     <0.001 <0.001 <0.001 
70/30 
UT 
      0.849 <0.001 
80/20 
UT 
       <0.001 
Table 1.7 Significant differences between the rate of polymerisation of UDMA/TEGDMA (UT) unfilled resin 
systems (One-way ANOVA, n=3). The numbers represent the p value, with the numbers in bold showing 
significant difference between sample conditions. Unfilled resin system percentage inclusions are shown within 
bar labels. 
 
 
III 
 
BUT 20/60/20 10/60/30 40/50/ 
10 
30/50/ 
20 
20/50/ 
30 
10/50/ 
40 
50/40/ 
10 
50/30/ 
20 
50/20/ 
30 
50/10/ 
40 
30/60/10 0.009 0.002 0.003 0.027 0.060 0.599 <0.001 <0.001 0.003 <0.001 
20/60/20  0.862 0.001 0.029 0.221 0.006 <0.001 <0.001 0.001 <0.001 
10/60/30   <0.001 <0.001 0.116 <0.001 <0.001 <0.001 0.001 <0.001 
40/50/10    <0.001 0.002 0.001 0.001 0.007 0.032 0.002 
30/50/20     0.398 <0.001 <0.001 <0.001 0.002 <0.001 
20/50/30      0.056 <0.001 <0.001 0.002 <0.001 
10/50/40       <0.001 <0.001 0.002 <0.001 
50/40/10        0.001 0.692 0.028 
50/30/20         0.188 0.004 
50/20/30          0.063 
Table 1.8 Significant differences between the rate of polymerisation of bisGMA/UDMA/TEGDMA (BUT) 
unfilled resin systems (One-way ANOVA, n=3). The numbers represent the p value, with the numbers in bold 
showing significant difference between sample conditions. Unfilled resin system percentage inclusions are shown 
within bar labels. 
Hardness of unfilled resin systems 
 20/80 BT 30/70 BT 40/60 BT 50/50 BT 60/40 BT 70/30 BT 80/20 BT bisGMA 
TEGDMA <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 
20/80 BT  <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 
30/70 BT   <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 
40/60 BT    <0.001 <0.001 <0.001 <0.001 <0.001 
50/50 BT     <0.001 <0.001 <0.001 <0.001 
60/40 BT      <0.001 <0.001 <0.001 
70/30 BT       <0.001 <0.001 
80/20 BT        <0.001 
Table 1.9 Significant differences between the upper surface (specimen was cured on this surface), hardness values 
of bisGMA/TEGDMA (BT) unfilled resin systems (1-way ANOVA, n=9). The numbers represent the p value, 
with the numbers in bold showing significant difference between sample conditions. Unfilled resin system 
percentage inclusions are shown within bar labels. 
 20/80 BT 30/70 BT 40/60 BT 50/50 BT 60/40 BT 70/30 BT 80/20 BT bisGMA 
TEGDMA <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 
20/80 BT  <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 
30/70 BT   0.042 <0.001 <0.001 <0.001 <0.001 <0.001 
40/60 BT    <0.001 <0.001 <0.001 <0.001 <0.001 
50/50 BT     <0.001 <0.001 <0.001 <0.001 
60/40 BT      <0.001 <0.001 <0.001 
70/30 BT       <0.001 <0.001 
80/20 BT        <0.001 
Table 1.10 Significant differences between the lower surface hardness values of bisGMA/TEGDMA (BT) unfilled 
resin systems (1-way ANOVA, n=9). The numbers represent the p value, with the numbers in bold showing 
significant difference between sample conditions. Unfilled resin system percentage inclusions are shown within 
bar labels. 
 TEGDMA 20/80 
BT 
30/70 
BT 
40/60 
BT 
50/50 
BT 
60/40 
BT 
70/30 
BT 
80/20 
BT 
bisGMA 
Upper/Lower 
Surface 
<0.001 <0.001 <0.001 <0.001 <0.001 <0.001 0.001 0.008 <0.001 
Table 1.11 Significant differences between the upper (specimen was cured on this surface) and lower surface of 
each bisGMA/TEGDMA (BT) unfilled resin systems (1-way ANOVA, n=9). The numbers represent the p value, 
with the numbers in bold showing significant difference between sample conditions. Unfilled resin system 
percentage inclusions are shown within bar labels. 
 
IV 
 
 20/80 
UT 
30/70 
UT 
40/60 UT 50/50 
UT 
60/40 
UT 
70/30 
UT 
80/20 
UT 
TEGDMA 
UDMA 0.818 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 
20/80 
UT 
 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 
30/70 
UT 
  <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 
40/60 
UT 
   <0.001 <0.001 <0.001 <0.001 <0.001 
50/50 
UT 
    <0.001 <0.001 <0.001 <0.001 
60/40 
UT 
     <0.001 <0.001 <0.001 
70/30 
UT 
      <0.001 <0.001 
80/20 
U/T 
       <0.001 
Table 1.12 Significant differences between the upper surface (specimen was cured on this surface), hardness values 
of UDMA/TEGDMA (UT) unfilled resin systems (1-way ANOVA, n=9). The numbers represent the p value, with 
the numbers in bold showing significant difference between sample conditions. Unfilled resin system percentage 
inclusions are shown within bar labels. 
 
 20/80 
UT 
30/70 
UT 
40/60 UT 50/50 UT 60/40 
UT 
70/30 
UT 
80/20 
UT 
TEGDMA 
UDMA 0.002 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 0.150 
20/80 
UT 
 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 
30/70 
UT 
  <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 
40/60 
UT 
   <0.001 <0.001 <0.001 <0.001 <0.001 
50/50 
UT 
    0.051 0.032 <0.001 <0.001 
60/40 
UT 
     0.532 <0.001 <0.001 
70/30 
UT 
      <0.001 <0.001 
80/20 
UT 
       <0.001 
Table 1.13 Significant differences between the lower surface hardness values of UDMA/TEGDMA (UT) unfilled 
resin systems (1-way ANOVA, n=9). The numbers represent the p value, with the numbers in bold showing 
significant difference between sample conditions. Unfilled resin system percentage inclusions are shown within 
bar labels. 
 UDMA 20/80 
UT 
30/70 
UT 
40/60 
UT 
50/50 
UT 
60/40 
UT 
70/30 
UT 
80/20 
UT 
TEGDMA 
CURED/ 
UNCURED 
<0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 
Table 1.14 Significant differences between the upper (specimen was cured on this surface) and lower surface of 
each UDMA/TEGDMA resins (1-way ANOVA, n=9). The numbers represent the p value, with the numbers in 
bold showing significant difference between sample conditions. Unfilled resin system percentage inclusions are 
shown within bar labels. 
 
 
V 
 
 20/60/20 10/60/30 40/50/ 
10 
30/50/ 
20 
20/50/ 
30 
10/50/ 
40 
50/40/ 
10 
50/30/ 
20 
50/20/ 
30 
50/10/ 
40 
30/60/10 <0.001 <0.001 <0.001 0.454 <0.001 <0.001 <0.001 0.550 <0.001 <0.001 
20/60/20  0.525 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 0.072 <0.001 
10/60/30   <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 0.023 <0.001 
40/50/10    <0.001 <0.001 <0.001 0.014 <0.001 <0.001 <0.001 
30/50/20     <0.001 <0.001 <0.001 0.246 <0.001 <0.001 
20/50/30      0.004 <0.001 <0.001 <0.001 0.001 
10/50/40       <0.001 <0.001 <0.001 <0.001 
50/40/10        <0.001 <0.001 <0.001 
50/30/20         <0.001 <0.001 
50/20/30          <0.001 
Table 1.15 Significant differences between the upper surface (specimen was cured on this surface) hardness values 
of bisGMA/UDMATEGDMA (BUT) unfilled resin systems (1-way ANOVA, n=9). The numbers represent the p 
value, with the numbers in bold showing significant difference between sample conditions. Unfilled resin system 
percentage inclusions are shown within bar labels. 
 
 20/60/20 10/60/30 40/50/ 
10 
30/50/ 
20 
20/50/ 
30 
10/50/ 
40 
50/40/ 
10 
50/30/ 
20 
50/20/ 
30 
50/10/ 
40 
30/60/10 <0.001 <0.001 <0.001 0.001 <0.001 <0.001 <0.001 0.030 <0.001 <0.001 
20/60/20  <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 
10/60/30   <0.001 <0.001 0.081 0.011 <0.001 <0.001 <0.001 0.037 
40/50/10    <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 
30/50/20     <0.001 0.007 <0.001 0.101 <0.001 <0.001 
20/50/30      0.039 <0.001 <0.001 <0.001 0.373 
10/50/40       <0.001 0.002 <0.001 0.098 
50/40/10        <0.001 <0.001 <0.001 
50/30/20         <0.001 <0.001 
50/20/30          <0.001 
Table 1.16 Significant differences between the lower surface hardness values of bisGMA/UDMA/TEGDMA 
unfilled resin systems (1-way ANOVA, n=9). The numbers represent the p value, with the numbers in bold 
showing significant difference between sample conditions. Unfilled resin system percentage inclusions are shown 
within bar labels. 
 
 
BU
T 
 
HV 
20/60/2
0 
10/60/
30 
40/50/ 
10 
30/50/ 
20 
20/50/ 
30 
10/50/ 
40 
50/40/ 
10 
50/30/ 
20 
50/20/ 
30 
50/10/ 
40 
20/60/
20 
<0.001 <0.001 <0.001 <0.001 <0.001 <0.001 0.011 <0.001 <0.001 <0.001 <0.001 
Table 1.17 Significant differences between the upper (specimen was cured on this surface) and lower surface 
hardness values of bisGMA/UDMA/TEGDMA unfilled resin systems (1-way ANOVA, n=10). The numbers 
represent the p value, with the numbers in bold showing significant difference between sample conditions. Unfilled 
resin system percentage inclusions are shown within bar labels. 
 
 
 
 
 
 
 
VI 
 
Flexural strength of unfilled resin systems 
 20/80 BT 30/70 BT 40/60 BT 50/50 BT 60/40 BT 70/30 BT 80/20 BT bisGMA 
TEGDMA 0.378 0.028 0.005 <0.001 0.001 0.001 0.077 <0.001 
20/80 BT  0.031 <0.001 <0.001 <0.001 <0.001 0.081 <0.001 
30/70 BT   0.664 0.070 0.144 0.074 0.252 <0.001 
40/60 BT    0.028 0.093 0.058 0.021 <0.001 
50/50 BT     0.442 0.687 <0.001 <0.001 
60/40 BT      0.375 <0.001 <0.001 
70/30 BT       0.001 <0.001 
80/20 BT        <0.001 
Table 1.18 Significant differences between the flexural strength of UDMA/TEGDMA (UT) unfilled resin systems 
(1-way ANOVA, n=10). The numbers represent the p value, with the numbers in bold showing significant 
difference between sample conditions. Unfilled resin system percentage inclusions are shown within bar labels. 
 
 20/80 UT 30/70 
UT 
40/60 
UT 
50/50 
UT 
60/40 
UT 
70/30 
UT 
80/20 
UT 
TEGDMA 
UDMA <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 0.561 0.913 
20/80 
UT 
 0.143 0.360 0.012 0.429 0.101 <0.001 <0.001 
30/70 
UT 
  0.356 0.381 0.056 0.005 <0.001 <0.001 
40/60 
UT 
   0.023 0.122 0.005 <0.001 <0.001 
50/50 
UT 
    0.007 <0.001 <0.001 <0.001 
60/40 
UT 
     0.602 <0.001 0.003 
70/30 
UT 
      <0.001 0.002 
80/20 
UT 
       0.615 
Table 1.19 Significant differences between the flexural strength of UDMA/TEGDMA (UT) unfilled resin systems 
(1-way ANOVA, n=10). The numbers represent the p value, with the numbers in bold showing significant 
difference between sample conditions. Unfilled resin system percentage inclusions are shown within bar labels. 
 
UT 20/60/20 10/60/30 40/50/ 
10 
30/50/ 
20 
20/50/ 
30 
10/50/ 
40 
50/40/ 
10 
50/30/ 
20 
50/20/ 
30 
50/10/ 
40 
30/60/10 0.002 0.047 0.003 0.001 0.116 0.146 <0.001 0.611 0.393 0.088 
20/60/20  <0.001 <0.001 0.902 0.108 0.188 <0.001 0.001 <0.001 <0.001 
10/60/30   0.120 <0.001 0.003 0.006 0.007 0.137 0.203 0.601 
40/50/10    <0.001 <0.001 0.001 0.521 0.010 0.014 0.045 
30/50/20     0.071 0.143 <0.001 <0.001 <0.001 <0.001 
20/50/30      0.921 <0.001 0.053 0.025 0.004 
10/50/40       <0.001 0.076 0.042 0.010 
50/40/10        <0.001 <0.001 0.001 
50/30/20         0.754 0.253 
50/20/30          0.378 
Table 1.20 Significant differences between the flexural strength of bisGMA/UDDMA/TEGDMA (BUT) unfilled 
resin systems (1-way ANOVA, n=10). The numbers represent the p value, with the numbers in bold showing 
significant difference between sample conditions. Unfilled resin system percentage inclusions are shown within 
bar labels. 
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Flexural modulus of unfilled resin systems 
 20/80 BT 30/70 BT 40/60 BT 50/50 BT 60/40 BT 70/30 BT 80/20 BT bisGMA 
TEGDMA 0.222 0.004 0.002 <0.001 0.001 0.003 0.145 <0.001 
20/80 BT  0.005 <0.001 <0.001 <0.001 0.001 0.498 <0.001 
30/70 BT   0.592 0.505 0.675 0.630 0.022 <0.001 
40/60 BT    0.080 0.812 0.972 0.007 <0.001 
50/50 BT     0.088 0.125 <0.001 <0.001 
60/40 BT      0.870 0.002 <0.001 
70/30 BT       0.013 <0.001 
80/20 BT        <0.001 
Table 1.21 Significant differences between the flexural modulus of bisGMA/TEGDMA (BT) unfilled resin 
systems (1-way ANOVA, n=10). The numbers represent the p value, with the numbers in bold showing significant 
difference between sample conditions. Unfilled resin system percentage inclusions are shown within bar labels. 
 
 20/80 
UT 
30/70 UT 40/60 
UT 
50/50 
UT 
60/40 
UT 
70/30 
UT 
80/20 
UT 
TEGDMA 
UDMA <0.001 <0.001 <0.001 <0.001 0.001 0.003 0.511 0.714 
20/80 
UT 
 0.029 0.015 0.006 0.701 0.066 <0.001 0.001 
30/70 
UT 
  0.369 0.904 0.031 0.002 <0.001 <0.001 
40/60 
UT 
   0.224 0.033 <0.001 <0.001 <0.001 
50/50 
UT 
    0.012 <0.001 <0.001 <0.001 
60/40 
UT 
     0.246 <0.001 0.007 
70/30 
UT 
      0.001 0.032 
80/20 
UT 
       0.387 
Table 1.22 Significant differences between the flexural modulus of UDMA/TEGDMA unfilled resin systems (1-
way ANOVA, n=10). The numbers represent the p value, with the numbers in bold showing significant difference 
between sample conditions. Unfilled resin system percentage inclusions are shown within bar labels. 
 
 20/60/20 10/60/30 40/50/ 
10 
30/50/ 
20 
20/50/ 
30 
10/50/ 
40 
50/40/ 
10 
50/30/ 
20 
50/20/ 
30 
50/10/ 
40 
30/60/10 0.002 0.955 0.045 0.003 0.009 0.053 0.008 0.217 0.583 0.832 
20/60/20  0.004 <0.001 0.252 0.240 0.423 <0.001 <0.001 0.006 0.002 
10/60/30   0.093 0.010 0.020 0.066 0.023 0.355 0.597 0.811 
40/50/10    <0.001 <0.001 0.002 0.407 0.256 0.013 0.016 
30/50/20     0.869 0.997 <0.001 <0.001 0.012 0.002 
20/50/30      0.925 <0.001 <0.001 0.030 0.007 
10/50/40       0.001 0.007 0.108 0.057 
50/40/10        0.044 0.002 0.002 
50/30/20         0.069 0.098 
50/20/30          0.690 
Table 1.23 Significant differences between the flexural modulus of bisGMA/UDMA/TEGDMA (BUT) unfilled 
resin systems (1-way ANOVA, n=10). The numbers represent the p value, with the numbers in bold showing 
significant difference between sample conditions. Unfilled resin system percentage inclusions are shown within 
bar labels. 
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Appendix 2 Statistical analysis of filled resin composites and PMMA 
Degree of conversion of filled resin composites 
 SIL20 SIL30 SIL40 SIL70 Silica70 
SIL10 0.695 0.403 0.017 0.087 <0.001 
SIL20  0.321 0.012 0.383 <0.001 
SIL30    0.081 0.003 <0.001 
SIL40     0.082 <0.001 
SIL70     <0.001 
Table 2.1 Significant differences between the degree of conversion of low filler content Type I filled resin 
composites (1-way ANOVA, n=10). Filled resin composite percentage inclusions are shown within bar labels. The 
numbers represent the p value, with the numbers in bold showing significant difference between sample 
conditions.  
 
 SIL23 SIL34 SIL45 SIL80 Silica80 
SIL11 <0.001 0.003 0.603 <0.001 <0.001 
SIL23  0.032 <0.001 0.071 <0.001 
SIL34    0.022 0.001 <0.001 
SIL45     <0.001 <0.001 
SIL80     <0.001 
Table 2.2 Significant differences between the degree of conversion of high filler content Type I filled resin 
composites (1-way ANOVA, n=10). Filled resin composite percentage inclusions are shown within bar labels. The 
numbers represent the p value, with the numbers in bold showing significant difference between sample 
conditions.   
 
 SIL10/ 
SIL11 
SIL20/ 
SIL23 
SIL30/ 
SIL34 
SIL40/ 
SIL45 
Silica70/ 
Silica80 
Low/High filler 0.418 <0.001 0.288 0.040 0.037 
Table 2.3 Significant differences between the degree of conversion of low versus high filler content Type I filled 
resin composites (1-way ANOVA, n=10). Filled resin composite percentage inclusions are shown within bar 
labels. The numbers represent the p value, with the numbers in bold showing significant difference between sample 
conditions.  
 
 NS20 NS30 NS40 NS70 Silica70 
NS10 0.126 0.108 0.045 <0.001 <0.001 
NS20  0.986 0.001 <0.001 <0.001 
NS30   0.002 <0.001 0.010 
NS40    <0.001 <0.001 
NS70     <0.001 
Table 2.24 Significant differences between the degree of conversion of low filler content Type II filled resin 
composites (1-way ANOVA, n=10). Filled resin composite percentage inclusions are shown within bar labels. The 
numbers represent the p value, with the numbers in bold showing significant difference between sample 
conditions.  
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 NS23 NS34 NS45 NS80 Silica80 
NS11 0.498 0.930 <0.001 <0.001 <0.001 
NS23  0.457 <0.001 <0.001 <0.001 
NS34    <0.001 <0.001 <0.001 
NS45    <0.001 <0.001 
Silica80     <0.001 
Table 2.25 Significant differences between the degree of conversion of high filler content Type II filled resin 
composites (1-way ANOVA, n=10). Filled resin composite percentage inclusions are shown within bar labels. The 
numbers represent the p value, with the numbers in bold showing significant difference between sample 
conditions.   
 NS10/NS11 NS20/NS23 NS30/NS34 NS40/NS45 Silica70/Silica80 
Low/High filler 0.002 0.007 0.355 0.429 0.963 
Table 2.26 Significant differences between the degree of conversion of low versus high filler content Type II filled 
resin composites (1-way ANOVA, n=10). Filled resin composite percentage inclusions are shown within bar 
labels. The numbers represent the p value, with the numbers in bold showing significant difference between sample 
conditions.  
 
 AB20 AB30 AB40 AB70 Silica70 
AB10 0.465 0.399 0.392 <0.001 <0.001 
AB20  0.973 0.123 <0.001 <0.001 
AB30   0.034 <0.001 <0.001 
AB40    <0.001 <0.001 
AB70     <0.001 
Table 2.27 Significant differences between the degree of conversion of low filler content Type III filled resin 
composites (1-way ANOVA, n=10). Filled resin composite percentage inclusions are shown within bar labels. The 
numbers represent the p value, with the numbers in bold showing significant difference between sample 
conditions.  
 
 AB23 AB34 AB45 Silica80 
AB11 0.209 0.001 <0.001 <0.001 
AB23  0.001 <0.001 <0.001 
AB34   <0.001 <0.001 
AB45    <0.001 
Table 2.28 Significant differences between the degree of conversion of high filler content Type III filled resin 
composites (1-way ANOVA, n=10). Filled resin composite percentage inclusions are shown within bar labels. The 
numbers represent the p value, with the numbers in bold showing significant difference between sample 
conditions.  
 
 AB10/AB11 AB20/AB23 AB30/AB34 AB40/AB45 Silica70/Silica80  
Low/High filler 0.083 0.376 0.637 <0.001 0.874 
Table 2.29 Significant differences between the degree of conversion of low versus high filler content Type III 
filled resin composites (1-way ANOVA, n=10). Filled resin composite percentage inclusions are shown within bar 
labels. The numbers represent the p value, with the numbers in bold showing significant difference between sample 
conditions.  
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Flexural strength of filled resin composites  
 SIL20 SIL30 SIL40 Silica70 
SILl10 0.002 0.848 <0.001 <0.001 
SIL20  <0.001 <0.001 0.011 
SIL30   <0.001 <0.001 
SIL40    <0.001 
Table 2.30 Significant differences between the flexural strength of low filler content Type I filled resin composites 
(One-way ANOVA, n=10). Filled resin composite percentage inclusions are shown within bar labels. The numbers 
represent the p value, with the numbers in bold showing significant difference between sample conditions. 
 
 SIL23 SIL34 SIL45 Silica80 
SIL11 0.021 <0.001 <0.001 0.409 
SIL23  0.134 <0.001 0.040 
SIL34   <0.001 0.004 
SIL45    <0.001 
Table 2.31 Significant differences between the flexural strength of high filler content Type I filled resin composites 
(One-way ANOVA, n=10). Filled resin composite percentage inclusions are shown within bar labels. The numbers 
represent the p value, with the numbers in bold showing significant difference between sample conditions. 
 
 SIL10/SIL11 SIL20/SIL23 SIL30/SIL34 SIL40/SIL45 Silica70/Silica80 
Low/High filler 0.038 0.001 0.018 0.026 0.206 
Table 2.32 Significant differences between the flexural strength of low versus high filler content Type I filled resin 
composites (1-way ANOVA, n=10). Filled resin composite percentage inclusions are shown within bar labels. The 
numbers represent the p value, with the numbers in bold showing significant difference between sample 
conditions.  
 
 NS20 NS30 NS40 Silica70 
NS10 0.630 0.042 <0.001 0.003 
NS20  <0.001 <0.001 0.002 
NS30   <0.001 <0.001 
NS40    <0.001 
Table 2.33 Significant differences between the flexural strength of low filler content Type II filled resin composites 
(1-way ANOVA, n=10). Filled resin composite percentage inclusions are shown within bar labels. The numbers 
represent the p value, with the numbers in bold showing significant difference between sample conditions. 
 
 NS23 NS34 NS45 Silica80 
NS11 0.594 0.017 <0.001 0.419 
NS23  0.057 <0.001 0.236 
NS34   <0.001 0.019 
NS45    <0.001 
Table 2.34 Significant differences between the flexural strength of high filler content Type II filled resin 
composites (1-way ANOVA, n=10). Filled resin composite percentage inclusions are shown within bar labels. The 
numbers represent the p value, with the numbers in bold showing significant difference between sample 
conditions. 
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 NS10/NS11 NS20/NS23 NS30/NS34 NS40/NS45 Silica70/Silica80 
Low/High filler 0.762 0.443 0.899 0.157 0.206 
Table 2.35 Significant differences between the flexural strength of low versus high filler content Type II filled 
resin composites (1-way ANOVA, n=10). Filled resin composite percentage inclusions are shown within bar 
labels. The numbers represent the p value, with the numbers in bold showing significant difference between sample 
conditions.  
 
 AB20 AB30 AB40 Silica70 
AB10 0.034 0.030 <0.001 0.020 
AB20  <0.001 <0.001 0.357 
AB30   <0.001 <0.001 
AB40    <0.001 
Table 2.36 Significant differences between the flexural strength of low filler content Type III filled resin 
composites (1-way ANOVA, n=10). Filled resin composite percentage inclusions are shown within bar labels. The 
numbers represent the p value, with the numbers in bold showing significant difference between sample 
conditions. 
 
 AB23 AB34 Silica80 
AB11 0.006 0.255 0.704 
AB23  0.001 0.093 
AB34   0.373 
Table 2.37 Significant differences between the flexural strength of high filler content Type III filled resin 
composites (1-way ANOVA, n=10). Filled resin composite percentage inclusions are shown within bar labels. The 
numbers represent the p value, with the numbers in bold showing significant difference between sample 
conditions. 
 
 AB10/AB11 AB20/AB23 AB30/AB34 Silica70/Silica80  
Low/High filler 0.921 0.119 0.152 0.206 
Table 2.38 Significant differences between the flexural strength of low versus high filler content Type III filled 
resin composites (1-way ANOVA, n=10). Filled resin composite percentage inclusions are shown within bar 
labels. The numbers represent the p value, with the numbers in bold showing significant difference between sample 
conditions.  
 
Flexural modulus of filled resin composites 
 SIL20 SIL30 SIL40 Silica70 
SIL10 0.227 0.793 <0.001 0.148 
SIL20  0.088 <0.001 0.002 
SIL30   <0.001 0.206 
SIL40    <0.001 
Table 2.39 Significant differences between the flexural modulus of low filler content Type I filled resin composites 
(1-way ANOVA, n=10). Filled resin composite percentage inclusions are shown within bar labels. The numbers 
represent the p value, with the numbers in bold showing significant difference between sample conditions. 
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Table 2.40 Significant differences between the flexural modulus of high filler content Type I filled resin 
composites (1-way ANOVA, n=10). Filled resin composite percentage inclusions are shown within bar labels. The 
numbers represent the p value, with the numbers in bold showing significant difference between sample 
conditions. 
 
 SIL10/SIL11 SIL20/SIL23 SIL30/SIL34 SIL40/SIL45 Silica70/Silica80 
Low/High filler 0.034 0.002 0.416 0.609 0.967 
Table 2.41 Significant differences between the flexural modulus of low versus high filler content Type I filled 
resin composites (1-way ANOVA, n=10). Filled resin composite percentage inclusions are shown within bar 
labels. The numbers represent the p value, with the numbers in bold showing significant difference between sample 
conditions.  
 
 NS20 NS30 NS40 Silica70 
NS10 0.005 0.002 <0.001 0.438 
NS20  0.556 <0.001 0.009 
NS30   <0.001 0.002 
NS40    <0.001 
Table 2.42 Significant differences between the flexural modulus of low filler content Type II filled resin 
composites (1-way ANOVA, n=10). Filled resin composite percentage inclusions are shown within bar labels. The 
numbers represent the p value, with the numbers in bold showing significant difference between sample 
conditions. 
 
 NS23 NS34 NS45 Silica80 
NS11 0.037 0.150 <0.001 0.222 
NS23  0.437 <0.001 0.643 
NS34   <0.001 0.909 
NS45    <0.001 
Table 2.43 Significant differences between the flexural modulus of high filler content Type II filled resin 
composites (1-way ANOVA, n=10). Filled resin composite percentage inclusions are shown within bar labels. The 
numbers represent the p value, with the numbers in bold showing significant difference between sample 
conditions. 
 
 NS10/NS11 NS20/NS23 NS30/NS34 NS40/NS45 Silica70/Silica80 
Low/High filler 0.428 0.069 0.004 0.082 0.967 
Table 2.44 Significant differences between the flexural modulus of low versus high filler content Type II filled 
resin composites (1-way ANOVA, n=10). Filled resin composite percentage inclusions are shown within bar 
labels. The numbers represent the p value, with the numbers in bold showing significant difference between sample 
conditions.  
 
 
 
 SIL23 SIL34 SIL45 Silica80 
SIL11 0.978 0.145 <0.001 0.546 
SIL23  0.204 <0.001 0.575 
SIL34   <0.001 0.734 
SIL45    <0.001 
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 AB20 AB30 AB40 Silica70 
AB10 0.024 <0.001 <0.001 0.016 
AB20  <0.001 <0.001 0.839 
AB30   0.001 <0.001 
AB40    <0.001 
Table 2.45 Significant differences between the flexural modulus of low filler content Type III filled resin 
composites (1-way ANOVA, n=10). Filled resin composite percentage inclusions are shown within bar labels. The 
numbers represent the p value, with the numbers in bold showing significant difference between sample 
conditions. 
 
 AB23 AB34 Silica80 
AB11 <0.001 0.772 <0.001 
AB23  <0.001 0.036 
AB34   <0.001 
Table 2.46 Significant differences between the flexural modulus of high filler content Type III filled resin 
composites containing high amount of filler (One-way ANOVA, n=9). Filled resin composite percentage 
inclusions are shown within bar labels. The numbers represent the p value, with the numbers in bold showing 
significant difference between sample conditions. 
 
 AB10/AB11 AB20/AB23 AB30/AB34 Silica70/Silica80  
Low/High filler <0.001 0.008 0.186 0.967 
Table 2.47 Significant differences between the flexural modulus of low versus high filler content Type III filled 
resin composites (1-way ANOVA, n=10). Filled resin composite percentage inclusions are shown within bar 
labels. The numbers represent the p value, with the numbers in bold showing significant difference between sample 
conditions.  
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Appendix 3 Statistical analysis of water sorption, water solubility and bi-axial flexural 
strength values of filled resin composites and PMMA following wet ageing  
Statistical data of water sorption values of filled resin composites and PMMA 
 Day 7 Month 1 Month 3 
Day 1 0.002 <0.001 0.146 
Day 7  <0.001 0.206 
Month 1   0.364 
Table 3.1 Significant differences between the water sorption of low filler content filled resin composites containing 
70wt% barium silicate filler following water immersion for 1 day, 7 days, 1 month and 3 months (1-way ANOVA, 
n=10). The numbers represent the p value, with the numbers in bold showing significant difference between 
sample conditions. 
 
 Day 7 Month 1 Month 3 
Day 1 <0.001 <0.001 <0.001 
Day 7  0.011 0.112 
Month 1   0.551 
Table 3.2 Significant differences between the water sorption of low filler content Type I filled resin composites 
containing 20wt% bioactive glass following water immersion for 1 day, 7 days, 1 month and 3 months (1-way 
ANOVA, n=10). The numbers represent the p value, with the numbers in bold showing significant difference 
between sample conditions. 
 
 Day 7 Month 1 Month 3 
Day 1 0.042 0.045 0.106 
Day 7  0.892 <0.001 
Month 1   <0.001 
Table 3.3 Significant differences between the water sorption of low filler content Type I filled resin composites 
containing 40wt% bioactive glass following water immersion for 1 day, 7 days, 1 month and 3 months (1-way 
ANOVA, n=10). The numbers represent the p value, with the numbers in bold showing significant difference 
between sample conditions. 
 
 Day 7 Month 1 Month 3 
Day 1 <0.001 <0.001 <0.001 
Day 7  0.013 <0.001 
Month 1   <0.001 
Table 3.4 Significant differences between the water sorption of low filler content Type II filled resin composites 
containing 20wt% bioactive glass  following water immersion for 1 day, 7 days, 1 month and 3 months (1-way 
ANOVA, n=10). The numbers represent the p value, with the numbers in bold showing significant difference 
between sample conditions. 
 
 Day 7 Month 1 Month 3 
Day 1 0.004 0.001 0.068 
Day 7  0.583 0.093 
Month 1   0.024 
Table 3.5 Significant differences between the water sorption of low filler content Type II filled resin composites 
containing 40wt% bioactive glass following water immersion for 1 day, 7 days, 1 month and 3 months (1-way 
ANOVA, n=10). The numbers represent the p value, with the numbers in bold showing significant difference 
between sample conditions. 
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 Day 7 Month 1 Month 3 
Day 1 <0.001 <0.001 <0.001 
Day 7  <0.001 <0.001 
Month 1   0.002 
Table 3.6 Significant differences between the water sorption of low filler content Type III filled resin composites 
containing 20wt% bioactive glass following water immersion for 1 day, 7 days, 1 month and 3 months (1-way 
ANOVA, n=10). The numbers represent the p value, with the numbers in bold showing significant difference 
between sample conditions. 
 
 Day 7 Month 1 Month 3 
Day 1 0.016 <0.001 <0.001 
Day 7  <0.001 <0.001 
Month 1   <0.001 
Table 3.7 Significant differences between the water sorption of low filler content Type III filled resin composites 
containing 40wt% bioactive glass (1-way ANOVA, n=10). The numbers represent the p value, with the numbers 
in bold showing significant difference between sample conditions. 
 
 Day 7 Month 1 Month 3 
Day 1 0.006 0.001 <0.001 
Day 7  0.986 0.373 
Month 1   0.275 
Table 3.8 Significant differences between the water sorption of high filler content filled resin composites 
containing 80wt% barium silicate filler following water immersion for 1 day, 7 days, 1 month and 3 months (1-
way ANOVA, n=10). The numbers represent the p value, with the numbers in bold showing significant difference 
between sample conditions. 
 
 Day 7 Month 1 Month 3 
Day 1 0.200 <0.001 <0.001 
Day 7  <0.001 <0.001 
Month 1   0.409 
Table 3.9 Significant differences between the water sorption of high filler content Type I filled resin composites 
containing 23wt% bioactive glass  following water immersion for 1 day, 7 days, 1 month and 3 months (1-way 
ANOVA, n=10). The numbers represent the p value, with the numbers in bold showing significant difference 
between sample conditions. 
 
 Day 7 Month 1 Month 3 
Day 1 0.637 0.055 0.954 
Day 7  0.109 0.729 
Month 1   0.103 
Table 3.10 Significant differences between the water sorption of high filler content Type I filled resin composites 
containing 45wt% bioactive glass following water immersion for 1 day, 7 days, 1 month and 3 months (1-way 
ANOVA, n=10). The numbers represent the p value, with the numbers in bold showing significant difference 
between sample conditions. 
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 Day 7 Month 1 Month 3 
Day 1 <0.001 <0.001 <0.001 
Day 7  0.204 0.541 
Month 1   0.696 
Table 3.11 Significant differences between the water sorption of high filler content Type II filled resin composites 
containing 23wt% bioactive glass following water immersion for 1 day, 7 days, 1 month and 3 months (1-way 
ANOVA, n=10). The numbers represent the p value, with the numbers in bold showing significant difference 
between sample conditions. 
 
 Day 7 Month 1 Month 3 
Day 1 0.056 0.798 0.062 
Day 7  0.013 0.002 
Month 1   0.024 
Table 3.12 Significant differences between the water sorption of high filler content Type II filled resin composites 
containing 45wt% bioactive glass following water immersion for 1 day, 7 days, 1 month and 3 months (1-way 
ANOVA, n=10). The numbers represent the p value, with the numbers in bold showing significant difference 
between sample conditions. 
 
 Day 7 Month 1 Month 3 
Day 1 0.005 <0.001 <0.001 
Day 7  <0.001 <0.001 
Month 1   0.007 
Table 3.13 Significant differences between the water sorption of high filler content Type III filled resin composites 
containing 23wt% bioactive glass following water immersion for 1 day, 7 days, 1 month and 3 months (1-way 
ANOVA, n=10). The numbers represent the p value, with the numbers in bold showing significant difference 
between sample conditions. 
 
 Day 7 Month 1 Month 3 
Day 1 0.683 0.001 <0.001 
Day 7  0.022 <0.001 
Month 1   <0.001 
Table 3.14 Significant differences between the water sorption of PMMA following water immersion for 1 day, 7 
days, 1 month and 3 months (1-way ANOVA, n=10). The numbers represent the p value, with the numbers in bold 
showing significant difference between sample conditions. 
 
Statistical data of water solubility values of filled resin composites and PMMA 
 
 Day 7 Month 1 Month 3 
Day 1 0.794 0.093 0.548 
Day 7  0.119 0.369 
Month 1   0.043 
Table 3.15 Significant differences between the water solubility of low filler content filled resin composites 
containing 70wt% barium silicate filler following water immersion for 1 day, 7 days, 1 month and 3 months (1-
way ANOVA, n=10). The numbers represent the p value, with the numbers in bold showing significant difference 
between sample conditions. 
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 Day 7 Month 1 Month 3 
Day 1 0.233 <0.001 <0.001 
Day 7  0.703 0.044 
Month 1   0.001 
Table 3.16 Significant differences between the water solubility of low filler content Type I filled resin composites 
containing 20wt% bioactive glass following water immersion for 1 day, 7 days, 1 month and 3 months (1-way 
ANOVA, n=10). The numbers represent the p value, with the numbers in bold showing significant difference 
between sample conditions. 
 
 Day 7 Month 1 Month 3 
Day 1 <0.001 <0.001 <0.001 
Day 7  <0.001 <0.001 
Month 1   <0.001 
Table 3.17 Significant differences between water solubility of low filler content Type I filled resin composites 
containing 40wt% bioactive glass following water immersion for 1 day, 7 days, 1 month and 3 months (1-way 
ANOVA, n=10). The numbers represent the p value, with the numbers in bold showing significant difference 
between sample conditions. 
 
 Day 7 Month 1 Month 3 
Day 1 0.165 0..001 <0.001 
Day 7  0.060 <0.001 
Month 1   <0.001 
Table 3.18 Significant differences between the water solubility of low filler content Type II filled resin composites 
containing 20wt% bioactive glass following water immersion for 1 day, 7 days, 1 month and 3 months (1-way 
ANOVA, n=10). The numbers represent the p value, with the numbers in bold showing significant difference 
between sample conditions. 
 
 Day 7 Month 1 Month 3 
Day 1 <0.001 <0.001 <0.001 
Day 7  <0.001 <0.001 
Month 1   <0.001 
Table 319 Significant differences between the water solubility of low filler content Type II filled resin composites 
containing 40wt% bioactive glass following water immersion for 1 day, 7 days, 1 month and 3 months (1-way 
ANOVA, n=10). The numbers represent the p value, with the numbers in bold showing significant difference 
between sample conditions. 
 
 Day 7 Month 1 Month 3 
Day 1 0.295 0.001 <0.001 
Day 7  0.013 <0.001 
Month 1   <0.001 
Table 3.20 Significant differences between the water solubility of low filler content Type III filled resin composites 
containing 20wt% bioactive glass following water immersion for 1 day, 7 days, 1 month and 3 months (1-way 
ANOVA, n=10). The numbers represent the p value, with the numbers in bold showing significant difference 
between sample conditions. 
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 Day 7 Month 1 Month 3 
Day 1 <0.001 <0.001 0.001 
Day 7  0.784 0.006 
Month 1   0.010 
Table 3.21 Significant differences between the water solubility of low filler content Type III filled resin composites 
containing 40wt% bioactive glass following water immersion for 1 day, 7 days, 1 month and 3 months (1-way 
ANOVA, n=10). The numbers represent the p value, with the numbers in bold showing significant difference 
between sample conditions. 
 
 Day 7 Month 1 Month 3 
Day 1 0.800 0.933 0.674 
Day 7  0.757 0.945 
Month 1   0.618 
Table 3.22 Significant differences between the water solubility of high filler content filled resin composites 
containing 80wt% barium silicate filler following water immersion for 1 day, 7 days, 1 month and 3 months (1-
way ANOVA, n=10). The numbers represent the p value, with the numbers in bold showing significant difference 
between sample conditions. 
 
 Day 7 Month 1 Month 3 
Day 1 <0.001 0.076 <0.001 
Day 7  0.015 <0.001 
Month 1   0.552 
Table 3.23 Significant differences between the water solubility of high filler content Type I filled resin composites 
containing 23wt% bioactive glass following water immersion for 1 day, 7 days, 1 month and 3 months (1-way 
ANOVA, n=10). The numbers represent the p value, with the numbers in bold showing significant difference 
between sample conditions. 
 
 Day 7 Month 1 Month 3 
Day 1 <0.001 <0.001 <0.001 
Day 7  <0.001 <0.001 
Month 1   0.007 
Table 3.24 Significant differences between the water solubility of high filler content Type I filled resin composites 
containing 45wt% bioactive glass following water immersion for 1 day, 7 days, 1 month and 3 months (1-way 
ANOVA, n=10. The numbers represent the p value, with the numbers in bold showing significant difference 
between sample conditions. 
 
 Day 7 Month 1 Month 3 
Day 1 0.078 <0.001 <0.001 
Day 7  0.009 0.002 
Month 1   0.157 
Table 3.25 Significant differences between the water solubility of high filler content Type II filled resin composites 
containing 23wt% bioactive glass following water immersion for 1 day, 7 days, 1 month and 3 months (1-way 
ANOVA, n=10). The numbers represent the p value, with the numbers in bold showing significant difference 
between sample conditions. 
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 Day 7 Month 1 Month 3 
Day 1 <0.001 <0.001 <0.001 
Day 7  <0.001 <0.001 
Month 1   <0.001 
Table 3.26 Significant differences between the water solubility of high filler content Type II filed resin composites 
containing 45wt% bioactive glass following water immersion for 1 day, 7 days, 1 month and 3 months (1-way 
ANOVA, n=10). The numbers represent the p value, with the numbers in bold showing significant difference 
between sample conditions. 
 
 Day 7 Month 1 Month 3 
Day 1 0.532 <0.001 <0.001 
Day 7  <0.001 <0.001 
Month 1   <0.001 
Table 3.27 Significant differences between the water solubility of high filler content Type III filled resin 
composites containing 23wt% bioactive glass following water immersion for 1 day, 7 days, 1 month and 3 months 
(1-way ANOVA, n=10). The numbers represent the p value, with the numbers in bold showing significant 
difference between sample conditions. 
 
 Day 7 Month 1 Month 3 
Day 1 0.612 0.021 0.144 
Day 7  0.016 0.083 
Month 1   0.324 
Table 3.28 Significant differences between the water solubility of PMMA following water immersion for 1 day, 7 
days, 1 month and 3 months (1-way ANOVA, n=10). The numbers represent the p value, with the numbers in bold 
showing significant difference between sample conditions. 
 
Statistical data of bi-axial flexural strength values of filled resin composites and PMMA 
 
 Day 1 Day 7 Week 4 Month 3 
Dry 0.445 0.939 0.229 0.053 
Day 1  0.375 0.075 0.014 
Day 7   0.220 0.040 
Week 4    0.563 
Table 3.29 Significant differences between the bi-axial flexural strength of low filler content filled resin 
composites containing 70wt% barium silicate filler dry and following water immersion for 1 day, 7 days, 1 month 
and 3 months (1-way ANOVA, n=10). The numbers represent the p value, with the numbers in bold showing 
significant difference between sample conditions. 
 
 Day 1 Day 7 Week 4 Month 3 
Dry 0.298 <0.001 <0.001 <0.001 
Day 1  <0.001 <0.001 <0.001 
Day 7   0.732 0.104 
Week 4    0.153 
Table 3.30 Significant differences between the bi-axial flexural strength of low filler content Type I filled resin 
composites containing 20wt% bioactive glass dry and following water immersion for 1 day, 7 days, 1 month and 
3 months (1-way ANOVA, n=10). The numbers represent the p value, with the numbers in bold showing 
significant difference between sample conditions. 
XX 
 
 Day 1 Day 7 Week 4 Month 3 
Dry 0.035 0.028 0.004 0.004 
Day 1  0.691 0.248 0.190 
Day 7   0.555 0.450 
Week 4    0.822 
Table 3.31 Significant differences between the bi-axial flexural strength of low filler content Type I filled resin 
composites containing 40wt% bioactive glass dry and following water immersion for 1 day, 7 days, 1 month and 
3 months (1-way ANOVA, n=10). The numbers represent the p value, with the numbers in bold showing 
significant difference between sample conditions. 
 
 Day 1 Day 7 Week 4 Month 3 
Dry 0.051 <0.001 <0.001 <0.001 
Day 1  0.032 0.001 0.001 
Day 7   0.036 0.035 
Week 4    0.911 
Table 3.32 Significant differences between the bi-axial flexural strength of low filler content Type II filled resin 
composites containing 20wt% bioactive glass dry and following water immersion for 1 day, 7 days, 1 month and 
3 months (1-way ANOVA, n=10). The numbers represent the p value, with the numbers in bold showing 
significant difference between sample conditions. 
 
 Day 1 Day 7 Week 4 Month 3 
Dry 0.188 0.076 0.045 <0.001 
Day 1  0.487 0.420 0.002 
Day 7   0.919 0.012 
Week 4    0.002 
Table 3.33 Significant differences between the bi-axial flexural strength of low filler content Type II filled resin 
composites containing 40wt% bioactive glass dry and following water immersion for 1 day, 7 days, 1 month and 
3 months (1-way ANOVA, n=10). The numbers represent the p value, with the numbers in bold showing 
significant difference between sample conditions. 
 
 Day 1 Day 7 Week 4 Month 3 
Dry 0.039 0.030 <0.001 <0.001 
Day 1  <0.001 <0.001 <0.001 
Day 7   <0.001 <0.001 
Week 4    0.004 
Table 3.34 Significant differences between the bi-axial flexural strength of low filler content Type III filled resin 
composites containing 20wt% bioactive glass dry and following water immersion for 1 day, 7 days, 1 month and 
3 months (1-way ANOVA, n=10). The numbers represent the p value, with the numbers in bold showing 
significant difference between sample conditions. 
 Day 1 Day 7 Week 4 Month 3 
Dry 0.943 0.014 0.005 0.003 
Day 1  0.002 <0.001 <0.001 
Day 7   0.523 0.263 
Week 4    0.491 
Table 3.35 Significant differences between the bi-axial flexural strength of low filler content Type III filled resin 
composites containing 40wt% bioactive glass dry and following water immersion for 1 day, 7 days, 1 month and 
3 months (1-way ANOVA, n=10). The numbers represent the p value, with the numbers in bold showing 
significant difference between sample conditions. 
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 Day 1 Day 7 Week 4 Month 3 
Dry 0.997 0.313 0.217 0.183 
Day 1  0.295 0.195 0.161 
Day 7   0.931 0.867 
Week 4    0.902 
Table 3.36 Significant differences between the bi-axial flexural strength of high filler content filled resin 
composites containing 80wt% barium silicate filler dry and following water immersion for 1 day, 7 days, 1 month 
and 3 months following water immersion for 1 day, 7 days, 1 month and 3 months (1-way ANOVA, n=10). The 
numbers represent the p value, with the numbers in bold showing significant difference between sample 
conditions. 
 
 Day 1 Day 7 Week 4 Month 3 
Dry 0.568 <0.001 <0.001 <0.001 
Day 1  <0.001 <0.001 <0.001 
Day 7   0.024 <0.001 
Week 4    0.243 
Table 3.37 Significant differences between the bi-axial flexural strength of high filler content Type I filled resin 
composites containing 23wt% bioactive glass dry and following water immersion for 1 day, 7 days, 1 month and 
3 months (1-way ANOVA, n=10). The numbers represent the p value, with the numbers in bold showing 
significant difference between sample conditions. 
 
 Day 1 Day 7 Week 4 Month 3 
Dry 0.001 <0.001 <0.001 <0.001 
Day 1  0.405 0.332 0.039 
Day 7   0.039 0.158 
Week 4    0.157 
Table 3.38 Significant differences between the bi-axial flexural strength of high filler content Type I filled resin 
composites containing 45wt% bioactive glass dry and following water immersion for 1 day, 7 days, 1 month and 
3 months (1-way ANOVA, n=10). The numbers represent the p value, with the numbers in bold showing 
significant difference between sample conditions. 
 
 Day 1 Day 7 Week 4 Month 3 
Dry 0.546 <0.001 <0.001 <0.001 
Day 1  <0.001 <0.001 <0.001 
Day 7   0.001 0.002 
Week 4    0.241 
Table 3.39 Significant differences between the bi-axial flexural strength of high filler content Type II filled resin 
composites containing 23wt% bioactive glass dry and following water immersion for 1 day, 7 days, 1 month and 
3 months (1-way ANOVA, n=10). The numbers represent the p value, with the numbers in bold showing 
significant difference between sample conditions. 
 Day 1 Day 7 Week 4 Month 3 
Dry <0.001 <0.001 <0.001 <0.001 
Day 1  <0.001 <0.001 <0.001 
Day 7   0.845 0.221 
Week 4    0.410 
Table 3.40 Significant differences between the bi-axial flexural strength of high filler content Type II filled resin 
composites containing 45wt% bioactive glass dry and following water immersion for 1 day, 7 days, 1 month and 
3 months (1-way ANOVA, n=10). The numbers represent the p value, with the numbers in bold showing 
significant difference between sample conditions. 
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 Day 1 Day 7 Week 4 Month 3 
Dry <0.001 0.650 0.322 <0.001 
Day 1  <0.001 <0.001 <0.001 
Day 7   0.408 <0.001 
Week 4    0.001 
Table 3.41 Significant differences between the bi-axial flexural strength of high filler content Type III filled resin 
composites containing 23wt% bioactive glass dry and following water immersion for 1 day, 7 days, 1 month and 
3 months (1-way ANOVA, n=10). The numbers represent the p value, with the numbers in bold showing 
significant difference between sample conditions. 
 
  Day 1 Day 7 Week 4 Month 3 
Dry 0.522 0.146 0.053 0.003 
Day 1  0.060 0.024 0.003 
Day 7   0.396 0.006 
Week 4    0.033 
Table 3.42 Significant differences between the bi-axial flexural strength of PMMA dry and following water 
immersion for 1 day, 7 days, 1 month and 3 months (1-way ANOVA, n=10). The numbers represent the p value, 
with the numbers in bold showing significant difference between sample conditions. 
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Appendix 4 Statistical analysis of flexural strength and flexural modulus values of filled 
resin composites and PMMA tested following wet ageing  
Flexural strength following wet ageing of filled resin composites 
 
 Day 1 Day 7 Week 4 Month 3 Month 6 Month 9 Month 
12 
Dry 0.553 <0.001 0.002 0.180 0.418 0.265 0.049 
Day 1  0.359 0.043 0.087 0.214 0.118 0.025 
Day 7   0.445 0.005 0.026 0.003 0.001 
Week 4    <0.001 0.006 <0.001 <0.001 
Month 3     0.659 0.608 0.561 
Month 6      0.964 0.321 
Month 9       0.214 
Table 4.1 Significant differences between the flexural strength of low filler content filled resin composites 
containing 70wt% barium silicate filler dry and following wet ageing for 1 day, 7 days, 4 weeks, 3 months, 6 
months, 9 months and 12 months (1-way ANOVA, n=10). The numbers represent the p value, with the numbers 
in bold showing significant difference between sample conditions. 
 
 Day 1 Day 7 Week 4 Month 3 Month 6 Month 9 Month 
12 
Dry 0.271 0.021 0.003 0.006 0.063 0.027 0.021 
Day 1  <0.001 <0.001 0.017 0.305 0.107 0.082 
Day 7   0.440 <0.001 <0.001 <0.001 <0.001 
Week 4    <0.001 <0.001 <0.001 <0.001 
Month 3     0.058 0.387 0.288 
Month 6      0.351 0.319 
Month 9       0.924 
Table 4.2 Significant differences between the flexural strength of low filler content Type I filled resin composites 
containing 20wt% bioactive glass dry and following wet ageing for 1 day, 7 days, 4 weeks, 3 months, 6 months, 9 
months and 12 months (1-way ANOVA, n=10).  The numbers represent the p value, with the numbers in bold 
showing significant difference between sample conditions. 
 
 Day 1 Day 7 Week 4 Month 3 Month 6 Month 9 Month 
12 
Dry <0.001 0.023 0.020 0.002 0.048 0.470 0.422 
Day 1  <0.001 <0.001 <0.001 0.039 <0.001 <0.001 
Day 7   0.650 0.086 <0.001 0.229 0.370 
Week 4    0.323 <0.001 0.168 0.280 
Month 3     <0.001 0.036 0.085 
Month 6      0.017 0.022 
Month 9       0.887 
Table 4.3 Significant differences between the flexural strength of low filler content Type I filled resin composites 
containing 40wt% bioactive glass dry and following wet ageing for 1 day, 7 days, 4 weeks, 3 months, 6 months, 9 
months and 12 months (1-way ANOVA, n=10). The numbers represent the p value, with the numbers in bold 
showing significant difference between sample conditions. 
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 Day 1 Day 7 Week 4 Month 3 Month 6 Month 9 Month 
12 
Dry 0.044 0.001 <0.001 0.902 0.508 0.376 0.312 
Day 1  0.041 <0.001 0.034 0.189 0.240 0.156 
Day 7   0.058 0.001 0.004 0.005 0.001 
Week 4    <0.001 <0.001 <0.001 <0.001 
Month 3     0.439 0.315 0.241 
Month 6      0.847 0.843 
Month 9       0.979 
Table 4.4 Significant differences between the flexural strength of low filler content Type II filled resin composites 
containing 20wt% bioactive glass dry and following wet ageing for 1 day, 7 days, 4 weeks, 3 months, 6 months, 9 
months and 12 months (1-way ANOVA, n=10). The numbers represent the p value, with the numbers in bold 
showing significant difference between sample conditions. 
 
 Day 1 Day 7 Week 4 Month 3 Month 6 Month 9 Month 
12 
Dry <0.001 <0.001 <0.001 0.007 0.071 0.043 0.024 
Day 1  0.039 0.278 <0.001 <0.001 <0.001 <0.001 
Day 7   0.008 <0.001 <0.001 <0.001 <0.001 
Week 4    0.004 0.009 0.009 0.003 
Month 3     0.655 0.789 0.609 
Month 6      0.873 0.926 
Month 9       0.922 
Table 4.5 Significant differences between the flexural strength of low filler content Type II filled resin composites 
containing 40wt% bioactive glass dry and following wet ageing for 1 day, 7 days, 4 weeks, 3 months, 6 months, 9 
months and 12 months (1-way ANOVA, n=10). The numbers represent the p value, with the numbers in bold 
showing significant difference between sample conditions. 
 
 Day 1 Day 7 Week 4 Month 3 Month 6 Month 9 Month 
12 
Dry 0.008 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 
Day 1  0.064 0.010 0.013 0.007 0.005 0.002 
Day 7   0.050 0.071 0.032 0.005 0.001 
Week 4    0.686 0.670 0.426 0.208 
Month 3     0.416 0.187 0.061 
Month 6      0.791 0.524 
Month 9       0.657 
Table 4.6 Significant differences between the flexural strength of low filler content Type III filled resin composites 
containing 20wt% bioactive glass dry and following wet ageing for 1 day, 7 days, 4 weeks, 3 months, 6 months, 9 
months and 12 months (1-way ANOVA, n=10). The numbers represent the p value, with the numbers in bold 
showing significant difference between sample conditions. 
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 Day 1 Day 7 Week 4 Month 3 Month 6 Month 9 Month 
12 
Dry <0.001 <0.001 <0.001 <0.001 <0.001 0.001 <0.001 
Day 1  0.131 0.222 0.652 0.651 0.650 0.053 
Day 7   0.604 0.344 0.386 0.355 0.053 
Week 4    0.494 0.581 0.478 0.041 
Month 3     0.965 0.638 0.084 
Month 6      0.633 0.103 
Month 9       0.662 
Table 4.7 Significant differences between the flexural strength of low filler content Type III filled resin composites 
containing 40wt% bioactive glass dry and following wet ageing for 1 day, 7 days, 4 weeks, 3 months, 6 months, 9 
months and 12 months (1-way ANOVA, n=10). The numbers represent the p value, with the numbers in bold 
showing significant difference between sample conditions. 
 
 Day 1 Day 7 Week 4 Month 3 Month 6 Month 9 Month 
12 
Dry 0.124 0.031 0.885 0.592 0.360 0.006 0.104 
Day 1  0.520 0.158 0.157 0.433 0.829 0.827 
Day 7   0.043 0.018 0.128 0.691  0.719 
Week 4    0.716 0.442 0.122 0.130 
Month 3     0.571 0.100 0.115 
Month 6      0.323 0.337 
Month 9       0.991 
Table 4.8 Significant differences between the flexural strength of high filler content filled resin composites 
containing 80wt% barium silicate filler dry and following wet ageing for 1 day, 7 days, 4 weeks, 3 months, 6 
months, 9 months and 12 months (1-way ANOVA, n=10). The numbers represent the p value, with the numbers 
in bold showing significant difference between sample conditions. 
 
 Day 1 Day 7 Week 4 Month 3 Month 6 Month 9 Month 
12 
Dry 0.364 0.257 0.383 0.184 0.059 0.075 0.024 
Day 1  0.053 0.871 0.611 0.263 0.275 0.078 
Day 7   0.069 0.029 0.008 0.011 0.004 
Week 4    0.834 0.547 0.498 0.210 
Month 3     0.540 0.512 0.159 
Month 6      0.816 0.240 
Month 9       0.415 
Table 4.9 Significant differences between the flexural strength of high filler content Type I filled resin composites 
containing 23wt% bioactive glass dry and following wet ageing for 1 day, 7 days, 4 weeks, 3 months, 6 months, 9 
months and 12 months (1-way ANOVA, n=10). The numbers represent the p value, with the numbers in bold 
showing significant difference between sample conditions. 
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 Day 1 Day 7 Week 4 Month 3 Month 6 Month 9 Month 
12 
Dry 0.023 <0.001 0.005 0.732 0.018 0.367 0.925 
Day 1  0.001 0.970 0.186 0.370 0.145 0.029 
Day 7   <0.001 <0.001 <0.001 <0.001 <0.001 
Week 4    0.128 0.229 0.072 0.008 
Month 3     0.315 0.801 0.699 
Month 6      0.263 0.029 
Month 9       0.368 
Table 4 Significant differences between the flexural strength of high filler content Type I filled resin composites 
containing 45wt% bioactive glass dry and following wet ageing for 1 day, 7 days, 4 weeks, 3 months, 6 months, 9 
months and 12 months (One-way ANOVA, n=10).  The numbers represent the p value, with the numbers in bold 
showing significant difference between sample conditions. 
 
 Day 1 Day 7 Week 4 Month 3 Month 6 Month 9 Month 
12 
Dry 0.033 <0.001 0.128 0.001 0.003 <0.001 0.001 
Day 1  0.001 0.810 0.006 0.035 <0.001 0.008 
Day 7   0.016 0.868 0.104 0.857 0.098 
Week 4    0.033 0.140 0.015 0.095 
Month 3     0.225 0.975 0.241 
Month 6      0.102 0.839 
Month 9       0.088 
Table 4.11 Significant differences between the flexural strength of high filler content Type II filled resin 
composites containing 23wt% bioactive glass dry and following wet ageing for 1 day, 7 days, 4 weeks, 3 months, 
6 months, 9 months and 12 months (1-way ANOVA, n=10). The numbers represent the p value, with the numbers 
in bold showing significant difference between sample conditions. 
 
 Day 1 Day 7 Week 4 Month 3 Month 6 Month 9 Month 
12 
Dry <0.001 <0.001 0.014 0.215 0.087 0.016 0.002 
Day 1  <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 
Day 7   <0.001 <0.001 <0.001 <0.001 <0.001 
Week 4    0.001 <0.001 <0.001 <0.001 
Month 3     0.875 0.265 0.069 
Month 6      0.157 0.010 
Month 9       0.366 
Table 4.12 Significant differences between the flexural strength of high filler content Type II filled resin 
composites containing 45wt% bioactive glass dry and following wet ageing for 1 day, 7 days, 4 weeks, 3 months, 
6 months, 9 months and 12 months (1-way ANOVA, n=10). The numbers represent the p value, with the numbers 
in bold showing significant difference between sample conditions. 
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 Day 1 Day 7 Week 4 Month 3 Month 6 Month 9 Month 
12 
Dry 0.091 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 
Day 1  <0.001 0.004 <0.001 <0.001 0.001 <0.001 
Day 7   0.007 0.091 0.110 0.158 0.332 
Week 4    <0.001 <0.001 0.180 0.005 
Month 3     0.994 0.005 0.861 
Month 6      0.007 0.868 
Month 9       0.061 
Table 4.13 Significant differences between the flexural strength of high filler content Type III filled resin 
composites containing 23wt% bioactive glass dry and following wet ageing for 1 day, 7 days, 4 weeks, 3 months, 
6 months, 9 months and 12 months (1-way ANOVA, n=10). The numbers represent the p value, with the numbers 
in bold showing significant difference between sample conditions. 
 Day 1 Day 7 Week 4 Month 3 Month 6 Month 9 Month 
12 
Dry 0.081 0.602 0.660 0.461 0.161 0.060 0.064 
Day 1  0.136 0.013 0.133 0.483 0.767 0.796 
Day 7   0.193 0.847 0.290 0.101 0.105 
Week 4    0.051 0.013 0.001 0.013 
Month 3     0.291 0.077 0.103 
Month 6      0.568 0.356 
Month 9       0.570 
Table 4.14 Significant differences between the flexural strength of PMMA dry and following wet ageing for 1 day, 
7 days, 4 weeks, 3 months, 6 months, 9 months and 12 months (1-way ANOVA, n=10). The numbers represent 
the p value, with the numbers in bold showing significant difference between sample conditions. 
 
Flexural modulus of filled resin composites following wet ageing 
 
 Day 1 Day 7 Week 4 Month 3 Month 6 Month 9 Month 
12 
Dry <0.001 <0.001 0.001 <0.001 <0.001 <0.001 0.003 
Day 1  0.204 0.010 0.013 0.072 0.023 0.001 
Day 7   0.083 0.116 0.524 0.211 0.009 
Week 4    0.765 0.212 0.483 0.391 
Month 3     0.303 0.670 0.221 
Month 6      0.514 0.029 
Month 9       0.095 
Table 4.15 Significant differences between the flexural modulus of low filler content filled resin composites 
containing 70wt% barium silicate filler dry and following wet ageing for 1 day, 7 days, 4 weeks, 3 months, 6 
months, 9 months and 12 months (1-way ANOVA, n=10). The numbers represent the p value, with the numbers 
in bold showing significant difference between sample conditions. 
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 Day 1 Day 7 Week 4 Month 3 Month 6 Month 9 Month 
12 
Dry <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 
Day 1  <0.001 <0.001 0.001 <0.001 <0.001 <0.001 
Day 7   0.558 <0.001 0.054 0.137 0.066 
Week 4    <0.001 0.018 0.059 0.020 
Month 3     0.006 0.021 0.001 
Month 6      0.888 0.795 
Month 9       0.950 
Table 4.1648 Significant differences between the flexural modulus of low filler content Type I filled resin 
composites containing 20wt% bioactive glass dry and following wet ageing for 1 day, 7 days, 4 weeks, 3 months, 
6 months, 9 months and 12 months (1-way ANOVA, n=10). The numbers represent the p value, with the numbers 
in bold showing significant difference between sample conditions. 
 
 Day 1 Day 7 Week 4 Month 3 Month 6 Month 9 Month 
12 
Dry <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 
Day 1  0.237 0.353 <0.001 <0.001 <0.001 <0.001 
Day 7   0.758 <0.001 0.002 0.006 0.002 
Week 4    <0.001 0.001 0.002 0.001 
Month 3     <0.001 <0.001 <0.001 
Month 6      0.232 0.443 
Month 9       0.614 
Table 4.17 Significant differences between the flexural modulus of low filler content Type I filled resin composites 
containing 40wt% bioactive glass dry and following wet ageing for 1 day, 7 days, 4 weeks, 3 months, 6 months, 9 
months and 12 months (1-way ANOVA, n=10). The numbers represent the p value, with the numbers in bold 
showing significant difference between sample conditions. 
 
 Day 1 Day 7 Week 4 Month 3 Month 6 Month 9 Month 
12 
Dry <0.001 <0.001 0.002 <0.001 <0.001 0.002 <0.001 
Day 1  0.367 0.019 0.049 0.728 0.099 0.595 
Day 7   0.005 0.538 0.262 0.025 0.185 
Week 4    <0.001 0.085 0.583 0.080 
Month 3     0.047 0.001 0.016 
Month 6      0.247 0.892 
Month 9       0.265 
Table 4.18 Significant differences between the flexural modulus of low filler content Type II filled resin 
composites containing 20wt% bioactive glass dry and following wet ageing for 1 day, 7 days, 4 weeks, 3 months, 
6 months, 9 months and 12 months (1-way ANOVA, n=10). The numbers represent the p value, with the numbers 
in bold showing significant difference between sample conditions. 
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 Day 1 Day 7 Week 4 Month 3 Month 6 Month 9 Month 
12 
Dry 0.049 <0.001 0.079 0.090 0.092 0.891 0.047 
Day 1  <0.001 <0.001 0.603 0.913 0.013 0.804 
Day 7   <0.001 <0.001 <0.001 <0.001 <0.001 
Week 4    <0.001 0.001 0.029 <0.001 
Month 3     0.822 0.039 0.525 
Month 6      0.051 0.804 
Month 9       0.014 
Table 4.19 Significant differences between the flexural modulus of low filler content Type II filled resin 
composites containing 40wt% bioactive glass dry and following wet ageing for 1 day, 7 days, 4 weeks, 3 months, 
6 months, 9 months and 12 months (1-way ANOVA, n=10). The numbers represent the p value, with the numbers 
in bold showing significant difference between sample conditions. 
 
 Day 1 Day 7 Week 4 Month 3 Month 6 Month 9 Month 
12 
Dry 0.025 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 
Day 1  <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 
Day 7   0.716 0.001 0.001 0.031 0.340 
Week 4    0.001 0.001 0.026 0.232 
Month 3     0.324 0.091 0.002 
Month 6      0.316 0.003 
Month 9       0.089 
Table 4.20 Significant differences between the flexural modulus of low filler content Type III filled resin 
composites containing 20wt% bioactive glass dry and following wet ageing for 1 day, 7 days, 4 weeks, 3 months, 
6 months, 9 months and 12 months (1-way ANOVA, n=10). The numbers represent the p value, with the numbers 
in bold showing significant difference between sample conditions. 
 
 Day 1 Day 7 Week 4 Month 3 Month 6 Month 9 Month 
12 
Dry <0.001 <0.001 <0.001 <0.001 <0.001 0.464 <0.001 
Day 1  <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 
Day 7   <0.001 0.005 0.381 0.019 <0.001 
Week 4    0.024 <0.001 <0.001 0.726 
Month 3     0.004 0.001 0.010 
Month 6      0.007 <0.001 
Month 9       <0.001 
Table 4.21 Significant differences between the flexural modulus of low filler content Type III filled resin 
composites containing 40wt% bioactive glass dry and following wet ageing for 1 day, 7 days, 4 weeks, 3 months, 
6 months, 9 months and 12 months (1-way ANOVA, n=10). The numbers represent the p value, with the numbers 
in bold showing significant difference between sample conditions. 
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 Day 1 Day 7 Week 4 Month 3 Month 6 Month 9 Month 
12 
Dry 0.037 0.303 0.010 0.024 0.963 0.030 0.489 
Day 1  0.064 0.246 0.540 0.023 0.714 0.036 
Day 7   0.008 0.037 0.245 0.032 0.660 
Week 4    0.681 0.005 0.398 0.006 
Month 3     0.014 0.752 0.024 
Month 6      0.018 0.425 
Month 9       0.020 
Table 4.22 Significant differences between the flexural modulus of high filler content filled resin composites 
containing 80wt% barium silicate filler dry and following wet ageing for 1 day, 7 days, 4 weeks, 3 months, 6 
months, 9 months and 12 months (1-way ANOVA, n=10). The numbers represent the p value, with the numbers 
in bold showing significant difference between sample conditions. 
 
 Day 1 Day 7 Week 4 Month 3 Month 6 Month 9 Month 
12 
Dry <0.001 0.071 <0.001 <0.001 <0.001 <0.001 <0.001 
Day 1  <0.001 0.693 0.852 0.066 0.329 <0.001 
Day 7   <0.001 <0.001 <0.001 <0.001 <0.001 
Week 4    0.644 0.026 0.566 <0.001 
Month 3     0.326 0.385 0.002 
Month 6      0.004 <0.001 
Month 9       <0.001 
Table 4.23 Significant differences between the flexural modulus of high filler content Type I filled resin 
composites containing 23wt% bioactive glass dry and following wet ageing for 1 day, 7 days, 4 weeks, 3 months, 
6 months, 9 months and 12 months (1-way ANOVA, n=10). The numbers represent the p value, with the numbers 
in bold showing significant difference between sample conditions. 
 
 Day 1 Day 7 Week 4 Month 3 Month 6 Month 9 Month 
12 
Dry <0.001 <0.001 0.001 <0.001 <0.001 <0.001 <0.001 
Day 1  <0.001 <0.001 0.024 0.001 0.340 <0.001 
Day 7   <0.001 <0.001 <0.001 <0.001 <0.001 
Week 4    0.005 0.017 0.014 0.107 
Month 3     0.368 0.567 0.036 
Month 6      0.220 0.170 
Month 9       0.048 
Table 4.24 Significant differences between the flexural modulus of high filler content Type I filled resin 
composites containing 45wt% bioactive glass dry and following wet ageing for 1 day, 7 days, 4 weeks, 3 months, 
6 months, 9 months and 12 months (1-way ANOVA, n=10). The numbers represent the p value, with the numbers 
in bold showing significant difference between sample conditions. 
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 Day 1 Day 7 Week 4 Month 3 Month 6 Month 9 Month 
12 
Dry <0.001 0.001 <0.001 <0.001 <0.001 <0.001 <0.001 
Day 1  0.012 <0.001 0.067 0.047 0.003 <0.001 
Day 7   0.931 0.106 0.233 0.218 0.334 
Week 4    0.005 0.053 0.015 0.039 
Month 3     0.591 0.366 0.135 
Month 6      0.886 0.549 
Month 9       0.490 
Table 4.25 Significant differences between the flexural modulus of high filler content Type II filled resin 
composites containing 23wt% bioactive glass dry and following wet ageing for 1 day, 7 days, 4 weeks, 3 months, 
6 months, 9 months and 12 months (1-way ANOVA, n=10). The numbers represent the p value, with the numbers 
in bold showing significant difference between sample conditions. 
 
 Day 1 Day 7 Week 4 Month 3 Month 6 Month 9 Month 
12 
Dry 0.209 <0.001 0.057 0.030 0.116 0.001 0.055 
Day 1  <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 
Day 7   <0.001 <0.001 <0.001 <0.001 <0.001 
Week 4    0.662 0.283 0.001 0.740 
Month 3     0.137 0.003 0.416 
Month 6      <0.001 0.363 
Month 9       <0.001 
Table 4.26 Significant differences between the flexural modulus of high filler content Type II filled resin 
composites containing 45wt% bioactive glass dry and following wet ageing for 1 day, 7 days, 4 weeks, 3 months, 
6 months, 9 months and 12 months (1-way ANOVA, n=10). The numbers represent the p value, with the numbers 
in bold showing significant difference between sample conditions. 
 
 Day 1 Day 7 Week 4 Month 3 Month 6 Month 9 Month 
12 
Dry <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 <0.001 
Day 1  0.001 <0.001 <0.001 <0.001 0.098 0.003 
Day 7   0.460 0.122 0.405 0.166 0.175 
Week 4    0.319 0.890 0.038 0.014 
Month 3     0.392 0.007 <0.001 
Month 6      0.036 0.011 
Month 9       0.624 
Table 4.27 Significant differences between the flexural modulus of high filler content Type III filled resin 
composites containing 23wt% bioactive glass dry and following wet ageing for 1 day, 7 days, 4 weeks, 3 months, 
6 months, 9 months and 12 months (1-way ANOVA, n=10). The numbers represent the p value, with the numbers 
in bold showing significant difference between sample conditions. 
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 Day 1 Day 7 Week 4 Month 3 Month 6 Month 9 Month 
12 
Dry 0.988 0.759 0.009 0.009 0.727 0.474 0.065 
Day 1  0.794 0.015 0.017 0.760 0.535 0.087 
Day 7   0.004 0.004 0.936 0.058 0.859 
Week 4    0.859 0.009 0.003 0.426 
Month 3     0.009 0.003 0.426 
Month 6      0.717 0.088 
Month 9       0.080 
Table 4.28 Significant differences between the flexural modulus of PMMA dry and following wet ageing for 1 
day, 7 days, 4 weeks, 3 months, 6 months, 9 months and 12 months (1-way ANOVA, n=10). The numbers represent 
the p value, with the numbers in bold showing significant difference between sample conditions. 
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Appendix 5 Statistical analysis of culture media acidity values; viable and non-viable bone 
marrow stromal cells data in the presence of unfilled resin systems, filled resin composites and 
PMMA 
Statistical data of pH change of culture media in the absence/presence of filled resin 
composites and PMMA 
 Day 1 Day 3 Day 5 Day 7 Day 12 
Day 0 0.116 0.374 0.008 0.116 0.116 
Day 1  0.519 0.018 >0.999 >0.999 
Day 3   0.013 0.519 0.519 
Day 5    0.018 0.018 
Day 7     >0.999 
Table 5.1 Significant differences between the pH of culture media in the absence of filled composite discs (1-way 
ANOVA, n=9). The numbers represent the p value, with the numbers in bold showing significant difference 
between sample conditions.  
 
 Day 1 Day 3 Day 5 Day 7 Day 12 
Day 0 0.116 0.116 0.116 0.374 0.116 
Day 1  >0.999 >0.999 0.519 >0.999 
Day 3   >0.999 0.519 >0.999 
Day 5    0.519 >0.999 
Day 7     0.519 
Table 5.2 Significant differences between the pH of culture media following immersion of low viscosity filled resin 
composite discs containing 70wt% barium silicate filler (1-way ANOVA, n=9). The numbers represent the p value, 
with the numbers in bold showing significant difference between sample conditions.  
 
 Day 1 Day 3 Day 5 Day 7 Day 12 
Day 0 <0.001 <0.001 0.002 0.002 0.001 
Day 1  >0.999 0.251 0.643 0.116 
Day 3   0.251 0.643 0.116 
Day 5    0.492 0.725 
Day 7     0.288 
Table 5.3 Significant differences between the pH of culture media following immersion of low viscosity Type I filled 
resin composite discs containing 20wt% bioactive glass (1-way ANOVA, n=9). The numbers represent the p value, 
with the numbers in bold showing significant difference between sample conditions.  
 
 Day 1 Day 3 Day 5 Day 7 Day 12 
Day 0 <0.001 <0.001 <0.001 0.003 <0.001 
Day 1  0.101 0.101 0.230 0.067 
Day 3   >0.999 0.742 0.374 
Day 5    0.742 0.374 
Day 7     0.768 
Table 5.4 Significant differences between the pH of culture media following immersion of low viscosity Type I filled 
resin composite discs containing 40wt% bioactive glass (1-way ANOVA, n=9). The numbers represent the p value, 
with the numbers in bold showing significant difference between sample conditions.  
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 Day 1 Day 3 Day 5 Day 7 Day 12 
Day 0 <0.001 <0.001 0.001 <0.001 0.001 
Day 1  0.230 0.251 0.013 0.055 
Day 3   0.678 0.047 0.148 
Day 5    0.251 0.349 
Day 7     >0.999 
Table 5.5 Significant differences between the pH of culture media following immersion of low viscosity Type II 
filled resin composite discs containing 20wt% bioactive glass (1-way ANOVA, n=9). The numbers represent the p 
value, with the numbers in bold showing significant difference between sample conditions.  
 
 Day 1 Day 3 Day 5 Day 7 Day 12 
Day 0 <0.001 <0.001 <0.001 0.004 <0.001 
Day 1  0.519 >0.999 0.561 0.047 
Day 3   0.519 0.768 0.101 
Day 5    0.561 0.047 
Day 7     0.561 
Table 5.6 Significant differences between the pH of culture media following immersion of low viscosity Type II 
filled resin composite discs containing 40wt% bioactive glass (1-way ANOVA, n=9). The numbers represent the p 
value, with the numbers in bold showing significant difference between sample conditions.  
 
 Day 1 Day 3 Day 5 Day 7 Day 12 
Day 0 <0.001 0.002 <0.001 0.002 <0.001 
Day 1  >0.999 >0.999 >0.999 >0.999 
Day 3   >0.999 >0.999 >0.999 
Day 5    >0.999 >0.999 
Day 7     >0.999 
Table 5.7 Significant differences between the pH of culture media following immersion of low viscosity Type III 
filled resin composite discs containing 20wt% bioactive glass (1-way ANOVA, n=9). The numbers represent the p 
value, with the numbers in bold showing significant difference between sample conditions.  
 
 Day 1 Day 3 Day 5 Day 7 Day 12 
Day 0 0.002 <0.001 <0.001 0.003 0.001 
Day 1  >0.999 0.251 0.742 0.725 
Day 3   0.101 0.678 0.643 
Day 5    0.148 0.374 
Day 7     0.492 
Table 5.8 Significant differences between the pH of culture media following immersion of low viscosity Type III 
filled resin composite discs containing 40wt% bioactive glass (1-way ANOVA, n=9). The numbers represent the p 
value, with the numbers in bold showing significant difference between sample conditions.  
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 Day 1 Day 3 Day 5 Day 7 Day 12 
Day 0 0.217 0.374 0.374 0.116 0.116 
Day 1  0.834 0.834 0.628 0.628 
Day 3   >0.999 0.519 0.519 
Day 5    0.519 0.519 
Day 7     >0.999 
Table 5.9 Significant differences between the pH of culture media in the absence of filled composite discs (1-way 
ANOVA, n=9). The numbers represent the p value, with the numbers in bold showing significant difference 
between sample conditions.  
 
 Day 1 Day 3 Day 5 Day 7 Day 12 
Day 0 0.374 0.374 0.116 0.116 0.725 
Day 1  >0.999 0.519 0.519 >0.999 
Day 3   0.519 0.519 >0.999 
Day 5    >0.999 0.742 
Day 7     0.742 
Table 5.10 Significant differences between the pH of culture media following immersion of high viscosity filled 
resin composite discs containing 70wt% barium silicate filler (1-way ANOVA, n=9). The numbers represent the p 
value, with the numbers in bold showing significant difference between sample conditions.  
 
 Day 1 Day 3 Day 5 Day 7 Day 12 
Day 0 <0.001 <0.001 0.001 <0.001 0.002 
Day 1  >0.999 >0.999 >0.999 0.519 
Day 3   >0.999 >0.999 0.519 
Day 5    >0.999 0.579 
Day 7     0.519 
Table 5.11 Significant differences between the pH of culture media following immersion of high viscosity Type I 
filled resin composite discs containing 20wt% bioactive glass (1-way ANOVA, n=9). The numbers represent the p 
value, with the numbers in bold showing significant difference between sample conditions.  
 
 Day 1 Day 3 Day 5 Day 7 Day 12 
Day 0 <0.001 0.001 <0.001 <0.001 0.001 
Day 1  0.422 >0.999 >0.999 0.678 
Day 3   0.422 0.422 0.349 
Day 5    >0.999 0.678 
Day 7     0.678 
Table 5.12 Significant differences between the pH of culture media following immersion of high viscosity Type I 
filled resin composite discs containing 40wt% bioactive glass (1-way ANOVA, n=9). The numbers represent the p 
value, with the numbers in bold showing significant difference between sample conditions.  
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 Day 1 Day 3 Day 5 Day 7 Day 12 
Day 0 0.002 <0.001 <0.001 0.001 0.001 
Day 1  >0.999 0.742 0.778 0.468 
Day 3   0.519 0.678 0.349 
Day 5    >0.999 0.519 
Day 7     0.579 
Table 5.13 Significant differences between the pH of culture media following immersion of high viscosity Type II 
filled resin composite discs containing 20wt% bioactive glass (1-way ANOVA, n=9). The numbers represent the p 
value, with the numbers in bold showing significant difference between sample conditions.  
 
 Day 1 Day 3 Day 5 Day 7 Day 12 
Day 0 <0.001 <0.001 0.001 <0.001 <0.001 
Day 1  0.422 0.519 0.725 >0.999 
Day 3   >0.999 0.643 0.422 
Day 5    0.725 0.519 
Day 7     0.725 
Table 5.14 Significant differences between the pH of culture media following immersion of high viscosity Type II 
filled resin composite discs containing 40wt% bioactive glass (1-way ANOVA, n=9). The numbers represent the p 
value, with the numbers in bold showing significant difference between sample conditions.  
 
 Day 1 Day 3 Day 5 Day 7 Day 12 
Day 0 0.007 0.002 0.008 <0.001 <0.001 
Day 1  0.795 0.643 0.768 0.768 
Day 3   0.778 >0.999 >0.999 
Day 5    0.742 0.742 
Day 7     >0.999 
Table 5.15 Significant differences between the pH of culture media following immersion of high viscosity Type III 
filled resin composite discs containing 20wt% bioactive glass (1-way ANOVA, n=9). The numbers represent the p 
value, with the numbers in bold showing significant difference between sample conditions. 
 
 Day 1 Day 3 Day 5 Day 7 Day 12 
Day 0 0.279 0.001 0.001 0.025 >0.999 
Day 1  >0.999 0.816 0.734 0.289 
Day 3   0.230 0.251 0.007 
Day 5    0.678 0.016 
Day 12     0.057 
Table 5.16 Significant differences between the pH of culture media following immersion of PMMA discs containing 
(1-way ANOVA, n=9). The numbers represent the p value, with the numbers in bold showing significant difference 
between sample conditions. 
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Statistical data of viability values of bone marrow stromal cells seeded in the absence/presence 
of filled resin composites, unfilled resin systems and PMMA 
 
 Day 1 Day 3 Day 5 Day 7 Day 12 
Day 0 <0.001  <0.001 <0.001 <0.001 <0.001 
Day 1  >0.999 0.363 0.018 0.002 
Day 3   0.504 0.099 0.024 
Day 5    0.270 0.063 
Day 7     0.332 
Table 5.17 Significant differences between viable bone marrow stromal cells following culture in direct contact on 
unfilled resin system discs containing 60/40wt% UDMA/TEGDMA for 1 day, 3 days, 5 days, 7 days and 12 days (1-
way ANOVA, n=3 biological replicates). The culture media was replaced every 2-days.The numbers represent the 
p value, with the numbers in bold showing significant difference between sample conditions.  
 Day 1 Day 3 Day 5 Day 7 Day 12 
Day 0 <0.001 <0.001 0.035 <0.001 <0.001 
Day 1  <0.001 <0.001 <0.001 <0.001 
Day 3   0.008 <0.001 <0.001 
Day 5    <0.001 <0.001 
Day 7     <0.001 
Table 5.18 Significant differences between viable bone marrow stromal cells following culture in direct contact on 
discs containing PMMA for 1 day, 3 days, 5 days, 7 days and 12 days (1-way ANOVA, n=3 biological replicates). The 
culture media was replaced every 2-days. The numbers represent the p value, with the numbers in bold showing 
significant difference between sample conditions.  
 
 Day 1 Day 3 Day 5 Day 7 Day 12 
Day 0 0.114 0.779 <0.001 <0.001 <0.001 
Day 1  0.162 <0.001 <0.001 <0.001 
Day 3   0.004 <0.001 <0.001 
Day 5    <0.001 <0.001 
Day 7     0.011 
Table 5.19 Significant differences between the viability of bone marrow stromal cells following culture in the 
absence of filled resin composite discs for 1 day, 3 days, 5 days, 7 days and 12 days (1-way ANOVA, n=3 biological 
replicates). The culture media was replaced every 2-days.  The numbers represent the p value, with the numbers 
in bold showing significant difference between sample conditions.  
 
 Day 1 Day 3 Day 5 Day 7 Day 12 
Day 0 0.001 <0.001 <0.001 0.022 0.313 
Day 1  0.882 0.143 0.255 0.237 
Day 3   0.042 0.239 0.245 
Day 5    0.903 0.611 
Day 7     0.705 
Table 5.20 Significant differences between the viability of bone marrow stromal cells following culture in direct 
contact on low viscosity filled resin composite discs containing 70wt% barium silicate filler for 1 day, 3 days, 5 days, 
7 days and 12 days (1-way ANOVA, n=3 biological replicates). The culture media was replaced every 2-days.  The 
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numbers represent the p value, with the numbers in bold showing significant difference between sample 
conditions.  
 
 Day 1 Day 3 Day 5 Day 7 Day 12 
Day 0 0.002 <0.001 0.675 0.003 <0.001 
Day 1  0.128 0.008 <0.001 <0.001 
Day 3   0.031 0.001 <0.001 
Day 5    0.003 <0.001 
Day 7     0.009 
Table 5.21 Significant differences between the viability of bone marrow stromal cells following culture in direct 
contact on low viscosity Type I filled resin composite discs containing 20wt% bioactive glass for 1 day, 3 days, 5 
days, 7 days and 12 days (1-way ANOVA, n=3 biological replicates). The culture media was replaced every 2-days.  
The numbers represent the p value, with the numbers in bold showing significant difference between sample 
conditions.  
 
 Day 1 Day 3 Day 5 Day 7 Day 12 
Day 0 <0.001 <0.001 0.008 <0.001 <0.001 
Day 1  0.774 0.008 <0.001 <0.001 
Day 3   0.027 <0.001 <0.001 
Day 5    <0.001 <0.001 
Day 7     <0.001 
Table 5.22 Significant differences between the viability of bone marrow stromal cells following culture in direct 
contact on low viscosity Type I filled resin composite discs containing 40wt% bioactive glass for 1 day, 3 days, 5 
days, 7 days and 12 days (1-way ANOVA, n=3 biological replicates). The culture media was replaced every 2-days.  
The numbers represent the p value, with the numbers in bold showing significant difference between sample 
conditions.  
 
 Day 1 Day 3 Day 5 Day 7 Day 12 
Day 0 <0.001 0.001 0.390 <0.001 <0.001 
Day 1  >0.999 0.236 <0.001 <0.001 
Day 3   0.257 <0.001 <0.001 
Day 5    <0.001 <0.001 
Day 7     0.001 
Table 5.23 Significant differences between the viability of bone marrow stromal cells following culture in direct 
contact on low viscosity Type II filled resin composite discs containing 20wt% bioactive glass for 1 day, 3 days, 5 
days, 7 days and 12 days (1-way ANOVA, n=3 biological replicates). The culture media was replaced every 2-days.  
The numbers represent the p value, with the numbers in bold showing significant difference between sample 
conditions.  
 
 Day 1 Day 3 Day 5 Day 7 Day 12 
Day 0 <0.001 <0.001 <0.001 <0.001 <0.001 
Day 1  0.211 0.004 <0.001 <0.001 
Day 3   0.014 <0.001 <0.001 
Day 5    <0.001 <0.001 
Day 7     <0.001 
Table 5.24 Significant differences between the viability of bone marrow stromal cells following culture in direct 
contact on low viscosity Type II filled resin composite discs containing 40wt% bioactive glass for 1 day, 3 days, 5 
XXXIX 
 
days, 7 days and 12 days (1-way ANOVA, n=3 biological replicates). The culture media was replaced every 2-days.  
The numbers represent the p value, with the numbers in bold showing significant difference between sample 
conditions.  
 
 Day 1 Day 3 Day 5 Day 7 Day 12 
Day 0 <0.001 0.077 0.595 <0.001 <0.001 
Day 1  0.238 0.001 <0.001 <0.001 
Day 3   0.093 0.001 <0.001 
Day 5    0.039 <0.001 
Day 7     <0.001 
Table 5.25 Significant differences between the viability of bone marrow stromal cells following culture in direct 
contact on low viscosity Type III filled resin composite discs containing 20wt% bioactive glass for 1 day, 3 days, 5 
days, 7 days and 12 days (1-way ANOVA, n=3 biological replicates). The culture media was replaced every 2-days.  
The numbers represent the p value, with the numbers in bold showing significant difference between sample 
conditions.  
 
 Day 1 Day 3 Day 5 Day 7 Day 12 
Day 0 <0.001 <0.001 0.044 0.414 <0.001 
Day 1  0.700 0.018 <0.001 <0.001 
Day 3   0.076 <0.001 <0.001 
Day 5    0.037 <0.001 
Day 7     <0.001 
Table 5.26 Significant differences between the viability of bone marrow stromal cells following culture in direct 
contact on low viscosity Type III filled resin composite discs containing 40wt% bioactive glass for 1 day, 3 days, 5 
days, 7 days and 12 days (1-way ANOVA, n=3 biological replicates). The culture media was replaced every 2-days.  
The numbers represent the p value, with the numbers in bold showing significant difference between sample 
conditions.  
 
 Day 1 Day 3 Day 5 Day 7 Day 12 
Day 0 0.022 0.675 <0.001 <0.001 <0.001 
Day 1  0.094 <0.001 <0.001 <0.001 
Day 3   <0.001 <0.001 <0.001 
Day 5    <0.001 <0.001 
Day 7     <0.001 
Table 5.27 Significant differences between the viability of bone marrow stromal cells following culture in the 
absence of filled composite discs for 1 day, 3 days, 5 days, 7 days and 12 days (1-way ANOVA, n=3 biological 
replicates). The culture media was replaced every 2-days.  (1-way ANOVA, n=3 biological replicates). The numbers 
represent the p value, with the numbers in bold showing significant difference between sample conditions.  
 
 Day 1 Day 3 Day 5 Day 7 Day 12 
Day 0 <0.001 <0.001 <0.001 0.332 <0.001 
Day 1  0.020 <0.001 <0.001 <0.001 
Day 3   <0.001 <0.001 <0.001 
Day 5    <0.001 <0.001 
Day 7     <0.001 
Table 5.28 Significant differences between the viability of bone marrow stromal cells following culture in in direct 
contact on high viscosity filled resin composite discs containing 70wt% barium silicate filler for 1 day, 3 days, 5 
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days, 7 days and 12 days (1-way ANOVA, n=3 biological replicates). The culture media was replaced every 2-days. 
The numbers represent the p value, with the numbers in bold showing significant difference between sample 
conditions.  
 
 Day 1 Day 3 Day 5 Day 7 Day 12 
Day 0 0.001 0.150 0.003 <0.001 <0.001 
Day 1  0.160 <0.001 <0.001 <0.001 
Day 3   0.003 <0.001 <0.001 
Day 5    <0.001 <0.001 
Day 7     0.002 
Table 5.29 Significant differences between the viability of bone marrow stromal cells following culture in in direct 
contact on high viscosity Type I filled resin composite discs containing 20wt% bioactive glass for 1 day, 3 days, 5 
days, 7 days and 12 days (1-way ANOVA, n=3 biological replicates). The culture media was replaced every 2-days. 
The numbers represent the p value, with the numbers in bold showing significant difference between sample 
conditions.  
 
 Day 1 Day 3 Day 5 Day 7 Day 12 
Day 0 0.001 <0.001 0.004 <0.001 <0.001 
Day 1  0.624 <0.001 <0.001 <0.001 
Day 3   <0.001 <0.001 <0.001 
Day 5    <0.001 <0.001 
Day 7     <0.001 
Table 5.30 Significant differences between the viability of bone marrow stromal cells following culture in in direct 
contact on high viscosity Type I filled resin composite discs containing 40wt% bioactive glass for 1 day, 3 days, 5 
days, 7 days and 12 days (1-way ANOVA, n=3 biological replicates). The culture media was replaced every 2-days. 
The numbers represent the p value, with the numbers in bold showing significant difference between sample 
conditions.  
 
 Day 1 Day 3 Day 5 Day 7 Day 12 
Day 0 0.265 0.435 <0.001 <0.001 <0.001 
Day 1  0.185 <0.001 <0.001 <0.001 
Day 3   0.001 <0.001 <0.001 
Day 5    0.074 <0.001 
Day 7     <0.001 
Table 5.31 Significant differences between the viability of bone marrow stromal cells following culture in direct 
contact on high viscosity Type II filled resin composite discs containing 20wt% bioactive glass for 1 day, 3 days, 5 
days, 7 days and 12 days (1-way ANOVA, n=3 biological replicates). The culture media was replaced every 2-days. 
The numbers represent the p value, with the numbers in bold showing significant difference between sample 
conditions.  
 
 Day 1 Day 3 Day 5 Day 7 Day 12 
Day 0 0.001 0.012 0.011 <0.001 <0.001 
Day 1  0.224 <0.001 <0.001 <0.001 
Day 3   0.001 <0.001 <0.001 
Day 5    0.102 <0.001 
Day 7     <0.001 
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Table 5.32 Significant differences between the viability of bone marrow stromal cells following culture in direct 
contact on high viscosity Type II filled resin composite discs containing 40wt% bioactive glass for 1 day, 3 days, 5 
days, 7 days and 12 days (1-way ANOVA, n=3 biological replicates). The culture media was replaced every 2-days. 
The numbers represent the p value, with the numbers in bold showing significant difference between sample 
conditions.  
 
 Day 1 Day 3 Day 5 Day 7 Day 12 
Day 0 0.013 0.332 <0.001 <0.001 <0.001 
Day 1  0.013 <0.001 <0.001 <0.001 
Day 3   <0.001 <0.001 <0.001 
Day 5    0.001 <0.001 
Day 7     <0.001 
Table 5.34 Significant differences between the viability of bone marrow stromal cells following culture in in direct 
contact on high viscosity Type III filled resin composite discs containing 20wt% bioactive glass for 1 day, 3 days, 5 
days, 7 days and 12 days (1-way ANOVA, n=3 biological replicates). The culture media was replaced every 2-days. 
The numbers represent the p value, with the numbers in bold showing significant difference between sample 
conditions.  
 
Statistical data of values for non-viable bone marrow stromal cells seeded in the 
absence/presence of filled resin composites, unfilled resin systems and PMMA  
 
 Day 1 Day 3 Day 5 Day 7 Day 12 
Day 0 0.006 0.004 0.013 0.012 0.022 
Day 1  0.305 0.509 0.710 0.661 
Day 3   0.774 0.536 0.176 
Day 5    0.764 0.326 
Day 7     0.461 
Table 5.35 Significant differences between non-viable bone marrow stromal cells following culture in the absence 
of filled resin composite discs for 1 day, 3 days, 5 days, 7 days and 12 days (1-way ANOVA, n=3 biological replicates). 
The culture media was replaced every 2-days.  The numbers represent the p value, with the numbers in bold 
showing significant difference between sample conditions.  
 
 Day 1 Day 3 Day 5 Day 7 Day 12 
Day 0 <0.001 <0.001 <0.001 <0.001 <0.001 
Day 1  0.014 0.014 <0.001 <0.001 
Day 3   >0.999 0.001 <0.001 
Day 5    0.001 <0.001 
Day 7     <0.001 
Table 5.36 Significant differences between non-viable bone marrow stromal cells following culture in direct 
contact on discs containing PMMA for 1 day, 3 days, 5 days, 7 days and 12 days (1-way ANOVA, n=3 biological 
replicates). The culture media was replaced every 2-days. The numbers represent the p value, with the numbers 
in bold showing significant difference between sample conditions.  
 
 Day 1 Day 3 Day 5 Day 7 Day 12 
Day 0 0.004 <0.001 <0.001 <0.001 <0.001 
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Day 1  0.015 0.005 0.004 <0.001 
Day 3   0.214 0.555 0.001 
Day 5    0.401 0.115 
Day 7     0.004 
Table 5.37 Significant differences between non-viable bone marrow stromal cells following culture in direct 
contact on low viscosity filled resin composite discs containing 70wt% barium silicate filler for 1 day, 3 days, 5 days, 
7 days and 12 days (1-way ANOVA, n=3 biological replicates). The culture media was replaced every 2-days.  The 
numbers represent the p value, with the numbers in bold showing significant difference between sample 
conditions.  
 
 Day 1 Day 3 Day 5 Day 7 Day 12 
Day 0 <0.001 <0.001 0.001 <0.001 <0.001 
Day 1  <0.001 <0.001 <0.001 <0.001 
Day 3   0.016 <0.001 <0.001 
Day 5    <0.001 <0.001 
Day 7     0.040 
Table 5.38 Significant differences between non-viable bone marrow stromal cells following culture in direct 
contact on unfilled resin system discs containing 60/40wt% UDMA/TEGDMA for 1 day, 3 days, 5 days, 7 days and 
12 days (1-way ANOVA, n=3 biological replicates). The culture media was replaced every 2-days.The numbers 
represent the p value, with the numbers in bold showing significant difference between sample conditions.  
 
 Day 1 Day 3 Day 5 Day 7 Day 12 
Day 0 0.001 0.001 <0.001 <0.001 0.013 
Day 1  0.756 0.077 0.265 0.550 
Day 3   0.176 0.483 0.394 
Day 5    0.372 0.031 
Day 7     0.106 
Table 5.39 Significant differences between non-viable bone marrow stromal cells following culture in direct 
contact on low viscosity Type I filled resin composite discs containing 20wt% bioactive glass for 1 day, 3 days, 5 
days, 7 days and 12 days (1-way ANOVA, n=3 biological replicates). The culture media was replaced every 2-days.  
The numbers represent the p value, with the numbers in bold showing significant difference between sample 
conditions.  
 
 Day 1 Day 3 Day 5 Day 7 Day 12 
Day 0 0.001 <0.001 <0.001 <0.001 <0.001 
Day 1  0.305 0.133 0.004 0.229 
Day 3   0.461 0.010 0.715 
Day 5    0.056 0.747 
Day 7     0.033 
Table 5.40 Significant differences between non-viable bone marrow stromal cells following culture in direct 
contact on low viscosity Type I filled resin composite discs containing 40wt% bioactive glass for 1 day, 3 days, 5 
days, 7 days and 12 days (1-way ANOVA, n=3 biological replicates). The culture media was replaced every 2-days.  
The numbers represent the p value, with the numbers in bold showing significant difference between sample 
conditions.  
 
 Day 1 Day 3 Day 5 Day 7 Day 12 
Day 0 0.003 <0.001 <0.001 0.001 0.001 
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Day 1  0.176 0.051 0.345 0.694 
Day 3   0.379 0.750 0.063 
Day 5    0.275 0.018 
Day 7     0.170 
Table 5.41 Significant differences between non-viable bone marrow stromal cells following culture in direct 
contact on low viscosity Type II filled resin composite discs containing 20wt% bioactive glass for 1 day, 3 days, 5 
days, 7 days and 12 days (1-way ANOVA, n=3 biological replicates). The culture media was replaced every 2-days.  
The numbers represent the p value, with the numbers in bold showing significant difference between sample 
conditions.  
 
 Day 1 Day 3 Day 5 Day 7 Day 12 
Day 0 0.003 <0.001 <0.001 0.003 0.001 
Day 1  <0.001 0.057 0.219 0.694 
Day 3   0.039 0.010 <0.001 
Day 5    0.536 0.026 
Day 7     0.122 
Table 5.42 Significant differences between non-viable bone marrow stromal cells following culture in direct 
contact on low viscosity Type II filled resin composite discs containing 40wt% bioactive glass for 1 day, 3 days, 5 
days, 7 days and 12 days (1-way ANOVA, n=3 biological replicates). The culture media was replaced every 2-days.  
The numbers represent the p value, with the numbers in bold showing significant difference between sample 
conditions.  
 
 Day 1 Day 3 Day 5 Day 7 Day 12 
Day 0 0.006 0.003 0.002 0.012 0.022 
Day 1  0.444 0.138 0.710 0.661 
Day 3   0.394 0.736 0.257 
Day 5    0.270 0.079 
Day 7     0.461 
Table 5.43 Significant differences between non-viable bone marrow stromal cells following culture in direct 
contact on low viscosity Type III filled resin composite discs containing 20wt% bioactive glass for 1 day, 3 days, 5 
days, 7 days and 12 days (1-way ANOVA, n=3 biological replicates). The culture media was replaced every 2-days.  
The numbers represent the p value, with the numbers in bold showing significant difference between sample 
conditions.  
 
 Day 1 Day 3 Day 5 Day 7 Day 12 
Day 0 0.003 <0.001 <0.001 <0.001 0.001 
Day 1  0.106 0.147 0.014 0.345 
Day 3   >0.999 0.461 0.536 
Day 5    0.520 0.576 
Day 7     0.176 
Table 5.44 Significant differences between non-viable bone marrow stromal cells following culture in direct 
contact on low viscosity Type III filled resin composite discs containing 40wt% bioactive glass for 1 day, 3 days, 5 
days, 7 days and 12 days (1-way ANOVA, n=3 biological replicates). The culture media was replaced every 2-days.  
The numbers represent the p value, with the numbers in bold showing significant difference between sample 
conditions.  
 
 Day 1 Day 3 Day 5 Day 7 Day 12 
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Day 0 0.006 0.022 0.013 0.006 0.006 
Day 1  0.661 0.509 >0.999 >0.999 
Day 3   0.326 0.661 0.661 
Day 5    0.509 0.509 
Day 7     >0.999 
Table 5.45 Significant differences between non-viable bone marrow stromal cells following culture in the absence 
of filled resin composite discs for 1 day, 3 days, 5 days, 7 days and 12 days (1-way ANOVA, n=3 biological replicates). 
The culture media was replaced every 2-days. The numbers represent the p value, with the numbers in bold 
showing significant difference between sample conditions.  
 
 
 Day 1 Day 3 Day 5 Day 7 Day 12 
Day 0 0.001 <0.001 <0.001 <0.001 <0.001 
Day 1  0.014 0.001 0.008 0.006 
Day 3   0.375 0.609 0.829 
Day 5    0.675 0.496 
Day 7     0.839 
Table 5.46 Significant differences between non-viable bone marrow stromal cells following culture in direct 
contact on high viscosity filled resin composite discs containing 70wt% barium silicate filler for 1 day, 3 days, 5 
days, 7 days and 12 days  (1-way ANOVA, n=3 biological replicates). The culture media was replaced every 2-days. 
The numbers represent the p value, with the numbers in bold showing significant difference between sample 
conditions.  
 
 Day 1 Day 3 Day 5 Day 7 Day 12 
Day 0 0.022 0.003 <0.001 <0.001 0.004 
Day 1  0.810 0.211 0.434 >0.999 
Day 3   0.255 0.550 0.779 
Day 5    0.509 0.138 
Day 7     0.345 
Table 5.47 Significant differences between non-viable bone marrow stromal cells following culture in direct 
contact on high viscosity Type I filled resin composite discs containing 20wt% bioactive glass for 1 day, 3 days, 5 
days, 7 days and 12 days (1-way ANOVA, n=3 biological replicates). The culture media was replaced every 2-days. 
The numbers represent the p value, with the numbers in bold showing significant difference between sample 
conditions.  
 
 Day 1 Day 3 Day 5 Day 7 Day 12 
Day 0 <0.001 <0.001 <0.001 <0.001 0.001 
Day 1  0.772 0.211 0.747 0.793 
Day 3   0.343 >0.999 0.624 
Day 5    0.309 0.190 
Day 7     0.597 
Table 5.48 Significant differences between non-viable bone marrow stromal cells following culture in direct 
contact on high viscosity Type I filled resin composite discs containing 40wt% bioactive glass for 1 day, 3 days, 5 
days, 7 days and 12 days (1-way ANOVA, n=3 biological replicates). The culture media was replaced every 2-days. 
The numbers represent the p value, with the numbers in bold showing significant difference between sample 
conditions.  
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 Day 1 Day 3 Day 5 Day 7 Day 12 
Day 0 0.001 <0.001 <0.001 <0.001 <0.001 
Day 1  0.063 0.050 0.022 0.120 
Day 3   0.490 0.536 0.747 
Day 5    0.821 0.363 
Day 7     0.363 
Table 5.49 Significant differences between non-viable bone marrow stromal cells following culture in direct 
contact on high viscosity Type II filled resin composite discs containing 20wt% bioactive glass for 1 day, 3 days, 5 
days, 7 days and 12 days (1-way ANOVA, n=3 biological replicates). The culture media was replaced every 2-days. 
The numbers represent the p value, with the numbers in bold showing significant difference between sample 
conditions.  
 
 Day 1 Day 3 Day 5 Day 7 Day 12 
Day 0 0.003 0.002 <0.001 <0.001 0.001 
Day 1  0.394 0.014 0.072 0.345 
Day 3   0.172 0.346 >0.999 
Day 5    0.791 0.133 
Day 7     0.313 
Table 5.50 Significant differences between non-viable bone marrow stromal cells following culture in direct 
contact on high viscosity Type II filled resin composite discs containing 40wt% bioactive glass for 1 day, 3 days, 5 
days, 7 days and 12 days (1-way ANOVA, n=3 biological replicates). The culture media was replaced every 2-days. 
The numbers represent the p value, with the numbers in bold showing significant difference between sample 
conditions.  
 
 Day 1 Day 3 Day 5 Day 7 Day 12 
Day 0 0.085 0.063 0.063 0.001 0.022 
Day 1  0.710 0.710 0.461 >0.999 
Day 3   >0.999 0.176 0.653 
Day 5    0.176 0.653 
Day 7     0.372 
Table 5.51 Significant differences between non-viable bone marrow stromal cells following culture in direct 
contact on high viscosity Type III filled resin composite discs containing 20wt% bioactive glass for 1 day, 3 days, 5 
days, 7 days and 12 days (1-way ANOVA, n=3 biological replicates). The culture media was replaced every 2-days. 
The numbers represent the p value, with the numbers in bold showing significant difference between sample 
conditions.  
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Appendix 5 Statistical analysis of culture media acidity values; viable and non-viable bone 
marrow stromal cells data in the presence of unfilled resin systems, filled resin composites 
and PMMA 
Statistical data of pH change of culture media in the absence/presence of filled resin composites 
and PMMA 
 Day 1 Day 3 Day 5 Day 7 Day 12 
Day 0 0.116 0.374 0.008 0.116 0.116 
Day 1  0.519 0.018 >0.999 >0.999 
Day 3   0.013 0.519 0.519 
Day 5    0.018 0.018 
Day 7     >0.999 
Table 5.1 Significant differences between the pH of culture media in the absence of filled resin composite discs 
(1-way ANOVA, n=9). The numbers represent the p value, with the numbers in bold showing significant 
difference between sample conditions.  
 Day 1 Day 3 Day 5 Day 7 Day 12 
Day 0 0.116 0.116 0.116 0.374 0.116 
Day 1  >0.999 >0.999 0.519 >0.999 
Day 3   >0.999 0.519 >0.999 
Day 5    0.519 >0.999 
Day 7     0.519 
Table 5.2 Significant differences between the pH of culture media following immersion of low viscosity filled 
resin composite discs containing 70wt% barium silicate filler (1-way ANOVA, n=9). The numbers represent the 
p value, with the numbers in bold showing significant difference between sample conditions.  
 Day 1 Day 3 Day 5 Day 7 Day 12 
Day 0 <0.001 <0.001 0.002 0.002 0.001 
Day 1  >0.999 0.251 0.643 0.116 
Day 3   0.251 0.643 0.116 
Day 5    0.492 0.725 
Day 7     0.288 
Table 5.3 Significant differences between the pH of culture media following immersion of low viscosity Type I 
filled resin composite discs containing 20wt% bioactive glass (1-way ANOVA, n=9). The numbers represent the 
p value, with the numbers in bold showing significant difference between sample conditions.  
 Day 1 Day 3 Day 5 Day 7 Day 12 
Day 0 <0.001 <0.001 <0.001 0.003 <0.001 
Day 1  0.101 0.101 0.230 0.067 
Day 3   >0.999 0.742 0.374 
Day 5    0.742 0.374 
Day 7     0.768 
Table 5.4 Significant differences between the pH of culture media following immersion of low viscosity Type I 
filled resin composite discs containing 40wt% bioactive glass (1-way ANOVA, n=9). The numbers represent the 
p value, with the numbers in bold showing significant difference between sample conditions.  
 Day 1 Day 3 Day 5 Day 7 Day 12 
Day 0 <0.001 <0.001 0.001 <0.001 0.001 
Day 1  0.230 0.251 0.013 0.055 
Day 3   0.678 0.047 0.148 
Day 5    0.251 0.349 
Day 7     >0.999 
Table 5.5 Significant differences between the pH of culture media following immersion of low viscosity Type II 
filled resin composite discs containing 20wt% bioactive glass (1-way ANOVA, n=9). The numbers represent the 
p value, with the numbers in bold showing significant difference between sample conditions.  
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 Day 1 Day 3 Day 5 Day 7 Day 12 
Day 0 <0.001 <0.001 <0.001 0.004 <0.001 
Day 1  0.519 >0.999 0.561 0.047 
Day 3   0.519 0.768 0.101 
Day 5    0.561 0.047 
Day 7     0.561 
Table 5.6 Significant differences between the pH of culture media following immersion of low viscosity Type II 
filled resin composite discs containing 40wt% bioactive glass (1-way ANOVA, n=9). The numbers represent the 
p value, with the numbers in bold showing significant difference between sample conditions.  
 Day 1 Day 3 Day 5 Day 7 Day 12 
Day 0 <0.001 0.002 <0.001 0.002 <0.001 
Day 1  >0.999 >0.999 >0.999 >0.999 
Day 3   >0.999 >0.999 >0.999 
Day 5    >0.999 >0.999 
Day 7     >0.999 
Table 5.7 Significant differences between the pH of culture media following immersion of low viscosity Type III 
filled resin composite discs containing 20wt% bioactive glass (1-way ANOVA, n=9). The numbers represent the 
p value, with the numbers in bold showing significant difference between sample conditions.  
 Day 1 Day 3 Day 5 Day 7 Day 12 
Day 0 0.002 <0.001 <0.001 0.003 0.001 
Day 1  >0.999 0.251 0.742 0.725 
Day 3   0.101 0.678 0.643 
Day 5    0.148 0.374 
Day 7     0.492 
Table 5.8 Significant differences between the pH of culture media following immersion of low viscosity Type III 
filled resin composite discs containing 40wt% bioactive glass (1-way ANOVA, n=9). The numbers represent the 
p value, with the numbers in bold showing significant difference between sample conditions.  
 Day 1 Day 3 Day 5 Day 7 Day 12 
Day 0 0.217 0.374 0.374 0.116 0.116 
Day 1  0.834 0.834 0.628 0.628 
Day 3   >0.999 0.519 0.519 
Day 5    0.519 0.519 
Day 7     >0.999 
Table 5.9 Significant differences between the pH of culture media in the absence of filled composite discs (1-way 
ANOVA, n=9). The numbers represent the p value, with the numbers in bold showing significant difference 
between sample conditions.  
 Day 1 Day 3 Day 5 Day 7 Day 12 
Day 0 0.374 0.374 0.116 0.116 0.725 
Day 1  >0.999 0.519 0.519 >0.999 
Day 3   0.519 0.519 >0.999 
Day 5    >0.999 0.742 
Day 7     0.742 
Table 5.10 Significant differences between the pH of culture media following immersion of high viscosity filled 
resin composite discs containing 80wt% barium silicate filler (1-way ANOVA, n=9). The numbers represent the 
p value, with the numbers in bold showing significant difference between sample conditions.  
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 Day 1 Day 3 Day 5 Day 7 Day 12 
Day 0 <0.001 <0.001 0.001 <0.001 0.002 
Day 1  >0.999 >0.999 >0.999 0.519 
Day 3   >0.999 >0.999 0.519 
Day 5    >0.999 0.579 
Day 7     0.519 
Table 5.11 Significant differences between the pH of culture media following immersion of high viscosity Type I 
filled resin composite discs containing 23wt% bioactive glass (1-way ANOVA, n=9). The numbers represent the 
p value, with the numbers in bold showing significant difference between sample conditions.  
 Day 1 Day 3 Day 5 Day 7 Day 12 
Day 0 <0.001 0.001 <0.001 <0.001 0.001 
Day 1  0.422 >0.999 >0.999 0.678 
Day 3   0.422 0.422 0.349 
Day 5    >0.999 0.678 
Day 7     0.678 
Table 5.12 Significant differences between the pH of culture media following immersion of high viscosity Type I 
filled resin composite discs containing 45wt% bioactive glass (1-way ANOVA, n=9). The numbers represent the 
p value, with the numbers in bold showing significant difference between sample conditions.  
 Day 1 Day 3 Day 5 Day 7 Day 12 
Day 0 0.002 <0.001 <0.001 0.001 0.001 
Day 1  >0.999 0.742 0.778 0.468 
Day 3   0.519 0.678 0.349 
Day 5    >0.999 0.519 
Day 7     0.579 
Table 5.13 Significant differences between the pH of culture media following immersion of high viscosity Type 
II filled resin composite discs containing 23wt% bioactive glass (1-way ANOVA, n=9). The numbers represent 
the p value, with the numbers in bold showing significant difference between sample conditions.  
 Day 1 Day 3 Day 5 Day 7 Day 12 
Day 0 <0.001 <0.001 0.001 <0.001 <0.001 
Day 1  0.422 0.519 0.725 >0.999 
Day 3   >0.999 0.643 0.422 
Day 5    0.725 0.519 
Day 7     0.725 
Table 5.14 Significant differences between the pH of culture media following immersion of high viscosity Type 
II filled resin composite discs containing 45wt% bioactive glass (1-way ANOVA, n=9). The numbers represent 
the p value, with the numbers in bold showing significant difference between sample conditions.  
 Day 1 Day 3 Day 5 Day 7 Day 12 
Day 0 0.007 0.002 0.008 <0.001 <0.001 
Day 1  0.795 0.643 0.768 0.768 
Day 3   0.778 >0.999 >0.999 
Day 5    0.742 0.742 
Day 7     >0.999 
Table 5.15 Significant differences between the pH of culture media following immersion of high viscosity Type 
III filled resin composite discs containing 20wt% bioactive glass (1-way ANOVA, n=9). The numbers represent 
the p value, with the numbers in bold showing significant difference between sample conditions. 
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 Day 1 Day 3 Day 5 Day 7 Day 12 
Day 0 0.279 0.001 0.001 0.025 >0.999 
Day 1  >0.999 0.816 0.734 0.289 
Day 3   0.230 0.251 0.007 
Day 5    0.678 0.016 
Day 12     0.057 
Table 5.16 Significant differences between the pH of culture media following immersion of PMMA discs 
containing (1-way ANOVA, n=9). The numbers represent the p value, with the numbers in bold showing 
significant difference between sample conditions. 
Statistical data of viability values of bone marrow stromal cells seeded in the absence/presence 
of filled resin composites, unfilled resin systems and PMMA 
 Day 1 Day 3 Day 5 Day 7 Day 12 
Day 0 <0.001  <0.001 <0.001 <0.001 <0.001 
Day 1  >0.999 0.363 0.018 0.002 
Day 3   0.504 0.099 0.024 
Day 5    0.270 0.063 
Day 7     0.332 
Table 5.17 Significant differences between viable bone marrow stromal cells following culture in direct contact 
on unfilled resin system discs containing 60/40wt% UDMA/TEGDMA for 1 day, 3 days, 5 days, 7 days and 12 
days (1-way ANOVA, n=3 biological replicates). The culture media was replaced every 2-days.The numbers 
represent the p value, with the numbers in bold showing significant difference between sample conditions.  
 Day 1 Day 3 Day 5 Day 7 Day 12 
Day 0 <0.001 <0.001 0.035 <0.001 <0.001 
Day 1  <0.001 <0.001 <0.001 <0.001 
Day 3   0.008 <0.001 <0.001 
Day 5    <0.001 <0.001 
Day 7     <0.001 
Table 5.18 Significant differences between viable bone marrow stromal cells following culture in direct contact 
on discs containing PMMA for 1 day, 3 days, 5 days, 7 days and 12 days (1-way ANOVA, n=3 biological 
replicates). The culture media was replaced every 2-days. The numbers represent the p value, with the numbers in 
bold showing significant difference between sample conditions.  
 Day 1 Day 3 Day 5 Day 7 Day 12 
Day 0 0.114 0.779 <0.001 <0.001 <0.001 
Day 1  0.162 <0.001 <0.001 <0.001 
Day 3   0.004 <0.001 <0.001 
Day 5    <0.001 <0.001 
Day 7     0.011 
Table 5.19 Significant differences between the viability of bone marrow stromal cells following culture in the 
absence of filled resin composite discs for 1 day, 3 days, 5 days, 7 days and 12 days (1-way ANOVA, n=3 
biological replicates). The culture media was replaced every 2-days.  The numbers represent the p value, with the 
numbers in bold showing significant difference between sample conditions.  
 Day 1 Day 3 Day 5 Day 7 Day 12 
Day 0 0.001 <0.001 <0.001 0.022 0.313 
Day 1  0.882 0.143 0.255 0.237 
Day 3   0.042 0.239 0.245 
Day 5    0.903 0.611 
Day 7     0.705 
Table 5.20 Significant differences between the viability of bone marrow stromal cells following culture in direct 
contact on low viscosity filled resin composite discs containing 70wt% barium silicate filler for 1 day, 3 days, 5 
days, 7 days and 12 days (1-way ANOVA, n=3 biological replicates). The culture media was replaced every 2-
days.  The numbers represent the p value, with the numbers in bold showing significant difference between sample 
conditions.  
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 Day 1 Day 3 Day 5 Day 7 Day 12 
Day 0 0.002 <0.001 0.675 0.003 <0.001 
Day 1  0.128 0.008 <0.001 <0.001 
Day 3   0.031 0.001 <0.001 
Day 5    0.003 <0.001 
Day 7     0.009 
Table 5.21 Significant differences between the viability of bone marrow stromal cells following culture in direct 
contact on low viscosity Type I filled resin composite discs containing 20wt% bioactive glass for 1 day, 3 days, 5 
days, 7 days and 12 days (1-way ANOVA, n=3 biological replicates). The culture media was replaced every 2-
days.  The numbers represent the p value, with the numbers in bold showing significant difference between sample 
conditions.  
 Day 1 Day 3 Day 5 Day 7 Day 12 
Day 0 <0.001 <0.001 0.008 <0.001 <0.001 
Day 1  0.774 0.008 <0.001 <0.001 
Day 3   0.027 <0.001 <0.001 
Day 5    <0.001 <0.001 
Day 7     <0.001 
Table 5.22 Significant differences between the viability of bone marrow stromal cells following culture in direct 
contact on low viscosity Type I filled resin composite discs containing 40wt% bioactive glass for 1 day, 3 days, 5 
days, 7 days and 12 days (1-way ANOVA, n=3 biological replicates). The culture media was replaced every 2-
days.  The numbers represent the p value, with the numbers in bold showing significant difference between sample 
conditions.  
 Day 1 Day 3 Day 5 Day 7 Day 12 
Day 0 <0.001 0.001 0.390 <0.001 <0.001 
Day 1  >0.999 0.236 <0.001 <0.001 
Day 3   0.257 <0.001 <0.001 
Day 5    <0.001 <0.001 
Day 7     0.001 
Table 5.23 Significant differences between the viability of bone marrow stromal cells following culture in direct 
contact on low viscosity Type II filled resin composite discs containing 20wt% bioactive glass for 1 day, 3 days, 
5 days, 7 days and 12 days (1-way ANOVA, n=3 biological replicates). The culture media was replaced every 2-
days.  The numbers represent the p value, with the numbers in bold showing significant difference between sample 
conditions.  
 Day 1 Day 3 Day 5 Day 7 Day 12 
Day 0 <0.001 <0.001 <0.001 <0.001 <0.001 
Day 1  0.211 0.004 <0.001 <0.001 
Day 3   0.014 <0.001 <0.001 
Day 5    <0.001 <0.001 
Day 7     <0.001 
Table 5.24 Significant differences between the viability of bone marrow stromal cells following culture in direct 
contact on low viscosity Type II filled resin composite discs containing 40wt% bioactive glass for 1 day, 3 days, 
5 days, 7 days and 12 days (1-way ANOVA, n=3 biological replicates). The culture media was replaced every 2-
days.  The numbers represent the p value, with the numbers in bold showing significant difference between sample 
conditions.  
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 Day 1 Day 3 Day 5 Day 7 Day 12 
Day 0 <0.001 0.077 0.595 <0.001 <0.001 
Day 1  0.238 0.001 <0.001 <0.001 
Day 3   0.093 0.001 <0.001 
Day 5    0.039 <0.001 
Day 7     <0.001 
Table 5.25 Significant differences between the viability of bone marrow stromal cells following culture in direct 
contact on low viscosity Type III filled resin composite discs containing 20wt% bioactive glass for 1 day, 3 days, 
5 days, 7 days and 12 days (1-way ANOVA, n=3 biological replicates). The culture media was replaced every 2-
days.  The numbers represent the p value, with the numbers in bold showing significant difference between sample 
conditions.  
 Day 1 Day 3 Day 5 Day 7 Day 12 
Day 0 <0.001 <0.001 0.044 0.414 <0.001 
Day 1  0.700 0.018 <0.001 <0.001 
Day 3   0.076 <0.001 <0.001 
Day 5    0.037 <0.001 
Day 7     <0.001 
Table 5.26 Significant differences between the viability of bone marrow stromal cells following culture in direct 
contact on low viscosity Type III filled resin composite discs containing 40wt% bioactive glass for 1 day, 3 days, 
5 days, 7 days and 12 days (1-way ANOVA, n=3 biological replicates). The culture media was replaced every 2-
days.  The numbers represent the p value, with the numbers in bold showing significant difference between sample 
conditions.  
 Day 1 Day 3 Day 5 Day 7 Day 12 
Day 0 0.022 0.675 <0.001 <0.001 <0.001 
Day 1  0.094 <0.001 <0.001 <0.001 
Day 3   <0.001 <0.001 <0.001 
Day 5    <0.001 <0.001 
Day 7     <0.001 
Table 5.27 Significant differences between the viability of bone marrow stromal cells following culture in the 
absence of filled composite discs for 1 day, 3 days, 5 days, 7 days and 12 days (1-way ANOVA, n=3 biological 
replicates). The culture media was replaced every 2-days.  (1-way ANOVA, n=3 biological replicates). The 
numbers represent the p value, with the numbers in bold showing significant difference between sample 
conditions.  
 Day 1 Day 3 Day 5 Day 7 Day 12 
Day 0 <0.001 <0.001 <0.001 0.332 <0.001 
Day 1  0.020 <0.001 <0.001 <0.001 
Day 3   <0.001 <0.001 <0.001 
Day 5    <0.001 <0.001 
Day 7     <0.001 
Table 5.28 Significant differences between the viability of bone marrow stromal cells following culture in in direct 
contact on high viscosity filled resin composite discs containing 80wt% barium silicate filler for 1 day, 3 days, 5 
days, 7 days and 12 days (1-way ANOVA, n=3 biological replicates). The culture media was replaced every 2-
days. The numbers represent the p value, with the numbers in bold showing significant difference between sample 
conditions.  
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 Day 1 Day 3 Day 5 Day 7 Day 12 
Day 0 0.001 0.150 0.003 <0.001 <0.001 
Day 1  0.160 <0.001 <0.001 <0.001 
Day 3   0.003 <0.001 <0.001 
Day 5    <0.001 <0.001 
Day 7     0.002 
Table 5.29 Significant differences between the viability of bone marrow stromal cells following culture in in direct 
contact on high viscosity Type I filled resin composite discs containing 23wt% bioactive glass for 1 day, 3 days, 
5 days, 7 days and 12 days (1-way ANOVA, n=3 biological replicates). The culture media was replaced every 2-
days. The numbers represent the p value, with the numbers in bold showing significant difference between sample 
conditions.  
 Day 1 Day 3 Day 5 Day 7 Day 12 
Day 0 0.001 <0.001 0.004 <0.001 <0.001 
Day 1  0.624 <0.001 <0.001 <0.001 
Day 3   <0.001 <0.001 <0.001 
Day 5    <0.001 <0.001 
Day 7     <0.001 
Table 5.30 Significant differences between the viability of bone marrow stromal cells following culture in in direct 
contact on high viscosity Type I filled resin composite discs containing 45wt% bioactive glass for 1 day, 3 days, 
5 days, 7 days and 12 days (1-way ANOVA, n=3 biological replicates). The culture media was replaced every 2-
days. The numbers represent the p value, with the numbers in bold showing significant difference between sample 
conditions.  
 Day 1 Day 3 Day 5 Day 7 Day 12 
Day 0 0.265 0.435 <0.001 <0.001 <0.001 
Day 1  0.185 <0.001 <0.001 <0.001 
Day 3   0.001 <0.001 <0.001 
Day 5    0.074 <0.001 
Day 7     <0.001 
Table 5.31 Significant differences between the viability of bone marrow stromal cells following culture in direct 
contact on high viscosity Type II filled resin composite discs containing 23wt% bioactive glass for 1 day, 3 days, 
5 days, 7 days and 12 days (1-way ANOVA, n=3 biological replicates). The culture media was replaced every 2-
days. The numbers represent the p value, with the numbers in bold showing significant difference between sample 
conditions.  
  Day 1 Day 3 Day 5 Day 7 Day 12 
Day 0 0.001 0.012 0.011 <0.001 <0.001 
Day 1  0.224 <0.001 <0.001 <0.001 
Day 3   0.001 <0.001 <0.001 
Day 5    0.102 <0.001 
Day 7     <0.001 
Table 5.32 Significant differences between the viability of bone marrow stromal cells following culture in direct 
contact on high viscosity Type II filled resin composite discs containing 45wt% bioactive glass for 1 day, 3 days, 
5 days, 7 days and 12 days (1-way ANOVA, n=3 biological replicates). The culture media was replaced every 2-
days. The numbers represent the p value, with the numbers in bold showing significant difference between sample 
conditions.  
 
 
 
 
 
LIII 
 
 Day 1 Day 3 Day 5 Day 7 Day 12 
Day 0 0.013 0.332 <0.001 <0.001 <0.001 
Day 1  0.013 <0.001 <0.001 <0.001 
Day 3   <0.001 <0.001 <0.001 
Day 5    0.001 <0.001 
Day 7     <0.001 
Table 5.34 Significant differences between the viability of bone marrow stromal cells following culture in in direct 
contact on high viscosity Type III filled resin composite discs containing 23wt% bioactive glass for 1 day, 3 days, 
5 days, 7 days and 12 days (1-way ANOVA, n=3 biological replicates). The culture media was replaced every 2-
days. The numbers represent the p value, with the numbers in bold showing significant difference between sample 
conditions.  
Statistical data of values for non-viable bone marrow stromal cells seeded in the 
absence/presence of filled resin composites, unfilled resin systems and PMMA  
 Day 1 Day 3 Day 5 Day 7 Day 12 
Day 0 0.006 0.004 0.013 0.012 0.022 
Day 1  0.305 0.509 0.710 0.661 
Day 3   0.774 0.536 0.176 
Day 5    0.764 0.326 
Day 7     0.461 
Table 5.35 Significant differences between non-viable bone marrow stromal cells following culture in the absence 
of filled resin composite discs for 1 day, 3 days, 5 days, 7 days and 12 days (1-way ANOVA, n=3 biological 
replicates). The culture media was replaced every 2-days.  The numbers represent the p value, with the numbers 
in bold showing significant difference between sample conditions.  
 Day 1 Day 3 Day 5 Day 7 Day 12 
Day 0 <0.001 <0.001 <0.001 <0.001 <0.001 
Day 1  0.014 0.014 <0.001 <0.001 
Day 3   >0.999 0.001 <0.001 
Day 5    0.001 <0.001 
Day 7     <0.001 
Table 5.36 Significant differences between non-viable bone marrow stromal cells following culture in direct 
contact on discs containing PMMA for 1 day, 3 days, 5 days, 7 days and 12 days (1-way ANOVA, n=3 biological 
replicates). The culture media was replaced every 2-days. The numbers represent the p value, with the numbers in 
bold showing significant difference between sample conditions.  
 Day 1 Day 3 Day 5 Day 7 Day 12 
Day 0 0.004 <0.001 <0.001 <0.001 <0.001 
Day 1  0.015 0.005 0.004 <0.001 
Day 3   0.214 0.555 0.001 
Day 5    0.401 0.115 
Day 7     0.004 
Table 5.37 Significant differences between non-viable bone marrow stromal cells following culture in direct 
contact on low viscosity filled resin composite discs containing 70wt% barium silicate filler for 1 day, 3 days, 5 
days, 7 days and 12 days (1-way ANOVA, n=3 biological replicates). The culture media was replaced every 2-
days.  The numbers represent the p value, with the numbers in bold showing significant difference between sample 
conditions.  
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 Day 1 Day 3 Day 5 Day 7 Day 12 
Day 0 <0.001 <0.001 0.001 <0.001 <0.001 
Day 1  <0.001 <0.001 <0.001 <0.001 
Day 3   0.016 <0.001 <0.001 
Day 5    <0.001 <0.001 
Day 7     0.040 
Table 5.38 Significant differences between non-viable bone marrow stromal cells following culture in direct 
contact on unfilled resin system discs containing 60/40wt% UDMA/TEGDMA for 1 day, 3 days, 5 days, 7 days 
and 12 days (1-way ANOVA, n=3 biological replicates). The culture media was replaced every 2-days.The 
numbers represent the p value, with the numbers in bold showing significant difference between sample 
conditions.  
 Day 1 Day 3 Day 5 Day 7 Day 12 
Day 0 0.001 0.001 <0.001 <0.001 0.013 
Day 1  0.756 0.077 0.265 0.550 
Day 3   0.176 0.483 0.394 
Day 5    0.372 0.031 
Day 7     0.106 
Table 5.39 Significant differences between non-viable bone marrow stromal cells following culture in direct 
contact on low viscosity Type I filled resin composite discs containing 20wt% bioactive glass for 1 day, 3 days, 5 
days, 7 days and 12 days (1-way ANOVA, n=3 biological replicates). The culture media was replaced every 2-
days.  The numbers represent the p value, with the numbers in bold showing significant difference between sample 
conditions.  
 Day 1 Day 3 Day 5 Day 7 Day 12 
Day 0 0.001 <0.001 <0.001 <0.001 <0.001 
Day 1  0.305 0.133 0.004 0.229 
Day 3   0.461 0.010 0.715 
Day 5    0.056 0.747 
Day 7     0.033 
Table 5.40 Significant differences between non-viable bone marrow stromal cells following culture in direct 
contact on low viscosity Type I filled resin composite discs containing 40wt% bioactive glass for 1 day, 3 days, 5 
days, 7 days and 12 days (1-way ANOVA, n=3 biological replicates). The culture media was replaced every 2-
days.  The numbers represent the p value, with the numbers in bold showing significant difference between sample 
conditions. 
 Day 1 Day 3 Day 5 Day 7 Day 12 
Day 0 0.003 <0.001 <0.001 0.001 0.001 
Day 1  0.176 0.051 0.345 0.694 
Day 3   0.379 0.750 0.063 
Day 5    0.275 0.018 
Day 7     0.170 
Table 5.41 Significant differences between non-viable bone marrow stromal cells following culture in direct 
contact on low viscosity Type II filled resin composite discs containing 20wt% bioactive glass for 1 day, 3 days, 
5 days, 7 days and 12 days (1-way ANOVA, n=3 biological replicates). The culture media was replaced every 2-
days.  The numbers represent the p value, with the numbers in bold showing significant difference between sample 
conditions.  
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 Day 1 Day 3 Day 5 Day 7 Day 12 
Day 0 0.003 <0.001 <0.001 0.003 0.001 
Day 1  <0.001 0.057 0.219 0.694 
Day 3   0.039 0.010 <0.001 
Day 5    0.536 0.026 
Day 7     0.122 
Table 5.42 Significant differences between non-viable bone marrow stromal cells following culture in direct 
contact on low viscosity Type II filled resin composite discs containing 40wt% bioactive glass for 1 day, 3 days, 
5 days, 7 days and 12 days (1-way ANOVA, n=3 biological replicates). The culture media was replaced every 2-
days.  The numbers represent the p value, with the numbers in bold showing significant difference between sample 
conditions.  
 Day 1 Day 3 Day 5 Day 7 Day 12 
Day 0 0.006 0.003 0.002 0.012 0.022 
Day 1  0.444 0.138 0.710 0.661 
Day 3   0.394 0.736 0.257 
Day 5    0.270 0.079 
Day 7     0.461 
Table 5.43 Significant differences between non-viable bone marrow stromal cells following culture in direct 
contact on low viscosity Type III filled resin composite discs containing 20wt% bioactive glass for 1 day, 3 days, 
5 days, 7 days and 12 days (1-way ANOVA, n=3 biological replicates). The culture media was replaced every 2-
days.  The numbers represent the p value, with the numbers in bold showing significant difference between sample 
conditions.  
 Day 1 Day 3 Day 5 Day 7 Day 12 
Day 0 0.003 <0.001 <0.001 <0.001 0.001 
Day 1  0.106 0.147 0.014 0.345 
Day 3   >0.999 0.461 0.536 
Day 5    0.520 0.576 
Day 7     0.176 
Table 5.44 Significant differences between non-viable bone marrow stromal cells following culture in direct 
contact on low viscosity Type III filled resin composite discs containing 40wt% bioactive glass for 1 day, 3 days, 
5 days, 7 days and 12 days (1-way ANOVA, n=3 biological replicates). The culture media was replaced every 2-
days.  The numbers represent the p value, with the numbers in bold showing significant difference between sample 
conditions.  
 Day 1 Day 3 Day 5 Day 7 Day 12 
Day 0 0.006 0.022 0.013 0.006 0.006 
Day 1  0.661 0.509 >0.999 >0.999 
Day 3   0.326 0.661 0.661 
Day 5    0.509 0.509 
Day 7     >0.999 
Table 5.45 Significant differences between non-viable bone marrow stromal cells following culture in the absence 
of filled resin composite discs for 1 day, 3 days, 5 days, 7 days and 12 days (1-way ANOVA, n=3 biological 
replicates). The culture media was replaced every 2-days. The numbers represent the p value, with the numbers in 
bold showing significant difference between sample conditions.  
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 Day 1 Day 3 Day 5 Day 7 Day 12 
Day 0 0.001 <0.001 <0.001 <0.001 <0.001 
Day 1  0.014 0.001 0.008 0.006 
Day 3   0.375 0.609 0.829 
Day 5    0.675 0.496 
Day 7     0.839 
Table 5.46 Significant differences between non-viable bone marrow stromal cells following culture in direct 
contact on high viscosity filled resin composite discs containing 80wt% barium silicate filler for 1 day, 3 days, 5 
days, 7 days and 12 days  (1-way ANOVA, n=3 biological replicates). The culture media was replaced every 2-
days. The numbers represent the p value, with the numbers in bold showing significant difference between sample 
conditions.  
 Day 1 Day 3 Day 5 Day 7 Day 12 
Day 0 0.022 0.003 <0.001 <0.001 0.004 
Day 1  0.810 0.211 0.434 >0.999 
Day 3   0.255 0.550 0.779 
Day 5    0.509 0.138 
Day 7     0.345 
Table 5.47 Significant differences between non-viable bone marrow stromal cells following culture in direct 
contact on high viscosity Type I filled resin composite discs containing 23wt% bioactive glass for 1 day, 3 days, 
5 days, 7 days and 12 days (1-way ANOVA, n=3 biological replicates). The culture media was replaced every 2-
days. The numbers represent the p value, with the numbers in bold showing significant difference between sample 
conditions.  
 Day 1 Day 3 Day 5 Day 7 Day 12 
Day 0 <0.001 <0.001 <0.001 <0.001 0.001 
Day 1  0.772 0.211 0.747 0.793 
Day 3   0.343 >0.999 0.624 
Day 5    0.309 0.190 
Day 7     0.597 
Table 5.48 Significant differences between non-viable bone marrow stromal cells following culture in direct 
contact on high viscosity Type I filled resin composite discs containing 45wt% bioactive glass for 1 day, 3 days, 
5 days, 7 days and 12 days (1-way ANOVA, n=3 biological replicates). The culture media was replaced every 2-
days. The numbers represent the p value, with the numbers in bold showing significant difference between sample 
conditions.  
 Day 1 Day 3 Day 5 Day 7 Day 12 
Day 0 0.001 <0.001 <0.001 <0.001 <0.001 
Day 1  0.063 0.050 0.022 0.120 
Day 3   0.490 0.536 0.747 
Day 5    0.821 0.363 
Day 7     0.363 
Table 5.49 Significant differences between non-viable bone marrow stromal cells following culture in direct 
contact on high viscosity Type II filled resin composite discs containing 23wt% bioactive glass for 1 day, 3 days, 
5 days, 7 days and 12 days (1-way ANOVA, n=3 biological replicates). The culture media was replaced every 2-
days. The numbers represent the p value, with the numbers in bold showing significant difference between sample 
conditions.  
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 Day 1 Day 3 Day 5 Day 7 Day 12 
Day 0 0.003 0.002 <0.001 <0.001 0.001 
Day 1  0.394 0.014 0.072 0.345 
Day 3   0.172 0.346 >0.999 
Day 5    0.791 0.133 
Day 7     0.313 
Table 5.50 Significant differences between non-viable bone marrow stromal cells following culture in direct 
contact on high viscosity Type II filled resin composite discs containing 45wt% bioactive glass for 1 day, 3 days, 
5 days, 7 days and 12 days (1-way ANOVA, n=3 biological replicates). The culture media was replaced every 2-
days. The numbers represent the p value, with the numbers in bold showing significant difference between sample 
conditions.  
 Day 1 Day 3 Day 5 Day 7 Day 12 
Day 0 0.085 0.063 0.063 0.001 0.022 
Day 1  0.710 0.710 0.461 >0.999 
Day 3   >0.999 0.176 0.653 
Day 5    0.176 0.653 
Day 7     0.372 
Table 5.51 Significant differences between non-viable bone marrow stromal cells following culture in direct 
contact on high viscosity Type III filled resin composite discs containing 23wt% bioactive glass for 1 day, 3 days, 
5 days, 7 days and 12 days (1-way ANOVA, n=3 biological replicates). The culture media was replaced every 2-
days. The numbers represent the p value, with the numbers in bold showing significant difference between sample 
conditions.  
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Appendix 6 Correlation analysis of unfilled resin systems and filled resin composites 
Correlation analysis of unfilled resin systems 
 FS  FM DC HV US 
FM 0.748    
DC -0.808 -0.385   
HV US -0.051 0.475 0.630  
HV LS -0.321 0.217 0.818 0.962 
Table 6.1 Correlations between the flexural strength (FS), flexural modulus (FM), degree of conversion (DC), 
hardness value for upper surface (HV US) and hardness value for lower surface (HV LS) of unfilled resin systems 
containing 20/80wt% UDMA/TEGDMA. The numbers represent the Pearson correlation coefficient, with the 
numbers in bold showing a strong correlation between sample conditions.  
 FS FM DC HV US 
FM 0.915    
DC -1.000 -0.994   
HV US -0.364 -0.266 0.369  
HV LS 0.461 0.550 -0.456 0.659 
Table 6.2 Correlations between the flexural strength (FS), flexural modulus (FM), degree of conversion (DC), 
hardness value for upper surface (HV US) and hardness value for lower surface (HV LS) of unfilled resin systems 
containing 30/70wt% UDMA/TEGDMA. The numbers represent the Pearson correlation coefficient, with the 
numbers in bold showing a strong correlation between sample conditions.  
 FS FM DC HV US 
FM 0.926    
DC 0.472 0.368   
HV US 0.800 0.726 0.907  
HV LS -0.986 -0.960 -0.613 -0.889 
Table 6.3 Correlations between the flexural strength (FS), flexural modulus (FM), degree of conversion (DC), 
hardness value for upper surface (HV US) and hardness value for lower surface (HV LS) of unfilled resin systems 
containing 40/60wt% UDMA/TEGDMA. The numbers represent the Pearson correlation coefficient, with the 
numbers in bold showing a strong correlation between sample conditions.  
 FS FM DC HV US 
FM 0.614    
DC 0.425 0.476   
HV US 0.673 0.714 0.956  
HV LS -0.860 -0.888 -0.828 -0.956 
Table 6.4 Correlations between the flexural strength (FS), flexural modulus (FM), degree of conversion (DC), 
hardness value for upper surface (HV US) and hardness value for lower surface (HV LS) of unfilled resin systems 
containing 50/50wt% UDMA/TEGDMA. The numbers represent the Pearson correlation coefficient, with the 
numbers in bold showing a strong correlation between sample conditions.  
 FS FM DC HV US 
FM 0.081    
DC -0.999 0.788   
HV US -0.852 0.989 0.870  
HV LS -0.622 0.980 0.650 0.940 
Table 6.5 Correlations between the flexural strength (FS), flexural modulus (FM), degree of conversion (DC), 
hardness value for upper surface (HV US) and hardness value for lower surface (HV LS) of unfilled resin systems 
containing 60/40wt% UDMA/TEGDMA. The numbers represent the Pearson correlation coefficient, with the 
numbers in bold showing a strong correlation between sample conditions.  
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 FS FM DC HV US 
FM 0.958    
DC -0.543 -0.572   
HV US 0.758 0.781 -0.959  
HV LS 0.336 0.369 -0.973 0.869 
Table 6.6 Correlations between the flexural strength (FS), flexural modulus (FM), degree of conversion (DC), 
hardness value for upper surface (HV US) and hardness value for lower surface (HV LS) of unfilled resin systems 
containing 70/30wt% UDMA/TEGDMA. The numbers represent the Pearson correlation coefficient, with the 
numbers in bold showing a strong correlation between sample conditions.  
 FS FM DC HV US 
FM 0.889    
DC 0.408 0.291   
HV US -0.801 -0.870 0.220  
HV LS 0.095 -0.029 0.948 0.519 
Table 6.7 Correlations between the flexural strength (FS), flexural modulus (FM), degree of conversion (DC), 
hardness value for upper surface (HV US) and hardness value for lower surface (HV LS) of unfilled resin systems 
containing 80/20wt% UDMA/TEGDMA. The numbers represent the Pearson correlation coefficient, with the 
numbers in bold showing a strong correlation between sample conditions.  
 FS FM DC HV US 
FM 0.830    
DC 0.115 -0.077   
HV US 0.007 0.197 -0.993  
HV LS -0.458 -0.620 0.830 -0.892 
Table 6.8 Correlations between the flexural strength (FS), flexural modulus (FM), degree of conversion (DC), 
hardness value for upper surface (HV US) and hardness value for lower surface (HV LS) of unfilled resin systems 
containing 100/0wt% UDMA/TEGDMA. The numbers represent the Pearson correlation coefficient, with the 
numbers in bold showing a strong correlation between sample conditions.  
 FS FM DC HV US 
FM 0.807    
DC -0.999 -0.987   
HV US 1.000 0.978 -0.999  
HV LS -0.067 -0.264 0.108 -0.058 
Table 6.9 Correlations between the flexural strength (FS), flexural modulus (FM), degree of conversion (DC), 
hardness value for upper surface (HV US) and hardness value for lower surface (HV LS) of unfilled resin systems 
containing 0/100wt% UDMA/TEGDMA. The numbers represent the Pearson correlation coefficient, with the 
numbers in bold showing a strong correlation between sample conditions.  
 
 FS FM DC HV US 
FM 0.734    
DC 0.980 0.999   
HV US -0.334 -0.470 -0.516  
HV LS 0.773 0.670 0.630 0.339 
Table 6.10 Correlations between the flexural strength (FS), flexural modulus (FM), degree of conversion (DC), 
hardness value for upper surface (HV US) and hardness value for lower surface (HV LS) of unfilled resin systems 
containing 20/80wt% bisGMA/TEGDMA. The numbers represent the Pearson correlation coefficient, with the 
numbers in bold showing a strong correlation between sample conditions.  
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 FS FM DC HV US 
FM 0.966    
DC 1.000 0.995   
HV US -0.841 -0.794 -0.852  
HV LS -0.380 -0.305 -0.401 0.821 
Table 6.11 Correlations between the flexural strength (FS), flexural modulus (FM), degree of conversion (DC), 
hardness value for upper surface (HV US) and hardness value for lower surface (HV LS) of unfilled resin systems 
containing 30/70wt% bisGMA/TEGDMA. The numbers represent the Pearson correlation coefficient, with the 
numbers in bold showing a strong correlation between sample conditions.  
 FS FM DC HV US 
FM 0.322    
DC -0.781 0.040   
HV US -0.972 -0.389 0.905  
HV LS 0.383 -0.516 -0.876 -0.588 
Table 6.12 Correlations between the flexural strength (FS), flexural modulus (FM), degree of conversion (DC), 
hardness value for upper surface (HV US) and hardness value for lower surface (HV LS) of unfilled resin systems 
containing 40/60wt% bisGMA/TEGDMA. The numbers represent the Pearson correlation coefficient, with the 
numbers in bold showing a strong correlation between sample conditions.  
 FS FM DC HV US 
FM 0.573    
DC 1.000 -0.982   
HV US 0.998 -0.966 0.998  
HV LS 0.579 -0.730 0.586 0.529 
Table 6.13 Correlations between the flexural strength (FS), flexural modulus (FM), degree of conversion (DC), 
hardness value for upper surface (HV US) and hardness value for lower surface (HV LS) of unfilled resin systems 
containing 50/50wt% bisGMA/TEGDMA. The numbers represent the Pearson correlation coefficient, with the 
numbers in bold showing a strong correlation between sample conditions.  
 FS FM DC HV US 
FM 0.845    
DC -0.924 -0.993   
HV US -0.711 -0.278 0.388  
HV LS -0.759 -0.345 0.452 0.997 
Table 6.14 Correlations between the flexural strength (FS), flexural modulus (FM), degree of conversion (DC), 
hardness value for upper surface (HV US) and hardness value for lower surface (HV LS) of unfilled resin systems 
containing 60/40wt% bisGMA/TEGDMA. The numbers represent the Pearson correlation coefficient, with the 
numbers in bold showing a strong correlation between sample conditions.  
 FS FM DC HV US 
FM 0.925    
DC -0.283 -0.551   
HV US -0.314 -0.023 -0.822  
HV LS 0.995 0.924 -0.189 -0.404 
Table 6.15 Correlations between the flexural strength (FS), flexural modulus (FM), degree of conversion (DC), 
hardness value for upper surface (HV US) and hardness value for lower surface (HV LS) of unfilled resin systems 
containing 70/30wt% bisGMA/TEGDMA. The numbers represent the Pearson correlation coefficient, with the 
numbers in bold showing a strong correlation between sample conditions.  
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 FS FM DC HV US 
FM 0.851    
DC 0.651 0.619   
HV US 0.970 0.959 0.816  
HV LS 0.001 -0.040 0.760 0.245 
Table 6.16 Correlations between the flexural strength (FS), flexural modulus (FM), degree of conversion (DC), 
hardness value for upper surface (HV US) and hardness value for lower surface (HV LS) of unfilled resin systems 
containing 80/20wt% bisGMA/TEGDMA. The numbers represent the Pearson correlation coefficient, with the 
numbers in bold showing a strong correlation between sample conditions.  
 FS FM DC HV US 
FM 0.984    
DC 0.983 0.998   
HV US 0.684 0.769 0.807  
HV LS -0.883 -0.817 -0.780 -0.260 
Table 6.17 Correlations between the flexural strength (FS), flexural modulus (FM), degree of conversion (DC), 
hardness value for upper surface (HV US) and hardness value for lower surface (HV LS) of unfilled resin systems 
containing 100/0wt% bisGMA/TEGDMA. The numbers represent the Pearson correlation coefficient, with the 
numbers in bold showing a strong correlation between sample conditions.  
  FS  FM DC HV US 
FM 0.977    
DC -0.911 -0.946   
HV US 0.424 0.508 -0.759  
HV LS 0.583 0.502 -0.196 -0.489 
Table 6.18 Correlations between the flexural strength (FS), flexural modulus (FM), degree of conversion (DC), 
hardness value for upper surface (HV US) and hardness value for lower surface (HV LS) of unfilled resin systems 
containing 30/60/10wt% bisGMA/UDMA/TEGDMA. The numbers represent the Pearson correlation coefficient, 
with the numbers in bold showing a strong correlation between sample conditions.  
 
 FS FM DC HV US 
FM 0.880    
DC 0.955 0.996   
HV US -0.191 -0.388 -0.473  
HV LS 0.960 0.883 0.835 0.090 
Table 6.19 Correlations between the flexural strength (FS), flexural modulus (FM), degree of conversion (DC), 
hardness value for upper surface (HV US) and hardness value for lower surface (HV LS) of unfilled resin systems 
containing 20/60/20wt% bisGMA/UDMA/TEGDMA. The numbers represent the Pearson correlation coefficient, 
with the numbers in bold showing a strong correlation between sample conditions.  
 FS FM DC HV US 
FM 0.892    
DC 0.284 0.383   
HV US 0.171 0.067 -0.896  
HV LS 0.161 0.263 0.992 -0.945 
Table 6.20 Correlations between the flexural strength (FS), flexural modulus (FM), degree of conversion (DC), 
hardness value for upper surface (HV US) and hardness value for lower surface (HV LS) of unfilled resin systems 
containing 10/60/30wt% bisGMA/UDMA/TEGDMA. The numbers represent the Pearson correlation coefficient, 
with the numbers in bold showing a strong correlation between sample conditions.  
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 FS FM DC HV US 
FM 0.639    
DC -0.891 -0.811   
HV US -0.988 -1.000 0.811  
HV LS 0.984 0.944 -0.958 -0.944 
Table 6.21 Correlations between the flexural strength (FS), flexural modulus (FM), degree of conversion (DC), 
hardness value for upper surface (HV US) and hardness value for lower surface (HV LS) of unfilled resin systems 
containing 40/50/10wt% bisGMA/UDMA/TEGDMA. The numbers represent the Pearson correlation coefficient, 
with the numbers in bold showing a strong correlation between sample conditions.  
 FS FM DC HV US 
FM 0.776    
DC 0.587 0.632   
HV US 0.093 0.149 0.860  
HV LS 0.558 0.604 0.999 0.878 
Table 6.22 Correlations between the flexural strength (FS), flexural modulus (FM), degree of conversion (DC), 
hardness value for upper surface (HV US) and hardness value for lower surface (HV LS) of unfilled resin systems 
containing 30/50/20wt% bisGMA/UDMA/TEGDMA. The numbers represent the Pearson correlation coefficient, 
with the numbers in bold showing a strong correlation between sample conditions.  
 FS FM DC HV US 
FM 0.817    
DC 0.867 -0.296   
HV US 0.973 -0.558 0.958  
HV LS 0.729 -0.068 0.973 0.866 
Table 6.23 Correlations between the flexural strength (FS), flexural modulus (FM), degree of conversion (DC), 
hardness value for upper surface (HV US) and hardness value for lower surface (HV LS) of unfilled resin systems 
containing 20/50/30wt% bisGMA/UDMA/TEGDMA. The numbers represent the Pearson correlation coefficient, 
with the numbers in bold showing a strong correlation between sample conditions.  
 FS FM DC HV US 
FM 0.838    
DC -0.780 -0.209   
HV US 0.999 -0.494 -0.747  
HV LS -0.981 0.613 0.645 -0.990 
Table 6.24 Correlations between the flexural strength (FS), flexural modulus (FM), degree of conversion (DC), 
hardness value for upper surface (HV US) and hardness value for lower surface (HV LS) of unfilled resin systems 
containing 10/50/40wt% bisGMA/UDMA/TEGDMA. The numbers represent the Pearson correlation coefficient, 
with the numbers in bold showing a strong correlation between sample conditions.  
 FS FM DC HV US 
FM 0.811    
DC -0.597 -0.386   
HV US -0.965 -1.000 0.365  
HV LS -0.618 -0.411 1.000 0.390 
Table 6.25 Correlations between the flexural strength (FS), flexural modulus (FM), degree of conversion (DC), 
hardness value for upper surface (HV US) and hardness value for lower surface (HV LS) of unfilled resin systems 
containing 50/40/10wt% bisGMA/UDMA/TEGDMA. The numbers represent the Pearson correlation coefficient, 
with the numbers in bold showing a strong correlation between sample conditions.  
 
 
 
 
LXIII 
 
 FS FM DC HV US 
FM 0.470    
DC -0.409 0.816   
HV US 0.795 -0.376 0.228  
HV LS 0.895 -0.544 0.040 0.982 
Table 6.26 Correlations between the flexural strength (FS), flexural modulus (FM), degree of conversion (DC), 
hardness value for upper surface (HV US) and hardness value for lower surface (HV LS) of unfilled resin systems 
containing 50/30/20wt% bisGMA/UDMA/TEGDMA. The numbers represent the Pearson correlation coefficient, 
with the numbers in bold showing a strong correlation between sample conditions.  
 FS FM DC HV US 
FM 0.851    
DC 0.931 0.504   
HV US -0.990 -0.864 -0.870  
HV LS -0.696 -0.101 -0.910 0.588 
Table 6.27 Correlations between the flexural strength (FS), flexural modulus (FM), degree of conversion (DC), 
hardness value for upper surface (HV US) and hardness value for lower surface (HV LS) of unfilled resin systems 
containing 50/20/30wt% bisGMA/UDMA/TEGDMA. The numbers represent the Pearson correlation coefficient, 
with the numbers in bold showing a strong correlation between sample conditions.  
 FS FM DC HV US 
FM 0.904    
DC 0.416 0.260   
HV US -0.018 0.147 -0.917  
HV LS 0.316 0.468 -0.731 0.943 
Table 6.28 Correlations between the flexural strength (FS), flexural modulus (FM), degree of conversion (DC), 
hardness value for upper surface (HV US) and hardness value for lower surface (HV LS) of unfilled resin systems 
containing 50/10/40wt% bisGMA/UDMA/TEGDMA. The numbers represent the Pearson correlation coefficient, 
with the numbers in bold showing a strong correlation between sample conditions.  
 
Correlation analysis of filled resin composites 
 FS FM 
FM 0.625  
DC -0.018 -0.265 
Table 6.29 Correlations between the flexural strength (FS), flexural modulus (FM) and degree of conversion (DC) 
of 60/40wt% UDMA/TEGDMA filled resin composites containing 70wt% barium silicate filler. The numbers 
represent the Pearson correlation coefficient, with the numbers in bold showing a strong correlation between 
sample conditions.  
 FS FM 
FM 0.569  
DC -0.147 0.348 
Table 6.30 Correlations between the flexural strength (FS), flexural modulus (FM) and degree of conversion (DC) 
of 60/40wt% UDMA/TEGDMA filled resin composites containing 80wt% barium silicate filler. The numbers 
represent the Pearson correlation coefficient.   
 FS FM 
FM 0.751  
DC 0.012 0.106 
Table 6.31 Correlations between the flexural strength (FS), flexural modulus (FM) and degree of conversion (DC) 
of PMMA. The numbers represent the Pearson correlation coefficient, with the numbers in bold showing a strong 
correlation between sample conditions.  
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 FS FM 
FM -0.070  
DC -0.187 0.096 
Table 6.32 Correlations between the flexural strength (FS), flexural modulus (FM) and degree of conversion (DC) 
of 60/40wt% UDMA/TEGDMA filled resin composites containing 60wt% barium silicate filler and 10wt% Type 
I silanated filler. The numbers represent the Pearson correlation coefficient.  
 FS FM 
FM 0.677  
DC 0.261 0.280 
Table 6.33 Correlations between the flexural strength (FS), flexural modulus (FM) and degree of conversion (DC) 
of 60/40wt% UDMA/TEGDMA filled resin composites containing 50wt% barium silicate filler and 20wt% Type 
I silanated filler. The numbers represent the Pearson correlation coefficient, with the numbers in bold showing a 
strong correlation between sample conditions. 
 FS FM 
FM 0.317  
DC -0.138 -0.052 
Table 6.34 Correlations between the flexural strength (FS), flexural modulus (FM) and degree of conversion (DC) 
of 60/40wt% UDMA/TEGDMA filled resin composites containing 40wt% barium silicate filler and 30wt% Type 
I silanated filler. The numbers represent the Pearson correlation coefficient.  
 FS FM 
FM 0.385  
DC 0.516 0.388 
Table 6.35 Correlations between the flexural strength (FS), flexural modulus (FM) and degree of conversion (DC) 
of 60/40wt% UDMA/TEGDMA filled resin composites containing 30wt% barium silicate filler and 40wt% Type 
I silanated filler. The numbers represent the Pearson correlation coefficient.  
 FS FM 
FM 0.565  
DC -0.436 0.186 
Table 6.36 Correlations between the flexural strength (FS), flexural modulus (FM) and degree of conversion (DC) 
of 60/40wt% UDMA/TEGDMA filled resin composites containing 60wt% barium silicate filler and 10wt% Type 
II non-silanated filler. The numbers represent the Pearson correlation coefficient.  
 FS FM 
FM 0.584  
DC 0.017 -0.363 
Table 6.37 Correlations between the flexural strength (FS), flexural modulus (FM) and degree of conversion (DC) 
of 60/40wt% UDMA/TEGDMA filled resin composites containing 50wt% barium silicate filler and 20wt% Type 
II non-silanated filler. The numbers represent the Pearson correlation coefficient.  
 FS FM 
FM 0.584  
DC 0.017 -0.363 
Table 6.38 Correlations between the flexural strength (FS), flexural modulus (FM) and degree of conversion (DC) 
of 60/40wt% UDMA/TEGDMA filled resin composites containing 40wt% barium silicate filler and 30wt% Type 
II non-silanated filler. The numbers represent the Pearson correlation coefficient.   
 FS FM 
FM 0.746  
DC 0.324 -0.038 
Table 6.39 Correlations between the flexural strength (FS), flexural modulus (FM) and degree of conversion (DC) 
of 60/40wt% UDMA/TEGDMA filled resin composites containing 30wt% barium silicate filler and 40wt% Type 
II non-silanated filler. The numbers represent the Pearson correlation coefficient, with the numbers in bold 
showing a strong correlation between sample conditions.  
LXV 
 
 FS FM 
FM 0.306  
DC -0.576 -0.308 
Table 6.40 Correlations between the flexural strength (FS), flexural modulus (FM) and degree of conversion (DC) 
of 60/40wt% UDMA/TEGDMA filled resin composites containing 60wt% barium silicate filler and 10wt% Type 
III non-silanated filler. The numbers represent the Pearson correlation coefficient.  
 FS FM 
FM 0.226  
DC 0.951 0.281 
Table 6.41 Correlations between the flexural strength (FS), flexural modulus (FM) and degree of conversion (DC) 
of 60/40wt% UDMA/TEGDMA filled resin composites containing 50wt% barium silicate filler and 20wt% Type 
III non-silanated filler. The numbers represent the Pearson correlation coefficient, with the numbers in bold 
showing a strong correlation between sample conditions.  
 FS FM 
FM -0.377  
DC -0.539 0.455 
Table 6.42 Correlations between the flexural strength (FS), flexural modulus (FM) and degree of conversion (DC) 
of 60/40wt% UDMA/TEGDMA filled resin composites containing 40wt% barium silicate filler and 30wt% Type 
III non-silanated filler. The numbers represent the Pearson correlation coefficient.  
 FS FM 
FM 0.335  
DC 0.579 -0.409 
Table 6.43 Correlations between the flexural strength (FS), flexural modulus (FM) and degree of conversion (DC) 
of 60/40wt% UDMA/TEGDMA filled resin composites containing 30wt% barium silicate filler and 40wt% Type 
III non-silanated filler. The numbers represent the Pearson correlation coefficient.  
 FS FM 
FM 0.341  
DC -0.440 -0.058 
Table 6.44 Correlations between the flexural strength (FS), flexural modulus (FM) and degree of conversion (DC) 
of 60/40wt% UDMA/TEGDMA filled resin composites containing 69wt% barium silicate filler and 11wt% Type 
I silanated filler. The numbers represent the Pearson correlation coefficient.  
 FS FM 
FM 0.699  
DC -0.371 0.253 
Table 6.45 Correlations between the flexural strength (FS), flexural modulus (FM) and degree of conversion (DC) 
of 60/40wt% UDMA/TEGDMA filled resin composites containing 57wt% barium silicate filler and 23wt% Type 
I silanated filler. The numbers represent the Pearson correlation coefficient, with the numbers in bold showing a 
strong correlation between sample conditions.  
 FS FM 
FM 0.701  
DC 0.451 0.361 
Table 6.46 Correlations between the flexural strength (FS), flexural modulus (FM) and degree of conversion (DC) 
of 60/40wt% UDMA/TEGDMA filled resin composites containing 45wt% barium silicate filler and 34wt% Type 
I silanated filler. The numbers represent the Pearson correlation coefficient, with the numbers in bold showing a 
strong correlation between sample conditions.  
 
 
 
LXVI 
 
 FS FM 
FM 0.052  
DC 0.141 -0.430 
Table 6.47 Correlations between the flexural strength (FS), flexural modulus (FM) and degree of conversion (DC) 
of 60/40wt% UDMA/TEGDMA filled resin composites containing 45wt% barium silicate filler and 34wt% Type 
I silanated filler. The numbers represent the Pearson correlation coefficient.  
 FS FM 
FM 0.883  
DC 0.021 0.159 
Table 6.48 Correlations between the flexural strength (FS), flexural modulus (FM) and degree of conversion (DC) 
of 60/40wt% UDMA/TEGDMA filled resin composites containing 11wt% barium silicate filler and 69wt% Type 
II non-silanated filler. The numbers represent the Pearson correlation coefficient, with the numbers in bold 
showing a strong correlation between sample conditions.  
 FS FM 
FM 0.522  
DC -0.035 -0.494 
Table 6.49 Correlations between the flexural strength (FS), flexural modulus (FM) and degree of conversion (DC) 
of 60/40wt% UDMA/TEGDMA filled resin composites containing 57wt% barium silicate filler and 23wt% Type 
II non-silanated filler. The numbers represent the Pearson correlation coefficient.   
 FS FM 
FM 0.748  
DC -0.806 -0.666 
Table 6.50 Correlations between the flexural strength (FS), flexural modulus (FM) and degree of conversion (DC) 
of 60/40wt% UDMA/TEGDMA filled resin composites containing 45wt% barium silicate filler and 34wt% Type 
II non-silanated filler. The numbers represent the Pearson correlation coefficient, with the numbers in bold 
showing a strong correlation between sample conditions.  
 FS FM 
FM 0.585  
DC -0.273 -0.663 
Table 6.51 Correlations between the flexural strength (FS), flexural modulus (FM) and degree of conversion (DC) 
of 60/40wt% UDMA/TEGDMA filled resin composites containing 34wt% barium silicate filler and 45wt% Type 
II non-silanated filler. The numbers represent the Pearson correlation coefficient, with the numbers in bold 
showing a strong correlation between sample conditions.  
 FS FM 
FM 0.176  
DC 0.610 0.539 
Table 6.52 Correlations between the flexural strength (FS), flexural modulus (FM) and degree of conversion (DC) 
of 60/40wt% UDMA/TEGDMA filled resin composites containing 69wt% barium silicate filler and 11wt% Type 
III non-silanated filler. The numbers represent the Pearson correlation coefficient, with the numbers in bold 
showing a strong correlation between sample conditions.  
 FS FM 
FM 0.801  
DC 0.134 0.009 
Table 6.53 Correlations between the flexural strength (FS), flexural modulus (FM) and degree of conversion (DC) 
of 60/40wt% UDMA/TEGDMA filled resin composites containing 57wt% barium silicate filler and 23wt% Type 
III non-silanated filler. The numbers represent the Pearson correlation coefficient, with the numbers in bold 
showing a strong correlation between sample conditions. 
  
 
LXVII 
 
 FS FM 
FM -0.292  
DC 0.031 -0.288 
Table 6.54 Correlations between the flexural strength (FS), flexural modulus (FM) and degree of conversion (DC) 
of 60/40wt% UDMA/TEGDMA filled resin composites containing 45wt% barium silicate filler and 34wt% Type 
III non-silanated filler. The numbers represent the Pearson correlation coefficient. , with the numbers in bold 
showing a strong correlation between sample conditions.  
 
 
